{"id": 50876655, "time": "2026-02-26 00:08:02", "headline": "MrBeast Says Once Enough Airlines Start Using Starlink, He's Only Gonna Book Flights With Those That Offer The Service: Elon Musk Reacts", "summary": "Elon Musk responded after MrBeast said he would only book flights offering Starlink once widely available, praising SpaceX&#39;s satellite internet as &#34;amazing,&#34; highlighting its reliability in extreme locations, and voicing confidence in Musk&#39;s broader Moon and Mars ambitions amid the company&#39;s $1.25 trillion xAI deal.", "symbols": [], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/markets/tech/26/02/50876655/mrbeast-says-once-enough-airlines-start-using-starlink-hes-only-gonna-book-flights-with-those-that-offer-the-service-elon-musk-reacts", "tags": ["offering", "contract"]}
{"id": 50876684, "time": "2026-02-26 00:23:14", "headline": "Kamala Harris Says Trump's State Of The Union Speech Was Full Of Lies: 'So Many Are Suffering...'", "summary": "Kamala Harris criticized Trump&#39;s SOTU speech, calling it full of lies and rejecting his claims of a strong economy. She also slammed his policies on voting rights and Iran, while other Democrats criticized his lack of focus on affordability and health care.", "symbols": [], "source": "benzinga", "author": "Snigdha Gairola", "url": "https://www.benzinga.com/news/politics/26/02/50876684/kamala-harris-says-trumps-state-of-the-union-speech-was-full-of-lies-so-many-are-suffering", "tags": []}
{"id": 50876693, "time": "2026-02-26 00:26:28", "headline": "Nu Holdings (NU) Stock Drops Over 6% After Hours \u2013 Here's Why", "summary": "Nu Holdings shares fell 6.3% after hours to $15.60 despite a slight EPS beat and $4.69 billion in Q4 2025 revenue.", "symbols": ["NU"], "source": "benzinga", "author": "Mohd Haider", "url": "https://www.benzinga.com/markets/equities/26/02/50876693/nu-holdings-nu-stock-drops-over-6-after-hours-heres-why", "tags": ["earnings"]}
{"id": 50876881, "time": "2026-02-26 01:03:44", "headline": "Jensen Huang Thinks Orbital Datacenters Have Poor Economics Right Now, Says Cooling Is The Bottleneck", "summary": "Nvidia CEO Jensen Huang shares views on orbital datacenters during Q4 earnings call, highlighting economic challenges with the endeavor.", "symbols": ["NVDA"], "source": "benzinga", "author": "Badar Shaikh", "url": "https://www.benzinga.com/news/space/26/02/50876881/jensen-huang-thinks-orbital-datacenters-have-poor-economics-right-now-says-cooling-is-the-bottleneck", "tags": ["earnings", "management"]}
{"id": 50876899, "time": "2026-02-26 01:11:34", "headline": "argenx Q4 EPS $8.02 Beats $6.02 Estimate, Sales $1.322B Beat $1.291B Estimate", "summary": "", "symbols": ["ARGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50876899/argenx-q4-eps-8-02-beats-6-02-estimate-sales-1-322b-beat-1-291b-estimate", "tags": ["earnings"]}
{"id": 50876914, "time": "2026-02-26 01:16:53", "headline": "CMB.TECH Q4 EPS $0.31 Misses $0.34 Estimate, Sales $589.123M Beat $450.289M Estimate", "summary": "", "symbols": ["CMBT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50876914/cmb-tech-q4-eps-0-31-misses-0-34-estimate-sales-589-123m-beat-450-289m-estimate", "tags": ["earnings"]}
{"id": 50876925, "time": "2026-02-26 01:19:18", "headline": "Adtran Q4 Adj. EPS $0.16 Beats $0.08 Estimate, Sales $291.560M Beat $282.385M Estimate", "summary": "", "symbols": ["ADTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50876925/adtran-q4-adj-eps-0-16-beats-0-08-estimate-sales-291-560m-beat-282-385m-estimate", "tags": ["earnings"]}
{"id": 50876934, "time": "2026-02-26 01:20:25", "headline": "Adtran Holdings Sees Q1 Sales $275.000M-$297.000M vs $277.986M Est", "summary": "", "symbols": ["ADTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50876934/adtran-holdings-sees-q1-sales-275-000m-297-000m-vs-277-986m-est", "tags": []}
{"id": 50876952, "time": "2026-02-26 01:24:39", "headline": "Enerflex Q4 Adj. EPS $0.20 Beats $0.10 Estimate, Sales $627.000M Beat $571.150M Estimate", "summary": "", "symbols": ["EFXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50876952/enerflex-q4-adj-eps-0-20-beats-0-10-estimate-sales-627-000m-beat-571-150m-estimate", "tags": ["earnings"]}
{"id": 50876962, "time": "2026-02-26 01:25:31", "headline": "Nvidia CEO Jensen Huang Pushes Back On Fears Surrounding Big Tech's $700 Billion CapEx Surge: 'Compute Equals Revenues' In The New AI World", "summary": "Nvidia CEO Jensen Huang said he is confident Big Tech&#39;s nearly $700 billion AI capital spending boom will continue as &#34;compute equals revenues,&#34; highlighting strong demand visibility into 2027 alongside the company&#39;s 73% revenue surge and upbeat first-quarter outlook.", "symbols": ["AMZN", "GOOG", "GOOGL", "META", "MSFT", "NVDA"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/markets/tech/26/02/50876962/nvidia-ceo-jensen-huang-pushes-back-on-fears-surrounding-big-techs-700-billion-capex-surge-compute-equals-revenues-in-the-new-ai-world", "tags": ["earnings", "guidance", "management"]}
{"id": 50877022, "time": "2026-02-26 01:27:15", "headline": "Reported Earlier, Enerflex Signs Definitive Agreement To Sell Majority Australia, Indonesia And Thailand Operations To INNIO Group, Will Continue ES Solutions In APAC", "summary": "", "symbols": ["EFXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877022/reported-earlier-enerflex-signs-definitive-agreement-to-sell-majority-australia-indonesia-and-thaila", "tags": ["contract"]}
{"id": 50877032, "time": "2026-02-26 01:28:06", "headline": "American Airlines To Invest $1 Billion In Miami Airport Expansion To Accommodate Larger Aircraft", "summary": "American Airlines will invest $1 billion in Miami International Airport to build a new concourse D, with the project starting in 2027.", "symbols": ["AAL"], "source": "benzinga", "author": "Badar Shaikh", "url": "https://www.benzinga.com/markets/equities/26/02/50877032/american-airlines-to-invest-1-billion-in-miami-airport-expansion-to-accommodate-larger-aircraft", "tags": []}
{"id": 50877048, "time": "2026-02-26 01:31:15", "headline": "Ellington Financial Q4 Adj. EPS $0.47 Beats $0.45 Estimate, Sales $53.637M Beat $48.318M Estimate", "summary": "", "symbols": ["EFC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50877048/ellington-financial-q4-adj-eps-0-47-beats-0-45-estimate-sales-53-637m-beat-48-318m-estimate", "tags": ["earnings"]}
{"id": 50877067, "time": "2026-02-26 01:33:58", "headline": "US Physical Therapy Q4 Adj. EPS $0.67, Inline, Sales $202.726M Beat $200.425M Estimate", "summary": "", "symbols": ["USPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50877067/us-physical-therapy-q4-adj-eps-0-67-inline-sales-202-726m-beat-200-425m-estimate", "tags": ["earnings"]}
{"id": 50877105, "time": "2026-02-26 01:45:21", "headline": "Crypto Hardware Partnership Sends iPower Stock Spiking: What You Should Know", "summary": "iPower Inc. shares rose 5.42% after hours to $2.14 following a crypto hardware distribution partnership with Nanopulse Technology.", "symbols": ["IPW"], "source": "benzinga", "author": "Mohd Haider", "url": "https://www.benzinga.com/markets/equities/26/02/50877105/crypto-hardware-partnership-sends-ipower-stock-spiking-what-you-should-know", "tags": ["contract"]}
{"id": 50877180, "time": "2026-02-26 01:59:08", "headline": "Nvidia, Hormel Foods And 3 Stocks To Watch Heading Into Thursday", "summary": "US stock futures down; HRL, NVDA, SJM, TTD, DELL in focus. Nvidia beats expectations, Trade Desk disappointed, Dell earnings awaited.", "symbols": ["DELL", "HRL", "NVDA", "SJM", "TTD"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/markets/equities/26/02/50877180/nvidia-hormel-foods-and-3-stocks-to-watch-heading-into-thursday", "tags": ["earnings"]}
{"id": 50877198, "time": "2026-02-26 02:00:44", "headline": "Warner Bros. Discovery Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts", "summary": " ", "symbols": ["WBD"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50877198/warner-bros-discovery-gears-up-for-q4-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts", "tags": ["guidance"]}
{"id": 50877222, "time": "2026-02-26 02:11:44", "headline": "What's Behind Curanex Pharmaceuticals (CURX) 56% Surge After Hours", "summary": "Curanex Pharmaceuticals shares surged in after-hours trading after the company completed a GMP-compliant batch supporting its planned IND submission for ulcerative colitis.\n", "symbols": ["CURX"], "source": "benzinga", "author": "Mohd Haider", "url": "https://www.benzinga.com/markets/equities/26/02/50877222/whats-behind-curanex-pharmaceuticals-curx-56-surge-after-hours", "tags": []}
{"id": 50877244, "time": "2026-02-26 02:15:23", "headline": "Jamie Dimon Says 'Now's The Time' To Prepare For Automation's Worker Impact, Warns AI Could Displace Jobs", "summary": "Jamie Dimon warns AI could disrupt jobs, urges proactive planning. Industry leaders express concerns over AI reshaping workforce.", "symbols": ["JPM"], "source": "benzinga", "author": "Snigdha Gairola", "url": "https://www.benzinga.com/markets/tech/26/02/50877244/jamie-dimon-says-nows-the-time-to-prepare-for-automations-worker-impact-warns-ai-could-displace-jobs", "tags": []}
{"id": 50877252, "time": "2026-02-26 02:15:41", "headline": "Top Wall Street Forecasters Revamp Shake Shack Expectations Ahead Of Q4 Earnings", "summary": " ", "symbols": ["SHAK"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/26/02/50877252/top-wall-street-forecasters-revamp-shake-shack-expectations-ahead-of-q4-earnings", "tags": ["earnings"]}
{"id": 50877261, "time": "2026-02-26 02:16:13", "headline": "Circle CEO Says Company's Stablecoin Infrastructure Has Benefitted Prediction Markets: Here's How", "summary": "Circle Internet Group Inc.\u00a0(NYSE:CRCL) CEO Jeremy Allaire said Wednesday that the company\u2019s flagship USDC ", "symbols": ["CRCL", "USDCUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/crypto/cryptocurrency/26/02/50877261/circle-ceo-says-companys-stablecoin-infrastructure-has-benefitted-prediction-markets-heres-how", "tags": ["management"]}
{"id": 50877273, "time": "2026-02-26 02:17:58", "headline": "Will S&P 500 Open Up Or Down On February 26? Markets Wobble As Nvidia Fades, Tariff Jitters Linger", "summary": "The S&amp;P closed at 6,946.13 on Wednesday. Polymarket bettors think it won&#39;t open there Thursday \u2014 and have over $42,000 riding on it.", "symbols": ["CRWV", "DELL", "INTU", "NVDA"], "source": "benzinga", "author": "Eva Mathew", "url": "https://www.benzinga.com/markets/prediction-markets/26/02/50877273/will-sp-500-open-up-or-down-on-february-26-markets-wobble-as-nvidia-fades-tariff-jitters-linger", "tags": []}
{"id": 50877274, "time": "2026-02-26 02:18:00", "headline": "Nasdaq Jumps Over 1%, Dow Gains 300 Points: Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone", "summary": "Overall market sentiment improved as CNN Money Fear and Greed index moved to Neutral zone. U.S. stocks rose, led by tech and AI names.", "symbols": ["CAVA", "DELL", "ECG", "HRL", "LOW", "SJM"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/markets/equities/26/02/50877274/nasdaq-jumps-over-1-dow-gains-300-points-investor-sentiment-improves-fear-greed-index-moves-to-neutral-zone", "tags": []}
{"id": 50877292, "time": "2026-02-26 02:19:46", "headline": "Stellantis FY Adj. EPS $(0.49) Down From $2.68 YoY, Sales $178.710B Miss $188.300B Estimate", "summary": "", "symbols": ["STLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50877292/stellantis-fy-adj-eps-0-49-down-from-2-68-yoy-sales-178-710b-miss-188-300b-estimate", "tags": ["earnings"]}
{"id": 50877302, "time": "2026-02-26 02:21:04", "headline": "Stellantis FY 2026 Guidance Reiterated With Mid-Single Digit Net Revenue Increase, Low-Single Digit AOI Margin And Improved Industrial Free Cash Flow", "summary": "", "symbols": ["STLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877302/stellantis-fy-2026-guidance-reiterated-with-mid-single-digit-net-revenue-increase-low-single-digit-a", "tags": ["earnings", "guidance"]}
{"id": 50877311, "time": "2026-02-26 02:23:09", "headline": "Hafnia Q4 EPS $0.22 Misses $0.23 Estimate, Sales $340.300M Beat $266.880M Estimate", "summary": "", "symbols": ["HAFN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50877311/hafnia-q4-eps-0-22-misses-0-23-estimate-sales-340-300m-beat-266-880m-estimate", "tags": ["earnings"]}
{"id": 50877320, "time": "2026-02-26 02:24:40", "headline": "Hafnia Reports 76% Of Q1 Earning Days Covered At Average $29,979 Per Day, 33% Of 2026 Days Fixed At $27,972 Per Day", "summary": "", "symbols": ["HAFN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877320/hafnia-reports-76-of-q1-earning-days-covered-at-average-29-979-per-day-33-of-2026-days-fixed-at-27-9", "tags": []}
{"id": 50877428, "time": "2026-02-26 02:27:07", "headline": "argenx's Phase 3 ADAPT OCULUS Study Meets Primary Endpoint, Advancing VYVGART As First Targeted Therapy For Ocular Myasthenia Gravis", "summary": "", "symbols": ["ARGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877428/argenxs-phase-3-adapt-oculus-study-meets-primary-endpoint-advancing-vyvgart-as-first-targeted-therap", "tags": ["fda"]}
{"id": 50877437, "time": "2026-02-26 02:27:40", "headline": "Molecular Partners Enters Development Agreement With Eckert & Ziegler, Leveraging Berlin Alpha Laboratory For Radio-DARPin Radiopharmaceutical Advancement", "summary": "", "symbols": ["MOLN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877437/molecular-partners-enters-development-agreement-with-eckert-ziegler-leveraging-berlin-alpha-laborato", "tags": ["contract"]}
{"id": 50877446, "time": "2026-02-26 02:28:24", "headline": "AIxCrypto Expands AIxC Hub Ecosystem To 4.8M Registered Wallets, Unveils Agentir Benchmarking Environment For AI Agent Performance Evaluation", "summary": "", "symbols": ["AIXC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877446/aixcrypto-expands-aixc-hub-ecosystem-to-4-8m-registered-wallets-unveils-agentir-benchmarking-environ", "tags": []}
{"id": 50877455, "time": "2026-02-26 02:29:01", "headline": "Faraday Future Launches First EAI Robotics Deliveries To Florida-Based Airbnb Operator Golden Hills Investment, Pioneering New Commercial Application Scenario", "summary": "", "symbols": ["FFAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877455/faraday-future-launches-first-eai-robotics-deliveries-to-florida-based-airbnb-operator-golden-hills", "tags": []}
{"id": 50877464, "time": "2026-02-26 02:29:28", "headline": "Tigo Energy Unveils Advanced Commissioning Software And TS4-A MLPE Devices At KEY 2026, Providing Up To 7.6% Reclaimed Energy On Residential Solar Systems", "summary": "", "symbols": ["TYGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877464/tigo-energy-unveils-advanced-commissioning-software-and-ts4-a-mlpe-devices-at-key-2026-providing-up", "tags": []}
{"id": 50877481, "time": "2026-02-26 02:32:27", "headline": "Northland Power Q4 EPS $0.93 Beats $0.40 Estimate, Sales $722.841M Beat $662.471M Estimate", "summary": "", "symbols": ["TSX:NPI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50877481/northland-power-q4-eps-0-93-beats-0-40-estimate-sales-722-841m-beat-662-471m-estimate", "tags": ["earnings"]}
{"id": 50877506, "time": "2026-02-26 02:38:25", "headline": "IMF Warns Trump Tariffs Could Slow US Economic Growth, Criticizes Federal Workforce Cuts", "summary": "IMF warns Trump&#39;s tariffs create a &#34;negative supply&#34; effect and job cuts to &#34;strong institutions&#34; threaten the US economic &#34;public good.&#34;", "symbols": ["QQQ", "SPY"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/markets/macro-economic-events/26/02/50877506/imf-warns-trump-tariffs-could-slow-us-economic-growth-criticizes-federal-workforce-cuts", "tags": []}
{"id": 50877517, "time": "2026-02-26 02:40:39", "headline": "Netflix CEO Ted Sarandos Braces For White House Meeting Days After Saying Warner Bros. Bid Is 'Not A Political Deal': Report", "summary": "Netflix Inc. (NASDAQ: NFLX) CEO Ted Sarandos is reportedly scheduled to\u00a0attend meetings at the White\u00a0House on Thursday as the bidding war to acquire Warner Bros. Discovery (NASDAQ: WBD) heats up.", "symbols": ["NFLX", "ORCL", "PSKY", "WBD"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/m-a/26/02/50877517/netflix-ceo-ted-sarandos-braces-for-white-house-meeting-days-after-saying-warner-bros-bid-is-not-a-political-deal-report", "tags": ["merger", "contract", "management"]}
{"id": 50877518, "time": "2026-02-26 02:40:42", "headline": "Reported Earlier, Metropolitan Bank Holding Prices Public Offering Of 2.1M Shares At $85.00 Per Share, Raising Approximately $178.5M To Support Organic Growth Initiatives", "summary": "", "symbols": ["MCB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877518/reported-earlier-metropolitan-bank-holding-prices-public-offering-of-2-1m-shares-at-85-00-per-share", "tags": ["offering"]}
{"id": 50877535, "time": "2026-02-26 02:43:16", "headline": "Reported Earlier, Innovex International Prices 5.75M Share Offering At $25.75 Per Share By Amberjack Capital Affiliates, Plans To Repurchase 575,000 Shares From Underwriters", "summary": "", "symbols": ["INVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877535/reported-earlier-innovex-international-prices-5-75m-share-offering-at-25-75-per-share-by-amberjack-c", "tags": ["offering", "buyback"]}
{"id": 50877547, "time": "2026-02-26 02:49:52", "headline": "Reported Earlier, Vir Biotechnology Prices Public Offering Of 17,647,058 Common Shares At $8.50 Per Share, Raising $150M To Advance Infectious Disease And Cancer Pipeline", "summary": "", "symbols": ["VIR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877547/reported-earlier-vir-biotechnology-prices-public-offering-of-17-647-058-common-shares-at-8-50-per-sh", "tags": ["offering"]}
{"id": 50877557, "time": "2026-02-26 02:50:53", "headline": "Reported Earlier, Larimar Therapeutics Prices Upsized $100M Public Offering Of 20M Common Shares At $5.00 Each, To Fund Nomlabofusp Development", "summary": "", "symbols": ["LRMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877557/reported-earlier-larimar-therapeutics-prices-upsized-100m-public-offering-of-20m-common-shares-at-5", "tags": ["offering"]}
{"id": 50877569, "time": "2026-02-26 02:52:26", "headline": "Reported Earlier, TRG Latin America Acquisitions Corp. Prices 20M Unit Initial Public Offering At $10.00 Per Unit, Raising $200M To Target Latin America Business Combination Opportunities", "summary": "", "symbols": ["TRGSU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877569/reported-earlier-trg-latin-america-acquisitions-corp-prices-20m-unit-initial-public-offering-at-10-0", "tags": ["offering"]}
{"id": 50877578, "time": "2026-02-26 02:52:59", "headline": "Reported Earlier, LG Display Achieves Industry-First 100% Dimming Consistency Certification, As LCD-Based Mini LED Panels Record As Low As 43% In Comparative Testing", "summary": "", "symbols": ["LPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877578/reported-earlier-lg-display-achieves-industry-first-100-dimming-consistency-certification-as-lcd-bas", "tags": []}
{"id": 50877665, "time": "2026-02-26 03:00:00", "headline": "Bernie Sanders Targets Elon Musk, Jeff Bezos, Mark Zuckerberg In Senate Speech, Proposes Ban On New AI Data Centers: 'Long Overdue'", "summary": "Sen. Bernie Sanders warned that AI could eliminate up to 100 million U.S. jobs and deepen inequality, targeting tech leaders.", "symbols": ["AMZN", "GOOG", "META", "MSFT", "TSLA"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/markets/tech/26/02/50877665/bernie-sanders-targets-elon-musk-jeff-bezos-mark-zuckerberg-in-senate-speech-proposes-ban-on-new-ai-data-centers-long-overdue", "tags": []}
{"id": 50877688, "time": "2026-02-26 03:01:31", "headline": "Reported Earlier, Palvella Therapeutics Prices Upsized $200M Public Offering Of 1.6M Common Shares At $125 Per Share To Advance QTORIN Pipeline", "summary": "", "symbols": ["PVLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877688/reported-earlier-palvella-therapeutics-prices-upsized-200m-public-offering-of-1-6m-common-shares-at", "tags": ["offering"]}
{"id": 50877703, "time": "2026-02-26 03:02:53", "headline": "Reported Earlier, APEX Tech Acquisition Prices $100M Initial Public Offering Of 10M Units At $10.00 Per Unit", "summary": "", "symbols": ["TRADU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877703/reported-earlier-apex-tech-acquisition-prices-100m-initial-public-offering-of-10m-units-at-10-00-per", "tags": ["offering"]}
{"id": 50877712, "time": "2026-02-26 03:02:52", "headline": "What Drove CASI Pharmaceuticals' 24% Rise After Hours?", "summary": "CASI Pharmaceuticals shares surged over 24% after hours to $0.28 despite a formal Nasdaq delisting and plans to transition to OTC Markets.", "symbols": ["CASI", "OTCM"], "source": "benzinga", "author": "Mohd Haider", "url": "https://www.benzinga.com/markets/equities/26/02/50877712/what-drove-casi-pharmaceuticals-24-rise-after-hours", "tags": []}
{"id": 50877721, "time": "2026-02-26 03:03:51", "headline": "Reported Earlier, Omnicom Prices $1.7B USD Senior Notes And \u20ac600M Euro Senior Notes Offerings Across Four Tranches, Proceeds To Repay 2026 Senior Notes And General Corporate Purposes", "summary": "", "symbols": ["OMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877721/reported-earlier-omnicom-prices-1-7b-usd-senior-notes-and-600m-euro-senior-notes-offerings-across-fo", "tags": []}
{"id": 50877733, "time": "2026-02-26 03:04:50", "headline": "Reported Earlier, Gaming And Leisure Properties Prices $800M Of 5.625% Senior Notes Due 2036, To Repay Outstanding Term Loan Credit Facility Borrowings", "summary": "", "symbols": ["GLPI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877733/reported-earlier-gaming-and-leisure-properties-prices-800m-of-5-625-senior-notes-due-2036-to-repay-o", "tags": []}
{"id": 50877752, "time": "2026-02-26 03:10:06", "headline": "Reported Earlier, Ryman Hospitality Properties Prices $700M Of 5.750% Senior Notes Due 2034, Generating ~$687M Net Proceeds To Redeem Outstanding 4.750% Senior Notes Due 2027", "summary": "", "symbols": ["RHP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877752/reported-earlier-ryman-hospitality-properties-prices-700m-of-5-750-senior-notes-due-2034-generating", "tags": []}
{"id": 50877762, "time": "2026-02-26 03:10:48", "headline": "Reported Earlier, Targa Resources Prices $1.5B Senior Notes Offering In Two Equal $750M Tranches At 4.350% Due 2031 And 6.050% Due 2056", "summary": "", "symbols": ["TRGP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877762/reported-earlier-targa-resources-prices-1-5b-senior-notes-offering-in-two-equal-750m-tranches-at-4-3", "tags": ["offering"]}
{"id": 50877773, "time": "2026-02-26 03:14:21", "headline": "Fermi America Receives Final 6GW Texas Commission On Environmental Quality Air Permit, Positioning 11GW Project Matador For Immediate Construction Mobilization", "summary": "", "symbols": ["FRMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877773/fermi-america-receives-final-6gw-texas-commission-on-environmental-quality-air-permit-positioning-11", "tags": []}
{"id": 50877783, "time": "2026-02-26 03:15:42", "headline": "GSK Receives China Priority Review Acceptance For Linerixibat In Rare Autoimmune Liver Disease PBC, Based On Positive Phase III GLISTEN Trial Data", "summary": "", "symbols": ["FXI", "GSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877783/gsk-receives-china-priority-review-acceptance-for-linerixibat-in-rare-autoimmune-liver-disease-pbc-b", "tags": ["fda"]}
{"id": 50877793, "time": "2026-02-26 03:16:04", "headline": "Reported earlier, Schrodinger Sees FY2026 Sales $273.000M-$293.000M vs $301.358M Est", "summary": "", "symbols": ["SDGR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877793/reported-earlier-schrodinger-sees-fy2026-sales-273-000m-293-000m-vs-301-358m-est", "tags": []}
{"id": 50877803, "time": "2026-02-26 03:17:18", "headline": "GSK Secures Japan Regulatory Review For Bepirovirsen In Chronic Hepatitis B, Targeting Nearly 1 Million Patients With First Global Regulatory Filing", "summary": "", "symbols": ["EWJ", "GSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877803/gsk-secures-japan-regulatory-review-for-bepirovirsen-in-chronic-hepatitis-b-targeting-nearly-1-milli", "tags": []}
{"id": 50877899, "time": "2026-02-26 03:30:14", "headline": "Nokia Selected As Sole Networking Partner For Telef\u00f3nica's 17 Edge Data Centers Across Spain, Supporting AI Training And Sovereign Digital Infrastructure", "summary": "", "symbols": ["NOK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877899/nokia-selected-as-sole-networking-partner-for-telef-nicas-17-edge-data-centers-across-spain-supporti", "tags": []}
{"id": 50877912, "time": "2026-02-26 03:31:28", "headline": "'Apple In Talks With Banks To Start Payment Service In India' - Bloomberg", "summary": "", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877912/apple-in-talks-with-banks-to-start-payment-service-in-india-bloomberg", "tags": []}
{"id": 50877928, "time": "2026-02-26 03:36:46", "headline": "Reported earlier, Encore Capital Gr Sees FY2026 GAAP EPS $12.00 vs $8.76 Est", "summary": "", "symbols": ["ECPG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877928/reported-earlier-encore-capital-gr-sees-fy2026-gaap-eps-12-00-vs-8-76-est", "tags": ["earnings"]}
{"id": 50877937, "time": "2026-02-26 03:38:08", "headline": "Toyota Group Reports 887,266 Global Units Sold In January 2026, Up 4.8% YoY, Overseas Deliveries Advance 5.9% To 716,443 Units", "summary": "", "symbols": ["TM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877937/toyota-group-reports-887-266-global-units-sold-in-january-2026-up-4-8-yoy-overseas-deliveries-advanc", "tags": []}
{"id": 50877946, "time": "2026-02-26 03:38:38", "headline": "CORRECTION: Sezzle Raises FY2026 Adj EPS Guidance from $4.35 to $4.70 vs $4.33 Est; Sees Sales $562.849M-$585.363M vs $559.804M Est.", "summary": "", "symbols": ["SEZL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877946/correction-sezzle-raises-fy2026-adj-eps-guidance-from-4-35-to-4-70-vs-4-33-est-sees-sales-562-849m-5", "tags": ["earnings", "guidance"]}
{"id": 50877958, "time": "2026-02-26 03:42:06", "headline": "Salesforce's Quietest Earnings Call In 22 Years Is High-Conviction Signal: Eric Jackson Points Benioff Drops 'Revolution' As Revenue Returns", "summary": "Analyze Marc Benioff&#39;s cooling rhetoric as a bullish signal for Salesforce (CRM) after Q4 growth reaccelerated and buzzwords dropped.", "symbols": ["CRM"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/markets/earnings/26/02/50877958/salesforces-quietest-earnings-call-in-22-years-is-high-conviction-signal-eric-jackson-points-benioff-drops-revolution-as-revenue-returns", "tags": ["earnings"]}
{"id": 50877973, "time": "2026-02-26 03:44:18", "headline": "'Rare Earth Shortages Worsen In US Aerospace, Chips Despite Trade Truce, Sources Say' - Reuters Exclusive", "summary": "", "symbols": ["GE", "HON", "REMX", "RTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50877973/rare-earth-shortages-worsen-in-us-aerospace-chips-despite-trade-truce-sources-say-reuters-exclusive", "tags": []}
{"id": 50877986, "time": "2026-02-26 03:46:53", "headline": "Reported Earlier, FS Bancorp And Pacific West Bancorp Sign Definitive Merger Agreement In $34.6M Stock And Cash Deal Valued At $12.52 Per Share, Combined Assets To Reach $3.6B", "summary": "", "symbols": ["FSBW", "PWBK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50877986/reported-earlier-fs-bancorp-and-pacific-west-bancorp-sign-definitive-merger-agreement-in-34-6m-stock", "tags": ["merger", "contract"]}
{"id": 50878006, "time": "2026-02-26 03:49:31", "headline": "'Amazon's $50 Billion Investment In OpenAI Could Hinge On IPO, AGI' - The Information", "summary": "", "symbols": ["AMZN", "MSFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50878006/amazons-50-billion-investment-in-openai-could-hinge-on-ipo-agi-the-information", "tags": []}
{"id": 50878016, "time": "2026-02-26 03:51:37", "headline": "Reported Earlier, Draganfly Announces Pricing Of $50.0M Registered Direct Offering Of 7.15M Common Shares At $7.00 Per Share", "summary": "", "symbols": ["DPRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50878016/reported-earlier-draganfly-announces-pricing-of-50-0m-registered-direct-offering-of-7-15m-common-sha", "tags": ["offering"]}
{"id": 50878025, "time": "2026-02-26 03:52:06", "headline": "Treasury Department Authorizes Resale Of Venezuelan Oil To Cuba's Private Sector", "summary": "The U.S. Treasury Department said that it would allow companies to apply for licenses to resell Venezuelan oil to Cuba&#39;s private sector on Wednesday \u2014 a move that could help ease the island&#39;s worsening fuel shortage.", "symbols": [], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/commodities/26/02/50878025/treasury-department-authorizes-resale-of-venezuelan-oil-to-cubas-private-sector", "tags": []}
{"id": 50878037, "time": "2026-02-26 03:56:17", "headline": "Reported Earlier, Boston Scientific Removes Certain AXIOS Stents And Electrocautery Enhanced Delivery Systems In FDA Class I Recall Linked To 167 Injuries, Three Deaths", "summary": "", "symbols": ["BSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50878037/reported-earlier-boston-scientific-removes-certain-axios-stents-and-electrocautery-enhanced-delivery", "tags": ["fda"]}
{"id": 50878121, "time": "2026-02-26 03:59:41", "headline": "'Toyota Plans Around $19 Billion Share Sale By Financial Institutions, Sources Say' - Reuters Exclusive", "summary": "", "symbols": ["TM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50878121/toyota-plans-around-19-billion-share-sale-by-financial-institutions-sources-say-reuters-exclusive", "tags": []}
{"id": 50878149, "time": "2026-02-26 04:02:49", "headline": "Baidu Q4 Adj. EPS $1.52 Beats $1.12 Estimate, Sales $4.682B Beat $4.680B Estimate", "summary": "", "symbols": ["BIDU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50878149/baidu-q4-adj-eps-1-52-beats-1-12-estimate-sales-4-682b-beat-4-680b-estimate", "tags": ["earnings"]}
{"id": 50878162, "time": "2026-02-26 04:05:18", "headline": "Tesla Cybercab: Chicago Highway Testing, Elon Musk's $30,000 Price Tag, Trademark Woes And More", "summary": "Tesla&#39;s Cybercab was recently spotted testing in Chicago as Elon Musk gears up for April production and $30K retail price.", "symbols": ["TSLA"], "source": "benzinga", "author": "Badar Shaikh", "url": "https://www.benzinga.com/markets/tech/26/02/50878162/tesla-cybercab-chicago-highway-testing-elon-musks-30000-price-tag-trademark-woes-and-more", "tags": []}
{"id": 50878176, "time": "2026-02-26 04:09:28", "headline": "iQIYI Q4 Adj. EPS $0.02 Beats $(0.01) Estimate, Sales $971.600M Beat $970.480M Estimate", "summary": "", "symbols": ["IQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50878176/iqiyi-q4-adj-eps-0-02-beats-0-01-estimate-sales-971-600m-beat-970-480m-estimate", "tags": ["earnings"]}
{"id": 50878187, "time": "2026-02-26 04:10:43", "headline": "Gavin Newsom Calls Marco Rubio 'Complete Fraud,' Says JD Vance 'Scares Me,' Calls Him 'Unique Fraud'", "summary": "Gavin Newsom criticizes Rubio and Vance for opportunism and questions their role in shaping MAGA movement.", "symbols": [], "source": "benzinga", "author": "Snigdha Gairola", "url": "https://www.benzinga.com/news/politics/26/02/50878187/gavin-newsom-calls-marco-rubio-complete-fraud-says-jd-vance-scares-me-calls-him-unique-fraud", "tags": []}
{"id": 50878197, "time": "2026-02-26 04:12:13", "headline": "8x8 And KCOM Partner To Deliver Carrier-Grade Reliability And Secure Unified Communications Across UK Enterprise And Public Sector", "summary": "", "symbols": ["EGHT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50878197/8x8-and-kcom-partner-to-deliver-carrier-grade-reliability-and-secure-unified-communications-across-u", "tags": []}
{"id": 50878206, "time": "2026-02-26 04:12:30", "headline": "Piper Sandler Reiterates Overweight on Salesforce, Lowers Price Target to $250", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50878206/piper-sandler-reiterates-overweight-on-salesforce-lowers-price-target-to-250", "tags": ["analyst_other", "price_target_down"]}
{"id": 50878226, "time": "2026-02-26 04:13:45", "headline": "WTW's Willis Unveils Global Digital Infrastructure Group Delivering End-To-End Advisory Across Data Center Lifecycle And Emerging Risks", "summary": "", "symbols": ["WTW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50878226/wtws-willis-unveils-global-digital-infrastructure-group-delivering-end-to-end-advisory-across-data-c", "tags": []}
{"id": 50878236, "time": "2026-02-26 04:15:47", "headline": "Trump Administration 'Temporarily' Halts Minnesota Medicaid Funding Amid Fraud Allegations\u2014 Tim Walz Calls It 'Campaign Of Retribution'", "summary": "Vice President JD Vance and\u00a0Dr Mehmet Oz, the administrator\u00a0for the Centers for Medicare\u00a0and Medicaid Services (CMS) announced on Wednesday that the administration would &#34;temporarily halt&#34; $259.5 million in Medicaid funding to \u00a0to Minnesota amid a crackdown on public funds misuse.", "symbols": [], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/news/politics/26/02/50878236/trump-administration-temporarily-halts-minnesota-medicaid-funding-amid-fraud-allegations-tim-walz-calls-it-campaign-of-retribution", "tags": []}
{"id": 50878250, "time": "2026-02-26 04:19:30", "headline": "Piper Sandler Maintains Overweight on Snowflake, Lowers Price Target to $230", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50878250/piper-sandler-maintains-overweight-on-snowflake-lowers-price-target-to-230", "tags": ["analyst_other", "price_target_down"]}
{"id": 50878269, "time": "2026-02-26 04:20:47", "headline": "Bloomberg Reported Apollo, BNP Paribas Near Deal On European Private Credit Tie-Up", "summary": "", "symbols": ["APO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50878269/bloomberg-reported-apollo-bnp-paribas-near-deal-on-european-private-credit-tie-up", "tags": ["contract"]}
{"id": 50878283, "time": "2026-02-26 04:24:29", "headline": "Bloomberg Reported Earlier KKR Sold Stake In $3.1B Post-trade Firm Osttra To Banks", "summary": "", "symbols": ["KKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50878283/bloomberg-reported-earlier-kkr-sold-stake-in-3-1b-post-trade-firm-osttra-to-banks", "tags": []}
{"id": 50878401, "time": "2026-02-26 04:30:31", "headline": "Nvidia's $68 Billion Record Revenue Meets $150 Billion Question: Munster Flags Revenue Concentration Among 'Just 8 Companies'", "summary": "Nvidia&#39;s record $68B Q4 revenue faces a sustainability test as Gene Munster warns 70% of sales come from just 8 giants. AI boom too fragile?", "symbols": ["NVDA"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/markets/equities/26/02/50878401/nvidias-68-billion-record-revenue-meets-150-billion-question-munster-flags-revenue-concentration-among-just-8-companies", "tags": ["earnings"]}
{"id": 50878413, "time": "2026-02-26 04:31:59", "headline": "Deutsche Bank Downgrades First Solar to Hold, Lowers Price Target to $245", "summary": "", "symbols": ["FSLR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50878413/deutsche-bank-downgrades-first-solar-to-hold-lowers-price-target-to-245", "tags": ["analyst_down", "price_target_down"]}
{"id": 50878441, "time": "2026-02-26 04:35:45", "headline": "NIO Announced RMB2.257B Investment In GeniTech Subsidiary Shenji From China Investors, NIO To Retain 62.7% Controlling Stake And Consolidate Financials, Investors To Hold 27% Stake", "summary": "", "symbols": ["NIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50878441/nio-announced-rmb2-257b-investment-in-genitech-subsidiary-shenji-from-china-investors-nio-to-retain", "tags": []}
{"id": 50878451, "time": "2026-02-26 04:38:11", "headline": "Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket", "summary": " ", "symbols": ["AI", "ARRY", "BTQ", "CURX", "ERII", "GDRX", "HCTI", "INVX", "IONQ", "LRMR", "MTNB", "NTNX", "PFSA", "PRCT", "RRGB", "SEZL", "TTD", "UOKA", "VAC", "VIR"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/26/02/50878451/why-marriott-vacations-shares-are-trading-higher-by-over-12-here-are-20-stocks-moving-premarket", "tags": ["why_moving"]}
{"id": 50878460, "time": "2026-02-26 04:39:44", "headline": "Michael Saylor Unveils 'Digital Credit' Vision, Signals Expansion Beyond Bitcoin To Solana", "summary": "Strategy Inc.\u00a0(NASDAQ:MSTR)\u00a0Executive Chair\u00a0Michael Saylor\u00a0shared his vision Wednesday for the future of \u201cdigital credit,\u201d emphasizing its pote", "symbols": ["BTCUSD", "ETHUSD", "MSTR", "SOLUSD", "STRC"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/crypto/cryptocurrency/26/02/50878460/michael-saylor-unveils-digital-credit-vision-signals-expansion-beyond-bitcoin-to-solana", "tags": []}
{"id": 50878474, "time": "2026-02-26 04:47:09", "headline": "Piper Sandler Maintains Neutral on Synopsys, Lowers Price Target to $430", "summary": "", "symbols": ["SNPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50878474/piper-sandler-maintains-neutral-on-synopsys-lowers-price-target-to-430", "tags": ["analyst_other", "price_target_down"]}
{"id": 50878580, "time": "2026-02-26 04:57:29", "headline": "Loop Capital Downgrades Trade Desk to Hold, Lowers Price Target to $25", "summary": "", "symbols": ["TTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50878580/loop-capital-downgrades-trade-desk-to-hold-lowers-price-target-to-25", "tags": ["analyst_down", "price_target_down"]}
{"id": 50878488, "time": "2026-02-26 04:53:51", "headline": "Nokia Wins Exclusive AI Network Deal With Telef\u00f3nica", "summary": "Nokia (NOK) to implement advanced networking solutions for Telef\u00f3nica in Spain, expanding AI and cloud services in various sectors.", "symbols": ["AMZN", "NOK"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/markets/tech/26/02/50878488/nokia-wins-exclusive-ai-network-deal-with-telefonica", "tags": ["contract"]}
{"id": 50878669, "time": "2026-02-26 05:05:51", "headline": "Vipshop Holdings Q4 Adj. EPS $0.81 Beats $0.68 Estimate, Sales $4.644B Miss $4.780B Estimate", "summary": "", "symbols": ["VIPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50878669/vipshop-holdings-q4-adj-eps-0-81-beats-0-68-estimate-sales-4-644b-miss-4-780b-estimate", "tags": ["earnings"]}
{"id": 50878679, "time": "2026-02-26 05:06:06", "headline": "Earnings Breakdown: Vipshop Holdings Q4", "summary": " ", "symbols": ["VIPS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50878679/earnings-breakdown-vipshop-holdings-q4", "tags": ["earnings"]}
{"id": 50878733, "time": "2026-02-26 05:10:55", "headline": "Daqo New Energy Q4 Adj. EPS $(0.11) Beats $(0.17) Estimate, Sales $221.700M Miss $273.704M Estimate", "summary": "", "symbols": ["DQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50878733/daqo-new-energy-q4-adj-eps-0-11-beats-0-17-estimate-sales-221-700m-miss-273-704m-estimate", "tags": ["earnings"]}
{"id": 50878744, "time": "2026-02-26 05:12:06", "headline": "Daqo New Energy: Q4 Earnings Insights", "summary": " ", "symbols": ["DQ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50878744/daqo-new-energy-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50878756, "time": "2026-02-26 05:14:49", "headline": "Josh Shapiro Warns AI Companion Bots Are Replacing Trusted Adults For Kids, Urges Safeguards: 'I'm Worried...'", "summary": "Pennsylvania Governor Josh Shapiro urged safeguards for children using AI companion bots, citing risks of exploitation and harmful content.", "symbols": ["META", "TUYA"], "source": "benzinga", "author": "Mohd Haider", "url": "https://www.benzinga.com/markets/tech/26/02/50878756/josh-shapiro-warns-ai-companion-bots-are-replacing-trusted-adults-for-kids-urges-safeguards-im-worried", "tags": []}
{"id": 50878755, "time": "2026-02-26 05:14:37", "headline": "Ray Dalio Says 'Open-Mindedness Doesn't Mean Going Along' As He Urges Leaders To Question Assumptions, Embrace Dissent", "summary": "Ray Dalio emphasizes radical open-mindedness for growth and better outcomes. Open-mindedness means considering others&#39; reasoning.", "symbols": [], "source": "benzinga", "author": "Snigdha Gairola", "url": "https://www.benzinga.com/personal-finance/financial-advisors/26/02/50878755/ray-dalio-says-open-mindedness-doesnt-mean-going-along-as-he-urges-leaders-to-question-assumptions-embrace-dissent", "tags": []}
{"id": 50878773, "time": "2026-02-26 05:16:29", "headline": "Taiwan Semiconductor Joins The $2 Trillion Elite Club", "summary": "TSM reaches $2 trillion milestone, produces chips for major customers like Nvidia, Broadcom, Tesla, and Apple.", "symbols": ["AAPL", "AMZN", "AVGO", "GOOGL", "META", "NVDA", "TSLA", "TSM"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/markets/tech/26/02/50878773/taiwan-semiconductor-joins-the-2-trillion-elite-club", "tags": []}
{"id": 50878794, "time": "2026-02-26 05:23:28", "headline": "Department Of Energy Loans Record $26.5 Billion To Boost Southern Power Grid, Targets Massive Cost Savings", "summary": "The U.S. Energy Department announced its largest-ever loan of $26.5 billion on Wednesday to bolster\u00a0electric power in Georgia and\u00a0Alabama, delivering over $7 billion in electricity cost savings. ", "symbols": ["AMZN", "MSFT"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/news/politics/26/02/50878794/department-of-energy-loans-record-26-5-billion-to-boost-southern-power-grid-targets-massive-cost-savings", "tags": []}
{"id": 50878803, "time": "2026-02-26 05:24:30", "headline": "Banco Macro Q4 EPS $1.08 Misses $1.38 Estimate, Sales $628.814M Miss $773.070M Estimate", "summary": "", "symbols": ["BMA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50878803/banco-macro-q4-eps-1-08-misses-1-38-estimate-sales-628-814m-miss-773-070m-estimate", "tags": ["earnings"]}
{"id": 50878804, "time": "2026-02-26 05:24:30", "headline": "Datadog, Sakana AI Join Forces To Accelerate Enterprise AI Adoption", "summary": "Datadog, Inc. (DDOG) shares up on strategic partnership with Sakana AI to enhance AI innovation and observability.", "symbols": ["DDOG"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/markets/large-cap/26/02/50878804/datadog-sakana-ai-join-forces-to-accelerate-enterprise-ai-adoption", "tags": ["contract"]}
{"id": 50878813, "time": "2026-02-26 05:24:41", "headline": "B. Riley Securities Downgrades Spok Holdings to Neutral, Lowers Price Target to $14", "summary": "", "symbols": ["SPOK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50878813/b-riley-securities-downgrades-spok-holdings-to-neutral-lowers-price-target-to-14", "tags": ["analyst_down", "price_target_down"]}
{"id": 50878935, "time": "2026-02-26 05:28:18", "headline": "Canadian Imperial Bank Q1 Adj. EPS C$2.76 Up From C$2.20 YoY, Sales C$8.398B Up From C$7.281B YoY.", "summary": "", "symbols": ["CM", "TSX:CM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50878935/canadian-imperial-bank-q1-adj-eps-c-2-76-up-from-c-2-20-yoy-sales-c-8-398b-up-from-c-7-281b-yoy", "tags": ["earnings"]}
{"id": 50878945, "time": "2026-02-26 05:30:07", "headline": "Canadian Imperial Bank Earnings Review: Q1 Summary", "summary": " ", "symbols": ["CM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50878945/canadian-imperial-bank-earnings-review-q1-summary", "tags": ["earnings"]}
{"id": 50878946, "time": "2026-02-26 05:30:12", "headline": "Canadian Imperial Bank Q1 Earnings Assessment", "summary": " ", "symbols": ["CM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50878946/canadian-imperial-bank-q1-earnings-assessment", "tags": ["earnings"]}
{"id": 50878958, "time": "2026-02-26 05:30:22", "headline": "Canadian Imperial Bank Q1 Adj. EPS USD $1.98 Beats USD $1.74 Estimate, Sales USD $6.023B Beat USD $5.240B Estimate.", "summary": "", "symbols": ["CM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50878958/canadian-imperial-bank-q1-adj-eps-usd-1-98-beats-usd-1-74-estimate-sales-usd-6-023b-beat-usd-5-240b", "tags": ["earnings"]}
{"id": 50878982, "time": "2026-02-26 05:33:34", "headline": "B of A Securities Downgrades Southern Copper to Underperform, Raises Price Target to $175", "summary": "", "symbols": ["SCCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50878982/b-of-a-securities-downgrades-southern-copper-to-underperform-raises-price-target-to-175", "tags": ["analyst_down", "price_target_up"]}
{"id": 50879019, "time": "2026-02-26 05:44:28", "headline": "B of A Securities Downgrades Vale to Neutral, Raises Price Target to $18", "summary": "", "symbols": ["VALE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879019/b-of-a-securities-downgrades-vale-to-neutral-raises-price-target-to-18", "tags": ["analyst_down", "price_target_up"]}
{"id": 50879034, "time": "2026-02-26 05:52:43", "headline": "Sarepta CEO To Jump Ship After 'Tumultuous' Year", "summary": "Sarepta stock drops after a wider loss, Elevidys sales fall 33%, and CEO retirement plans add fresh uncertainty for investors.", "symbols": ["DYN", "SRPT"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/markets/earnings/26/02/50879034/sarepta-ceo-to-jump-ship-after-tumultuous-year", "tags": ["management"]}
{"id": 50879184, "time": "2026-02-26 06:00:16", "headline": "Benchmark Reiterates Buy on NVIDIA, Maintains $250 Price Target", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879184/benchmark-reiterates-buy-on-nvidia-maintains-250-price-target", "tags": ["analyst_other"]}
{"id": 50879217, "time": "2026-02-26 06:01:01", "headline": "Celsius Holdings Q4 Adj. EPS $0.26 Beats $0.20 Estimate, Sales $721.628M Beat $640.834M Estimate", "summary": "", "symbols": ["CELH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879217/celsius-holdings-q4-adj-eps-0-26-beats-0-20-estimate-sales-721-628m-beat-640-834m-estimate", "tags": ["earnings"]}
{"id": 50879218, "time": "2026-02-26 06:01:02", "headline": "Donaldson Q2 Adj. EPS $0.83 Misses $0.89 Estimate, Sales $896.300M Miss $898.740M Estimate", "summary": "", "symbols": ["DCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879218/donaldson-q2-adj-eps-0-83-misses-0-89-estimate-sales-896-300m-miss-898-740m-estimate", "tags": ["earnings"]}
{"id": 50879234, "time": "2026-02-26 06:01:11", "headline": "Royal Bank of Canada Q1 Adj. EPS $4.08 Beats $3.37 Estimate, Sales $17.960B Beat $15.090B Estimate", "summary": "", "symbols": ["TSX:RY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879234/royal-bank-of-canada-q1-adj-eps-4-08-beats-3-37-estimate-sales-17-960b-beat-15-090b-estimate", "tags": ["earnings"]}
{"id": 50879241, "time": "2026-02-26 06:01:15", "headline": "Aurinia Pharmaceuticals Q4 EPS $1.53, Sales $77.114M Beat $74.845M Estimate", "summary": "", "symbols": ["AUPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879241/aurinia-pharmaceuticals-q4-eps-1-53-sales-77-114m-beat-74-845m-estimate", "tags": ["earnings"]}
{"id": 50879254, "time": "2026-02-26 06:01:22", "headline": "Qnity Electronics Q4 EPS $0.82 Beats $0.63 Estimate, Sales $1.190B Beat $1.146B Estimate", "summary": "", "symbols": ["Q"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879254/qnity-electronics-q4-eps-0-82-beats-0-63-estimate-sales-1-190b-beat-1-146b-estimate", "tags": ["earnings"]}
{"id": 50879262, "time": "2026-02-26 06:01:25", "headline": "Perimeter Solutions Q4 2025 Adj. EPS $0.13 Beats $0.10 Estimate, Sales $102.750M Beat $94.050M Estimate", "summary": "", "symbols": ["PRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879262/perimeter-solutions-q4-2025-adj-eps-0-13-beats-0-10-estimate-sales-102-750m-beat-94-050m-estimate", "tags": ["earnings"]}
{"id": 50879269, "time": "2026-02-26 06:01:30", "headline": "Integra Lifesciences Q4 Adj. EPS $0.83 Beats $0.80 Estimate, Sales $434.925M Beat $429.621M Estimate", "summary": "", "symbols": ["IART"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879269/integra-lifesciences-q4-adj-eps-0-83-beats-0-80-estimate-sales-434-925m-beat-429-621m-estimate", "tags": ["earnings"]}
{"id": 50879288, "time": "2026-02-26 06:01:39", "headline": "KBR Q4 Adj. EPS $0.99 Beats $0.95 Estimate, Sales $1.885B Miss $1.905B Estimate", "summary": "", "symbols": ["KBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879288/kbr-q4-adj-eps-0-99-beats-0-95-estimate-sales-1-885b-miss-1-905b-estimate", "tags": ["earnings"]}
{"id": 50879297, "time": "2026-02-26 06:01:48", "headline": "BeiGene Q4 Adj. EPS $1.95 Beats $1.42 Estimate, Sales $1.498B Beat $1.453B Estimate.", "summary": "", "symbols": ["ONC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879297/beigene-q4-adj-eps-1-95-beats-1-42-estimate-sales-1-498b-beat-1-453b-estimate", "tags": ["earnings"]}
{"id": 50879307, "time": "2026-02-26 06:02:04", "headline": "Royal Bank of Canada Q1 Adj. EPS $2.93 Beats $2.76 Estimate, Sales $12.881B Beat $12.100B Estimate", "summary": "", "symbols": ["RY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879307/royal-bank-of-canada-q1-adj-eps-2-93-beats-2-76-estimate-sales-12-881b-beat-12-100b-estimate", "tags": ["earnings"]}
{"id": 50879309, "time": "2026-02-26 06:02:05", "headline": "Arhaus Q4 EPS $0.11 Beats $0.09 Estimate, Sales $364.845M Beat $351.310M Estimate", "summary": "", "symbols": ["ARHS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879309/arhaus-q4-eps-0-11-beats-0-09-estimate-sales-364-845m-beat-351-310m-estimate", "tags": ["earnings"]}
{"id": 50879310, "time": "2026-02-26 06:02:08", "headline": "Arhaus Q4 Earnings Assessment", "summary": " ", "symbols": ["ARHS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50879310/arhaus-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50879318, "time": "2026-02-26 06:02:14", "headline": "BeOne Medicines Earnings Report: Q4 Overview", "summary": " ", "symbols": ["ONC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50879318/beone-medicines-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50879324, "time": "2026-02-26 06:02:15", "headline": "Privia Health Gr Q4 Adj. EPS $0.25 Beats $0.04 Estimate, Sales $541.200M Miss $565.535M Estimate", "summary": "", "symbols": ["PRVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879324/privia-health-gr-q4-adj-eps-0-25-beats-0-04-estimate-sales-541-200m-miss-565-535m-estimate", "tags": ["earnings"]}
{"id": 50879329, "time": "2026-02-26 06:02:19", "headline": "Primo Brands Q4 Adj. EPS $0.26 Beats $0.21 Estimate, Sales $1.554B Beat $1.509B Estimate", "summary": "", "symbols": ["PRMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879329/primo-brands-q4-adj-eps-0-26-beats-0-21-estimate-sales-1-554b-beat-1-509b-estimate", "tags": ["earnings"]}
{"id": 50879330, "time": "2026-02-26 06:02:19", "headline": "Perimeter Solutions Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["PRM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50879330/perimeter-solutions-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50879334, "time": "2026-02-26 06:02:22", "headline": "Aurinia Pharmaceuticals Sees FY2026 Sales $315.000M-$325.000M vs $326.858M Est", "summary": "", "symbols": ["AUPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879334/aurinia-pharmaceuticals-sees-fy2026-sales-315-000m-325-000m-vs-326-858m-est", "tags": []}
{"id": 50879337, "time": "2026-02-26 06:02:24", "headline": "KBR Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["KBR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50879337/kbr-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50879342, "time": "2026-02-26 06:02:29", "headline": "First Advantage Q4 Adj. EPS $0.30 Beats $0.26 Estimate, Sales $420.017M Beat $391.885M Estimate", "summary": "", "symbols": ["FA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879342/first-advantage-q4-adj-eps-0-30-beats-0-26-estimate-sales-420-017m-beat-391-885m-estimate", "tags": ["earnings"]}
{"id": 50879345, "time": "2026-02-26 06:02:29", "headline": "Earnings Summary: Aurinia Pharmaceuticals Q4", "summary": " ", "symbols": ["AUPH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50879345/earnings-summary-aurinia-pharmaceuticals-q4", "tags": ["earnings"]}
{"id": 50879352, "time": "2026-02-26 06:02:34", "headline": "Donaldson Q2 Earnings Assessment", "summary": " ", "symbols": ["DCI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50879352/donaldson-q2-earnings-assessment", "tags": ["earnings"]}
{"id": 50879353, "time": "2026-02-26 06:02:35", "headline": "BeOne Medicines Sees FY2026 Sales $6.200B-$6.400B vs $6.501B Est.", "summary": "", "symbols": ["ONC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879353/beone-medicines-sees-fy2026-sales-6-200b-6-400b-vs-6-501b-est", "tags": []}
{"id": 50879360, "time": "2026-02-26 06:02:40", "headline": "Earnings Breakdown: Celsius Holdings Q4", "summary": " ", "symbols": ["CELH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50879360/earnings-breakdown-celsius-holdings-q4", "tags": ["earnings"]}
{"id": 50879374, "time": "2026-02-26 06:02:42", "headline": "Arhaus Sees Q1 Sales $300.000M-$320.000M vs $327.558M Est", "summary": "", "symbols": ["ARHS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879374/arhaus-sees-q1-sales-300-000m-320-000m-vs-327-558m-est", "tags": []}
{"id": 50879388, "time": "2026-02-26 06:02:51", "headline": "Arhaus Sees FY2026 Sales $1.430B-$1.470B vs $1.451B Est", "summary": "", "symbols": ["ARHS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879388/arhaus-sees-fy2026-sales-1-430b-1-470b-vs-1-451b-est", "tags": []}
{"id": 50879400, "time": "2026-02-26 06:02:59", "headline": "Walker & Dunlop Q4 Adj. EPS $0.28 Misses $1.23 Estimate, Sales $340.024M Miss $343.663M Estimate", "summary": "", "symbols": ["WD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879400/walker-dunlop-q4-adj-eps-0-28-misses-1-23-estimate-sales-340-024m-miss-343-663m-estimate", "tags": ["earnings"]}
{"id": 50879417, "time": "2026-02-26 06:03:13", "headline": "KBR Sees FY2026 Adj EPS $3.87-$4.22 vs $4.06 Est; Sees Sales $7.900B-$8.360B vs $8.159B Est", "summary": "", "symbols": ["KBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879417/kbr-sees-fy2026-adj-eps-3-87-4-22-vs-4-06-est-sees-sales-7-900b-8-360b-vs-8-159b-est", "tags": ["earnings"]}
{"id": 50879425, "time": "2026-02-26 06:03:20", "headline": "Qnity Electronics Sees FY2026 Adj EPS $3.55-$3.95; Sees Sales $4.970B-$5.170B", "summary": "", "symbols": ["Q"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879425/qnity-electronics-sees-fy2026-adj-eps-3-55-3-95-sees-sales-4-970b-5-170b", "tags": ["earnings"]}
{"id": 50879427, "time": "2026-02-26 06:03:20", "headline": "First Advantage Sees FY2026 Adj EPS $1.15-$1.25 vs $1.19 Est; Sees Sales $1.625B-$1.700B vs $1.623B Est", "summary": "", "symbols": ["FA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879427/first-advantage-sees-fy2026-adj-eps-1-15-1-25-vs-1-19-est-sees-sales-1-625b-1-700b-vs-1-623b-est", "tags": ["earnings"]}
{"id": 50879445, "time": "2026-02-26 06:03:30", "headline": "Millicom Intl Cellular Q4 EPS $1.50 Beats $0.88 Estimate, Sales $1.652B Beat $1.566B Estimate", "summary": "", "symbols": ["TIGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879445/millicom-intl-cellular-q4-eps-1-50-beats-0-88-estimate-sales-1-652b-beat-1-566b-estimate", "tags": ["earnings"]}
{"id": 50879502, "time": "2026-02-26 06:03:52", "headline": "Copper Is 'Going Places,' And Everyone Is Hitching A Ride", "summary": "Copper inventories rise as demand shifts towards long-term supply, driven by electrification, digital infrastructure, and urbanization.", "symbols": ["AAUKF", "BHP", "COPX", "GLCNF", "IVPAF", "RIO", "TECK"], "source": "benzinga", "author": "Stjepan Kalinic", "url": "https://www.benzinga.com/markets/commodities/26/02/50879502/copper-is-going-places-and-everyone-is-hitching-a-ride", "tags": []}
{"id": 50879512, "time": "2026-02-26 06:04:02", "headline": "Donaldson Lowers FY2026 Adj EPS Guidance from $3.95-$4.11 to $3.93-$4.01 vs $4.05 Est", "summary": "", "symbols": ["DCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879512/donaldson-lowers-fy2026-adj-eps-guidance-from-3-95-4-11-to-3-93-4-01-vs-4-05-est", "tags": ["earnings", "guidance"]}
{"id": 50879521, "time": "2026-02-26 06:04:10", "headline": "Earnings Summary: Ecovyst Q4", "summary": " ", "symbols": ["ECVT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50879521/earnings-summary-ecovyst-q4", "tags": ["earnings"]}
{"id": 50879528, "time": "2026-02-26 06:04:13", "headline": "Cascades Q4 Adj. EPS $0.40 Beats $0.38 Estimate, Sales $1.197B Miss $1.202B Estimate", "summary": "", "symbols": ["TSX:CAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879528/cascades-q4-adj-eps-0-40-beats-0-38-estimate-sales-1-197b-miss-1-202b-estimate", "tags": ["earnings"]}
{"id": 50879530, "time": "2026-02-26 06:04:15", "headline": "Earnings Summary: Millicom Intl Cellular Q4", "summary": " ", "symbols": ["TIGO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50879530/earnings-summary-millicom-intl-cellular-q4", "tags": ["earnings"]}
{"id": 50879535, "time": "2026-02-26 06:04:20", "headline": "Earnings Summary: Walker & Dunlop Q4", "summary": " ", "symbols": ["WD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50879535/earnings-summary-walker-dunlop-q4", "tags": ["earnings"]}
{"id": 50879536, "time": "2026-02-26 06:04:21", "headline": "Integra Lifesciences Sees FY2026 Adj EPS $2.30-$2.40 vs $2.35 Est; Sees Sales $1.662B-$1.702B vs $1.675B Est", "summary": "", "symbols": ["IART"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879536/integra-lifesciences-sees-fy2026-adj-eps-2-30-2-40-vs-2-35-est-sees-sales-1-662b-1-702b-vs-1-675b-es", "tags": ["earnings"]}
{"id": 50879543, "time": "2026-02-26 06:04:24", "headline": "Privia Health Gr Sees FY2026 Sales $2.350B-$2.450B vs $2.380B Est", "summary": "", "symbols": ["PRVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879543/privia-health-gr-sees-fy2026-sales-2-350b-2-450b-vs-2-380b-est", "tags": []}
{"id": 50879545, "time": "2026-02-26 06:04:25", "headline": "Primo Brands Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["PRMB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50879545/primo-brands-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50879550, "time": "2026-02-26 06:04:27", "headline": "Ecovyst Q4 Adj. EPS $0.28 Beats $0.15 Estimate, Sales $199.400M Beat $184.905M Estimate", "summary": "", "symbols": ["ECVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879550/ecovyst-q4-adj-eps-0-28-beats-0-15-estimate-sales-199-400m-beat-184-905m-estimate", "tags": ["earnings"]}
{"id": 50879552, "time": "2026-02-26 06:04:29", "headline": "ACI Worldwide Q4 Adj. EPS $0.90 Beats $0.80 Estimate, Sales $481.600M Beat $464.683M Estimate", "summary": "", "symbols": ["ACIW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879552/aci-worldwide-q4-adj-eps-0-90-beats-0-80-estimate-sales-481-600m-beat-464-683m-estimate", "tags": ["earnings"]}
{"id": 50879554, "time": "2026-02-26 06:04:30", "headline": "Privia Health Gr Earnings Report: Q4 Overview", "summary": " ", "symbols": ["PRVA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50879554/privia-health-gr-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50879565, "time": "2026-02-26 06:04:38", "headline": "Quebecor Q4 Adj. EPS $0.99 Up From $0.80 YoY, Sales $1.546B Up From $1.499B YoY", "summary": "", "symbols": ["TSX:QBR", "TSX:QBR.A"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879565/quebecor-q4-adj-eps-0-99-up-from-0-80-yoy-sales-1-546b-up-from-1-499b-yoy", "tags": ["earnings"]}
{"id": 50879602, "time": "2026-02-26 06:05:03", "headline": "Flowco Holdings Q4 Adj. EPS $0.51 Beats $0.30 Estimate, Sales $197.213M Beat $189.472M Estimate", "summary": "", "symbols": ["FLOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879602/flowco-holdings-q4-adj-eps-0-51-beats-0-30-estimate-sales-197-213m-beat-189-472m-estimate", "tags": ["earnings"]}
{"id": 50879606, "time": "2026-02-26 06:05:05", "headline": "Integra Lifesciences Sees Q1 Adj EPS $0.37-$0.45 vs $0.48 Est; Sees Sales $375.000M-$390.000M vs $392.147M Est", "summary": "", "symbols": ["IART"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879606/integra-lifesciences-sees-q1-adj-eps-0-37-0-45-vs-0-48-est-sees-sales-375-000m-390-000m-vs-392-147m", "tags": ["earnings"]}
{"id": 50879631, "time": "2026-02-26 06:05:18", "headline": "Accenture And Mistral AI Have Announced A Multi-year Strategic Collaboration To Help Clients Rapidly Move To Secure, Large-scale AI Deployments Aligned With Regional Requirements", "summary": "", "symbols": ["ACN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/large-cap/26/02/50879631/accenture-and-mistral-ai-have-announced-a-multi-year-strategic-collaboration-to-help-clients-rapid", "tags": []}
{"id": 50879648, "time": "2026-02-26 06:05:35", "headline": "ACI Worldwide Sees FY2026 Sales $1.880B-$1.910B vs $1.863B Est", "summary": "", "symbols": ["ACIW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879648/aci-worldwide-sees-fy2026-sales-1-880b-1-910b-vs-1-863b-est", "tags": []}
{"id": 50879664, "time": "2026-02-26 06:05:58", "headline": "Donaldson Affirms FY2026 Sales Guidance of $3.728B-$3.875B vs $3.826B Est", "summary": "", "symbols": ["DCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879664/donaldson-affirms-fy2026-sales-guidance-of-3-728b-3-875b-vs-3-826b-est", "tags": ["guidance"]}
{"id": 50879666, "time": "2026-02-26 06:06:00", "headline": "Ecovyst Sees FY2026 Adj EPS $0.45-$0.65 vs $0.60 Est; Sees Sales $860.000M-$940.000M vs $754.585M Est", "summary": "", "symbols": ["ECVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879666/ecovyst-sees-fy2026-adj-eps-0-45-0-65-vs-0-60-est-sees-sales-860-000m-940-000m-vs-754-585m-est", "tags": ["earnings"]}
{"id": 50879683, "time": "2026-02-26 06:06:15", "headline": "Stella-Jones Q4 EPS $0.91 Misses $1.02 Estimate, Sales $727.000M Miss $758.755M Estimate", "summary": "", "symbols": ["TSX:SJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879683/stella-jones-q4-eps-0-91-misses-1-02-estimate-sales-727-000m-miss-758-755m-estimate", "tags": ["earnings"]}
{"id": 50879693, "time": "2026-02-26 06:06:24", "headline": "Insights into ACI Worldwide Q4 Earnings", "summary": " ", "symbols": ["ACIW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50879693/insights-into-aci-worldwide-q4-earnings", "tags": ["earnings"]}
{"id": 50879702, "time": "2026-02-26 06:06:40", "headline": "Arhaus Announces Special Cash Dividend Of $0.35/Share", "summary": "", "symbols": ["ARHS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879702/arhaus-announces-special-cash-dividend-of-0-35share", "tags": ["dividend"]}
{"id": 50879712, "time": "2026-02-26 06:06:47", "headline": "Clear Channel Outdoor Q4 EPS $0.02 Beats $0.00 Estimate, Sales $461.515M Beat $448.860M Estimate", "summary": "", "symbols": ["CCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879712/clear-channel-outdoor-q4-eps-0-02-beats-0-00-estimate-sales-461-515m-beat-448-860m-estimate", "tags": ["earnings"]}
{"id": 50879730, "time": "2026-02-26 06:06:59", "headline": "Ducommun Q4 Adj. EPS $1.05 Beats $0.96 Estimate, Sales $215.800M Miss $221.005M Estimate", "summary": "", "symbols": ["DCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879730/ducommun-q4-adj-eps-1-05-beats-0-96-estimate-sales-215-800m-miss-221-005m-estimate", "tags": ["earnings"]}
{"id": 50879759, "time": "2026-02-26 06:07:28", "headline": "ACI Worldwide Sees Q1 Sales $405.000M-$415.000M vs $395.803M Est", "summary": "", "symbols": ["ACIW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879759/aci-worldwide-sees-q1-sales-405-000m-415-000m-vs-395-803m-est", "tags": []}
{"id": 50879786, "time": "2026-02-26 06:07:48", "headline": "Ecovyst Expects Year-Over-Year Growth In Virgin Sulfuric Acid Sales On Strong Mining Demand Despite Cautious Macro Outlook And Potential Nylon Precursor Oleum Weakness", "summary": "", "symbols": ["ECVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879786/ecovyst-expects-year-over-year-growth-in-virgin-sulfuric-acid-sales-on-strong-mining-demand-despite", "tags": ["guidance"]}
{"id": 50879797, "time": "2026-02-26 06:08:08", "headline": "Earnings Summary: Clear Channel Outdoor Q4", "summary": " ", "symbols": ["CCO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50879797/earnings-summary-clear-channel-outdoor-q4", "tags": ["earnings"]}
{"id": 50879800, "time": "2026-02-26 06:08:13", "headline": "Ducommun Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["DCO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50879800/ducommun-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50879835, "time": "2026-02-26 06:08:29", "headline": "Needham Reiterates Buy on Unisys, Maintains $4 Price Target", "summary": "", "symbols": ["UIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879835/needham-reiterates-buy-on-unisys-maintains-4-price-target", "tags": ["analyst_other"]}
{"id": 50879873, "time": "2026-02-26 06:08:46", "headline": "Morgan Stanley Downgrades RenaissanceRe Holdings to Equal-Weight, Maintains Price Target to $310", "summary": "", "symbols": ["RNR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879873/morgan-stanley-downgrades-renaissancere-holdings-to-equal-weight-maintains-price-target-to-310", "tags": ["analyst_down", "analyst_other"]}
{"id": 50879919, "time": "2026-02-26 06:09:22", "headline": "Cenovus Energy To Exercise Right To Redeem 2.577% Series 1 Preferred Shares And 3.948% Series 2 Preferred Shares On March 31", "summary": "", "symbols": ["CVE", "TSX:CVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50879919/cenovus-energy-to-exercise-right-to-redeem-2-577-series-1-preferred-shares-and-3-948-series-2-prefer", "tags": []}
{"id": 50879955, "time": "2026-02-26 06:09:54", "headline": "Gray Television Q4 EPS $(0.24) Misses $(0.20) Estimate, Sales $792.000M Beat $780.002M Estimate", "summary": "", "symbols": ["GTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879955/gray-television-q4-eps-0-24-misses-0-20-estimate-sales-792-000m-beat-780-002m-estimate", "tags": ["earnings"]}
{"id": 50879976, "time": "2026-02-26 06:10:06", "headline": "Gray Media: Q4 Earnings Insights", "summary": " ", "symbols": ["GTN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50879976/gray-media-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50879995, "time": "2026-02-26 06:10:35", "headline": "Fortrea Holdings Q4 Adj. EPS $0.09 Misses $0.16 Estimate, Sales $660.500M Miss $665.222M Estimate", "summary": "", "symbols": ["FTRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879995/fortrea-holdings-q4-adj-eps-0-09-misses-0-16-estimate-sales-660-500m-miss-665-222m-estimate", "tags": ["earnings"]}
{"id": 50879997, "time": "2026-02-26 06:10:41", "headline": "Enovis Q4 Adj. EPS $0.95 Beats $0.82 Estimate, Sales $575.758M Miss $583.848M Estimate", "summary": "", "symbols": ["ENOV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50879997/enovis-q4-adj-eps-0-95-beats-0-82-estimate-sales-575-758m-miss-583-848m-estimate", "tags": ["earnings"]}
{"id": 50880027, "time": "2026-02-26 06:11:10", "headline": "Enovis Sees FY2026 Adj EPS $3.52-$3.73 vs $3.43 Est; Sees Sales $2.310B-$2.370B vs $2.362B Est", "summary": "", "symbols": ["ENOV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880027/enovis-sees-fy2026-adj-eps-3-52-3-73-vs-3-43-est-sees-sales-2-310b-2-370b-vs-2-362b-est", "tags": ["earnings"]}
{"id": 50880040, "time": "2026-02-26 06:11:20", "headline": "Fortrea Holdings Sees FY2026 Sales $2.550B-$2.650B vs $2.736B Est", "summary": "", "symbols": ["FTRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880040/fortrea-holdings-sees-fy2026-sales-2-550b-2-650b-vs-2-736b-est", "tags": []}
{"id": 50880042, "time": "2026-02-26 06:11:24", "headline": "Nautilus Biotechnology Q4 EPS $(0.11) Beats $(0.14) Estimate", "summary": "", "symbols": ["NAUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50880042/nautilus-biotechnology-q4-eps-0-11-beats-0-14-estimate", "tags": ["earnings"]}
{"id": 50880066, "time": "2026-02-26 06:11:41", "headline": "Earnings Scheduled For February 26, 2026", "summary": " ", "symbols": ["AAOI", "ABTC", "ACA", "ACIW", "ACMR", "ACU", "ADSK", "AES", "AEVA", "AGO", "AHR", "AIRG", "AKBA", "ALHC", "ALTG", "AMBA", "AMBP", "AMPH", "ANIK", "ARBE", "ARGX", "ARHS", "ARLO", "ASUR", "AUGO", "AUPH", "AVPT", "BCO", "BCRX", "BCSF", "BDSX", "BFLY", "BHR", "BIDU", "BKSY", "BLD", "BLFS", "BMA", "BSY", "BUR", "BVN", "BWIN", "BWMX", "CABO", "CAI", "CARS", "CAS", "CCO", "CELH", "CERT", "CLOV", "CLPR", "CM", "CMBT", "CODI", "COLL", "COMP", "CON", "CPNG", "CRAI", "CRNX", "CRON", "CRWV", "CSTL", "CTKB", "CTRA", "CUBE", "DAIO", "DCI", "DCO", "DCTH", "DELL", "DFTX", "DH", "DNA", "DNUT", "DQ", "DRH", "DSX", "DUOL", "DV", "EBS", "ECVT", "EFR", "EIC", "EME", "ENOV", "EOSE", "ESTC", "EVTC", "EXE", "EXFY", "FA", "FCN", "FDUS", "FIGR", "FIGS", "FIP", "FLOC", "FLUT", "FOUR", "FOXF", "FSZ", "FTDR", "FTRE", "FWONA", "FWONK", "GCT", "GIL", "GLOB", "GOLF", "GRND", "GSBD", "GTN", "HAFN", "HEPS", "HGTY", "HGV", "HPP", "HRL", "HRTX", "HTZ", "IART", "IBP", "ICFI", "ICG", "INDV", "INOD", "INSW", "INTU", "IQ", "JWEL", "KBR", "KIDS", "KOP", "KRP", "KYMR", "LASR", "LGND", "LIND", "LNG", "LNTH", "LOAR", "MAIN", "MARA", "MASI", "MBI", "MCS", "MDXH", "MESO", "MFIC", "MIDD", "MNKD", "MNST", "MP", "MRP", "MTZ", "NAT", "NATL", "NCDL", "NCMI", "NEXA", "NHI", "NNI", "NOMD", "NRDY", "NREF", "NTAP", "NTLA", "NTRA", "NVAX", "NVCR", "NXST", "ONC", "OPK", "OPRA", "OPRT", "ORGO", "OS", "OSPN", "PACS", "PAR", "PAYO", "PBA", "PBYI", "PCRX", "PCT", "PEG", "PENN", "PGNY", "PHAT", "PLTK", "PPL", "PRAA", "PRGO", "PRKS", "PRM", "PRMB", "PRVA", "PSBD", "PSI", "PSNL", "PUBM", "PZZA", "Q", "QBTS", "QVCGA", "RC", "REAL", "RKLB", "RKT", "RLAY", "RLJ", "ROCK", "RUN", "RXT", "RY", "RYTM", "SBAC", "SEER", "SG", "SHAK", "SHEN", "SITC", "SJ", "SJM", "SMP", "SMR", "SNDX", "SOLV", "SOUN", "SPT", "SRE", "STLA", "STRA", "STRZ", "SUIG", "TD", "TDAY", "TFX", "TGLS", "TGTX", "THRY", "TIGO", "TKNO", "TLN", "TPC", "TRS", "TTEC", "TWI", "UUUU", "VCEL", "VIPS", "VISN", "VITL", "VST", "VTEX", "VTRS", "VYX", "WBD", "WD", "WFCF", "WLDN", "WRBY", "WULF", "WVE", "WWW", "XPOF", "XRAY", "XYZ", "ZLAB", "ZS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50880066/earnings-scheduled-for-february-26-2026", "tags": ["earnings"]}
{"id": 50880101, "time": "2026-02-26 06:12:25", "headline": "Nautilus Does Not Anticipate Material Revenue In 2026 From Early Access Program Engagement", "summary": "", "symbols": ["NAUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880101/nautilus-does-not-anticipate-material-revenue-in-2026-from-early-access-program-engagement", "tags": ["earnings"]}
{"id": 50880107, "time": "2026-02-26 06:12:29", "headline": "Primo Brands Expects Fiscal 2026 Organic Net Sales Growth Of 0%-1%", "summary": "", "symbols": ["PRMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880107/primo-brands-expects-fiscal-2026-organic-net-sales-growth-of-0-1", "tags": []}
{"id": 50880127, "time": "2026-02-26 06:12:48", "headline": "Acushnet Hldgs Q4 2025 EPS $(0.58) Misses $(0.28) Estimate, Sales $477.224M Beat $452.411M Estimate", "summary": "", "symbols": ["GOLF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50880127/acushnet-hldgs-q4-2025-eps-0-58-misses-0-28-estimate-sales-477-224m-beat-452-411m-estimate", "tags": ["earnings"]}
{"id": 50880143, "time": "2026-02-26 06:13:10", "headline": "Needham Maintains Buy on Alcon, Raises Price Target to $100", "summary": "", "symbols": ["ALC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880143/needham-maintains-buy-on-alcon-raises-price-target-to-100", "tags": ["analyst_other", "price_target_up"]}
{"id": 50880174, "time": "2026-02-26 06:14:04", "headline": "Titan Intl Q4 Adj. EPS $(0.27), Inline, Sales $410.439M Beat $403.502M Estimate", "summary": "", "symbols": ["TWI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50880174/titan-intl-q4-adj-eps-0-27-inline-sales-410-439m-beat-403-502m-estimate", "tags": ["earnings"]}
{"id": 50880175, "time": "2026-02-26 06:14:05", "headline": "Acushnet Declares An Increase Of Its Quarterly Cash Dividend Of 8.5% To $0.255/Share", "summary": "", "symbols": ["GOLF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880175/acushnet-declares-an-increase-of-its-quarterly-cash-dividend-of-8-5-to-0-255share", "tags": ["dividend"]}
{"id": 50880207, "time": "2026-02-26 06:14:53", "headline": "Acushnet Holdings Sees FY2026 Sales $2.625B-$2.675B vs $2.603B Est", "summary": "", "symbols": ["GOLF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880207/acushnet-holdings-sees-fy2026-sales-2-625b-2-675b-vs-2-603b-est", "tags": []}
{"id": 50880237, "time": "2026-02-26 06:15:50", "headline": "Needham Reiterates Buy on MoonLake, Maintains $25 Price Target", "summary": "", "symbols": ["MLTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880237/needham-reiterates-buy-on-moonlake-maintains-25-price-target", "tags": ["analyst_other"]}
{"id": 50880279, "time": "2026-02-26 06:16:45", "headline": "Titan Intl Sees Q1 Sales $490.000M-$510.000M vs $490.312M Est", "summary": "", "symbols": ["TWI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880279/titan-intl-sees-q1-sales-490-000m-510-000m-vs-490-312m-est", "tags": []}
{"id": 50880283, "time": "2026-02-26 06:16:49", "headline": "Trulieve Cannabis Q4 Adj. EPS $(0.02), Inline, Sales $293.100M Miss $297.092M Estimate", "summary": "", "symbols": ["TCNNF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50880283/trulieve-cannabis-q4-adj-eps-0-02-inline-sales-293-100m-miss-297-092m-estimate", "tags": ["earnings"]}
{"id": 50880318, "time": "2026-02-26 06:17:41", "headline": "Needham Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $103", "summary": "", "symbols": ["IONS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880318/needham-maintains-buy-on-ionis-pharmaceuticals-raises-price-target-to-103", "tags": ["analyst_other", "price_target_up"]}
{"id": 50880336, "time": "2026-02-26 06:18:08", "headline": "Earnings Summary: Trulieve Cannabis Q4", "summary": " ", "symbols": ["TCNNF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50880336/earnings-summary-trulieve-cannabis-q4", "tags": ["earnings"]}
{"id": 50880337, "time": "2026-02-26 06:18:12", "headline": "Titan Intl Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["TWI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50880337/titan-intl-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50880342, "time": "2026-02-26 06:18:18", "headline": "Earnings Summary: Acushnet Holdings Q4", "summary": " ", "symbols": ["GOLF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50880342/earnings-summary-acushnet-holdings-q4", "tags": ["earnings"]}
{"id": 50880485, "time": "2026-02-26 06:20:24", "headline": "BTIG Maintains Buy on Vaxcyte, Raises Price Target to $89", "summary": "", "symbols": ["PCVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880485/btig-maintains-buy-on-vaxcyte-raises-price-target-to-89", "tags": ["analyst_other", "price_target_up"]}
{"id": 50880535, "time": "2026-02-26 06:21:14", "headline": "HC Wainwright & Co. Upgrades Joby Aviation to Buy, Announces $18 Price Target", "summary": "", "symbols": ["JOBY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880535/hc-wainwright-co-upgrades-joby-aviation-to-buy-announces-18-price-target", "tags": ["analyst_up"]}
{"id": 50880553, "time": "2026-02-26 06:22:02", "headline": "Needham Maintains Buy on ExlService Hldgs, Lowers Price Target to $40", "summary": "", "symbols": ["EXLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880553/needham-maintains-buy-on-exlservice-hldgs-lowers-price-target-to-40", "tags": ["analyst_other", "price_target_down"]}
{"id": 50880572, "time": "2026-02-26 06:23:27", "headline": "NexPoint Real Estate Q4 Adj. EPS $0.48 Misses $0.49 Estimate, Sales $11.102M Miss $21.607M Estimate", "summary": "", "symbols": ["NREF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50880572/nexpoint-real-estate-q4-adj-eps-0-48-misses-0-49-estimate-sales-11-102m-miss-21-607m-estimate", "tags": ["earnings"]}
{"id": 50880573, "time": "2026-02-26 06:23:31", "headline": "Hormel Foods Q1 Adj. EPS $0.34 Beats $0.32 Estimate, Sales $3.033B Miss $3.067B Estimate", "summary": "", "symbols": ["HRL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50880573/hormel-foods-q1-adj-eps-0-34-beats-0-32-estimate-sales-3-033b-miss-3-067b-estimate", "tags": ["earnings"]}
{"id": 50880591, "time": "2026-02-26 06:24:08", "headline": "Earnings Summary: Hormel Foods Q1", "summary": " ", "symbols": ["HRL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50880591/earnings-summary-hormel-foods-q1", "tags": ["earnings"]}
{"id": 50880592, "time": "2026-02-26 06:24:09", "headline": "Hormel Foods Affirms FY2026 Adj EPS Guidance of $1.43-$1.51 vs $1.47 Est; Affirms FY2026 Sales Guidance of $12.200B-$12.500B vs $12.384B Est", "summary": "", "symbols": ["HRL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880592/hormel-foods-affirms-fy2026-adj-eps-guidance-of-1-43-1-51-vs-1-47-est-affirms-fy2026-sales-guidance", "tags": ["earnings", "guidance"]}
{"id": 50880593, "time": "2026-02-26 06:24:13", "headline": "NexPoint Real Estate Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["NREF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50880593/nexpoint-real-estate-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50880621, "time": "2026-02-26 06:24:54", "headline": "Needham Reiterates Buy on Recursion Pharmaceuticals, Maintains $8 Price Target", "summary": "", "symbols": ["RXRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880621/needham-reiterates-buy-on-recursion-pharmaceuticals-maintains-8-price-target", "tags": ["analyst_other"]}
{"id": 50880632, "time": "2026-02-26 06:25:45", "headline": "Cemex Agrees To Acquire All Assets Of Omega Products; Terms Undisclosed", "summary": "", "symbols": ["CX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50880632/cemex-agrees-to-acquire-all-assets-of-omega-products-terms-undisclosed", "tags": ["merger"]}
{"id": 50880648, "time": "2026-02-26 06:27:22", "headline": "What's Going On With Xpeng Stock Thursday?", "summary": "XPEV stock falls amid industry headwinds, despite plans for new robot factory in China. January deliveries down 34%.", "symbols": ["NIO", "TSLA", "XPEV"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50880648/whats-going-on-with-xpeng-stock-thursday", "tags": ["why_moving"]}
{"id": 50880659, "time": "2026-02-26 06:27:42", "headline": "BTIG Reiterates Buy on Invivyd, Maintains $10 Price Target", "summary": "", "symbols": ["IVVD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880659/btig-reiterates-buy-on-invivyd-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 50880771, "time": "2026-02-26 06:28:32", "headline": "Robo.ai And DaBoss.AI Complete Initial Collection And Delivery Of Intelligent Data In Middle East", "summary": "", "symbols": ["AIIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880771/robo-ai-and-daboss-ai-complete-initial-collection-and-delivery-of-intelligent-data-in-middle-east", "tags": []}
{"id": 50880785, "time": "2026-02-26 06:29:28", "headline": "Hormel Foods Raises FY2026 GAAP EPS Guidance from $1.29-$1.39 to $1.37-$1.46 vs $1.42 Est", "summary": "", "symbols": ["HRL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880785/hormel-foods-raises-fy2026-gaap-eps-guidance-from-1-29-1-39-to-1-37-1-46-vs-1-42-est", "tags": ["earnings", "guidance"]}
{"id": 50880828, "time": "2026-02-26 06:30:49", "headline": "Stellantis Weighs Using Chinese EV Tech for First Time in Europe - Bloomberg", "summary": "", "symbols": ["STLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880828/stellantis-weighs-using-chinese-ev-tech-for-first-time-in-europe-bloomberg", "tags": []}
{"id": 50880840, "time": "2026-02-26 06:31:16", "headline": "Butterfly Network Q4 Adj. EPS $(0.02) Beats $(0.06) Estimate, Sales $31.514M Beat $25.922M Estimate", "summary": "", "symbols": ["BFLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50880840/butterfly-network-q4-adj-eps-0-02-beats-0-06-estimate-sales-31-514m-beat-25-922m-estimate", "tags": ["earnings"]}
{"id": 50880841, "time": "2026-02-26 06:31:18", "headline": "Wolverine World Wide Q4 Adj. EPS $0.45 Beats $0.44 Estimate, Sales $517.500M Beat $510.718M Estimate", "summary": "", "symbols": ["WWW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50880841/wolverine-world-wide-q4-adj-eps-0-45-beats-0-44-estimate-sales-517-500m-beat-510-718m-estimate", "tags": ["earnings"]}
{"id": 50880864, "time": "2026-02-26 06:31:50", "headline": "Acme United Q4 EPS $0.46 Beats $0.42 Estimate, Sales $47.524M Miss $47.755M Estimate", "summary": "", "symbols": ["ACU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50880864/acme-united-q4-eps-0-46-beats-0-42-estimate-sales-47-524m-miss-47-755m-estimate", "tags": ["earnings"]}
{"id": 50880874, "time": "2026-02-26 06:31:59", "headline": "Needham Downgrades ODDITY Tech to Hold", "summary": "", "symbols": ["ODD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880874/needham-downgrades-oddity-tech-to-hold", "tags": ["analyst_down"]}
{"id": 50880883, "time": "2026-02-26 06:32:08", "headline": "Acme United Q4 Earnings Assessment", "summary": " ", "symbols": ["ACU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50880883/acme-united-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50880884, "time": "2026-02-26 06:32:13", "headline": "Butterfly Network Q4 Earnings Assessment", "summary": " ", "symbols": ["BFLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50880884/butterfly-network-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50880885, "time": "2026-02-26 06:32:15", "headline": "Wolverine World Wide Sees FY2026 Adj EPS $1.35-$1.50 vs $1.35 Est; Sees Sales $1.962B-$1.985B vs $1.953B Est", "summary": "", "symbols": ["WWW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880885/wolverine-world-wide-sees-fy2026-adj-eps-1-35-1-50-vs-1-35-est-sees-sales-1-962b-1-985b-vs-1-953b-es", "tags": ["earnings"]}
{"id": 50880888, "time": "2026-02-26 06:32:19", "headline": "Earnings Summary: Wolverine World Wide Q4", "summary": " ", "symbols": ["WWW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50880888/earnings-summary-wolverine-world-wide-q4", "tags": ["earnings"]}
{"id": 50880895, "time": "2026-02-26 06:32:22", "headline": "Butterfly Network Sees FY2026 Sales $117.000M-$121.000M vs $106.480M Est", "summary": "", "symbols": ["BFLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880895/butterfly-network-sees-fy2026-sales-117-000m-121-000m-vs-106-480m-est", "tags": []}
{"id": 50880924, "time": "2026-02-26 06:32:40", "headline": "Wolverine World Wide Sees FY2026 GAAP EPS $1.31-$1.46 vs $1.37 Est", "summary": "", "symbols": ["WWW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50880924/wolverine-world-wide-sees-fy2026-gaap-eps-1-31-1-46-vs-1-37-est", "tags": ["earnings"]}
{"id": 50880936, "time": "2026-02-26 06:32:42", "headline": "Toronto-Dominion Bank Q1 Adj. EPS C$2.44 Up From C$2.02 YoY, Sales C$16.585B Up From C$14.049B YoY.", "summary": "", "symbols": ["TD", "TSX:TD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50880936/toronto-dominion-bank-q1-adj-eps-c-2-44-up-from-c-2-02-yoy-sales-c-16-585b-up-from-c-14-049b-yoy", "tags": ["earnings"]}
{"id": 50880956, "time": "2026-02-26 06:33:14", "headline": "American Bitcoin Q4 Sales $78.321M Miss $79.641M Estimate, With Net Loss Of $59.45M Vs. Income Of $3.475M YoY", "summary": "", "symbols": ["ABTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50880956/american-bitcoin-q4-sales-78-321m-miss-79-641m-estimate-with-net-loss-of-59-45m-vs-income-of-3-475m", "tags": []}
{"id": 50880964, "time": "2026-02-26 06:33:22", "headline": "NCR Voyix Q4 Adj. EPS $0.31 Beats $0.29 Estimate, Sales $720.000M Beat $690.053M Estimate", "summary": "", "symbols": ["VYX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50880964/ncr-voyix-q4-adj-eps-0-31-beats-0-29-estimate-sales-720-000m-beat-690-053m-estimate", "tags": ["earnings"]}
{"id": 50880966, "time": "2026-02-26 06:33:24", "headline": "Perrigo Q4 Adj. EPS $0.77 Misses $0.79 Estimate, Sales $1.138B Beat $1.102B Estimate", "summary": "", "symbols": ["PRGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50880966/perrigo-q4-adj-eps-0-77-misses-0-79-estimate-sales-1-138b-beat-1-102b-estimate", "tags": ["earnings"]}
{"id": 50880987, "time": "2026-02-26 06:33:41", "headline": "Teleflex Q4 Adj. EPS $1.93 Misses $3.73 Estimate, Sales $568.984M Miss $919.302M Estimate", "summary": "", "symbols": ["TFX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50880987/teleflex-q4-adj-eps-1-93-misses-3-73-estimate-sales-568-984m-miss-919-302m-estimate", "tags": ["earnings"]}
{"id": 50881004, "time": "2026-02-26 06:34:02", "headline": "Toronto-Dominion Bank Q1 Adj. EPS US$1.75 Beats US$1.63 Estimate, Sales US$11.895B Beat US$11.140B Estimate.", "summary": "", "symbols": ["TD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881004/toronto-dominion-bank-q1-adj-eps-us-1-75-beats-us-1-63-estimate-sales-us-11-895b-beat-us-11-140b-es", "tags": ["earnings"]}
{"id": 50881006, "time": "2026-02-26 06:34:07", "headline": "Insights into Teleflex Q4 Earnings", "summary": " ", "symbols": ["TFX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881006/insights-into-teleflex-q4-earnings", "tags": ["earnings"]}
{"id": 50881016, "time": "2026-02-26 06:34:13", "headline": "Perrigo Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["PRGO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881016/perrigo-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50881023, "time": "2026-02-26 06:34:18", "headline": "Earnings Summary: NCR Voyix Q4", "summary": " ", "symbols": ["VYX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881023/earnings-summary-ncr-voyix-q4", "tags": ["earnings"]}
{"id": 50881030, "time": "2026-02-26 06:34:26", "headline": "Needham Maintains Buy on Immunocore Holdings, Raises Price Target to $75", "summary": "", "symbols": ["IMCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881030/needham-maintains-buy-on-immunocore-holdings-raises-price-target-to-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 50881034, "time": "2026-02-26 06:34:28", "headline": "Teleflex Sees FY2026 GAAP EPS $2.90-$3.20 vs $12.22 Est", "summary": "", "symbols": ["TFX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881034/teleflex-sees-fy2026-gaap-eps-2-90-3-20-vs-12-22-est", "tags": ["earnings"]}
{"id": 50881060, "time": "2026-02-26 06:34:45", "headline": "Top 3 Tech And Telecom Stocks You'll Regret Missing In February", "summary": " ", "symbols": ["ANGI", "FOX", "TTD"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/long-ideas/26/02/50881060/top-3-tech-and-telecom-stocks-youll-regret-missing-in-february", "tags": []}
{"id": 50881062, "time": "2026-02-26 06:34:47", "headline": "NCR Voyix Sees FY2026 Adj EPS $0.93-$0.96 vs $1.02 Est; Sees Sales $2.210B-$2.325B vs $2.224B Est", "summary": "", "symbols": ["VYX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881062/ncr-voyix-sees-fy2026-adj-eps-0-93-0-96-vs-1-02-est-sees-sales-2-210b-2-325b-vs-2-224b-est", "tags": ["earnings"]}
{"id": 50881079, "time": "2026-02-26 06:35:11", "headline": "Perrigo Sees FY2026 Adj EPS $2.25-$2.55 vs $2.65 Est,", "summary": "", "symbols": ["PRGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881079/perrigo-sees-fy2026-adj-eps-2-25-2-55-vs-2-65-est", "tags": ["earnings"]}
{"id": 50881095, "time": "2026-02-26 06:36:06", "headline": "BTIG Maintains Buy on CareDx, Raises Price Target to $26", "summary": "", "symbols": ["CDNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881095/btig-maintains-buy-on-caredx-raises-price-target-to-26", "tags": ["analyst_other", "price_target_up"]}
{"id": 50881097, "time": "2026-02-26 06:36:10", "headline": "Teleflex Sees FY2026 Adj EPS $6.25-$6.55 vs $14.28 Est; Sees Sales $2.280B-$2.300B vs $3.650B Est", "summary": "", "symbols": ["TFX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881097/teleflex-sees-fy2026-adj-eps-6-25-6-55-vs-14-28-est-sees-sales-2-280b-2-300b-vs-3-650b-est", "tags": ["earnings"]}
{"id": 50881114, "time": "2026-02-26 06:36:20", "headline": "Eli Lilly Shared Detailed Results From ACHIEVE-3, the first head-to-head Phase 3 trial Of Orforglipron Compared With Oral Semaglutide, Outperforming Oral Semaglutide Across Primary And All Key Secondary Endpoints", "summary": "", "symbols": ["LLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/26/02/50881114/eli-lilly-shared-detailed-results-from-achieve-3-the-first-head-to-head-phase-3-trial-of-orforgli", "tags": ["fda"]}
{"id": 50881125, "time": "2026-02-26 06:36:34", "headline": "Gildan Activewear Q4 Adj. EPS $0.96 Beats $0.94 Estimate, Sales $1.079B Beat $978.708M Estimate", "summary": "", "symbols": ["TSX:GIL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881125/gildan-activewear-q4-adj-eps-0-96-beats-0-94-estimate-sales-1-079b-beat-978-708m-estimate", "tags": ["earnings"]}
{"id": 50881135, "time": "2026-02-26 06:37:28", "headline": "United Parks & Resorts Q4 Adj. EPS $0.39 Misses $0.54 Estimate, Sales $373.547M Miss $376.461M Estimate", "summary": "", "symbols": ["PRKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881135/united-parks-resorts-q4-adj-eps-0-39-misses-0-54-estimate-sales-373-547m-miss-376-461m-estimate", "tags": ["earnings"]}
{"id": 50881144, "time": "2026-02-26 06:37:45", "headline": "Truist Securities Upgrades U.S. Bancorp to Buy, Raises Price Target to $66", "summary": "", "symbols": ["USB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881144/truist-securities-upgrades-u-s-bancorp-to-buy-raises-price-target-to-66", "tags": ["analyst_up", "price_target_up"]}
{"id": 50881152, "time": "2026-02-26 06:38:00", "headline": "Playtika Holding Q4 Adj. EPS $0.24 Beats $0.14 Estimate, Sales $678.800M Beat $661.911M Estimate", "summary": "", "symbols": ["PLTK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881152/playtika-holding-q4-adj-eps-0-24-beats-0-14-estimate-sales-678-800m-beat-661-911m-estimate", "tags": ["earnings"]}
{"id": 50881153, "time": "2026-02-26 06:38:01", "headline": "Gildan Activewear Sees FY2026 Adj EPS $4.20-$4.40 vs $4.46 Est; Sees Sales $6.000B-$6.200B vs $7.043B Est", "summary": "", "symbols": ["TSX:GIL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881153/gildan-activewear-sees-fy2026-adj-eps-4-20-4-40-vs-4-46-est-sees-sales-6-000b-6-200b-vs-7-043b-est", "tags": ["earnings"]}
{"id": 50881162, "time": "2026-02-26 06:38:08", "headline": "Earnings Summary: Playtika Holding Q4", "summary": " ", "symbols": ["PLTK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881162/earnings-summary-playtika-holding-q4", "tags": ["earnings"]}
{"id": 50881170, "time": "2026-02-26 06:38:14", "headline": "United Parks & Resorts Earnings Review: Q4 Summary", "summary": " ", "symbols": ["PRKS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881170/united-parks-resorts-earnings-review-q4-summary", "tags": ["earnings"]}
{"id": 50881187, "time": "2026-02-26 06:38:32", "headline": "Playtika Holding Sees FY2026 Sales $2.700B-$2.800B vs $2.805B Est", "summary": "", "symbols": ["PLTK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881187/playtika-holding-sees-fy2026-sales-2-700b-2-800b-vs-2-805b-est", "tags": []}
{"id": 50881199, "time": "2026-02-26 06:39:26", "headline": "BTIG Reiterates Buy on Steven Madden, Maintains $50 Price Target", "summary": "", "symbols": ["SHOO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881199/btig-reiterates-buy-on-steven-madden-maintains-50-price-target", "tags": ["analyst_other"]}
{"id": 50881214, "time": "2026-02-26 06:40:12", "headline": "Mark Salman To Lead Middleby's Food Processing Spin-Off As CEO In 2026, Tim FitzGerald Continues As CEO Of The Middleby Corporation During Business Separation", "summary": "", "symbols": ["MIDD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881214/mark-salman-to-lead-middlebys-food-processing-spin-off-as-ceo-in-2026-tim-fitzgerald-continues-as-ce", "tags": ["management"]}
{"id": 50881215, "time": "2026-02-26 06:40:16", "headline": "Compass Pathways Announces Exercise Of 35,059,448 Warrants For Proceeds Of ~$200M", "summary": "", "symbols": ["CMPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881215/compass-pathways-announces-exercise-of-35-059-448-warrants-for-proceeds-of-200m", "tags": []}
{"id": 50881242, "time": "2026-02-26 06:44:27", "headline": "Nuvalent Q4 EPS $(1.58) Misses $(1.49) Estimate", "summary": "", "symbols": ["NUVL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881242/nuvalent-q4-eps-1-58-misses-1-49-estimate", "tags": ["earnings"]}
{"id": 50881251, "time": "2026-02-26 06:44:45", "headline": "Perrigo Sees FY2026 Adj EPS $2.25-$2.55 vs $2.65 Est; Sees Sales $4.019B-$4.189B vs $4.171B Est", "summary": "", "symbols": ["PRGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881251/perrigo-sees-fy2026-adj-eps-2-25-2-55-vs-2-65-est-sees-sales-4-019b-4-189b-vs-4-171b-est", "tags": ["earnings"]}
{"id": 50881271, "time": "2026-02-26 06:45:42", "headline": "This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday", "summary": " ", "symbols": ["FSLR", "RNR", "SCCO", "SPOK", "TTD"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50881271/this-trade-desk-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-thursday-2", "tags": ["analyst_down"]}
{"id": 50881272, "time": "2026-02-26 06:45:47", "headline": "Warby Parker Q4 EPS $(0.05) Misses $0.02 Estimate, Sales $211.968M Miss $213.056M Estimate", "summary": "", "symbols": ["WRBY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881272/warby-parker-q4-eps-0-05-misses-0-02-estimate-sales-211-968m-miss-213-056m-estimate", "tags": ["earnings"]}
{"id": 50881289, "time": "2026-02-26 06:46:09", "headline": "Warby Parker: Q4 Earnings Insights", "summary": " ", "symbols": ["WRBY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881289/warby-parker-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50881304, "time": "2026-02-26 06:46:56", "headline": "Nomad Foods Q4 Adj. EPS $0.50, Inline, Sales $900.005M Miss $908.930M Estimate", "summary": "", "symbols": ["NOMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881304/nomad-foods-q4-adj-eps-0-50-inline-sales-900-005m-miss-908-930m-estimate", "tags": ["earnings"]}
{"id": 50881305, "time": "2026-02-26 06:46:58", "headline": "Warby Parker Sees FY2026 Sales $959.000M-$976.000M vs $986.970M Est", "summary": "", "symbols": ["WRBY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881305/warby-parker-sees-fy2026-sales-959-000m-976-000m-vs-986-970m-est", "tags": []}
{"id": 50881308, "time": "2026-02-26 06:47:03", "headline": "International Seaways Q4 Adj. EPS $2.45 Beats $1.92 Estimate, Sales $267.879M Beat $244.650M Estimate", "summary": "", "symbols": ["INSW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881308/international-seaways-q4-adj-eps-2-45-beats-1-92-estimate-sales-267-879m-beat-244-650m-estimate", "tags": ["earnings"]}
{"id": 50881314, "time": "2026-02-26 06:47:05", "headline": "Gildan Activewear Q4 Adj. EPS $0.96 Beats $0.95 Estimate, Sales $1.079B Beat $1.041B Estimate", "summary": "", "symbols": ["GIL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881314/gildan-activewear-q4-adj-eps-0-96-beats-0-95-estimate-sales-1-079b-beat-1-041b-estimate", "tags": ["earnings"]}
{"id": 50881344, "time": "2026-02-26 06:47:39", "headline": "Nomad Foods Sees FY2026 Adj EPS $1.71-$1.89 vs $2.06 Est", "summary": "", "symbols": ["NOMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881344/nomad-foods-sees-fy2026-adj-eps-1-71-1-89-vs-2-06-est", "tags": ["earnings"]}
{"id": 50881353, "time": "2026-02-26 06:47:58", "headline": "BTIG Maintains Buy on TJX Companies, Raises Price Target to $185", "summary": "", "symbols": ["TJX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881353/btig-maintains-buy-on-tjx-companies-raises-price-target-to-185", "tags": ["analyst_other", "price_target_up"]}
{"id": 50881361, "time": "2026-02-26 06:48:05", "headline": "Gildan Activewear Sees FY2026 Adj EPS $4.20-$4.40 vs $4.51 Est", "summary": "", "symbols": ["GIL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881361/gildan-activewear-sees-fy2026-adj-eps-4-20-4-40-vs-4-51-est", "tags": ["earnings"]}
{"id": 50881363, "time": "2026-02-26 06:48:09", "headline": "Earnings Breakdown: Gildan Activewear Q4", "summary": " ", "symbols": ["GIL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881363/earnings-breakdown-gildan-activewear-q4", "tags": ["earnings"]}
{"id": 50881372, "time": "2026-02-26 06:48:14", "headline": "International Seaways Earnings Report: Q4 Overview", "summary": " ", "symbols": ["INSW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881372/international-seaways-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50881375, "time": "2026-02-26 06:48:19", "headline": "Nomad Foods Earnings Review: Q4 Summary", "summary": " ", "symbols": ["NOMD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881375/nomad-foods-earnings-review-q4-summary", "tags": ["earnings"]}
{"id": 50881400, "time": "2026-02-26 06:48:59", "headline": "TopBuild Q4 Adj. EPS $4.50 Misses $4.54 Estimate, Sales $1.485B Miss $1.490B Estimate", "summary": "", "symbols": ["BLD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881400/topbuild-q4-adj-eps-4-50-misses-4-54-estimate-sales-1-485b-miss-1-490b-estimate", "tags": ["earnings"]}
{"id": 50881411, "time": "2026-02-26 06:49:46", "headline": "Nordic American Tankers Q4 EPS $0.06 Misses $0.09 Estimate, Sales $58.755M Miss $72.166M Estimate", "summary": "", "symbols": ["NAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881411/nordic-american-tankers-q4-eps-0-06-misses-0-09-estimate-sales-58-755m-miss-72-166m-estimate", "tags": ["earnings"]}
{"id": 50881412, "time": "2026-02-26 06:49:50", "headline": "TopBuild Sees FY2026 Sales $5.925B-$6.225B vs $6.165B Est", "summary": "", "symbols": ["BLD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881412/topbuild-sees-fy2026-sales-5-925b-6-225b-vs-6-165b-est", "tags": []}
{"id": 50881430, "time": "2026-02-26 06:50:14", "headline": "Earnings Breakdown: Nordic American Tankers Q4", "summary": " ", "symbols": ["NAT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881430/earnings-breakdown-nordic-american-tankers-q4", "tags": ["earnings"]}
{"id": 50881443, "time": "2026-02-26 06:50:50", "headline": "Vistance Networks Q4 Adj. EPS $0.17 Misses $0.45 Estimate, Sales $514.500M Miss $1.524B Estimate", "summary": "", "symbols": ["VISN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881443/vistance-networks-q4-adj-eps-0-17-misses-0-45-estimate-sales-514-500m-miss-1-524b-estimate", "tags": ["earnings"]}
{"id": 50881452, "time": "2026-02-26 06:51:05", "headline": "BTIG Maintains Buy on CoStar Group, Lowers Price Target to $60", "summary": "", "symbols": ["CSGP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881452/btig-maintains-buy-on-costar-group-lowers-price-target-to-60", "tags": ["analyst_other", "price_target_down"]}
{"id": 50881461, "time": "2026-02-26 06:51:13", "headline": "Krispy Kreme Q4 Adj. EPS $0.09 Beats $0.03 Estimate, Sales $392.367M Beat $386.715M Estimate", "summary": "", "symbols": ["DNUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881461/krispy-kreme-q4-adj-eps-0-09-beats-0-03-estimate-sales-392-367m-beat-386-715m-estimate", "tags": ["earnings"]}
{"id": 50881473, "time": "2026-02-26 06:52:07", "headline": "Earnings Breakdown: Krispy Kreme Q4", "summary": " ", "symbols": ["DNUT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881473/earnings-breakdown-krispy-kreme-q4", "tags": ["earnings"]}
{"id": 50881474, "time": "2026-02-26 06:52:17", "headline": "Arthur J. Gallagher Acquires Krose GmbH; Terms Not Disclosed", "summary": "", "symbols": ["AJG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50881474/arthur-j-gallagher-acquires-krose-gmbh-terms-not-disclosed", "tags": ["merger"]}
{"id": 50881503, "time": "2026-02-26 06:53:27", "headline": "Krispy Kreme Reported  Global Points of Access Of 15,194 As of December 28, 2025,  Digital Sales As Percent of Retail Sales Was 18.2%", "summary": "", "symbols": ["DNUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881503/krispy-kreme-reported-global-points-of-access-of-15-194-as-of-december-28-2025-digital-sales-as-per", "tags": []}
{"id": 50881525, "time": "2026-02-26 06:54:39", "headline": "Krispy Kreme Expects Fiscal 2026 Systemwide Sales Up 2% to 4% In Constant Currency From $1.96B In 2025", "summary": "", "symbols": ["DNUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881525/krispy-kreme-expects-fiscal-2026-systemwide-sales-up-2-to-4-in-constant-currency-from-1-96b-in-2025", "tags": []}
{"id": 50881534, "time": "2026-02-26 06:54:49", "headline": "BTIG Maintains Buy on DraftKings, Lowers Price Target to $35", "summary": "", "symbols": ["DKNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881534/btig-maintains-buy-on-draftkings-lowers-price-target-to-35", "tags": ["analyst_other", "price_target_down"]}
{"id": 50881543, "time": "2026-02-26 06:54:58", "headline": "Musk's Tesla Robotaxi Is Cheaper Than Waymo, But Longer Waiting Times And More Human Drivers Are A Drag, Analysts Say", "summary": "Tesla&#39;s Robotaxi service in Austin is over 2x cheaper than rival Waymo, but underperforms in terms of efficiency.", "symbols": ["GOOG", "GOOGL", "TSLA", "UBER"], "source": "benzinga", "author": "Badar Shaikh", "url": "https://www.benzinga.com/markets/tech/26/02/50881543/musks-tesla-robotaxi-is-cheaper-than-waymo-but-longer-waiting-times-and-more-human-drivers-are-a-drag-analysts-say", "tags": []}
{"id": 50881546, "time": "2026-02-26 06:55:04", "headline": "Trading Halt: Halted at 6:55:00 a.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["VCTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/26/02/50881546/trading-halt-halted-at-6-55-00-a-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 50881566, "time": "2026-02-26 06:55:50", "headline": "B of A Securities Maintains Neutral on Recursion Pharmaceuticals, Lowers Price Target to $6", "summary": "", "symbols": ["RXRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881566/b-of-a-securities-maintains-neutral-on-recursion-pharmaceuticals-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 50881686, "time": "2026-02-26 06:59:14", "headline": "B of A Securities Maintains Buy on Nutanix, Lowers Price Target to $60", "summary": "", "symbols": ["NTNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881686/b-of-a-securities-maintains-buy-on-nutanix-lowers-price-target-to-60", "tags": ["analyst_other", "price_target_down"]}
{"id": 50881687, "time": "2026-02-26 06:59:16", "headline": "Hagerty Q4 Adj. EPS $0.08 Beats $0.04 Estimate, Sales $357.000M Beat $324.942M Estimate", "summary": "", "symbols": ["HGTY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881687/hagerty-q4-adj-eps-0-08-beats-0-04-estimate-sales-357-000m-beat-324-942m-estimate", "tags": ["earnings"]}
{"id": 50881704, "time": "2026-02-26 06:59:55", "headline": "Viatris Q4 Adj. EPS $0.57 Beats $0.53 Estimate, Sales $3.690B Beat $3.532B Estimate", "summary": "", "symbols": ["VTRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881704/viatris-q4-adj-eps-0-57-beats-0-53-estimate-sales-3-690b-beat-3-532b-estimate", "tags": ["earnings"]}
{"id": 50881767, "time": "2026-02-26 07:00:09", "headline": "Insights into Viatris Q4 Earnings", "summary": " ", "symbols": ["VTRS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881767/insights-into-viatris-q4-earnings", "tags": ["earnings"]}
{"id": 50881784, "time": "2026-02-26 07:00:15", "headline": "Hagerty Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["HGTY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881784/hagerty-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50881814, "time": "2026-02-26 07:00:30", "headline": "What Analysts Are Saying About U.S. Bancorp Stock", "summary": " ", "symbols": ["USB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50881814/what-analysts-are-saying-about-u-s-bancorp-stock", "tags": []}
{"id": 50881817, "time": "2026-02-26 07:00:31", "headline": "NextEra Energy Intends To Sell $2B Of Equity Units In A Public Offering. Nextera Energy, Inc. Expects To Grant To The Underwriters An Option To Purchase Up To An Additional $0.3B", "summary": "", "symbols": ["NEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/commodities/26/02/50881817/nextera-energy-intends-to-sell-2b-of-equity-units-in-a-public-offering-nextera-energy-inc-exp", "tags": ["offering"]}
{"id": 50881852, "time": "2026-02-26 07:00:38", "headline": "Forecasting The Future: 5 Analyst Projections For PROCEPT BioRobotics", "summary": " ", "symbols": ["PRCT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50881852/forecasting-the-future-5-analyst-projections-for-procept-biorobotics", "tags": []}
{"id": 50881854, "time": "2026-02-26 07:00:45", "headline": "A Glimpse Into The Expert Outlook On TJX Companies Through 9 Analysts", "summary": " ", "symbols": ["TJX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50881854/a-glimpse-into-the-expert-outlook-on-tjx-companies-through-9-analysts", "tags": ["guidance"]}
{"id": 50881857, "time": "2026-02-26 07:00:53", "headline": "Forecasting The Future: 15 Analyst Projections For RenaissanceRe Holdings", "summary": " ", "symbols": ["RNR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50881857/forecasting-the-future-15-analyst-projections-for-renaissancere-holdings", "tags": []}
{"id": 50881877, "time": "2026-02-26 07:01:08", "headline": "6 Analysts Have This To Say About Ionis Pharmaceuticals", "summary": " ", "symbols": ["IONS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50881877/6-analysts-have-this-to-say-about-ionis-pharmaceuticals", "tags": []}
{"id": 50881879, "time": "2026-02-26 07:01:09", "headline": "Indivior Q4 Adj. EPS $0.82 Beats $0.67 Estimate, Sales $358.000M Beat $305.620M Estimate", "summary": "", "symbols": ["INDV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881879/indivior-q4-adj-eps-0-82-beats-0-67-estimate-sales-358-000m-beat-305-620m-estimate", "tags": ["earnings"]}
{"id": 50881886, "time": "2026-02-26 07:01:14", "headline": "Viatris Sees FY2026 Adj EPS $2.33-$2.47 vs $2.49 Est; Sees Sales $14.450B-$14.950B vs $14.351B Est", "summary": "", "symbols": ["VTRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881886/viatris-sees-fy2026-adj-eps-2-33-2-47-vs-2-49-est-sees-sales-14-450b-14-950b-vs-14-351b-est", "tags": ["earnings"]}
{"id": 50881887, "time": "2026-02-26 07:01:16", "headline": "What Analysts Are Saying About CoStar Group Stock", "summary": " ", "symbols": ["CSGP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50881887/what-analysts-are-saying-about-costar-group-stock", "tags": []}
{"id": 50881895, "time": "2026-02-26 07:01:27", "headline": "Shenandoah Q4 EPS $(0.10) Beats $(0.15) Estimate, Sales $91.592M Beat $90.026M Estimate", "summary": "", "symbols": ["SHEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881895/shenandoah-q4-eps-0-10-beats-0-15-estimate-sales-91-592m-beat-90-026m-estimate", "tags": ["earnings"]}
{"id": 50881897, "time": "2026-02-26 07:01:29", "headline": "Lantheus Holdings Q4 Adj. EPS $1.67 Beats $1.17 Estimate, Sales $406.786M Beat $367.820M Estimate", "summary": "", "symbols": ["LNTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881897/lantheus-holdings-q4-adj-eps-1-67-beats-1-17-estimate-sales-406-786m-beat-367-820m-estimate", "tags": ["earnings"]}
{"id": 50881899, "time": "2026-02-26 07:01:31", "headline": "Phathom Pharmaceuticals Q4 Adj. EPS $(0.08) Beats $(0.38) Estimate, Sales $57.584M Beat $57.050M Estimate", "summary": "", "symbols": ["PHAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881899/phathom-pharmaceuticals-q4-adj-eps-0-08-beats-0-38-estimate-sales-57-584m-beat-57-050m-estimate", "tags": ["earnings"]}
{"id": 50881902, "time": "2026-02-26 07:01:33", "headline": "Ligand Pharmaceuticals Q4 Adj. EPS $2.02 Beats $1.56 Estimate, Sales $59.666M Beat $55.589M Estimate.", "summary": "", "symbols": ["LGND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881902/ligand-pharmaceuticals-q4-adj-eps-2-02-beats-1-56-estimate-sales-59-666m-beat-55-589m-estimate", "tags": ["earnings"]}
{"id": 50881908, "time": "2026-02-26 07:01:47", "headline": "Indivior Pharmaceuticals Affirms FY2026 Sales Guidance of $1.125B-$1.195B", "summary": "", "symbols": ["INDV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881908/indivior-pharmaceuticals-affirms-fy2026-sales-guidance-of-1-125b-1-195b", "tags": ["guidance"]}
{"id": 50881913, "time": "2026-02-26 07:01:51", "headline": "Kymera Therapeutics Q4 EPS $(0.97) Misses $(0.78) Estimate, Sales $2.871M Miss $14.798M Estimate. Cash And Equivalents Of $1.6B", "summary": "", "symbols": ["KYMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881913/kymera-therapeutics-q4-eps-0-97-misses-0-78-estimate-sales-2-871m-miss-14-798m-estimate-cash-and-eq", "tags": ["earnings"]}
{"id": 50881920, "time": "2026-02-26 07:01:57", "headline": "Shenandoah Sees FY2026 Sales $370.000M-$377.000M vs $373.909M Est", "summary": "", "symbols": ["SHEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881920/shenandoah-sees-fy2026-sales-370-000m-377-000m-vs-373-909m-est", "tags": []}
{"id": 50881924, "time": "2026-02-26 07:02:05", "headline": "Hidden AI Costs? Big Tech Hyperscalers Hold $662 Billion In Off-Balance-Sheet Data Center Leases: Report", "summary": "Moody&#39;s Ratings revealed that the five leading hyperscalers, Amazon.com Inc. (NASDAQ: AMZN), Meta Platforms Inc.\u00a0(NASDAQ:META), Alphabet Inc.\u00a0(NASDAQ:GOOG)\u00a0(NASDAQ:GOOGL), Microsoft Corp. (NASDAQ: MSFT) and Oracle Corp. (NYSE: ORCL), have racked up $662 billion in future data center lease obligations that remain off their balance sheets.", "symbols": ["AMZN", "BX", "GOOG", "GOOGL", "KKR", "MSFT", "ORCL"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/tech/26/02/50881924/hidden-ai-costs-big-tech-hyperscalers-hold-662-billion-in-off-balance-sheet-data-center-leases-report", "tags": []}
{"id": 50881926, "time": "2026-02-26 07:02:07", "headline": "Middleby Q4 Adj. EPS $2.42 Beats $2.27 Estimate, Sales $866.425M Miss $985.972M Estimate", "summary": "", "symbols": ["MIDD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881926/middleby-q4-adj-eps-2-42-beats-2-27-estimate-sales-866-425m-miss-985-972m-estimate", "tags": ["earnings"]}
{"id": 50881928, "time": "2026-02-26 07:02:08", "headline": "Phathom Pharmaceuticals Earnings Review: Q4 Summary", "summary": " ", "symbols": ["PHAT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881928/phathom-pharmaceuticals-earnings-review-q4-summary", "tags": ["earnings"]}
{"id": 50881929, "time": "2026-02-26 07:02:10", "headline": "Shake Shack Q4 Adj. EPS $0.37 Beats $0.35 Estimate, Sales $400.531M Miss $401.318M Estimate", "summary": "", "symbols": ["SHAK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881929/shake-shack-q4-adj-eps-0-37-beats-0-35-estimate-sales-400-531m-miss-401-318m-estimate", "tags": ["earnings"]}
{"id": 50881931, "time": "2026-02-26 07:02:13", "headline": "Kymera Therapeutics Earnings Review: Q4 Summary", "summary": " ", "symbols": ["KYMR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881931/kymera-therapeutics-earnings-review-q4-summary", "tags": ["earnings"]}
{"id": 50881932, "time": "2026-02-26 07:02:19", "headline": "Ligand Pharmaceuticals: Q4 Earnings Insights", "summary": " ", "symbols": ["LGND"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881932/ligand-pharmaceuticals-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50881936, "time": "2026-02-26 07:02:23", "headline": "TG Therapeutics Q4 2025 EPS $0.14 Misses $0.33 Estimate, Sales $192.574M Beat $192.213M Estimate", "summary": "", "symbols": ["TGTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881936/tg-therapeutics-q4-2025-eps-0-14-misses-0-33-estimate-sales-192-574m-beat-192-213m-estimate", "tags": ["earnings"]}
{"id": 50881937, "time": "2026-02-26 07:02:24", "headline": "Shenandoah Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["SHEN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881937/shenandoah-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50881941, "time": "2026-02-26 07:02:28", "headline": "Insights into Indivior Pharmaceuticals Q4 Earnings", "summary": " ", "symbols": ["INDV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50881941/insights-into-indivior-pharmaceuticals-q4-earnings", "tags": ["earnings"]}
{"id": 50881947, "time": "2026-02-26 07:02:35", "headline": "D-Wave Quantum Q4 Adj. EPS $(0.09) Misses $(0.07) Estimate, Sales $2.752M Miss $3.749M Estimate", "summary": "", "symbols": ["QBTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881947/d-wave-quantum-q4-adj-eps-0-09-misses-0-07-estimate-sales-2-752m-miss-3-749m-estimate", "tags": ["earnings"]}
{"id": 50881948, "time": "2026-02-26 07:02:35", "headline": "Phathom Pharmaceuticals Sees FY2026 Sales $320.000M-$345.000M vs $314.481M Est", "summary": "", "symbols": ["PHAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881948/phathom-pharmaceuticals-sees-fy2026-sales-320-000m-345-000m-vs-314-481m-est", "tags": []}
{"id": 50881953, "time": "2026-02-26 07:02:43", "headline": "Certara Q4 Adj. EPS $0.09 Misses $0.11 Estimate, Sales $103.600M Beat $103.193M Estimate", "summary": "", "symbols": ["CERT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881953/certara-q4-adj-eps-0-09-misses-0-11-estimate-sales-103-600m-beat-103-193m-estimate", "tags": ["earnings"]}
{"id": 50881956, "time": "2026-02-26 07:02:45", "headline": "Hilton Grand Vacations Q4 Adj. EPS $0.88 Misses $1.01 Estimate, Sales $1.333B Miss $1.354B Estimate", "summary": "", "symbols": ["HGV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881956/hilton-grand-vacations-q4-adj-eps-0-88-misses-1-01-estimate-sales-1-333b-miss-1-354b-estimate", "tags": ["earnings"]}
{"id": 50881969, "time": "2026-02-26 07:02:59", "headline": "GigaCloud Tech Q4 Adj. EPS $1.16 Beats $0.75 Estimate, Sales $362.767M Beat $326.894M Estimate", "summary": "", "symbols": ["GCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881969/gigacloud-tech-q4-adj-eps-1-16-beats-0-75-estimate-sales-362-767m-beat-326-894m-estimate", "tags": ["earnings"]}
{"id": 50881971, "time": "2026-02-26 07:03:03", "headline": "Bentley Systems Q4 Adj. EPS $0.27 Beats $0.26 Estimate, Sales $391.582M Beat $381.822M Estimate", "summary": "", "symbols": ["BSY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881971/bentley-systems-q4-adj-eps-0-27-beats-0-26-estimate-sales-391-582m-beat-381-822m-estimate", "tags": ["earnings"]}
{"id": 50881972, "time": "2026-02-26 07:03:03", "headline": "Ligand Pharmaceuticals Affirms FY2026 Adj EPS Guidance of $8.00-$9.00 vs $8.29 Est; Affirms FY2026 Sales Guidance of $245.000M-$285.000M vs $265.679M Est.", "summary": "", "symbols": ["LGND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881972/ligand-pharmaceuticals-affirms-fy2026-adj-eps-guidance-of-8-00-9-00-vs-8-29-est-affirms-fy2026-sales", "tags": ["earnings", "guidance"]}
{"id": 50881976, "time": "2026-02-26 07:03:09", "headline": "Lantheus Holdings Sees FY2026 Adj EPS $5.00-$5.25 vs $5.51 Est; Sees Sales $1.400B-$1.450B vs $1.508B Est", "summary": "", "symbols": ["LNTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881976/lantheus-holdings-sees-fy2026-adj-eps-5-00-5-25-vs-5-51-est-sees-sales-1-400b-1-450b-vs-1-508b-est", "tags": ["earnings"]}
{"id": 50881979, "time": "2026-02-26 07:03:11", "headline": "JM Smucker Q3 Adj. EPS $2.38 Beats $2.27 Estimate, Sales $2.339B Beat $2.322B Estimate", "summary": "", "symbols": ["SJM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881979/jm-smucker-q3-adj-eps-2-38-beats-2-27-estimate-sales-2-339b-beat-2-322b-estimate", "tags": ["earnings"]}
{"id": 50881985, "time": "2026-02-26 07:03:17", "headline": "NovoCure Q4 EPS $(0.22) Beats $(0.41) Estimate, Sales $174.350M Beat $173.355M Estimate", "summary": "", "symbols": ["NVCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50881985/novocure-q4-eps-0-22-beats-0-41-estimate-sales-174-350m-beat-173-355m-estimate", "tags": ["earnings"]}
{"id": 50881987, "time": "2026-02-26 07:03:19", "headline": "TG Therapeutics Affirms FY2026 Sales Guidance of $875.000M-$900.000M", "summary": "", "symbols": ["TGTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50881987/tg-therapeutics-affirms-fy2026-sales-guidance-of-875-000m-900-000m", "tags": ["guidance"]}
{"id": 50882004, "time": "2026-02-26 07:03:33", "headline": "Papa John's International Q4 Adj. EPS $0.34, Inline, Sales $498.179M Miss $515.002M Estimate", "summary": "", "symbols": ["PZZA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882004/papa-johns-international-q4-adj-eps-0-34-inline-sales-498-179m-miss-515-002m-estimate", "tags": ["earnings"]}
{"id": 50882045, "time": "2026-02-26 07:04:01", "headline": "Arbe Robotics Q4 Adj. EPS $(0.08) Beats $(0.09) Estimate, Sales $458.000K Miss $664.900K Estimate", "summary": "", "symbols": ["ARBE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882045/arbe-robotics-q4-adj-eps-0-08-beats-0-09-estimate-sales-458-000k-miss-664-900k-estimate", "tags": ["earnings"]}
{"id": 50882053, "time": "2026-02-26 07:04:04", "headline": "NovoCure Sees FY2026 Sales $675.000M-$705.000M vs $681.975M Est", "summary": "", "symbols": ["NVCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882053/novocure-sees-fy2026-sales-675-000m-705-000m-vs-681-975m-est", "tags": []}
{"id": 50882054, "time": "2026-02-26 07:04:05", "headline": "Certara Sees FY2026 Adj EPS $0.44-$0.48 vs $0.54 Est, FY 2026 Revenue Growth of 0%-4%", "summary": "", "symbols": ["CERT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882054/certara-sees-fy2026-adj-eps-0-44-0-48-vs-0-54-est-fy-2026-revenue-growth-of-0-4", "tags": ["earnings"]}
{"id": 50882055, "time": "2026-02-26 07:04:06", "headline": "PROCEPT BioRobotics Stock Hits 52-Week Low - Here's Why", "summary": "PROCEPT BioRobotics (NASDAQ: PRCT) shares down on Q4 2025 results and updated revenue guidance. Q1 sales expected at $79-82 million.", "symbols": ["PRCT"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/markets/earnings/26/02/50882055/procept-biorobotics-stock-hits-52-week-low-heres-why", "tags": ["earnings", "guidance"]}
{"id": 50882065, "time": "2026-02-26 07:04:12", "headline": "Arbe Robotics: Q4 Earnings Insights", "summary": " ", "symbols": ["ARBE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882065/arbe-robotics-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50882073, "time": "2026-02-26 07:04:18", "headline": "JM Smucker Q3 Earnings Assessment", "summary": " ", "symbols": ["SJM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882073/jm-smucker-q3-earnings-assessment", "tags": ["earnings"]}
{"id": 50882076, "time": "2026-02-26 07:04:18", "headline": "Palmer Square Capital BDC Q4 EPS $0.41, Inline, Sales $29.800M Miss $30.477M Estimate", "summary": "", "symbols": ["PSBD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882076/palmer-square-capital-bdc-q4-eps-0-41-inline-sales-29-800m-miss-30-477m-estimate", "tags": ["earnings"]}
{"id": 50882079, "time": "2026-02-26 07:04:20", "headline": "TG Therapeutics Expects Q1 2026 BRIUMVI US Net Product Revenue Of ~$185M-$190M", "summary": "", "symbols": ["TGTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/26/02/50882079/tg-therapeutics-expects-q1-2026-briumvi-us-net-product-revenue-of-185m-190m", "tags": ["earnings"]}
{"id": 50882082, "time": "2026-02-26 07:04:22", "headline": "NovoCure Earnings Report: Q4 Overview", "summary": " ", "symbols": ["NVCR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882082/novocure-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50882090, "time": "2026-02-26 07:04:28", "headline": "Earnings Summary: GigaCloud Tech Q4", "summary": " ", "symbols": ["GCT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882090/earnings-summary-gigacloud-tech-q4", "tags": ["earnings"]}
{"id": 50882096, "time": "2026-02-26 07:04:30", "headline": "Akebia Therapeutics Q4 EPS $(0.05) Misses $(0.03) Estimate, Sales $57.620M Beat $48.373M Estimate.", "summary": "", "symbols": ["AKBA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882096/akebia-therapeutics-q4-eps-0-05-misses-0-03-estimate-sales-57-620m-beat-48-373m-estimate", "tags": ["earnings"]}
{"id": 50882100, "time": "2026-02-26 07:04:32", "headline": "Arbe Robotics Sees FY2026 Sales $4.000M-$6.000M vs $8.291M Est", "summary": "", "symbols": ["ARBE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882100/arbe-robotics-sees-fy2026-sales-4-000m-6-000m-vs-8-291m-est", "tags": []}
{"id": 50882101, "time": "2026-02-26 07:04:32", "headline": "Vital Farms Q4 EPS $0.35 Misses $0.40 Estimate, Sales $213.552M Miss $214.439M Estimate", "summary": "", "symbols": ["VITL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882101/vital-farms-q4-eps-0-35-misses-0-40-estimate-sales-213-552m-miss-214-439m-estimate", "tags": ["earnings"]}
{"id": 50882102, "time": "2026-02-26 07:04:32", "headline": "Bentley Systems Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["BSY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882102/bentley-systems-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50882108, "time": "2026-02-26 07:04:38", "headline": "Hilton Grand Vacations Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["HGV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882108/hilton-grand-vacations-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50882121, "time": "2026-02-26 07:04:43", "headline": "Earnings Breakdown: Certara Q4", "summary": " ", "symbols": ["CERT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882121/earnings-breakdown-certara-q4", "tags": ["earnings"]}
{"id": 50882131, "time": "2026-02-26 07:04:47", "headline": "TG Therapeutics Q4 Earnings Assessment", "summary": " ", "symbols": ["TGTX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882131/tg-therapeutics-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50882137, "time": "2026-02-26 07:04:52", "headline": "D-Wave Quantum Earnings Report: Q4 Overview", "summary": " ", "symbols": ["QBTS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882137/d-wave-quantum-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50882148, "time": "2026-02-26 07:04:57", "headline": "Shake Shack Q4 Earnings Assessment", "summary": " ", "symbols": ["SHAK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882148/shake-shack-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50882165, "time": "2026-02-26 07:05:04", "headline": "JM Smucker Affirms FY2026 Adj EPS Guidance of $8.75-$9.25 vs $8.99 Est", "summary": "", "symbols": ["SJM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882165/jm-smucker-affirms-fy2026-adj-eps-guidance-of-8-75-9-25-vs-8-99-est", "tags": ["earnings", "guidance"]}
{"id": 50882177, "time": "2026-02-26 07:05:11", "headline": "Opera Q4 Adj. EPS $0.30 Misses $0.38 Estimate, Sales $177.210M Beat $165.002M Estimate", "summary": "", "symbols": ["OPRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882177/opera-q4-adj-eps-0-30-misses-0-38-estimate-sales-177-210m-beat-165-002m-estimate", "tags": ["earnings"]}
{"id": 50882198, "time": "2026-02-26 07:05:23", "headline": "Shift4 Payments Q4 Adj. EPS $1.60 Misses $1.62 Estimate, Sales $1.189B Miss $1.204B Estimate", "summary": "", "symbols": ["FOUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882198/shift4-payments-q4-adj-eps-1-60-misses-1-62-estimate-sales-1-189b-miss-1-204b-estimate", "tags": ["earnings"]}
{"id": 50882208, "time": "2026-02-26 07:05:28", "headline": "Vision Marine Technologies Granted Two U.S. Patents Securing Core Electric Marine Architecture", "summary": "", "symbols": ["VMAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882208/vision-marine-technologies-granted-two-u-s-patents-securing-core-electric-marine-architecture", "tags": []}
{"id": 50882219, "time": "2026-02-26 07:05:36", "headline": "12 Information Technology Stocks Moving In Thursday's Pre-Market Session", "summary": " ", "symbols": ["ACMR", "AI", "BNAI", "BTQ", "CISO", "IONQ", "LHSW", "NEON", "NTNX", "SKYT", "VISN", "ZENV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/26/02/50882219/12-information-technology-stocks-moving-in-thursdays-pre-market-session", "tags": ["why_moving"]}
{"id": 50882226, "time": "2026-02-26 07:05:39", "headline": "Rhythm Pharmaceuticals Q4 2025 EPS $(0.73) Beats $(0.81) Estimate, Sales $57.253M Beat $56.042M Estimate", "summary": "", "symbols": ["RYTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882226/rhythm-pharmaceuticals-q4-2025-eps-0-73-beats-0-81-estimate-sales-57-253m-beat-56-042m-estimate", "tags": ["earnings"]}
{"id": 50882228, "time": "2026-02-26 07:05:41", "headline": "12 Industrials Stocks Moving In Thursday's Pre-Market Session", "summary": " ", "symbols": ["ARRY", "CISS", "DCI", "ELPW", "EOSE", "ERII", "JOBY", "LICN", "MEG", "STRL", "TASK", "VLRS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/26/02/50882228/12-industrials-stocks-moving-in-thursdays-pre-market-session", "tags": ["why_moving"]}
{"id": 50882237, "time": "2026-02-26 07:05:44", "headline": "Vital Farms Lowers FY2026 Sales Guidance from $930.000M-$950.000M to $900.000M-$920.000M", "summary": "", "symbols": ["VITL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882237/vital-farms-lowers-fy2026-sales-guidance-from-930-000m-950-000m-to-900-000m-920-000m", "tags": ["guidance"]}
{"id": 50882243, "time": "2026-02-26 07:05:46", "headline": "12 Health Care Stocks Moving In Thursday's Pre-Market Session", "summary": " ", "symbols": ["BFLY", "CURX", "GDRX", "HCTI", "IPSC", "KAPA", "MTNB", "PFSA", "PRCT", "PRGO", "TFX", "VIR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/26/02/50882243/12-health-care-stocks-moving-in-thursdays-pre-market-session", "tags": ["why_moving"]}
{"id": 50882253, "time": "2026-02-26 07:05:52", "headline": "12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session", "summary": " ", "symbols": ["DNUT", "EMPD", "JDZG", "KIDZ", "LFS", "LOBO", "LXEH", "RRGB", "SMJF", "VAC", "VMAR", "XWEL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/26/02/50882253/12-consumer-discretionary-stocks-moving-in-thursdays-pre-market-session", "tags": ["why_moving"]}
{"id": 50882277, "time": "2026-02-26 07:06:09", "headline": "Tecnoglass Q4 Adj. EPS $0.63 Misses $0.84 Estimate, Sales $245.297M Beat $239.388M Estimate", "summary": "", "symbols": ["TGLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882277/tecnoglass-q4-adj-eps-0-63-misses-0-84-estimate-sales-245-297m-beat-239-388m-estimate", "tags": ["earnings"]}
{"id": 50882278, "time": "2026-02-26 07:06:09", "headline": "Tecnoglass Q4 Earnings Assessment", "summary": " ", "symbols": ["TGLS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882278/tecnoglass-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50882286, "time": "2026-02-26 07:06:14", "headline": "Insights into Rhythm Pharmaceuticals Q4 Earnings", "summary": " ", "symbols": ["RYTM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882286/insights-into-rhythm-pharmaceuticals-q4-earnings", "tags": ["earnings"]}
{"id": 50882297, "time": "2026-02-26 07:06:18", "headline": "Shift4 Payments Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["FOUR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882297/shift4-payments-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50882303, "time": "2026-02-26 07:06:24", "headline": "Opera Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["OPRA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882303/opera-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50882314, "time": "2026-02-26 07:06:29", "headline": "Vital Farms Q4 Earnings Assessment", "summary": " ", "symbols": ["VITL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882314/vital-farms-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50882322, "time": "2026-02-26 07:06:35", "headline": "Akebia Therapeutics Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["AKBA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882322/akebia-therapeutics-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50882329, "time": "2026-02-26 07:06:40", "headline": "Palmer Square Capital BDC Earnings Report: Q4 Overview", "summary": " ", "symbols": ["PSBD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882329/palmer-square-capital-bdc-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50882343, "time": "2026-02-26 07:06:45", "headline": "Tecnoglass Sees FY2026 Sales $1.060B-$1.130B vs $1.083B Est", "summary": "", "symbols": ["TGLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882343/tecnoglass-sees-fy2026-sales-1-060b-1-130b-vs-1-083b-est", "tags": []}
{"id": 50882346, "time": "2026-02-26 07:06:48", "headline": "JM Smucker Affirms FY2026 Adj EPS Guidance of $8.75-$9.25 vs $8.99 Est; Narrows FY2026 Sales Guidance from $9.031B-$9.119B to $9.031B-$9.075B vs $9.070B Est", "summary": "", "symbols": ["SJM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882346/jm-smucker-affirms-fy2026-adj-eps-guidance-of-8-75-9-25-vs-8-99-est-narrows-fy2026-sales-guidance-fr", "tags": ["earnings", "guidance"]}
{"id": 50882354, "time": "2026-02-26 07:06:51", "headline": "PENN Entertainment Q4 Adj. EPS $0.07 Beats $(0.05) Estimate, Sales $1.806B Beat $1.760B Estimate", "summary": "", "symbols": ["PENN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882354/penn-entertainment-q4-adj-eps-0-07-beats-0-05-estimate-sales-1-806b-beat-1-760b-estimate", "tags": ["earnings"]}
{"id": 50882371, "time": "2026-02-26 07:07:02", "headline": "Anika Therapeutics Q4 Adj. EPS $0.31 Beats $(0.21) Estimate, Sales $30.615M Beat $28.875M Estimate", "summary": "", "symbols": ["ANIK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882371/anika-therapeutics-q4-adj-eps-0-31-beats-0-21-estimate-sales-30-615m-beat-28-875m-estimate", "tags": ["earnings"]}
{"id": 50882394, "time": "2026-02-26 07:07:16", "headline": "Opera Sees FY2026 Sales $720.000M-$735.000M vs $690.219M Est", "summary": "", "symbols": ["OPRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882394/opera-sees-fy2026-sales-720-000m-735-000m-vs-690-219m-est", "tags": []}
{"id": 50882402, "time": "2026-02-26 07:07:23", "headline": "Warner Bros. Discovery Q4 EPS $(0.10) Misses $(0.01) Estimate, Sales $9.460B Beat $9.306B Estimate", "summary": "", "symbols": ["WBD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882402/warner-bros-discovery-q4-eps-0-10-misses-0-01-estimate-sales-9-460b-beat-9-306b-estimate", "tags": ["earnings"]}
{"id": 50882409, "time": "2026-02-26 07:07:26", "headline": "Opera Sees Q1 Sales $169.000M-$172.000M vs $159.545M Est", "summary": "", "symbols": ["OPRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882409/opera-sees-q1-sales-169-000m-172-000m-vs-159-545m-est", "tags": []}
{"id": 50882424, "time": "2026-02-26 07:07:38", "headline": "Kimbell Royalty Partners Q4 EPS $0.21 Beats $0.12 Estimate, Sales $82.453M Beat $77.691M Estimate", "summary": "", "symbols": ["KRP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882424/kimbell-royalty-partners-q4-eps-0-21-beats-0-12-estimate-sales-82-453m-beat-77-691m-estimate", "tags": ["earnings"]}
{"id": 50882455, "time": "2026-02-26 07:08:00", "headline": "Anika Therapeutics Sees FY2026 Sales $114.000M-$122.500M vs $116.351M Est", "summary": "", "symbols": ["ANIK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882455/anika-therapeutics-sees-fy2026-sales-114-000m-122-500m-vs-116-351m-est", "tags": []}
{"id": 50882465, "time": "2026-02-26 07:08:07", "headline": "Kimbell Royalty Partners Q4 Earnings Assessment", "summary": " ", "symbols": ["KRP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882465/kimbell-royalty-partners-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50882469, "time": "2026-02-26 07:08:10", "headline": "Arbe Robotics Appoints Ram Machness, Arbe's Chief Business Officer, As Chief Executive Officer And Appointed Current CEO And Co-founder Kobi Marenko As President, Effective April 1", "summary": "", "symbols": ["ARBE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882469/arbe-robotics-appoints-ram-machness-arbes-chief-business-officer-as-chief-executive-officer-and-appo", "tags": ["management"]}
{"id": 50882470, "time": "2026-02-26 07:08:10", "headline": "Shift4 Payments Sees FY2026 Adj EPS $5.50-$5.70 vs $6.47 Est; Sees Sales $2.500B-$2.600B vs $5.202B Est", "summary": "", "symbols": ["FOUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882470/shift4-payments-sees-fy2026-adj-eps-5-50-5-70-vs-6-47-est-sees-sales-2-500b-2-600b-vs-5-202b-est", "tags": ["earnings"]}
{"id": 50882472, "time": "2026-02-26 07:08:12", "headline": "Warner Bros. Discovery Earnings Report: Q4 Overview", "summary": " ", "symbols": ["WBD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882472/warner-bros-discovery-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50882477, "time": "2026-02-26 07:08:17", "headline": "Insights into Anika Therapeutics Q4 Earnings", "summary": " ", "symbols": ["ANIK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882477/insights-into-anika-therapeutics-q4-earnings", "tags": ["earnings"]}
{"id": 50882486, "time": "2026-02-26 07:08:22", "headline": "PENN Entertainment Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["PENN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882486/penn-entertainment-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50882488, "time": "2026-02-26 07:08:25", "headline": "BioCryst Pharma Q4 Sales $163.284M Beat $151.326M Estimate", "summary": "", "symbols": ["BCRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882488/biocryst-pharma-q4-sales-163-284m-beat-151-326m-estimate", "tags": []}
{"id": 50882511, "time": "2026-02-26 07:08:46", "headline": "Zai Lab Q4 EPS $0.46 Beats $(0.05) Estimate, Sales $127.597M Beat $124.472M Estimate", "summary": "", "symbols": ["ZLAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882511/zai-lab-q4-eps-0-46-beats-0-05-estimate-sales-127-597m-beat-124-472m-estimate", "tags": ["earnings"]}
{"id": 50882513, "time": "2026-02-26 07:08:46", "headline": "Ardagh Metal Packaging Q4 Adj. EPS $0.03 Beats $0.02 Estimate, Sales $1.346B Beat $1.279B Estimate", "summary": "", "symbols": ["AMBP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882513/ardagh-metal-packaging-q4-adj-eps-0-03-beats-0-02-estimate-sales-1-346b-beat-1-279b-estimate", "tags": ["earnings"]}
{"id": 50882522, "time": "2026-02-26 07:08:51", "headline": "Deutsche Bank Downgrades Array Technologies to Hold, Lowers Price Target to $9", "summary": "", "symbols": ["ARRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882522/deutsche-bank-downgrades-array-technologies-to-hold-lowers-price-target-to-9", "tags": ["analyst_down", "price_target_down"]}
{"id": 50882539, "time": "2026-02-26 07:09:04", "headline": "Middleby Sees Q1 Adj EPS $1.90-$2.02 vs $1.96 Est; Sees Sales $760.000M-$788.000M vs $933.578M Est", "summary": "", "symbols": ["MIDD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882539/middleby-sees-q1-adj-eps-1-90-2-02-vs-1-96-est-sees-sales-760-000m-788-000m-vs-933-578m-est", "tags": ["earnings"]}
{"id": 50882582, "time": "2026-02-26 07:09:32", "headline": "Magnachip Semiconductor Launches Its New 7Th-generation 24V MXT LV MOSFET Specifically Designed For Battery Protection Circuits In Next-generation Tri-fold Smartphones, Strengthening Its Presence In The Premium Foldable Smartphone Market", "summary": "", "symbols": ["MX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/tech/26/02/50882582/magnachip-semiconductor-launches-its-new-7th-generation-24v-mxt-lv-mosfet-specifically-designed-for", "tags": []}
{"id": 50882615, "time": "2026-02-26 07:09:57", "headline": "Middleby Sees FY2026 Adj EPS $9.20-$9.36 vs $9.54 Est; Sees Sales $3.270B-$3.360B vs $4.004B Est", "summary": "", "symbols": ["MIDD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882615/middleby-sees-fy2026-adj-eps-9-20-9-36-vs-9-54-est-sees-sales-3-270b-3-360b-vs-4-004b-est", "tags": ["earnings"]}
{"id": 50882640, "time": "2026-02-26 07:10:11", "headline": "BlackSky Technology Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["BKSY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882640/blacksky-technology-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50882642, "time": "2026-02-26 07:10:11", "headline": "BlackSky Technology Q4 EPS $(0.02) Beats $(0.21) Estimate, Sales $35.214M Miss $37.056M Estimate", "summary": "", "symbols": ["BKSY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882642/blacksky-technology-q4-eps-0-02-beats-0-21-estimate-sales-35-214m-miss-37-056m-estimate", "tags": ["earnings"]}
{"id": 50882653, "time": "2026-02-26 07:10:15", "headline": "Insights into Ardagh Metal Packaging Q4 Earnings", "summary": " ", "symbols": ["AMBP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882653/insights-into-ardagh-metal-packaging-q4-earnings", "tags": ["earnings"]}
{"id": 50882663, "time": "2026-02-26 07:10:20", "headline": "Zai Lab Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["ZLAB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882663/zai-lab-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50882738, "time": "2026-02-26 07:11:14", "headline": "SystImmune And Bristol Myers Squibb Announce SystImmune's Sichuan Biokin Reports Topline Results From Pre-Specified Interim Analysis Of Phase III Study Evaluating Iza-Bren In Patients With Unresectable TNBC", "summary": "", "symbols": ["BMY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882738/systimmune-and-bristol-myers-squibb-announce-systimmunes-sichuan-biokin-reports-topline-results-from", "tags": ["fda"]}
{"id": 50882751, "time": "2026-02-26 07:11:19", "headline": "Frontdoor Q4 Adj. EPS $0.23 Beats $0.13 Estimate, Sales $433.000M Beat $421.490M Estimate", "summary": "", "symbols": ["FTDR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882751/frontdoor-q4-adj-eps-0-23-beats-0-13-estimate-sales-433-000m-beat-421-490m-estimate", "tags": ["earnings"]}
{"id": 50882770, "time": "2026-02-26 07:11:28", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Root, Lowers Price Target to $104", "summary": "", "symbols": ["ROOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882770/keefe-bruyette-woods-maintains-outperform-on-root-lowers-price-target-to-104", "tags": ["analyst_other", "price_target_down"]}
{"id": 50882786, "time": "2026-02-26 07:11:38", "headline": "Magnificent Risk: Why Nvidia And Microsoft Are At The Center Of El-Erian's 'Rational Bubble'", "summary": "Mohamed El-Erian and Moody&#39;s warn of AI &#34;tears&#34; and debt &#34;accidents&#34; at Meta and Oracle as a &#34;rational bubble&#34; at Nvidia and Microsoft grows.", "symbols": ["META", "MSFT", "NVDA", "ORCL"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/markets/equities/26/02/50882786/magnificent-risk-why-nvidia-and-microsoft-are-at-the-center-of-el-erians-rational-bubble", "tags": []}
{"id": 50882820, "time": "2026-02-26 07:12:08", "headline": "Earnings Breakdown: Frontdoor Q4", "summary": " ", "symbols": ["FTDR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882820/earnings-breakdown-frontdoor-q4", "tags": ["earnings"]}
{"id": 50882836, "time": "2026-02-26 07:12:22", "headline": "Frontdoor Sees FY2026 Sales $2.155B-$2.195B vs $2.201B Est", "summary": "", "symbols": ["FTDR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882836/frontdoor-sees-fy2026-sales-2-155b-2-195b-vs-2-201b-est", "tags": []}
{"id": 50882841, "time": "2026-02-26 07:12:25", "headline": "The FDA accepts for Priority Review Ionis Pharmaceuticals' Supplemental New Drug Application For Olezarsen For Severe Hypertriglyceridemia, With PDUFA Target Action Date Of June 30", "summary": "", "symbols": ["IONS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/26/02/50882841/the-fda-accepts-for-priority-review-ionis-pharmaceuticals-supplemental-new-drug-application-for-o", "tags": ["fda"]}
{"id": 50882873, "time": "2026-02-26 07:12:54", "headline": "Niagen Bioscience Announces Sale Of ChromaDex Reference Standards Business To LGC In All-Cash Transaction", "summary": "", "symbols": ["NAGE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50882873/niagen-bioscience-announces-sale-of-chromadex-reference-standards-business-to-lgc-in-all-cash-transa", "tags": []}
{"id": 50882921, "time": "2026-02-26 07:14:00", "headline": "Gilat Satellite Networks Announces Demonstration Of 3GPP-Compliant 5G Non-Terrestrial Network Connectivity Over Geostationary Earth Orbit Satellite", "summary": "", "symbols": ["GILT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882921/gilat-satellite-networks-announces-demonstration-of-3gpp-compliant-5g-non-terrestrial-network-connec", "tags": []}
{"id": 50882925, "time": "2026-02-26 07:14:06", "headline": "Aclaris Therapeutics Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["ACRS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50882925/aclaris-therapeutics-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50882936, "time": "2026-02-26 07:14:15", "headline": "Aclaris Therapeutics Q4 EPS $(0.16) Misses $(0.14) Estimate, Sales $1.295M Miss $1.938M Estimate", "summary": "", "symbols": ["ACRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50882936/aclaris-therapeutics-q4-eps-0-16-misses-0-14-estimate-sales-1-295m-miss-1-938m-estimate", "tags": ["earnings"]}
{"id": 50882952, "time": "2026-02-26 07:14:25", "headline": "What's Going On With CrowdStrike Stock Thursday?", "summary": "VAST Data and CrowdStrike partner to improve security for AI systems, aiming to secure the entire AI lifecycle.", "symbols": ["CRWD"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/markets/large-cap/26/02/50882952/whats-going-on-with-crowdstrike-stock-thursday", "tags": ["why_moving"]}
{"id": 50882967, "time": "2026-02-26 07:14:42", "headline": "Needham Maintains Buy on Arcutis Biotherapeutics, Raises Price Target to $36", "summary": "", "symbols": ["ARQT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882967/needham-maintains-buy-on-arcutis-biotherapeutics-raises-price-target-to-36", "tags": ["analyst_other", "price_target_up"]}
{"id": 50882981, "time": "2026-02-26 07:14:49", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Blackstone Secured, Lowers Price Target to $27", "summary": "", "symbols": ["BXSL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882981/keefe-bruyette-woods-maintains-outperform-on-blackstone-secured-lowers-price-target-to-27", "tags": ["analyst_other", "price_target_down"]}
{"id": 50882996, "time": "2026-02-26 07:15:04", "headline": "TScan Therapeutics Completes Enrollment Into Cohort C Of ALLOHA Study", "summary": "", "symbols": ["TCRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882996/tscan-therapeutics-completes-enrollment-into-cohort-c-of-alloha-study", "tags": []}
{"id": 50882956, "time": "2026-02-26 07:14:30", "headline": "Kairos Pharma Signs Deal To Acquire Two Experimental Lung Cancer Drug Candidates From Celyn Therapeutics, Financial Terms Undisclosed", "summary": "", "symbols": ["KAPA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50882956/kairos-pharma-signs-deal-to-acquire-two-experimental-lung-cancer-drug-candidates-from-celyn-therapeu", "tags": ["merger", "contract"]}
{"id": 50883016, "time": "2026-02-26 07:15:55", "headline": "Nuveen Churchill Direct Q4 EPS $0.44 Beats $0.43 Estimate, Sales $50.035M Beat $49.554M Estimate.", "summary": "", "symbols": ["NCDL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883016/nuveen-churchill-direct-q4-eps-0-44-beats-0-43-estimate-sales-50-035m-beat-49-554m-estimate", "tags": ["earnings"]}
{"id": 50883027, "time": "2026-02-26 07:16:07", "headline": "Nuveen Churchill Direct: Q4 Earnings Insights", "summary": " ", "symbols": ["NCDL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883027/nuveen-churchill-direct-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50883036, "time": "2026-02-26 07:16:19", "headline": "Fractyl Health Completes Participant Randomization In REMAIN-1 Pivotal Cohort Evaluating Revita For Weight Maintenance Following GLP-1 Therapy Discontinuation", "summary": "", "symbols": ["GUTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883036/fractyl-health-completes-participant-randomization-in-remain-1-pivotal-cohort-evaluating-revita-for", "tags": []}
{"id": 50883044, "time": "2026-02-26 07:16:28", "headline": "Needham Maintains Buy on Veracyte, Raises Price Target to $48", "summary": "", "symbols": ["VCYT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883044/needham-maintains-buy-on-veracyte-raises-price-target-to-48", "tags": ["analyst_other", "price_target_up"]}
{"id": 50883056, "time": "2026-02-26 07:16:45", "headline": "ACM Research Q4 Adj. EPS $0.25 Misses $0.34 Estimate, Sales $244.430M Beat $238.964M Estimate", "summary": "", "symbols": ["ACMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883056/acm-research-q4-adj-eps-0-25-misses-0-34-estimate-sales-244-430m-beat-238-964m-estimate", "tags": ["earnings"]}
{"id": 50883067, "time": "2026-02-26 07:17:13", "headline": "IonQ Delivers Operational Quantum Key Distribution Networks To Romanian National Quantum Communication Infrastructure, Representing One Of The Largest And Most Complex Operational Quantum Key Distribution Networks In Europe And One Of The Largest Of Its Kind Outside Of China", "summary": "", "symbols": ["IONQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/tech/26/02/50883067/ionq-delivers-operational-quantum-key-distribution-networks-to-romanian-national-quantum-communicati", "tags": []}
{"id": 50883069, "time": "2026-02-26 07:17:15", "headline": "ACM Research Affirms FY2026 Sales Guidance of $1.080B-$1.175B", "summary": "", "symbols": ["ACMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883069/acm-research-affirms-fy2026-sales-guidance-of-1-080b-1-175b", "tags": ["guidance"]}
{"id": 50883070, "time": "2026-02-26 07:17:15", "headline": "Papa John's International Guides 2026 Global System-Wide Restaurant Sales Flat To Down Low Single-Digits; Sees Adjusted EBITDA Of $200M To $210M With Approximately 33M Diluted Shares Outstanding", "summary": "", "symbols": ["PZZA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883070/papa-johns-international-guides-2026-global-system-wide-restaurant-sales-flat-to-down-low-single-dig", "tags": ["offering"]}
{"id": 50883109, "time": "2026-02-26 07:18:07", "headline": "ACM Research Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["ACMR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883109/acm-research-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50883114, "time": "2026-02-26 07:18:19", "headline": "Jones Trading Maintains Buy on Angel Oak Mortgage REIT, Maintains $10.5 Price Target", "summary": "", "symbols": ["AOMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883114/jones-trading-maintains-buy-on-angel-oak-mortgage-reit-maintains-10-5-price-target", "tags": ["analyst_other"]}
{"id": 50883125, "time": "2026-02-26 07:18:31", "headline": "CPC Corp Agrees To Purchase Up To 1.2M Tonnes Per Annum Of LNG From Cheniere Energy's Subsidiary On Delivered Basis From 2026 Through 2050", "summary": "", "symbols": ["LNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883125/cpc-corp-agrees-to-purchase-up-to-1-2m-tonnes-per-annum-of-lng-from-cheniere-energys-subsidiary-on-d", "tags": []}
{"id": 50883137, "time": "2026-02-26 07:19:03", "headline": "Canadian Utilities Q4 Adj. EPS $0.72, Inline, Sales $971.000M Miss $1.003B Estimate", "summary": "", "symbols": ["TSX:CU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883137/canadian-utilities-q4-adj-eps-0-72-inline-sales-971-000m-miss-1-003b-estimate", "tags": ["earnings"]}
{"id": 50883138, "time": "2026-02-26 07:19:04", "headline": "Papa John's International Q4 2025 Global System-Wide Restaurant Sales $1.23B, Down 1%; North America Comparable Sales Down 5%, International Up 6%; 142 Openings", "summary": "", "symbols": ["PZZA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883138/papa-johns-international-q4-2025-global-system-wide-restaurant-sales-1-23b-down-1-north-america-com", "tags": []}
{"id": 50883158, "time": "2026-02-26 07:19:19", "headline": "Vistra Q4 Sales $4.584B Miss $5.789B Estimate", "summary": "", "symbols": ["VST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883158/vistra-q4-sales-4-584b-miss-5-789b-estimate", "tags": []}
{"id": 50883185, "time": "2026-02-26 07:20:56", "headline": "Public Service Enterprise Group Raises Quarterly Dividend From $0.63 To $0.67 Per Share", "summary": "", "symbols": ["PEG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883185/public-service-enterprise-group-raises-quarterly-dividend-from-0-63-to-0-67-per-share", "tags": ["dividend"]}
{"id": 50883201, "time": "2026-02-26 07:22:44", "headline": "C4 Therapeutics Q4 EPS $(0.18) Beats $(0.31) Estimate, Sales $11.016M Beat $6.460M Estimate", "summary": "", "symbols": ["CCCC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883201/c4-therapeutics-q4-eps-0-18-beats-0-31-estimate-sales-11-016m-beat-6-460m-estimate", "tags": ["earnings"]}
{"id": 50883210, "time": "2026-02-26 07:23:01", "headline": "Viridian Therapeutics Q4 EPS $(1.08) Misses $(0.93) Estimate, Sales $132.000K", "summary": "", "symbols": ["VRDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883210/viridian-therapeutics-q4-eps-1-08-misses-0-93-estimate-sales-132-000k", "tags": ["earnings"]}
{"id": 50883219, "time": "2026-02-26 07:23:12", "headline": "Bitcoin Holds $68,000 As Ethereum, XRP, Dogecoin Rally On Institutional Inflows", "summary": "Bitcoin extended its advance and held above $68,000 overnight as ETF inflows accelerated and market sentiment improved; liquidations stand at $600.40 million over the past 24 hours.\u00a0\n\n\n\nBitcoin ETFs saw $506.5 million in net inflows on Wednesday, while Ethereum ETFs reported $157.1 million in net inflows. \u00a0", "symbols": ["BTCUSD", "DOGEUSD", "ETHUSD", "SHIBUSD", "SOLUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/crypto/cryptocurrency/26/02/50883219/bitcoin-holds-68000-as-ethereum-xrp-dogecoin-rally-on-institutional-inflows", "tags": []}
{"id": 50883222, "time": "2026-02-26 07:23:26", "headline": "Needham Reiterates Buy on RxSight, Maintains $13 Price Target", "summary": "", "symbols": ["RXST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883222/needham-reiterates-buy-on-rxsight-maintains-13-price-target", "tags": ["analyst_other"]}
{"id": 50883238, "time": "2026-02-26 07:23:43", "headline": "Diana Shipping Q4 EPS $0.02 Beats $0.01 Estimate, Sales $52.054M Miss $52.328M Estimate", "summary": "", "symbols": ["DSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883238/diana-shipping-q4-eps-0-02-beats-0-01-estimate-sales-52-054m-miss-52-328m-estimate", "tags": ["earnings"]}
{"id": 50883248, "time": "2026-02-26 07:24:09", "headline": "Earnings Summary: C4 Therapeutics Q4", "summary": " ", "symbols": ["CCCC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883248/earnings-summary-c4-therapeutics-q4", "tags": ["earnings"]}
{"id": 50883249, "time": "2026-02-26 07:24:14", "headline": "Earnings Breakdown: Viridian Therapeutics Q4", "summary": " ", "symbols": ["VRDN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883249/earnings-breakdown-viridian-therapeutics-q4", "tags": ["earnings"]}
{"id": 50883266, "time": "2026-02-26 07:24:50", "headline": "Telsey Advisory Group Maintains Outperform on Zevia, Lowers Price Target to $5", "summary": "", "symbols": ["ZVIA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883266/telsey-advisory-group-maintains-outperform-on-zevia-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 50883267, "time": "2026-02-26 07:24:55", "headline": "Why Cramer Says Nvidia Sellers Are Getting It Dead Wrong", "summary": "CNBC&#39;s Jim Cramer criticizes traders who sold S&amp;P futures after Nvidia&#39;s blowout earnings, highlighting the company&#39;s success.", "symbols": ["NVDA"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50883267/why-cramer-says-nvidia-sellers-are-getting-it-dead-wrong", "tags": ["earnings"]}
{"id": 50883285, "time": "2026-02-26 07:25:17", "headline": "Entrada Therapeutics Q4 EPS $(0.94) Beats $(1.07) Estimate, Sales $1.299M Miss $13.886M Estimate", "summary": "", "symbols": ["TRDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883285/entrada-therapeutics-q4-eps-0-94-beats-1-07-estimate-sales-1-299m-miss-13-886m-estimate", "tags": ["earnings"]}
{"id": 50883294, "time": "2026-02-26 07:25:40", "headline": "Nexstar Media Gr Q4 Adj. EPS $6.93 Beats $3.72 Estimate, Sales $1.289B Beat $1.251B Estimate", "summary": "", "symbols": ["NXST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883294/nexstar-media-gr-q4-adj-eps-6-93-beats-3-72-estimate-sales-1-289b-beat-1-251b-estimate", "tags": ["earnings"]}
{"id": 50883303, "time": "2026-02-26 07:26:08", "headline": "Diana Shipping Declares $0.01 Per Share Cash Dividend Payable March 18; Record Date March 11", "summary": "", "symbols": ["DSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883303/diana-shipping-declares-0-01-per-share-cash-dividend-payable-march-18-record-date-march-11", "tags": ["dividend"]}
{"id": 50883304, "time": "2026-02-26 07:26:08", "headline": "Nexstar Media Gr: Q4 Earnings Insights", "summary": " ", "symbols": ["NXST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883304/nexstar-media-gr-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50883313, "time": "2026-02-26 07:26:13", "headline": "Earnings Summary: Entrada Therapeutics Q4", "summary": " ", "symbols": ["TRDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883313/earnings-summary-entrada-therapeutics-q4", "tags": ["earnings"]}
{"id": 50883314, "time": "2026-02-26 07:26:17", "headline": "Needham Reiterates Buy on NVIDIA, Maintains $240 Price Target", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883314/needham-reiterates-buy-on-nvidia-maintains-240-price-target", "tags": ["analyst_other"]}
{"id": 50883339, "time": "2026-02-26 07:26:38", "headline": "Ataibeckley' Topline Results From Phase 2a Study Of EMP\u201101 In Adults With Social Anxiety Disorder Met Its Primary Safety Objective And Generated Encouraging Secondary And Exploratory Efficacy Signals", "summary": "", "symbols": ["ATAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/26/02/50883339/ataibeckley-topline-results-from-phase-2a-study-of-emp-01-in-adults-with-social-anxiety-disorder-", "tags": []}
{"id": 50883353, "time": "2026-02-26 07:27:41", "headline": "ACM Research Receives Multiple Advanced Packaging Equipment Orders From Global Semiconductor And Technology Customers", "summary": "", "symbols": ["ACMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883353/acm-research-receives-multiple-advanced-packaging-equipment-orders-from-global-semiconductor-and-tec", "tags": []}
{"id": 50883354, "time": "2026-02-26 07:27:46", "headline": "Telsey Advisory Group Maintains Outperform on Clear Secure, Raises Price Target to $55", "summary": "", "symbols": ["YOU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883354/telsey-advisory-group-maintains-outperform-on-clear-secure-raises-price-target-to-55", "tags": ["analyst_other", "price_target_up"]}
{"id": 50883468, "time": "2026-02-26 07:28:30", "headline": "ACM Research Announces Recent Delivery Of Several 300mm Single-Wafer Cleaning Systems To Foundry Customer's Front-End Wafer Fabrication Facility In Singapore", "summary": "", "symbols": ["ACMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883468/acm-research-announces-recent-delivery-of-several-300mm-single-wafer-cleaning-systems-to-foundry-cus", "tags": []}
{"id": 50883483, "time": "2026-02-26 07:29:41", "headline": "Market-Moving News for February 26th", "summary": "", "symbols": ["AI", "DNUT", "SEZL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50883483/market-moving-news-for-february-26th", "tags": []}
{"id": 50883491, "time": "2026-02-26 07:29:49", "headline": "Telsey Advisory Group Maintains Outperform on Urban Outfitters, Maintains $98 Price Target", "summary": "", "symbols": ["URBN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883491/telsey-advisory-group-maintains-outperform-on-urban-outfitters-maintains-98-price-target", "tags": ["analyst_other"]}
{"id": 50883535, "time": "2026-02-26 07:30:05", "headline": "Trading Halt: Halt status updated at 7:30:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["VCTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/26/02/50883535/trading-halt-halt-status-updated-at-7-30-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 50883568, "time": "2026-02-26 07:30:57", "headline": "Wall Street's Most Accurate Analysts Give Their Take On 3 Risk Off Stocks Delivering High-Dividend Yields", "summary": " ", "symbols": ["CAG", "KHC", "MO"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/dividends/26/02/50883568/wall-streets-most-accurate-analysts-give-their-take-on-3-risk-off-stocks-delivering-high-dividend-yields-4", "tags": ["dividend"]}
{"id": 50883571, "time": "2026-02-26 07:31:05", "headline": "Cars.com Q4 Adj. EPS $0.44 Beats $0.22 Estimate, Sales $183.903M Beat $183.453M Estimate.", "summary": "", "symbols": ["CARS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883571/cars-com-q4-adj-eps-0-44-beats-0-22-estimate-sales-183-903m-beat-183-453m-estimate", "tags": ["earnings"]}
{"id": 50883581, "time": "2026-02-26 07:31:20", "headline": "Telsey Advisory Group Maintains Market Perform on American Eagle Outfitters, Maintains $28 Price Target", "summary": "", "symbols": ["AEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883581/telsey-advisory-group-maintains-market-perform-on-american-eagle-outfitters-maintains-28-price-targe", "tags": ["analyst_other"]}
{"id": 50883582, "time": "2026-02-26 07:31:21", "headline": "EMCOR Group Q4 Adj. EPS $7.19 Beats $6.68 Estimate, Sales $4.513B Beat $4.283B Estimate", "summary": "", "symbols": ["EME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883582/emcor-group-q4-adj-eps-7-19-beats-6-68-estimate-sales-4-513b-beat-4-283b-estimate", "tags": ["earnings"]}
{"id": 50883584, "time": "2026-02-26 07:31:22", "headline": "Chubb Limited To Recommend Dividend Increase To Shareholders From $0.97 To $1.02 Per Share", "summary": "", "symbols": ["CB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883584/chubb-limited-to-recommend-dividend-increase-to-shareholders-from-0-97-to-1-02-per-share", "tags": ["dividend"]}
{"id": 50883600, "time": "2026-02-26 07:31:29", "headline": "Fiera Cap Q4 Adj. EPS $0.28, Inline, Sales $180.062M Miss $188.806M Estimate", "summary": "", "symbols": ["TSX:FSZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883600/fiera-cap-q4-adj-eps-0-28-inline-sales-180-062m-miss-188-806m-estimate", "tags": ["earnings"]}
{"id": 50883607, "time": "2026-02-26 07:31:31", "headline": "Payoneer Global Q4 EPS $0.05 Misses $0.06 Estimate, Sales $274.693M Miss $282.347M Estimate", "summary": "", "symbols": ["PAYO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883607/payoneer-global-q4-eps-0-05-misses-0-06-estimate-sales-274-693m-miss-282-347m-estimate", "tags": ["earnings"]}
{"id": 50883627, "time": "2026-02-26 07:31:40", "headline": "Cass Information Systems Collaborates With Caspian To Provide Tariff Cost Services For U.S. Importers", "summary": "", "symbols": ["CASS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883627/cass-information-systems-collaborates-with-caspian-to-provide-tariff-cost-services-for-u-s-importers", "tags": []}
{"id": 50883641, "time": "2026-02-26 07:31:47", "headline": "Intellia Therapeutics Q4 EPS $(0.83) Beats $(0.96) Estimate, Sales $23.017M Beat $12.812M Estimate", "summary": "", "symbols": ["NTLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883641/intellia-therapeutics-q4-eps-0-83-beats-0-96-estimate-sales-23-017m-beat-12-812m-estimate", "tags": ["earnings"]}
{"id": 50883658, "time": "2026-02-26 07:32:05", "headline": "Cheniere Energy Q4 2025 EPS $10.68 Beats $3.92 Estimate, Sales $5.450B Beat $5.108B Estimate", "summary": "", "symbols": ["LNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883658/cheniere-energy-q4-2025-eps-10-68-beats-3-92-estimate-sales-5-450b-beat-5-108b-estimate", "tags": ["earnings"]}
{"id": 50883659, "time": "2026-02-26 07:32:08", "headline": "EMCOR Group Sees FY2026 Adj EPS $27.25-$29.25 vs $27.93 Est; Sees Sales $17.750B-$18.500B vs $17.816B Est", "summary": "", "symbols": ["EME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883659/emcor-group-sees-fy2026-adj-eps-27-25-29-25-vs-27-93-est-sees-sales-17-750b-18-500b-vs-17-816b-est", "tags": ["earnings"]}
{"id": 50883668, "time": "2026-02-26 07:32:15", "headline": "Payoneer Global Q4 Earnings Assessment", "summary": " ", "symbols": ["PAYO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883668/payoneer-global-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50883677, "time": "2026-02-26 07:32:20", "headline": "EMCOR Group: Q4 Earnings Insights", "summary": " ", "symbols": ["EME"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883677/emcor-group-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50883682, "time": "2026-02-26 07:32:25", "headline": "Cars.com Q4 Earnings Assessment", "summary": " ", "symbols": ["CARS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883682/cars-com-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50883686, "time": "2026-02-26 07:32:26", "headline": "Payoneer Global Sees FY2026 Sales $1.090B-$1.130B vs $1.127B Est", "summary": "", "symbols": ["PAYO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883686/payoneer-global-sees-fy2026-sales-1-090b-1-130b-vs-1-127b-est", "tags": []}
{"id": 50883692, "time": "2026-02-26 07:32:33", "headline": "Lindblad Expeditions Q4 EPS $(0.45) Misses $(0.32) Estimate, Sales $183.181M Beat $167.860M Estimate", "summary": "", "symbols": ["LIND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883692/lindblad-expeditions-q4-eps-0-45-misses-0-32-estimate-sales-183-181m-beat-167-860m-estimate", "tags": ["earnings"]}
{"id": 50883713, "time": "2026-02-26 07:32:48", "headline": "FTI Consulting Q4 Adj. EPS $1.78 Beats $1.46 Estimate, Sales $990.746M Beat $918.553M Estimate", "summary": "", "symbols": ["FCN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883713/fti-consulting-q4-adj-eps-1-78-beats-1-46-estimate-sales-990-746m-beat-918-553m-estimate", "tags": ["earnings"]}
{"id": 50883733, "time": "2026-02-26 07:33:10", "headline": "Collegium Pharmaceutical Q4 Adj. EPS $2.04 Misses $2.33 Estimate, Sales $205.449M Miss $206.362M Estimate", "summary": "", "symbols": ["COLL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883733/collegium-pharmaceutical-q4-adj-eps-2-04-misses-2-33-estimate-sales-205-449m-miss-206-362m-estimate", "tags": ["earnings"]}
{"id": 50883745, "time": "2026-02-26 07:33:30", "headline": "Lindblad Expeditions Sees FY2026 Sales $800.000M-$850.000M vs $824.360M Est", "summary": "", "symbols": ["LIND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883745/lindblad-expeditions-sees-fy2026-sales-800-000m-850-000m-vs-824-360m-est", "tags": []}
{"id": 50883754, "time": "2026-02-26 07:33:42", "headline": "Cheniere Energy Expects Fiscal 2026 Consolidated Adjusted EBITDA Of $6.75B-$7.25B, With Distributable Cash Flow Of $4.35B-$4.85B", "summary": "", "symbols": ["LNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883754/cheniere-energy-expects-fiscal-2026-consolidated-adjusted-ebitda-of-6-75b-7-25b-with-distributable-c", "tags": []}
{"id": 50883766, "time": "2026-02-26 07:34:09", "headline": "Insights into Collegium Pharmaceutical Q4 Earnings", "summary": " ", "symbols": ["COLL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883766/insights-into-collegium-pharmaceutical-q4-earnings", "tags": ["earnings"]}
{"id": 50883767, "time": "2026-02-26 07:34:14", "headline": "Insights into Cheniere Energy Q4 Earnings", "summary": " ", "symbols": ["LNG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883767/insights-into-cheniere-energy-q4-earnings", "tags": ["earnings"]}
{"id": 50883769, "time": "2026-02-26 07:34:18", "headline": "Earnings Breakdown: Lindblad Expeditions Q4", "summary": " ", "symbols": ["LIND"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883769/earnings-breakdown-lindblad-expeditions-q4", "tags": ["earnings"]}
{"id": 50883773, "time": "2026-02-26 07:34:19", "headline": "Collegium Pharmaceutical Sees FY2026 Sales $805.000M-$825.000M vs $808.877M Est", "summary": "", "symbols": ["COLL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883773/collegium-pharmaceutical-sees-fy2026-sales-805-000m-825-000m-vs-808-877m-est", "tags": []}
{"id": 50883776, "time": "2026-02-26 07:34:22", "headline": "Gibraltar Industries Q4 Adj. EPS $0.76 Beats $0.74 Estimate, Sales $268.688M Beat $265.133M Estimate", "summary": "", "symbols": ["ROCK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883776/gibraltar-industries-q4-adj-eps-0-76-beats-0-74-estimate-sales-268-688m-beat-265-133m-estimate", "tags": ["earnings"]}
{"id": 50883812, "time": "2026-02-26 07:34:55", "headline": "WAVE Life Sciences Q4 2025 EPS $(0.30) Misses $(0.27) Estimate, Sales $17.244M Beat $16.547M Estimate", "summary": "", "symbols": ["WVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883812/wave-life-sciences-q4-2025-eps-0-30-misses-0-27-estimate-sales-17-244m-beat-16-547m-estimate", "tags": ["earnings"]}
{"id": 50883824, "time": "2026-02-26 07:35:31", "headline": "FTI Consulting Sees FY2026 Adj EPS $8.90-$9.60 vs $9.48 Est; Sees Sales $3.940B-$4.100B vs $3.964B Est", "summary": "", "symbols": ["FCN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883824/fti-consulting-sees-fy2026-adj-eps-8-90-9-60-vs-9-48-est-sees-sales-3-940b-4-100b-vs-3-964b-est", "tags": ["earnings"]}
{"id": 50883835, "time": "2026-02-26 07:35:50", "headline": "Public Service Enterprise Q4 Adj. EPS $0.72 Beats $0.71 Estimate, Sales $2.915B Beat $2.683B Estimate", "summary": "", "symbols": ["PEG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883835/public-service-enterprise-q4-adj-eps-0-72-beats-0-71-estimate-sales-2-915b-beat-2-683b-estimate", "tags": ["earnings"]}
{"id": 50883836, "time": "2026-02-26 07:35:53", "headline": "WAVE Life Sciences Reported Cash And Cash Equivalents Of $602.1M As Of December 31, 2025 And Expected Cash Runway Into Q3 2028", "summary": "", "symbols": ["WVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/26/02/50883836/wave-life-sciences-reported-cash-and-cash-equivalents-of-602-1m-as-of-december-31-2025-and-expect", "tags": []}
{"id": 50883844, "time": "2026-02-26 07:35:58", "headline": "Anterix Expands Partnership With Qualcomm Technologies Over Connectivity For Utilities, Critical Infrastructure Operators In U.S.", "summary": "", "symbols": ["ATEX", "QCOM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883844/anterix-expands-partnership-with-qualcomm-technologies-over-connectivity-for-utilities-critical-infr", "tags": ["contract"]}
{"id": 50883863, "time": "2026-02-26 07:36:11", "headline": "Insights into Public Service Enterprise Q4 Earnings", "summary": " ", "symbols": ["PEG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883863/insights-into-public-service-enterprise-q4-earnings", "tags": ["earnings"]}
{"id": 50883868, "time": "2026-02-26 07:36:15", "headline": "Gibraltar Industries Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["ROCK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883868/gibraltar-industries-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50883877, "time": "2026-02-26 07:36:26", "headline": "Cars.com Sees Q1 Sales $179.024M-$180.814M vs $183.877M Est. First quarter revenue is expected to be flat to up 1% year-over-year from $179.024M in Q1 2025.", "summary": "", "symbols": ["CARS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883877/cars-com-sees-q1-sales-179-024m-180-814m-vs-183-877m-est-first-quarter-revenue-is-expected-to-be-fla", "tags": ["earnings"]}
{"id": 50883897, "time": "2026-02-26 07:36:53", "headline": "Cars.com Sees FY2026 Sales $723.239M-$737.704M vs $743.047M Est. Full year 2026 revenue is expected to be flat to up 2% year-over-year from $723.239M in FY 2025.", "summary": "", "symbols": ["CARS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883897/cars-com-sees-fy2026-sales-723-239m-737-704m-vs-743-047m-est-full-year-2026-revenue-is-expected-to-b", "tags": ["earnings"]}
{"id": 50883907, "time": "2026-02-26 07:37:05", "headline": "Thryv Holdings Q4 EPS $(0.22) Misses $0.18 Estimate, Sales $191.619M Miss $193.143M Estimate", "summary": "", "symbols": ["THRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883907/thryv-holdings-q4-eps-0-22-misses-0-18-estimate-sales-191-619m-miss-193-143m-estimate", "tags": ["earnings"]}
{"id": 50883908, "time": "2026-02-26 07:37:10", "headline": "Installed Building Prods Q4 Adj. EPS $3.24 Beats $2.76 Estimate, Sales $747.500M Beat $741.656M Estimate", "summary": "", "symbols": ["IBP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883908/installed-building-prods-q4-adj-eps-3-24-beats-2-76-estimate-sales-747-500m-beat-741-656m-estimate", "tags": ["earnings"]}
{"id": 50883925, "time": "2026-02-26 07:37:26", "headline": "Gibraltar Industries Sees FY2026 Adj EPS $3.65-$4.05 vs $4.33 Est; Sees Sales $1.760B-$1.830B vs $1.190B Est", "summary": "", "symbols": ["ROCK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883925/gibraltar-industries-sees-fy2026-adj-eps-3-65-4-05-vs-4-33-est-sees-sales-1-760b-1-830b-vs-1-190b-es", "tags": ["earnings"]}
{"id": 50883926, "time": "2026-02-26 07:37:30", "headline": "Cronos Group Q4 Sales $44.531M Beat $38.720M Estimate", "summary": "", "symbols": ["CRON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883926/cronos-group-q4-sales-44-531m-beat-38-720m-estimate", "tags": []}
{"id": 50883953, "time": "2026-02-26 07:37:52", "headline": "Cronos Group Q4 Sales $44.531M Miss $48.260M Estimate", "summary": "", "symbols": ["TSX:CRON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883953/cronos-group-q4-sales-44-531m-miss-48-260m-estimate", "tags": []}
{"id": 50883962, "time": "2026-02-26 07:38:08", "headline": "Insights into Cronos Group Q4 Earnings", "summary": " ", "symbols": ["CRON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883962/insights-into-cronos-group-q4-earnings", "tags": ["earnings"]}
{"id": 50883964, "time": "2026-02-26 07:38:14", "headline": "Cronos Group Earnings Review: Q4 Summary", "summary": " ", "symbols": ["CRON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883964/cronos-group-earnings-review-q4-summary", "tags": ["earnings"]}
{"id": 50883965, "time": "2026-02-26 07:38:16", "headline": "ImmunityBio Completes Phase 2 Clinical Study Enrollment To Evaluate ANKTIVA Plus Bacillus Calmette-Gu\u00e9rin", "summary": "", "symbols": ["IBRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50883965/immunitybio-completes-phase-2-clinical-study-enrollment-to-evaluate-anktiva-plus-bacillus-calmette-g", "tags": ["fda"]}
{"id": 50883971, "time": "2026-02-26 07:38:19", "headline": "Installed Building Prods Earnings Report: Q4 Overview", "summary": " ", "symbols": ["IBP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883971/installed-building-prods-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50883978, "time": "2026-02-26 07:38:25", "headline": "Earnings Summary: WAVE Life Sciences Q4", "summary": " ", "symbols": ["WVE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50883978/earnings-summary-wave-life-sciences-q4", "tags": ["earnings"]}
{"id": 50883989, "time": "2026-02-26 07:38:32", "headline": "BioCryst Pharma Q4 Adj. EPS $0.06 Beats $0.05 Estimate, Sales $163.284M Beat $151.326M Estimate", "summary": "", "symbols": ["BCRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50883989/biocryst-pharma-q4-adj-eps-0-06-beats-0-05-estimate-sales-163-284m-beat-151-326m-estimate", "tags": ["earnings"]}
{"id": 50884018, "time": "2026-02-26 07:39:20", "headline": "Telsey Advisory Group Maintains Outperform on Steven Madden, Maintains $50 Price Target", "summary": "", "symbols": ["SHOO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884018/telsey-advisory-group-maintains-outperform-on-steven-madden-maintains-50-price-target", "tags": ["analyst_other"]}
{"id": 50884034, "time": "2026-02-26 07:40:10", "headline": "BioCryst Pharma: Q4 Earnings Insights", "summary": " ", "symbols": ["BCRX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50884034/biocryst-pharma-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50884064, "time": "2026-02-26 07:41:15", "headline": "Wrap Technologies Expands Manufacturing Partnership With K-Form To Accelerate MERLIN-1 DFR-X Drone-Based Non-Lethal Systems Production And Commercialization", "summary": "", "symbols": ["WRAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884064/wrap-technologies-expands-manufacturing-partnership-with-k-form-to-accelerate-merlin-1-dfr-x-drone-b", "tags": ["contract"]}
{"id": 50884073, "time": "2026-02-26 07:41:33", "headline": "Crescent Biopharma Q4 EPS $(4.01) Misses $(2.31) Estimate, Sales $10.844M Beat $4.000M Estimate", "summary": "", "symbols": ["CBIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50884073/crescent-biopharma-q4-eps-4-01-misses-2-31-estimate-sales-10-844m-beat-4-000m-estimate", "tags": ["earnings"]}
{"id": 50884085, "time": "2026-02-26 07:42:18", "headline": "Public Service Enterprise Sees FY2026 Adj EPS $4.28-$4.40 vs $4.39 Est", "summary": "", "symbols": ["PEG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884085/public-service-enterprise-sees-fy2026-adj-eps-4-28-4-40-vs-4-39-est", "tags": ["earnings"]}
{"id": 50884096, "time": "2026-02-26 07:42:25", "headline": "Telsey Advisory Group Maintains Market Perform on Honest Co, Maintains $3 Price Target", "summary": "", "symbols": ["HNST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884096/telsey-advisory-group-maintains-market-perform-on-honest-co-maintains-3-price-target", "tags": ["analyst_other"]}
{"id": 50884106, "time": "2026-02-26 07:42:52", "headline": "Installed Building Products Announces $500M Buyback Plan", "summary": "", "symbols": ["IBP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884106/installed-building-products-announces-500m-buyback-plan", "tags": ["buyback"]}
{"id": 50884118, "time": "2026-02-26 07:43:06", "headline": "Aehr Receives $14M Order For Multiple Fully Automated FOX-XP Wafer-Level Burn-In Systems From Lead AI Processor Customer, With Shipments Due Within Six Months", "summary": "", "symbols": ["AEHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884118/aehr-receives-14m-order-for-multiple-fully-automated-fox-xp-wafer-level-burn-in-systems-from-lead-ai", "tags": []}
{"id": 50884127, "time": "2026-02-26 07:43:33", "headline": "Baidu Exec Says In Q4, AI Cloud Business Saw Increases In Usage And Spending As Leading Enterprise Clients Deepened Partnerships With Co", "summary": "", "symbols": ["BIDU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884127/baidu-exec-says-in-q4-ai-cloud-business-saw-increases-in-usage-and-spending-as-leading-enterprise-cl", "tags": []}
{"id": 50884137, "time": "2026-02-26 07:44:14", "headline": "Bread Financial Announces $600M Buyback Plan", "summary": "", "symbols": ["BFH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884137/bread-financial-announces-600m-buyback-plan", "tags": ["buyback"]}
{"id": 50884138, "time": "2026-02-26 07:44:15", "headline": "NioCorp Begins $44.6M Mine Portal Construction At Elk Creek Project After $100M Raise; Says More Than $500M Gross Capital Raised In 2025-2026 Supports EXIM Financing Effort", "summary": "", "symbols": ["NB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884138/niocorp-begins-44-6m-mine-portal-construction-at-elk-creek-project-after-100m-raise-says-more-than-5", "tags": []}
{"id": 50884150, "time": "2026-02-26 07:44:41", "headline": "Telsey Advisory Group Maintains Outperform on TJX Companies, Raises Price Target to $175", "summary": "", "symbols": ["TJX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884150/telsey-advisory-group-maintains-outperform-on-tjx-companies-raises-price-target-to-175", "tags": ["analyst_other", "price_target_up"]}
{"id": 50884151, "time": "2026-02-26 07:44:42", "headline": "Shake Shack Sees FY2026 Sales $1.600B-$1.700B vs $1.645B Est", "summary": "", "symbols": ["SHAK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884151/shake-shack-sees-fy2026-sales-1-600b-1-700b-vs-1-645b-est", "tags": []}
{"id": 50884170, "time": "2026-02-26 07:44:53", "headline": "Shake Shack Sees Q1 Sales $366.000M-$370.000M vs $370.931M Est", "summary": "", "symbols": ["SHAK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884170/shake-shack-sees-q1-sales-366-000m-370-000m-vs-370-931m-est", "tags": []}
{"id": 50884187, "time": "2026-02-26 07:45:19", "headline": "Soligenix Says EMA COMP Issues Positive Opinion On Orphan Drug Designation Request For SGX945 Dusquetide In Beh\u00e7et's Disease", "summary": "", "symbols": ["SNGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884187/soligenix-says-ema-comp-issues-positive-opinion-on-orphan-drug-designation-request-for-sgx945-dusque", "tags": []}
{"id": 50884198, "time": "2026-02-26 07:45:55", "headline": "Needham Maintains Buy on Snowflake, Lowers Price Target to $200", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884198/needham-maintains-buy-on-snowflake-lowers-price-target-to-200", "tags": ["analyst_other", "price_target_down"]}
{"id": 50884225, "time": "2026-02-26 07:50:46", "headline": "Telsey Advisory Group Maintains Market Perform on European Wax Center, Maintains $5.8 Price Target", "summary": "", "symbols": ["EWCZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884225/telsey-advisory-group-maintains-market-perform-on-european-wax-center-maintains-5-8-price-target", "tags": ["analyst_other"]}
{"id": 50884235, "time": "2026-02-26 07:51:36", "headline": "Johnson & Johnson Completes Launch Of CEREGLIDE 42, CEREGLIDE 57 Aspiration Catheters, Including INNERGLIDE 7 Delivery Aid", "summary": "", "symbols": ["JNJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884235/johnson-johnson-completes-launch-of-cereglide-42-cereglide-57-aspiration-catheters-including-innergl", "tags": []}
{"id": 50884249, "time": "2026-02-26 07:52:41", "headline": "Telsey Advisory Group Maintains Outperform on Abercrombie & Fitch, Maintains $125 Price Target", "summary": "", "symbols": ["ANF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884249/telsey-advisory-group-maintains-outperform-on-abercrombie-fitch-maintains-125-price-target", "tags": ["analyst_other"]}
{"id": 50884267, "time": "2026-02-26 07:54:07", "headline": "BTIG Reiterates Buy on Innoviva, Maintains $35 Price Target", "summary": "", "symbols": ["INVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884267/btig-reiterates-buy-on-innoviva-maintains-35-price-target", "tags": ["analyst_other"]}
{"id": 50884282, "time": "2026-02-26 07:55:57", "headline": "Koppers Hldgs Q4 Adj. EPS $0.70 Beats $0.59 Estimate, Sales $432.700M Miss $444.500M Estimate", "summary": "", "symbols": ["KOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50884282/koppers-hldgs-q4-adj-eps-0-70-beats-0-59-estimate-sales-432-700m-miss-444-500m-estimate", "tags": ["earnings"]}
{"id": 50884293, "time": "2026-02-26 07:56:08", "headline": "Insights into Marcus Q4 Earnings", "summary": " ", "symbols": ["MCS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50884293/insights-into-marcus-q4-earnings", "tags": ["earnings"]}
{"id": 50884294, "time": "2026-02-26 07:56:12", "headline": "Needham Maintains Buy on Hut 8, Raises Price Target to $66", "summary": "", "symbols": ["HUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884294/needham-maintains-buy-on-hut-8-raises-price-target-to-66", "tags": ["analyst_other", "price_target_up"]}
{"id": 50884296, "time": "2026-02-26 07:56:14", "headline": "Earnings Summary: Koppers Holdings Q4", "summary": " ", "symbols": ["KOP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50884296/earnings-summary-koppers-holdings-q4", "tags": ["earnings"]}
{"id": 50884299, "time": "2026-02-26 07:56:17", "headline": "Marcus Q4 EPS $0.19 Beats $0.06 Estimate, Sales $193.498M Beat $183.769M Estimate", "summary": "", "symbols": ["MCS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50884299/marcus-q4-eps-0-19-beats-0-06-estimate-sales-193-498m-beat-183-769m-estimate", "tags": ["earnings"]}
{"id": 50884321, "time": "2026-02-26 07:56:32", "headline": "Sempra Q4 Adj. EPS $1.28 Beats $1.17 Estimate, Sales $3.749B Miss $4.049B Estimate", "summary": "", "symbols": ["SRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50884321/sempra-q4-adj-eps-1-28-beats-1-17-estimate-sales-3-749b-miss-4-049b-estimate", "tags": ["earnings"]}
{"id": 50884335, "time": "2026-02-26 07:56:39", "headline": "Koppers Holdings Sees FY2026 Adj EPS $4.20-$5.00 vs $4.57 Est; Sees Sales $1.900B-$2.000B vs $1.928B Est", "summary": "", "symbols": ["KOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884335/koppers-holdings-sees-fy2026-adj-eps-4-20-5-00-vs-4-57-est-sees-sales-1-900b-2-000b-vs-1-928b-est", "tags": ["earnings"]}
{"id": 50884349, "time": "2026-02-26 07:56:52", "headline": "How To Earn $500 A Month From Carter's Stock Ahead Of Q4 Earnings", "summary": "Carter&#39;s has an annual dividend yield of 2.39% ($1.00 a year). How can investors exploit its dividend yield to pocket a regular $500 monthly?", "symbols": ["CRI"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/dividends/26/02/50884349/how-to-earn-500-a-month-from-carters-stock-ahead-of-q4-earnings", "tags": ["earnings", "dividend"]}
{"id": 50884363, "time": "2026-02-26 07:57:24", "headline": "Sempra Affirms FY2026 Adj EPS Guidance of $4.80-$5.30 vs $5.11 Est", "summary": "", "symbols": ["SRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884363/sempra-affirms-fy2026-adj-eps-guidance-of-4-80-5-30-vs-5-11-est", "tags": ["earnings", "guidance"]}
{"id": 50884373, "time": "2026-02-26 07:58:07", "headline": "Earnings Breakdown: Sempra Q4", "summary": " ", "symbols": ["SRE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50884373/earnings-breakdown-sempra-q4", "tags": ["earnings"]}
{"id": 50884482, "time": "2026-02-26 07:58:25", "headline": "'Goldman, JPMorgan Draw Elizabeth Warren's Scrutiny Over Epstein' - Bloomberg", "summary": "", "symbols": ["GS", "JPM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884482/goldman-jpmorgan-draw-elizabeth-warrens-scrutiny-over-epstein-bloomberg", "tags": []}
{"id": 50884492, "time": "2026-02-26 07:58:44", "headline": "Rosenblatt Maintains Buy on NVIDIA, Raises Price Target to $300", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884492/rosenblatt-maintains-buy-on-nvidia-raises-price-target-to-300", "tags": ["analyst_other", "price_target_up"]}
{"id": 50884493, "time": "2026-02-26 07:58:48", "headline": "Reported Earlier, 'Sony Expands Buyback Plan Through May to $1.6 Billion' - Bloomberg", "summary": "", "symbols": ["SONY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884493/reported-earlier-sony-expands-buyback-plan-through-may-to-1-6-billion-bloomberg", "tags": ["buyback"]}
{"id": 50884510, "time": "2026-02-26 07:59:18", "headline": "Needham Maintains Buy on IonQ, Lowers Price Target to $65", "summary": "", "symbols": ["IONQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884510/needham-maintains-buy-on-ionq-lowers-price-target-to-65", "tags": ["analyst_other", "price_target_down"]}
{"id": 50884521, "time": "2026-02-26 08:00:02", "headline": "EXCLUSIVE: Avalon GloboCare Subsidiary Avalon Quantum Accepted Into AMD AI Developer Program", "summary": "", "symbols": ["ALBT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884521/exclusive-avalon-globocare-subsidiary-avalon-quantum-accepted-into-amd-ai-developer-program", "tags": []}
{"id": 50884575, "time": "2026-02-26 08:00:11", "headline": "Rosenblatt Maintains Buy on Imax, Maintains $47 Price Target", "summary": "", "symbols": ["IMAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884575/rosenblatt-maintains-buy-on-imax-maintains-47-price-target", "tags": ["analyst_other"]}
{"id": 50884586, "time": "2026-02-26 08:00:12", "headline": "Deutsche Telekom Q4 Adj. EPS $0.51, Same YoY, Sales $36.927B Up From $33.013B YoY", "summary": "", "symbols": ["DTEGY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50884586/deutsche-telekom-q4-adj-eps-0-51-same-yoy-sales-36-927b-up-from-33-013b-yoy", "tags": ["earnings"]}
{"id": 50884624, "time": "2026-02-26 08:00:21", "headline": "Is AerCap Holdings NV Gaining or Losing Market Support?", "summary": " ", "symbols": ["AER"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50884624/is-aercap-holdings-nv-gaining-or-losing-market-support", "tags": []}
{"id": 50884633, "time": "2026-02-26 08:00:23", "headline": "8 Analysts Assess IonQ: What You Need To Know", "summary": " ", "symbols": ["IONQ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50884633/8-analysts-assess-ionq-what-you-need-to-know", "tags": []}
{"id": 50884659, "time": "2026-02-26 08:00:28", "headline": "How Do Investors Really Feel About Sony Group Corp?", "summary": " ", "symbols": ["SONY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50884659/how-do-investors-really-feel-about-sony-group-corp", "tags": []}
{"id": 50884676, "time": "2026-02-26 08:00:31", "headline": "Analyst Expectations For Hut 8's Future", "summary": " ", "symbols": ["HUT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50884676/analyst-expectations-for-hut-8s-future", "tags": []}
{"id": 50884678, "time": "2026-02-26 08:00:33", "headline": "What Does the Market Think About Cintas Corp?", "summary": " ", "symbols": ["CTAS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50884678/what-does-the-market-think-about-cintas-corp", "tags": []}
{"id": 50884722, "time": "2026-02-26 08:00:40", "headline": "Where Circle Internet Group Stands With Analysts", "summary": " ", "symbols": ["CRCL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50884722/where-circle-internet-group-stands-with-analysts", "tags": []}
{"id": 50884724, "time": "2026-02-26 08:00:49", "headline": "Demystifying American Eagle Outfitters: Insights From 11 Analyst Reviews", "summary": " ", "symbols": ["AEO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50884724/demystifying-american-eagle-outfitters-insights-from-11-analyst-reviews", "tags": []}
{"id": 50884745, "time": "2026-02-26 08:00:51", "headline": "HSBC Dismisses 'SaaSpocalypse' Fears Amid $1 Trillion Sell-Off, Says 'Software Is Already Eating AI'", "summary": "HSBC has downplayed concerns about AI replacing the software-as-a-service (SaaS) sector or an impending &#34;SaaSpocalypse,&#34; predicting instead that software will benefit from AI&#39;s development.", "symbols": ["CRM", "CRWD", "DOCU", "FDS", "GOOG", "GOOGL", "HPQ", "NOW", "NVDA", "ORCL", "SMWB", "TEAM", "WDAY", "ZS"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/tech/26/02/50884745/hsbc-dismisses-saaspocalypse-fears-amid-1-trillion-sell-off-says-software-is-already-eating-ai", "tags": []}
{"id": 50884755, "time": "2026-02-26 08:00:59", "headline": "Breaking Down Clear Secure: 4 Analysts Share Their Views", "summary": " ", "symbols": ["YOU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50884755/breaking-down-clear-secure-4-analysts-share-their-views", "tags": []}
{"id": 50884770, "time": "2026-02-26 08:01:09", "headline": "MannKind Q4 Adj. EPS $0.01, Inline, Sales $111.955M Beat $97.604M Estimate", "summary": "", "symbols": ["MNKD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50884770/mannkind-q4-adj-eps-0-01-inline-sales-111-955m-beat-97-604m-estimate", "tags": ["earnings"]}
{"id": 50884774, "time": "2026-02-26 08:01:10", "headline": "EXCLUSIVE: Avalon GloboCare Partners With AMD To Supercharge AI", "summary": "Avalon GloboCare (ALBT) just joined the AMD AI Developer Program to build next-gen video and automation tools. See how this partnership and their new FDA-registered KetoAir breathalyzer are positioning the company for a massive 2026.", "symbols": ["AAPL", "ALBT", "AMD", "GOOGL"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/markets/small-cap/26/02/50884774/exclusive-avalon-globocare-partners-with-amd-to-supercharge-ai", "tags": ["fda", "contract"]}
{"id": 50884787, "time": "2026-02-26 08:01:14", "headline": "ODDITY Tech Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)", "summary": " ", "symbols": ["ODD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50884787/oddity-tech-stock-a-deep-dive-into-analyst-perspectives-4-ratings", "tags": []}
{"id": 50884797, "time": "2026-02-26 08:01:27", "headline": "StoneX Group Division Introduces Digital Asset Lending Services", "summary": "", "symbols": ["SNEX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884797/stonex-group-division-introduces-digital-asset-lending-services", "tags": []}
{"id": 50884798, "time": "2026-02-26 08:01:28", "headline": "Heron Therapeutics Q4 EPS $(0.02), Inline, Sales $40.588M Beat $39.533M Estimate", "summary": "", "symbols": ["HRTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50884798/heron-therapeutics-q4-eps-0-02-inline-sales-40-588m-beat-39-533m-estimate", "tags": ["earnings"]}
{"id": 50884821, "time": "2026-02-26 08:02:08", "headline": "Delcath Systems Q4 Earnings Assessment", "summary": " ", "symbols": ["DCTH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50884821/delcath-systems-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50884823, "time": "2026-02-26 08:02:13", "headline": "Earnings Breakdown: Heron Therapeutics Q4", "summary": " ", "symbols": ["HRTX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50884823/earnings-breakdown-heron-therapeutics-q4", "tags": ["earnings"]}
{"id": 50884824, "time": "2026-02-26 08:02:15", "headline": "Delcath Systems Q4 EPS $(0.05) Beats $(0.06) Estimate, Sales $20.728M Beat $20.326M Estimate", "summary": "", "symbols": ["DCTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50884824/delcath-systems-q4-eps-0-05-beats-0-06-estimate-sales-20-728m-beat-20-326m-estimate", "tags": ["earnings"]}
{"id": 50884830, "time": "2026-02-26 08:02:18", "headline": "MannKind Earnings Review: Q4 Summary", "summary": " ", "symbols": ["MNKD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50884830/mannkind-earnings-review-q4-summary", "tags": ["earnings"]}
{"id": 50884840, "time": "2026-02-26 08:02:34", "headline": "TriMas Q4 Adj. EPS $0.40 Beats $0.00 Estimate, Sales $256.460M Beat $143.112M Estimate", "summary": "", "symbols": ["TRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50884840/trimas-q4-adj-eps-0-40-beats-0-00-estimate-sales-256-460m-beat-143-112m-estimate", "tags": ["earnings"]}
{"id": 50884848, "time": "2026-02-26 08:02:44", "headline": "Heron Therapeutics Sees FY2026 Sales $173.000M-$183.000M vs $171.733M Est", "summary": "", "symbols": ["HRTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884848/heron-therapeutics-sees-fy2026-sales-173-000m-183-000m-vs-171-733m-est", "tags": []}
{"id": 50884851, "time": "2026-02-26 08:02:46", "headline": "Needham Maintains Buy on Joby Aviation, Lowers Price Target to $18", "summary": "", "symbols": ["JOBY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884851/needham-maintains-buy-on-joby-aviation-lowers-price-target-to-18", "tags": ["analyst_other", "price_target_down"]}
{"id": 50884863, "time": "2026-02-26 08:02:54", "headline": "Cognyte Software Gets $5M Follow-On Order With Unnamed Tier-1 Military Organization", "summary": "", "symbols": ["CGNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884863/cognyte-software-gets-5m-follow-on-order-with-unnamed-tier-1-military-organization", "tags": []}
{"id": 50884867, "time": "2026-02-26 08:03:04", "headline": "AeroVironment Announces $186M Order From US Army For Explosive Munitions Systems", "summary": "", "symbols": ["AVAV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884867/aerovironment-announces-186m-order-from-us-army-for-explosive-munitions-systems", "tags": []}
{"id": 50884872, "time": "2026-02-26 08:03:15", "headline": "C3.ai Posts Downbeat Results, Joins Trade Desk, FTAI Aviation And Other Big Stocks Moving Lower In Thursday's Pre-Market Session", "summary": " ", "symbols": ["AI", "ARRY", "ERII", "FTAI", "GDRX", "INVX", "LRMR", "NU", "ONC", "PRCT", "SGML", "TTD", "VIR", "WPP"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50884872/c3-ai-posts-downbeat-results-joins-trade-desk-ftai-aviation-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session", "tags": ["why_moving"]}
{"id": 50884874, "time": "2026-02-26 08:03:16", "headline": "TriMas Increases Buyback Authorization To $150M", "summary": "", "symbols": ["TRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884874/trimas-increases-buyback-authorization-to-150m", "tags": ["buyback"]}
{"id": 50884876, "time": "2026-02-26 08:03:17", "headline": "Rackspace Tech Q4 Adj. EPS $(0.01) Beats $(0.03) Estimate, Sales $683.000M Beat $672.373M Estimate", "summary": "", "symbols": ["RXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50884876/rackspace-tech-q4-adj-eps-0-01-beats-0-03-estimate-sales-683-000m-beat-672-373m-estimate", "tags": ["earnings"]}
{"id": 50884893, "time": "2026-02-26 08:03:34", "headline": "Millrose Properties Q4 EPS $0.74 Beats $0.73 Estimate, Sales $189.501M Beat $188.307M Estimate", "summary": "", "symbols": ["MRP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50884893/millrose-properties-q4-eps-0-74-beats-0-73-estimate-sales-189-501m-beat-188-307m-estimate", "tags": ["earnings"]}
{"id": 50884902, "time": "2026-02-26 08:03:46", "headline": "Soleno Therapeutics Appoints Jennifer Fulk CFO, Succeeding James Mackaness", "summary": "", "symbols": ["SLNO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884902/soleno-therapeutics-appoints-jennifer-fulk-cfo-succeeding-james-mackaness", "tags": ["management"]}
{"id": 50884905, "time": "2026-02-26 08:03:49", "headline": "Rosenblatt Maintains Buy on Zoom Communications, Maintains $115 Price Target", "summary": "", "symbols": ["ZM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884905/rosenblatt-maintains-buy-on-zoom-communications-maintains-115-price-target", "tags": ["analyst_other"]}
{"id": 50884909, "time": "2026-02-26 08:03:53", "headline": "Forescout Technologies And Netskope Form Partnership For Zero Trust Security Development", "summary": "", "symbols": ["NTSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50884909/forescout-technologies-and-netskope-form-partnership-for-zero-trust-security-development", "tags": ["contract"]}
{"id": 50884940, "time": "2026-02-26 08:04:10", "headline": "Vericel Q4 EPS $0.45 Beats $0.39 Estimate, Sales $92.918M Beat $91.122M Estimate", "summary": "", "symbols": ["VCEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50884940/vericel-q4-eps-0-45-beats-0-39-estimate-sales-92-918m-beat-91-122m-estimate", "tags": ["earnings"]}
{"id": 50884941, "time": "2026-02-26 08:04:10", "headline": "Earnings Breakdown: Vericel Q4", "summary": " ", "symbols": ["VCEL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50884941/earnings-breakdown-vericel-q4", "tags": ["earnings"]}
{"id": 50884951, "time": "2026-02-26 08:04:15", "headline": "Insights into Rackspace Technology Q4 Earnings", "summary": " ", "symbols": ["RXT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50884951/insights-into-rackspace-technology-q4-earnings", "tags": ["earnings"]}
{"id": 50884962, "time": "2026-02-26 08:04:20", "headline": "Eos Energy Enterprises Q4 Earnings Assessment", "summary": " ", "symbols": ["EOSE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50884962/eos-energy-enterprises-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50884973, "time": "2026-02-26 08:04:25", "headline": "TriMas Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["TRS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50884973/trimas-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50885011, "time": "2026-02-26 08:04:49", "headline": "Vericel Sees FY2026 Sales $316.000M-$326.000M vs $325.310M Est", "summary": "", "symbols": ["VCEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885011/vericel-sees-fy2026-sales-316-000m-326-000m-vs-325-310m-est", "tags": []}
{"id": 50885023, "time": "2026-02-26 08:04:59", "headline": "CollPlant Biotechnologies Announced Korean Patent Allowance Secured for Its Photocurable Dermal Filler", "summary": "", "symbols": ["CLGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885023/collplant-biotechnologies-announced-korean-patent-allowance-secured-for-its-photocurable-dermal-fill", "tags": []}
{"id": 50885026, "time": "2026-02-26 08:05:00", "headline": "Novavax Q4 EPS $0.11, Sales $147.139M", "summary": "", "symbols": ["NVAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50885026/novavax-q4-eps-0-11-sales-147-139m", "tags": ["earnings"]}
{"id": 50885028, "time": "2026-02-26 08:05:00", "headline": "Sempra Sees FY2027 GAAP EPS $5.10-$5.70 vs $5.61 Est", "summary": "", "symbols": ["SRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885028/sempra-sees-fy2027-gaap-eps-5-10-5-70-vs-5-61-est", "tags": ["earnings"]}
{"id": 50885063, "time": "2026-02-26 08:05:15", "headline": "Sempra Sees FY2030 GAAP EPS $6.70-$7.50", "summary": "", "symbols": ["SRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885063/sempra-sees-fy2030-gaap-eps-6-70-7-50", "tags": ["earnings"]}
{"id": 50885092, "time": "2026-02-26 08:05:32", "headline": "CPI Aerostructures Receives $4.2M Order From Embraer Brazil For Business Jet Engine Inlet Assemblies", "summary": "", "symbols": ["CVU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885092/cpi-aerostructures-receives-4-2m-order-from-embraer-brazil-for-business-jet-engine-inlet-assemblies", "tags": []}
{"id": 50885109, "time": "2026-02-26 08:05:44", "headline": "CRA Intl Q4 Adj. EPS $2.06 Misses $2.07 Estimate, Sales $196.963M Beat $190.541M Estimate", "summary": "", "symbols": ["CRAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50885109/cra-intl-q4-adj-eps-2-06-misses-2-07-estimate-sales-196-963m-beat-190-541m-estimate", "tags": ["earnings"]}
{"id": 50885148, "time": "2026-02-26 08:06:07", "headline": "CRA Intl Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["CRAI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50885148/cra-intl-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50885149, "time": "2026-02-26 08:06:07", "headline": "CRA Intl Sees FY2026 Sales $785.000M-$805.000M vs $772.457M Est", "summary": "", "symbols": ["CRAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885149/cra-intl-sees-fy2026-sales-785-000m-805-000m-vs-772-457m-est", "tags": []}
{"id": 50885157, "time": "2026-02-26 08:06:13", "headline": "Novavax Earnings Review: Q4 Summary", "summary": " ", "symbols": ["NVAX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50885157/novavax-earnings-review-q4-summary", "tags": ["earnings"]}
{"id": 50885167, "time": "2026-02-26 08:06:21", "headline": "Novavax Sees FY2026 Sales $230.000M-$270.000M vs $381.222M Est", "summary": "", "symbols": ["NVAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885167/novavax-sees-fy2026-sales-230-000m-270-000m-vs-381-222m-est", "tags": []}
{"id": 50885194, "time": "2026-02-26 08:06:36", "headline": "Needham Maintains Buy on Sezzle, Raises Price Target to $94", "summary": "", "symbols": ["SEZL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885194/needham-maintains-buy-on-sezzle-raises-price-target-to-94", "tags": ["analyst_other", "price_target_up"]}
{"id": 50885216, "time": "2026-02-26 08:06:50", "headline": "Birchtech Announces $15M Public Offering", "summary": "", "symbols": ["BCHT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885216/birchtech-announces-15m-public-offering", "tags": ["offering"]}
{"id": 50885227, "time": "2026-02-26 08:06:55", "headline": "Eos Energy Enterprises Sees FY2026 Sales $300.000M-$400.000M vs $479.283M Est", "summary": "", "symbols": ["EOSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885227/eos-energy-enterprises-sees-fy2026-sales-300-000m-400-000m-vs-479-283m-est", "tags": []}
{"id": 50885248, "time": "2026-02-26 08:07:16", "headline": "Rosenblatt Maintains Buy on Snowflake, Maintains $275 Price Target", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885248/rosenblatt-maintains-buy-on-snowflake-maintains-275-price-target", "tags": ["analyst_other"]}
{"id": 50885294, "time": "2026-02-26 08:07:58", "headline": "NTT DATA And Ericsson Enter Into Strategic Partnership To Accelerate 5G Adoption", "summary": "", "symbols": ["ERIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885294/ntt-data-and-ericsson-enter-into-strategic-partnership-to-accelerate-5g-adoption", "tags": ["contract"]}
{"id": 50885297, "time": "2026-02-26 08:08:01", "headline": "Three Firms Buy Strategy's STRC\u2014Could This Push MSTR Above $140?", "summary": "Prevalon Energy, Anchorage Digital, and OranjeBTC added Strategy\u2019s (NASDAQ:MSTR) ", "symbols": ["BTCUSD", "MS", "MSTR", "STRC"], "source": "benzinga", "author": "Parshwa Turakhiya", "url": "https://www.benzinga.com/crypto/cryptocurrency/26/02/50885297/three-firms-buy-strategys-strc-could-this-push-mstr-above-140", "tags": []}
{"id": 50885306, "time": "2026-02-26 08:08:07", "headline": "USA Today Co Q4 Earnings Assessment", "summary": " ", "symbols": ["TDAY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50885306/usa-today-co-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50885310, "time": "2026-02-26 08:08:10", "headline": "USA Today Co Q4 Adj. EPS $(0.21) Beats $(0.35) Estimate, Sales $584.996M Beat $584.804M Estimate", "summary": "", "symbols": ["TDAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50885310/usa-today-co-q4-adj-eps-0-21-beats-0-35-estimate-sales-584-996m-beat-584-804m-estimate", "tags": ["earnings"]}
{"id": 50885327, "time": "2026-02-26 08:08:30", "headline": "Needham Maintains Buy on Nutanix, Lowers Price Target to $55", "summary": "", "symbols": ["NTNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885327/needham-maintains-buy-on-nutanix-lowers-price-target-to-55", "tags": ["analyst_other", "price_target_down"]}
{"id": 50885346, "time": "2026-02-26 08:08:54", "headline": "TriMas Sees FY2026 Sales $1.073B-$1.104B vs $657.922M Est", "summary": "", "symbols": ["TRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885346/trimas-sees-fy2026-sales-1-073b-1-104b-vs-657-922m-est", "tags": []}
{"id": 50885356, "time": "2026-02-26 08:09:04", "headline": "Freshworks Announces $400M Buyback Program", "summary": "", "symbols": ["FRSH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885356/freshworks-announces-400m-buyback-program", "tags": ["buyback"]}
{"id": 50885374, "time": "2026-02-26 08:09:21", "headline": "PMV Pharmaceuticals Announces NEJM Publication Showing Phase 1 Rezatapopt Demonstrates Safety And Antitumor Activity In TP53 Y220C\u2013Mutated Cancers", "summary": "", "symbols": ["PMVP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/26/02/50885374/pmv-pharmaceuticals-announces-nejm-publication-showing-phase-1-rezatapopt-demonstrates-safety-and", "tags": ["fda"]}
{"id": 50885377, "time": "2026-02-26 08:09:29", "headline": "ENDRA Life Sciences Announces Results From Study Evaluating TAEUS Live Device", "summary": "", "symbols": ["NDRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/26/02/50885377/endra-life-sciences-announces-results-from-study-evaluating-taeus-live-device", "tags": []}
{"id": 50885395, "time": "2026-02-26 08:09:44", "headline": "USA Today Co FY 2026 Total revenues are expected to be flat to down in the low single digits on a same store basis.", "summary": "", "symbols": ["TDAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885395/usa-today-co-fy-2026-total-revenues-are-expected-to-be-flat-to-down-in-the-low-single-digits-on-a-sa", "tags": []}
{"id": 50885404, "time": "2026-02-26 08:09:53", "headline": "Needham Maintains Buy on Alkami Technology, Lowers Price Target to $22", "summary": "", "symbols": ["ALKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885404/needham-maintains-buy-on-alkami-technology-lowers-price-target-to-22", "tags": ["analyst_other", "price_target_down"]}
{"id": 50885415, "time": "2026-02-26 08:10:05", "headline": "Genius Sports Expands AI-Powered NBA Advertising Platform To 15 Teams Through NBC Sports Regional Networks Partnership", "summary": "", "symbols": ["GENI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885415/genius-sports-expands-ai-powered-nba-advertising-platform-to-15-teams-through-nbc-sports-regional-ne", "tags": ["contract"]}
{"id": 50885416, "time": "2026-02-26 08:10:09", "headline": "Leading And Lagging Sectors For February 26, 2026", "summary": " ", "symbols": ["XLB", "XLC", "XLE", "XLF", "XLI", "XLK", "XLP", "XLRE", "XLU", "XLV", "XLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/sector-etfs/26/02/50885416/leading-and-lagging-sectors-for-february-26-2026", "tags": []}
{"id": 50885426, "time": "2026-02-26 08:10:24", "headline": "Rackspace Technology Sees FY2026 Adj EPS $(0.20)-$(0.15) vs $0.01 Est; Sees Sales $2.600B-$2.700B vs $2.719B Est", "summary": "", "symbols": ["RXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885426/rackspace-technology-sees-fy2026-adj-eps-0-20-0-15-vs-0-01-est-sees-sales-2-600b-2-700b-vs-2-719b-es", "tags": ["earnings"]}
{"id": 50885442, "time": "2026-02-26 08:10:58", "headline": "Rosenblatt Maintains Buy on Magnite, Maintains $39 Price Target", "summary": "", "symbols": ["MGNI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885442/rosenblatt-maintains-buy-on-magnite-maintains-39-price-target", "tags": ["analyst_other"]}
{"id": 50885455, "time": "2026-02-26 08:11:32", "headline": "Aero Velocity And BT Brands Enter Strategic Collaboration On Drone And Robotic Data Acquisition For Tank Inspections And Asset Integrity Programs", "summary": "", "symbols": ["BTBD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885455/aero-velocity-and-bt-brands-enter-strategic-collaboration-on-drone-and-robotic-data-acquisition-for", "tags": []}
{"id": 50885463, "time": "2026-02-26 08:11:37", "headline": "Golden Matrix Group Approves 1-For-12 Reverse Stock Split And Rebrand To Meridian Holdings, Effective March 3, 2026", "summary": "", "symbols": ["GMGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885463/golden-matrix-group-approves-1-for-12-reverse-stock-split-and-rebrand-to-meridian-holdings-effective", "tags": []}
{"id": 50885480, "time": "2026-02-26 08:12:49", "headline": "Needham Maintains Buy on Revolution Medicines, Lowers Price Target to $145", "summary": "", "symbols": ["RVMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885480/needham-maintains-buy-on-revolution-medicines-lowers-price-target-to-145", "tags": ["analyst_other", "price_target_down"]}
{"id": 50885481, "time": "2026-02-26 08:12:50", "headline": "Rithm Property Trust Announces $10M Buyback", "summary": "", "symbols": ["RITM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885481/rithm-property-trust-announces-10m-buyback", "tags": ["buyback"]}
{"id": 50885493, "time": "2026-02-26 08:12:57", "headline": "authID Selected By Unnamed US Point Of Sale Lending And Payment Platform For Identity Fraud Protections", "summary": "", "symbols": ["AUID"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885493/authid-selected-by-unnamed-us-point-of-sale-lending-and-payment-platform-for-identity-fraud-protecti", "tags": []}
{"id": 50885517, "time": "2026-02-26 08:15:06", "headline": "EXCLUSIVE: Guardforce AI Extends Partnership With Major Global Sportswear Brand", "summary": "", "symbols": ["GFAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885517/exclusive-guardforce-ai-extends-partnership-with-major-global-sportswear-brand", "tags": ["contract"]}
{"id": 50885518, "time": "2026-02-26 08:15:07", "headline": "Sensus Healthcare Introduces Sensus Link Cloud-Based Connectivity For SRT-100 Systems", "summary": "", "symbols": ["SRTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885518/sensus-healthcare-introduces-sensus-link-cloud-based-connectivity-for-srt-100-systems", "tags": []}
{"id": 50885536, "time": "2026-02-26 08:15:16", "headline": "Polyrizon Announces Results From Comparative Study Evaluating Regional Nasal Deposition Profile Of Naloxone Formulation Versus Commercial Reference Product", "summary": "", "symbols": ["PLRZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885536/polyrizon-announces-results-from-comparative-study-evaluating-regional-nasal-deposition-profile-of-n", "tags": []}
{"id": 50885550, "time": "2026-02-26 08:15:30", "headline": "Zscaler Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call", "summary": " ", "symbols": ["ZS"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50885550/zscaler-likely-to-report-higher-q2-earnings-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call", "tags": ["earnings"]}
{"id": 50885551, "time": "2026-02-26 08:15:32", "headline": "Research Solutions Launches Scite MCP, Connecting 250M+ Scientific Articles To ChatGPT, Claude, And Microsoft Copilot For Evidence-Backed AI Answers", "summary": "", "symbols": ["RSSS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885551/research-solutions-launches-scite-mcp-connecting-250m-scientific-articles-to-chatgpt-claude-and-micr", "tags": []}
{"id": 50885557, "time": "2026-02-26 08:15:44", "headline": "TJX, Microsoft, Apollo Global Management And More On CNBC's 'Final Trades'", "summary": "Joe Terranova of Virtus Investment Partners recommended TJX, which reported upbeat fourth-quarter results on Wednesday, Feb. 25.", "symbols": ["APO", "IYE", "MSFT", "TJX"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/26/02/50885557/tjx-microsoft-apollo-global-management-and-more-on-cnbcs-final-trades", "tags": []}
{"id": 50885562, "time": "2026-02-26 08:15:47", "headline": "EXCLUSIVE: Guardforce AI Expands Tech Partnership To Modernize Major Global Brand's Stores", "summary": "Guardforce AI (GFAI) is rolling out advanced AI cameras and inventory tech to power a nationwide store renovation for a global sportswear giant. See how this smart retail deal and a new $5 million share buyback are shaking up the stock.", "symbols": ["GFAI"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/markets/small-cap/26/02/50885562/exclusive-guardforce-ai-expands-tech-partnership-to-modernize-major-global-brands-stores", "tags": ["contract", "buyback"]}
{"id": 50885570, "time": "2026-02-26 08:15:59", "headline": "Needham Maintains Buy on Circle Internet Group, Lowers Price Target to $130", "summary": "", "symbols": ["CRCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885570/needham-maintains-buy-on-circle-internet-group-lowers-price-target-to-130", "tags": ["analyst_other", "price_target_down"]}
{"id": 50885579, "time": "2026-02-26 08:16:06", "headline": "Burford Capital: Q4 Earnings Insights", "summary": " ", "symbols": ["BUR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50885579/burford-capital-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50885596, "time": "2026-02-26 08:16:18", "headline": "Vertiv Unveils Digital Twin Platform To Accelerate AI Data Center Deployment With Vertiv OneCore", "summary": "", "symbols": ["VRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885596/vertiv-unveils-digital-twin-platform-to-accelerate-ai-data-center-deployment-with-vertiv-onecore", "tags": []}
{"id": 50885609, "time": "2026-02-26 08:16:29", "headline": "Oracle And Oracle Red Bull Racing Extend Title Partnership Ahead Of F1 Racing Regulatory Shift", "summary": "", "symbols": ["ORCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885609/oracle-and-oracle-red-bull-racing-extend-title-partnership-ahead-of-f1-racing-regulatory-shift", "tags": ["contract"]}
{"id": 50885627, "time": "2026-02-26 08:16:52", "headline": "GameSquare Holdings Signs New Campaign Collaboration With Capcom To Support Launch Of Resident Evil Requiem", "summary": "", "symbols": ["GAME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885627/gamesquare-holdings-signs-new-campaign-collaboration-with-capcom-to-support-launch-of-resident-evil", "tags": []}
{"id": 50885640, "time": "2026-02-26 08:17:07", "headline": "Rithm Property Trust Authorizes $10M Share Repurchase Program Through 2027", "summary": "", "symbols": ["RPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885640/rithm-property-trust-authorizes-10m-share-repurchase-program-through-2027", "tags": ["buyback"]}
{"id": 50885649, "time": "2026-02-26 08:17:19", "headline": "Rosenblatt Maintains Buy on Trade Desk, Lowers Price Target to $36", "summary": "", "symbols": ["TTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885649/rosenblatt-maintains-buy-on-trade-desk-lowers-price-target-to-36", "tags": ["analyst_other", "price_target_down"]}
{"id": 50885658, "time": "2026-02-26 08:17:33", "headline": "Hormel Foods CEO Says Says Expect Adjusted Diluted EPS In The Range Of Flat To Slightly Up In Q2 Vs 2025", "summary": "", "symbols": ["HRL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885658/hormel-foods-ceo-says-says-expect-adjusted-diluted-eps-in-the-range-of-flat-to-slightly-up-in-q2-vs", "tags": ["earnings", "offering", "management"]}
{"id": 50885667, "time": "2026-02-26 08:17:40", "headline": "CrowdStrike Announces FalconID Availability To Extend Identity Protection Against AI-Accelerated Phishing Attacks", "summary": "", "symbols": ["CRWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885667/crowdstrike-announces-falconid-availability-to-extend-identity-protection-against-ai-accelerated-phi", "tags": []}
{"id": 50885678, "time": "2026-02-26 08:18:13", "headline": "NexPoint Real Estate Sees Q1 Adj EPS $0.35-$0.45 vs $0.47 Est", "summary": "", "symbols": ["NREF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885678/nexpoint-real-estate-sees-q1-adj-eps-0-35-0-45-vs-0-47-est", "tags": ["earnings"]}
{"id": 50885692, "time": "2026-02-26 08:19:08", "headline": "NexPoint Real Estate Sees Q1 GAAP EPS $0.31-$0.36 vs $0.40 Est", "summary": "", "symbols": ["NREF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885692/nexpoint-real-estate-sees-q1-gaap-eps-0-31-0-36-vs-0-40-est", "tags": ["earnings"]}
{"id": 50885693, "time": "2026-02-26 08:19:10", "headline": "Pulmatrix Q4 EPS $(0.25) Up From $(0.55) YoY", "summary": "", "symbols": ["PULM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50885693/pulmatrix-q4-eps-0-25-up-from-0-55-yoy", "tags": ["earnings"]}
{"id": 50885712, "time": "2026-02-26 08:19:39", "headline": "Rosenblatt Maintains Buy on Cadence Design Systems, Maintains $360 Price Target", "summary": "", "symbols": ["CDNS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885712/rosenblatt-maintains-buy-on-cadence-design-systems-maintains-360-price-target", "tags": ["analyst_other"]}
{"id": 50885722, "time": "2026-02-26 08:20:02", "headline": "Warner Bros CEO Says Co Has Engaged With 4 Bidders, Which Led To 8 Price Increases And Have Thus Far Achieved 63% Increase In Value Versus First Offer Received In September", "summary": "", "symbols": ["WBD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885722/warner-bros-ceo-says-co-has-engaged-with-4-bidders-which-led-to-8-price-increases-and-have-thus-far", "tags": ["management"]}
{"id": 50885733, "time": "2026-02-26 08:20:15", "headline": "Restaurant Brands International Announces Plans To Distribute $1.6B Through Dividends, Repurchase In 2026; Reiterates Over 8% Organic Adjusted Operating Income Growth From 2024-2028", "summary": "", "symbols": ["QSR", "TSX:QSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885733/restaurant-brands-international-announces-plans-to-distribute-1-6b-through-dividends-repurchase-in-2", "tags": ["analyst_other", "buyback"]}
{"id": 50885745, "time": "2026-02-26 08:20:36", "headline": "Burford Capital Q4 EPS $(0.17) Down From $(0.06) YoY, Sales $33.412M Down From $93.025M YoY", "summary": "", "symbols": ["BUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50885745/burford-capital-q4-eps-0-17-down-from-0-06-yoy-sales-33-412m-down-from-93-025m-yoy", "tags": ["earnings"]}
{"id": 50885746, "time": "2026-02-26 08:20:39", "headline": "Why Is Trade Desk Stock Sinking Thursday?", "summary": "The Trade Desk, Inc. (NASDAQ: TTD) reported Q4 2025 earnings of 59 cents/share, beating estimates by 1 cent.", "symbols": ["AMD", "HOOD", "MRAD", "PLTR", "TTD"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50885746/why-is-trade-desk-stock-sinking-thursday", "tags": ["earnings", "why_moving"]}
{"id": 50885772, "time": "2026-02-26 08:21:10", "headline": "Biomerica Announces Responder Analysis Results From Ongoing Real-World Study Of inFoods IBS", "summary": "", "symbols": ["BMRA", "HSIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885772/biomerica-announces-responder-analysis-results-from-ongoing-real-world-study-of-infoods-ibs", "tags": []}
{"id": 50885775, "time": "2026-02-26 08:21:12", "headline": "ElevenLabs Partners With Google Cloud For Cloud Services And The Latest NVIDIA Blackwell GPUs", "summary": "", "symbols": ["GOOG", "GOOGL", "NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885775/elevenlabs-partners-with-google-cloud-for-cloud-services-and-the-latest-nvidia-blackwell-gpus", "tags": ["contract"]}
{"id": 50885794, "time": "2026-02-26 08:21:51", "headline": "Hertz Global Holdings Q4 Adj. EPS $(0.63) Misses $(0.52) Estimate, Sales $2.028B Beat $2.000B Estimate", "summary": "", "symbols": ["HTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50885794/hertz-global-holdings-q4-adj-eps-0-63-misses-0-52-estimate-sales-2-028b-beat-2-000b-estimate", "tags": ["earnings"]}
{"id": 50885802, "time": "2026-02-26 08:21:58", "headline": "Vertiv Partners With Hut 8 To Integrate Vertiv OneCore Converged Physical Infrastructure Into Select Data Center Projects Within Its Broader Infrastructure Roadmap", "summary": "", "symbols": ["HUT", "VRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885802/vertiv-partners-with-hut-8-to-integrate-vertiv-onecore-converged-physical-infrastructure-into-select", "tags": ["contract"]}
{"id": 50885812, "time": "2026-02-26 08:22:08", "headline": "Hertz Global Holdings Earnings Review: Q4 Summary", "summary": " ", "symbols": ["HTZ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50885812/hertz-global-holdings-earnings-review-q4-summary", "tags": ["earnings"]}
{"id": 50885815, "time": "2026-02-26 08:22:13", "headline": "Burford Capital Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["BUR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50885815/burford-capital-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50885839, "time": "2026-02-26 08:23:52", "headline": "Rosenblatt Maintains Buy on Synopsys, Lowers Price Target to $530", "summary": "", "symbols": ["SNPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885839/rosenblatt-maintains-buy-on-synopsys-lowers-price-target-to-530", "tags": ["analyst_other", "price_target_down"]}
{"id": 50885855, "time": "2026-02-26 08:24:49", "headline": "Atco Q4 Adj. EPS $1.37 Beats $1.28 Estimate, Sales $1.390B Inline", "summary": "", "symbols": ["TSX:ACO", "TSX:ACO.X"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50885855/atco-q4-adj-eps-1-37-beats-1-28-estimate-sales-1-390b-inline", "tags": ["earnings"]}
{"id": 50885868, "time": "2026-02-26 08:25:49", "headline": "Eagle Point Income Q4 Net Investment Income $0.35 Misses $0.37 Estimate", "summary": "", "symbols": ["EIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50885868/eagle-point-income-q4-net-investment-income-0-35-misses-0-37-estimate", "tags": []}
{"id": 50885881, "time": "2026-02-26 08:26:20", "headline": "SCYNEXIS Says First Participants Dosed In Phase 1 SAD And MAD Trial Evaluating IV Of Second-Gen Triterpenoid Antifungal Therapy, SCY-247; Trial Results Expected In 2026", "summary": "", "symbols": ["SCYX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50885881/scynexis-says-first-participants-dosed-in-phase-1-sad-and-mad-trial-evaluating-iv-of-second-gen-trit", "tags": ["fda"]}
{"id": 50885891, "time": "2026-02-26 08:26:50", "headline": "Global Affairs Correspondent For Axios Barak Ravid Posts On X \"Talks between the U.S. and Iran in Geneva this morning were both indirect and direct, per source with knowledge\"", "summary": "", "symbols": ["SPY", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/26/02/50885891/global-affairs-correspondent-for-axios-barak-ravid-posts-on-x-talks-between-the-u", "tags": []}
{"id": 50885903, "time": "2026-02-26 08:27:21", "headline": "What's Going On With Nio Stock Thursday?", "summary": "Nio stock up after securing $329.765 million investment in China. Nio&#39;s GeniTech aims to innovate in smart EV market.", "symbols": ["NIO", "XPEV"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/markets/equities/26/02/50885903/whats-going-on-with-nio-stock-thursday-7", "tags": ["why_moving"]}
{"id": 50885904, "time": "2026-02-26 08:27:24", "headline": "American Woodmark Q3 Adj. EPS $0.45 Beats $0.11 Estimate, Sales $324.300M Miss $358.137M Estimate", "summary": "", "symbols": ["AMWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50885904/american-woodmark-q3-adj-eps-0-45-beats-0-11-estimate-sales-324-300m-miss-358-137m-estimate", "tags": ["earnings"]}
{"id": 50886018, "time": "2026-02-26 08:28:57", "headline": "Primech Holdings' Subsidiary Secures Series Of New Residential Cleaning And Waste Management Service Contracts With Total Estimated Value Of ~$5.02M", "summary": "", "symbols": ["PMEC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886018/primech-holdings-subsidiary-secures-series-of-new-residential-cleaning-and-waste-management-service", "tags": []}
{"id": 50886089, "time": "2026-02-26 08:30:11", "headline": "USA Initial Jobless Claims 212K Vs 217K Est.", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/26/02/50886089/usa-initial-jobless-claims-212k-vs-217k-est", "tags": []}
{"id": 50886126, "time": "2026-02-26 08:30:26", "headline": "Airbnb Secures High Growth Ranking Even As Cathie Wood Trims Exposure After Record $12.2 Billion Annual Revenue", "summary": "Airbnb&#39;s Growth score hits the 94th percentile. Explore why ABNB is a growth leader even as Cathie Wood scales back her position.", "symbols": ["ABNB"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/markets/equities/26/02/50886126/airbnb-secures-high-growth-ranking-even-as-cathie-wood-trims-exposure-after-record-12-2-billion-annual-revenue", "tags": ["earnings"]}
{"id": 50886144, "time": "2026-02-26 08:30:59", "headline": "PennantPark Announces $200M Note Offering", "summary": "", "symbols": ["PFLT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886144/pennantpark-announces-200m-note-offering", "tags": ["offering"]}
{"id": 50886145, "time": "2026-02-26 08:30:59", "headline": "Where Food Comes From Q4 EPS $(0.04) Down From $0.18 YoY, Sales $6.042M Down From $6.662M YoY", "summary": "", "symbols": ["WFCF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50886145/where-food-comes-from-q4-eps-0-04-down-from-0-18-yoy-sales-6-042m-down-from-6-662m-yoy", "tags": ["earnings"]}
{"id": 50886166, "time": "2026-02-26 08:31:08", "headline": "Vipshop Holdings Sees Q1 Sales $3.761B-$3.947B", "summary": "", "symbols": ["VIPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886166/vipshop-holdings-sees-q1-sales-3-761b-3-947b", "tags": []}
{"id": 50886182, "time": "2026-02-26 08:31:27", "headline": "Science Applications International Awarded $95M U.S. Government Accountability Office Contract To Offer IT Services For Technical Information Services Program", "summary": "", "symbols": ["SAIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886182/science-applications-international-awarded-95m-u-s-government-accountability-office-contract-to-offe", "tags": ["contract"]}
{"id": 50886192, "time": "2026-02-26 08:31:41", "headline": "Initial Jobless Claims Prior Revised From 206K To 208K", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/26/02/50886192/initial-jobless-claims-prior-revised-from-206k-to-208k", "tags": []}
{"id": 50886193, "time": "2026-02-26 08:31:42", "headline": "Nvidia To Rally More Than 53%? Here Are 10 Top Analyst Forecasts For Thursday", "summary": " ", "symbols": ["ALC", "CRCL", "CRM", "FSLR", "NVDA", "PCVX", "SCCO", "SNPS", "SPOK", "TTD"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50886193/nvidia-to-rally-more-than-53-here-are-10-top-analyst-forecasts-for-thursday", "tags": []}
{"id": 50886210, "time": "2026-02-26 08:32:04", "headline": "USA Continuing Jobless Claims 1,833K Vs 1,860K Est.", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/26/02/50886210/usa-continuing-jobless-claims-1-833k-vs-1-860k-est", "tags": []}
{"id": 50886224, "time": "2026-02-26 08:32:24", "headline": "USA Jobless Claims 4-Week Avg. 220.25K Vs 219.50K Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/26/02/50886224/usa-jobless-claims-4-week-avg-220-25k-vs-219-50k-prior", "tags": []}
{"id": 50886236, "time": "2026-02-26 08:32:32", "headline": "Laser Photonics Receives Order For CMS Laset Marking System For Through-Fed Optical Cable", "summary": "", "symbols": ["LASE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886236/laser-photonics-receives-order-for-cms-laset-marking-system-for-through-fed-optical-cable", "tags": []}
{"id": 50886259, "time": "2026-02-26 08:33:20", "headline": "Loar Holdings Q4 Adj. EPS $0.26 Beats $0.19 Estimate, Sales $131.750M Beat $128.021M Estimate", "summary": "", "symbols": ["LOAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50886259/loar-holdings-q4-adj-eps-0-26-beats-0-19-estimate-sales-131-750m-beat-128-021m-estimate", "tags": ["earnings"]}
{"id": 50886264, "time": "2026-02-26 08:33:27", "headline": "Needham Reiterates Buy on Salesforce, Maintains $400 Price Target", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886264/needham-reiterates-buy-on-salesforce-maintains-400-price-target", "tags": ["analyst_other"]}
{"id": 50886269, "time": "2026-02-26 08:33:29", "headline": "Liberty Formula One Group Q4 Sales $1.609B Beat $1.547B Estimate", "summary": "", "symbols": ["FWONA", "FWONK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50886269/liberty-formula-one-group-q4-sales-1-609b-beat-1-547b-estimate", "tags": []}
{"id": 50886279, "time": "2026-02-26 08:33:35", "headline": "DeFi Development Announces Strategic Investment In Apyx, Dividend-Backed Stablecoin Protocol", "summary": "", "symbols": ["DFDV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886279/defi-development-announces-strategic-investment-in-apyx-dividend-backed-stablecoin-protocol", "tags": ["dividend"]}
{"id": 50886297, "time": "2026-02-26 08:33:56", "headline": "Kopin Secures $3.6M Purchase Order For Avionic Helmet\u2011Mounted Display System For Integration Into Rotary\u2011Wing Military Aircraft Platform For European Defense Client", "summary": "", "symbols": ["KOPN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886297/kopin-secures-3-6m-purchase-order-for-avionic-helmet-mounted-display-system-for-integration-into-rot", "tags": []}
{"id": 50886298, "time": "2026-02-26 08:33:57", "headline": "Gray Media Sees Q1 Sales $755.000M-$770.000M vs $767.092M Est", "summary": "", "symbols": ["GTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886298/gray-media-sees-q1-sales-755-000m-770-000m-vs-767-092m-est", "tags": []}
{"id": 50886336, "time": "2026-02-26 08:34:07", "headline": "Loar Holdings: Q4 Earnings Insights", "summary": " ", "symbols": ["LOAR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50886336/loar-holdings-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50886349, "time": "2026-02-26 08:34:31", "headline": "MSA Safety Announces $500M Share Buyback To Replace Previous $200M Buyback Program", "summary": "", "symbols": ["MSA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886349/msa-safety-announces-500m-share-buyback-to-replace-previous-200m-buyback-program", "tags": ["buyback"]}
{"id": 50886363, "time": "2026-02-26 08:35:08", "headline": "Blue Gold Inks $10M PIPE Agreement With Hudson Dunez FZCO", "summary": "", "symbols": ["BGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886363/blue-gold-inks-10m-pipe-agreement-with-hudson-dunez-fzco", "tags": ["contract"]}
{"id": 50886376, "time": "2026-02-26 08:35:31", "headline": "IGC Pharma Files Patent Covering Its AI-Based Data Harmonization System", "summary": "", "symbols": ["IGC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886376/igc-pharma-files-patent-covering-its-ai-based-data-harmonization-system", "tags": []}
{"id": 50886388, "time": "2026-02-26 08:36:11", "headline": "Loar Holdings Lowers FY2026 Adj EPS Guidance from $0.98-$1.03 to $0.76-$0.80 vs $1.00 Est; Raises FY2026 Sales Guidance from $540.000M-$550.000M to $640.000M-$650.000M vs $616.653M Est", "summary": "", "symbols": ["LOAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886388/loar-holdings-lowers-fy2026-adj-eps-guidance-from-0-98-1-03-to-0-76-0-80-vs-1-00-est-raises-fy2026-s", "tags": ["earnings", "guidance"]}
{"id": 50886397, "time": "2026-02-26 08:36:18", "headline": "Solitario Resources Issued U.S. Forest Service's Decision Memo For Ponderosa Drilling Program In South Dakota", "summary": "", "symbols": ["TSX:SLR", "XPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886397/solitario-resources-issued-u-s-forest-services-decision-memo-for-ponderosa-drilling-program-in-south", "tags": []}
{"id": 50886408, "time": "2026-02-26 08:36:28", "headline": "Loar Holdings Lowers FY2026 GAAP EPS Guidance from $0.82-$0.88 to $0.60-$0.65 vs $0.75 Est; Affirms FY2026 Sales Guidance of $640.000M-$650.000M vs $0.00 Est", "summary": "", "symbols": ["LOAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886408/loar-holdings-lowers-fy2026-gaap-eps-guidance-from-0-82-0-88-to-0-60-0-65-vs-0-75-est-affirms-fy2026", "tags": ["earnings", "guidance"]}
{"id": 50886418, "time": "2026-02-26 08:36:50", "headline": "Starfighters Space Expands Operational Presence At Midland, Texas Air & Space Port", "summary": "", "symbols": ["FJET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886418/starfighters-space-expands-operational-presence-at-midland-texas-air-space-port", "tags": []}
{"id": 50886419, "time": "2026-02-26 08:36:53", "headline": "Hagerty Sees FY2026 Sales $1.280B-$1.300B vs $1.368B Est", "summary": "", "symbols": ["HGTY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886419/hagerty-sees-fy2026-sales-1-280b-1-300b-vs-1-368b-est", "tags": []}
{"id": 50886439, "time": "2026-02-26 08:37:18", "headline": "Manhattan Associates CFO Dennis Story To Retire, Effective March 31, Linda Pinne Named Successor", "summary": "", "symbols": ["MANH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886439/manhattan-associates-cfo-dennis-story-to-retire-effective-march-31-linda-pinne-named-successor", "tags": ["management"]}
{"id": 50886441, "time": "2026-02-26 08:37:20", "headline": "Cheniere Energy Partners Q4 EPS $2.38 Beats $1.07 Estimate, Sales $2.910B Beat $2.870B Estimate", "summary": "", "symbols": ["CQP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50886441/cheniere-energy-partners-q4-eps-2-38-beats-1-07-estimate-sales-2-910b-beat-2-870b-estimate", "tags": ["earnings"]}
{"id": 50886451, "time": "2026-02-26 08:37:26", "headline": "Standard Motor Products Q4 Adj. EPS $0.56 Beats $0.53 Estimate, Sales $385.090M Miss $389.442M Estimate", "summary": "", "symbols": ["SMP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50886451/standard-motor-products-q4-adj-eps-0-56-beats-0-53-estimate-sales-385-090m-miss-389-442m-estimate", "tags": ["earnings"]}
{"id": 50886470, "time": "2026-02-26 08:37:40", "headline": "Auna S.A. Signs PPP Addendum With EsSalud To Launch Construction Of 23-Story Torre Trecca Facility In Lima", "summary": "", "symbols": ["AUNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886470/auna-s-a-signs-ppp-addendum-with-essalud-to-launch-construction-of-23-story-torre-trecca-facility-in", "tags": []}
{"id": 50886481, "time": "2026-02-26 08:38:03", "headline": "This Pfizer Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday", "summary": " ", "symbols": ["ALMS", "ANGX", "CEVA", "MRK", "PFE"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/initiation/26/02/50886481/this-pfizer-analyst-begins-coverage-on-a-bearish-note-here-are-top-5-initiations-for-thursday", "tags": ["analyst_init"]}
{"id": 50886482, "time": "2026-02-26 08:38:06", "headline": "Needham Maintains Buy on Allot, Lowers Price Target to $8.5", "summary": "", "symbols": ["ALLT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886482/needham-maintains-buy-on-allot-lowers-price-target-to-8-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 50886483, "time": "2026-02-26 08:38:12", "headline": "Earnings Breakdown: Cheniere Energy Partners Q4", "summary": " ", "symbols": ["CQP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50886483/earnings-breakdown-cheniere-energy-partners-q4", "tags": ["earnings"]}
{"id": 50886494, "time": "2026-02-26 08:38:17", "headline": "Sarepta Therapeutics To Present Data Muscular Dystrophy Association Clinical & Scientific Conference Across Its Rare Neuromuscular Portfolio", "summary": "", "symbols": ["SRPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886494/sarepta-therapeutics-to-present-data-muscular-dystrophy-association-clinical-scientific-conference-a", "tags": ["fda"]}
{"id": 50886496, "time": "2026-02-26 08:38:18", "headline": "Standard Motor Products: Q4 Earnings Insights", "summary": " ", "symbols": ["SMP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50886496/standard-motor-products-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50886550, "time": "2026-02-26 08:39:07", "headline": "Zhongchao Inc. Announces 1-For-8 Share Consolidation, Effective March 2, 2026", "summary": "", "symbols": ["ZCMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886550/zhongchao-inc-announces-1-for-8-share-consolidation-effective-march-2-2026", "tags": []}
{"id": 50886551, "time": "2026-02-26 08:39:12", "headline": "Universal Display Extends OLED Material Supply, License Deal With LG Display", "summary": "", "symbols": ["OLED"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886551/universal-display-extends-oled-material-supply-license-deal-with-lg-display", "tags": ["contract"]}
{"id": 50886554, "time": "2026-02-26 08:39:16", "headline": "BlackSky Technology Sees FY2026 Sales $120.000M-$145.000M vs $141.759M Est", "summary": "", "symbols": ["BKSY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886554/blacksky-technology-sees-fy2026-sales-120-000m-145-000m-vs-141-759m-est", "tags": []}
{"id": 50886581, "time": "2026-02-26 08:39:35", "headline": "EpicQuest Education Group Signs Memorandum Of Understanding With Davis University To Offer  Online Courses", "summary": "", "symbols": ["EEIQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886581/epicquest-education-group-signs-memorandum-of-understanding-with-davis-university-to-offer-online-co", "tags": []}
{"id": 50878659, "time": "2026-02-26 08:39:50", "headline": "Stock Market Today: Dow, S&P 500 Futures Gain As Jobless Claims Edge Up To 212K; Nasdaq Drops \u2014 Nvidia, Salesforce, Trade Desk In Focus (UPDATED)", "summary": "(Editor\u2019s note: The future prices of benchmark tracking ETFs, the lede, the economic data, and the headline were updated in the story.)\n\n\n\nU.S. stock futures were swinging between gains and losses on Thursday after advancing on Wednesday. Futures of the major benchmark indices were mixed.", "symbols": ["BTCUSD", "CRM", "DELL", "DRVN", "NVDA", "QQQ", "SPY", "TTD"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/markets/equities/26/02/50878659/stock-market-today-dow-futures-slide-sp-500-nasdaq-gain-ahead-of-weekly-jobless-claims-nvidia-salesforce-trade-desk-in-focus", "tags": []}
{"id": 50886601, "time": "2026-02-26 08:40:04", "headline": "XTI Aerospace Adds Antigravity A1 8K 360 Drone To Its Product Portfolio", "summary": "", "symbols": ["XTIA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886601/xti-aerospace-adds-antigravity-a1-8k-360-drone-to-its-product-portfolio", "tags": []}
{"id": 50886604, "time": "2026-02-26 08:40:28", "headline": "Commvault Partners With STACKIT's Sovereign Cloud Storage Solutions To Enable Greater Cyber Resilience For European Customers", "summary": "", "symbols": ["CVLT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886604/commvault-partners-with-stackits-sovereign-cloud-storage-solutions-to-enable-greater-cyber-resilienc", "tags": ["contract"]}
{"id": 50886605, "time": "2026-02-26 08:40:36", "headline": "BTIG Maintains Buy on GitLab, Lowers Price Target to $32", "summary": "", "symbols": ["GTLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886605/btig-maintains-buy-on-gitlab-lowers-price-target-to-32", "tags": ["analyst_other", "price_target_down"]}
{"id": 50886619, "time": "2026-02-26 08:40:56", "headline": "TORM Q4 EPS $0.88 Misses $0.90 Estimate, Sales $352.600M Beat $235.300M Estimate", "summary": "", "symbols": ["TRMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50886619/torm-q4-eps-0-88-misses-0-90-estimate-sales-352-600m-beat-235-300m-estimate", "tags": ["earnings"]}
{"id": 50886664, "time": "2026-02-26 08:42:07", "headline": "TORM Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["TRMD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50886664/torm-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50886665, "time": "2026-02-26 08:42:13", "headline": "Earnings Breakdown: Hilton Grand Vacations Q4", "summary": " ", "symbols": ["HGV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50886665/earnings-breakdown-hilton-grand-vacations-q4", "tags": ["earnings"]}
{"id": 50886686, "time": "2026-02-26 08:42:28", "headline": "Live On CNBC, NVIDIA CEO Jensen Huang Discusses Company Earnings, AI Competition", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886686/live-on-cnbc-nvidia-ceo-jensen-huang-discusses-company-earnings-ai-competition", "tags": ["earnings", "management"]}
{"id": 50886696, "time": "2026-02-26 08:43:03", "headline": "IonQ Stock Gains, Europe's Quantum Leap Sparks Rally", "summary": "IonQ stock rises after deploying a 36-link quantum network in Romania, boosting Europe&#39;s secure communications infrastructure.", "symbols": ["IONQ"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/news/contracts/26/02/50886696/ionq-stock-gains-europes-quantum-leap-sparks-rally", "tags": []}
{"id": 50886697, "time": "2026-02-26 08:43:12", "headline": "OneMedNet Partners With ViuHealth To Expand Autoimmune Clinical Ontology On iRWD Platform Powered By Palantir Foundry", "summary": "", "symbols": ["ONMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886697/onemednet-partners-with-viuhealth-to-expand-autoimmune-clinical-ontology-on-irwd-platform-powered-by", "tags": ["fda", "contract"]}
{"id": 50886721, "time": "2026-02-26 08:43:55", "headline": "Senior Iranian Official Says Reaching Deal Framework Possible If US 'Seriously Separates Nuclear And Non-Nuclear Issues'; Talks Raised New Ideas That Require Consultation With Tehran", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886721/senior-iranian-official-says-reaching-deal-framework-possible-if-us-seriously-separates-nuclear-and", "tags": ["contract"]}
{"id": 50886741, "time": "2026-02-26 08:44:25", "headline": "Immunic Q4 EPS $(0.04) Beats $(0.09) Estimate", "summary": "", "symbols": ["IMUX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50886741/immunic-q4-eps-0-04-beats-0-09-estimate", "tags": ["earnings"]}
{"id": 50886762, "time": "2026-02-26 08:45:04", "headline": "Covestro Q4 EPS $(1.15) Down From $(0.54) YoY, Sales $3.394B Down From $3.603B YoY", "summary": "", "symbols": ["COVTY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50886762/covestro-q4-eps-1-15-down-from-0-54-yoy-sales-3-394b-down-from-3-603b-yoy", "tags": ["earnings"]}
{"id": 50886789, "time": "2026-02-26 08:45:46", "headline": "Truist Securities Maintains Buy on APi Group, Raises Price Target to $53", "summary": "", "symbols": ["APG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886789/truist-securities-maintains-buy-on-api-group-raises-price-target-to-53", "tags": ["analyst_other", "price_target_up"]}
{"id": 50886799, "time": "2026-02-26 08:46:10", "headline": "Why Are SanDisk Shares Surging Thursday?", "summary": "SanDisk Corp (SNDK) is bouncing Thursday after a turbulent session, with shares climbing in early trading despite a high-profile short attack from Citron Research.", "symbols": ["NVDA", "SNDK", "SSNLF", "WDC"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50886799/why-are-sandisk-shares-surging-thursday", "tags": []}
{"id": 50886810, "time": "2026-02-26 08:46:53", "headline": "Antelope Enterprise Holdings Initiates Plan To Deploy Bitcoin And Fund Share Buybacks Through Structured Trading Strategy", "summary": "", "symbols": ["AEHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/26/02/50886810/antelope-enterprise-holdings-initiates-plan-to-deploy-bitcoin-and-fund-share-buybacks-thro", "tags": []}
{"id": 50886833, "time": "2026-02-26 08:48:06", "headline": "Jeffs' Brands' KeepZone AI Subsidiary Signs Channel Partner Agreement With SENSORZTECH To Be Granted Non-Exclusive Rights To Promote, Market, Resell Sensorz's SWORD AI Spectrum Intelligence Platform In Mexico", "summary": "", "symbols": ["JFBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886833/jeffs-brands-keepzone-ai-subsidiary-signs-channel-partner-agreement-with-sensorztech-to-be-granted-n", "tags": ["contract"]}
{"id": 50886862, "time": "2026-02-26 08:49:48", "headline": "Immunic Q4 EPS $(0.07) Beats $(0.09) Estimate", "summary": "", "symbols": ["IMUX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50886862/immunic-q4-eps-0-07-beats-0-09-estimate", "tags": ["earnings"]}
{"id": 50886882, "time": "2026-02-26 08:50:10", "headline": "Erste Group Bank Q4 EPS $1.23 Up From $0.71 YoY, Sales $2.360B Miss $3.570B Estimate", "summary": "", "symbols": ["EBKDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50886882/erste-group-bank-q4-eps-1-23-up-from-0-71-yoy-sales-2-360b-miss-3-570b-estimate", "tags": ["earnings"]}
{"id": 50886896, "time": "2026-02-26 08:51:09", "headline": "Truist Securities Maintains Buy on Encore Capital Gr, Raises Price Target to $80", "summary": "", "symbols": ["ECPG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886896/truist-securities-maintains-buy-on-encore-capital-gr-raises-price-target-to-80", "tags": ["analyst_other", "price_target_up"]}
{"id": 50886914, "time": "2026-02-26 08:51:19", "headline": "Why Is Zoom Stock Sliding After Q4 Results?", "summary": "Zoom Communications Inc. (ZM) shares fell in Thursday premarket trading, after the video-conferencing giant posted mixed fourth-quarter results.", "symbols": ["ZM"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50886914/why-is-zoom-stock-sliding-after-q4-results", "tags": ["earnings", "why_moving"]}
{"id": 50886932, "time": "2026-02-26 08:51:48", "headline": "Fed's Miran Says Banks Are Overregulated And That Harms Credit Creation; Have Not Seen Anything Worrisome Yet In Private Credit Despite Some Bumps", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/macro-notification/26/02/50886932/feds-miran-says-banks-are-overregulated-and-that-harms-credit-creation-have-not-seen-a", "tags": []}
{"id": 50886933, "time": "2026-02-26 08:51:52", "headline": "XRP Struggles Below $2: Why Is It Not Going Up?", "summary": "XRP (CRYPTO: XRP) remains below the $2 mark since mid-January, but rising network activity and institutional inflows are fueling speculation of a potential Q2 rebound.", "symbols": ["XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/crypto/cryptocurrency/26/02/50886933/xrp-struggles-below-2-why-is-it-not-going-up", "tags": []}
{"id": 50886952, "time": "2026-02-26 08:52:11", "headline": "'EBay Is Laying Off About 800 Workers, 6% of Global Workforce' - Bloomberg", "summary": "", "symbols": ["EBAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886952/ebay-is-laying-off-about-800-workers-6-of-global-workforce-bloomberg", "tags": []}
{"id": 50886990, "time": "2026-02-26 08:53:47", "headline": "Benchmark Maintains Buy on IonQ, Lowers Price Target to $65", "summary": "", "symbols": ["IONQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50886990/benchmark-maintains-buy-on-ionq-lowers-price-target-to-65", "tags": ["analyst_other", "price_target_down"]}
{"id": 50887009, "time": "2026-02-26 08:53:58", "headline": "Truist Securities Maintains Buy on Evolent Health, Lowers Price Target to $6", "summary": "", "symbols": ["EVH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887009/truist-securities-maintains-buy-on-evolent-health-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 50887020, "time": "2026-02-26 08:54:14", "headline": "CORRECTION: TriMas Sees FY2026 Sales $665.092M-$684.463M vs $657.922M Est", "summary": "", "symbols": ["TRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887020/correction-trimas-sees-fy2026-sales-665-092m-684-463m-vs-657-922m-est", "tags": []}
{"id": 50887039, "time": "2026-02-26 08:55:04", "headline": "Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["FRSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/26/02/50887039/trading-halt-halt-status-updated-at-8-55-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 50887061, "time": "2026-02-26 08:55:43", "headline": "Truist Securities Maintains Buy on Ferguson Enterprises, Raises Price Target to $300", "summary": "", "symbols": ["FERG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887061/truist-securities-maintains-buy-on-ferguson-enterprises-raises-price-target-to-300", "tags": ["analyst_other", "price_target_up"]}
{"id": 50887073, "time": "2026-02-26 08:56:01", "headline": "Top 2 Consumer Stocks You May Want To Dump This Quarter", "summary": " ", "symbols": ["ATR", "RCKY", "TPH"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/short-ideas/26/02/50887073/top-2-consumer-stocks-you-may-want-to-dump-this-quarter-2", "tags": []}
{"id": 50887075, "time": "2026-02-26 08:56:10", "headline": "Earnings Breakdown: Aurinia Pharmaceuticals Q4", "summary": " ", "symbols": ["AUPH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50887075/earnings-breakdown-aurinia-pharmaceuticals-q4", "tags": ["earnings"]}
{"id": 50887076, "time": "2026-02-26 08:56:11", "headline": "Fed's Miran Says Have Not Seen Anything Worrisome Yet In Private Credit Despite Some \"Bumps\"; Labor Market Data Has Been Quite A Bit Better But It Is Too Early To Sound An All Clear; Do Not Think The U.S. Has An Inflation Problem Now; AI Will Be \"Profoundly Disinflationary\"; Prices Right Now Seem Stable; On Food Prices, Notes That You Can Always Find Outliers", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887076/feds-miran-says-have-not-seen-anything-worrisome-yet-in-private-credit-despite-some-bumps-labor-mark", "tags": []}
{"id": 50887113, "time": "2026-02-26 08:56:43", "headline": "Fed's Miran Says The Fed Should Cut A Percentage Point This Years, In Four Quarter Point Cuts That Come Sooner Than Later; Do Not Know Why AI Along With Destroying Jobs Would Not Also Create New Jobs", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887113/feds-miran-says-the-fed-should-cut-a-percentage-point-this-years-in-four-quarter-point-cuts-that-com", "tags": []}
{"id": 50887122, "time": "2026-02-26 08:56:49", "headline": "HC Wainwright & Co. Maintains Buy on FibroBiologics, Lowers Price Target to $4", "summary": "", "symbols": ["FBLG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887122/hc-wainwright-co-maintains-buy-on-fibrobiologics-lowers-price-target-to-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 50887126, "time": "2026-02-26 08:56:51", "headline": "Synopsys Analysts Cut Their Forecasts Following Q1 Results", "summary": " ", "symbols": ["SNPS"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50887126/synopsys-analysts-cut-their-forecasts-following-q1-results", "tags": ["earnings"]}
{"id": 50887157, "time": "2026-02-26 08:57:33", "headline": "ImmunityBio Investors Rally Behind Cancer Trial Milestone", "summary": "ImmunityBio stock rises after 85% response rate in bladder cancer study, topping BCG alone; FDA filing planned for 2026.", "symbols": ["IBRX"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/news/health-care/26/02/50887157/immunitybio-investors-rally-behind-cancer-trial-milestone", "tags": ["fda"]}
{"id": 50887167, "time": "2026-02-26 08:57:51", "headline": "Truist Securities Maintains Hold on Fiserv, Lowers Price Target to $65", "summary": "", "symbols": ["FISV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887167/truist-securities-maintains-hold-on-fiserv-lowers-price-target-to-65", "tags": ["analyst_other", "price_target_down"]}
{"id": 50887176, "time": "2026-02-26 08:58:03", "headline": "Rosenblatt Maintains Buy on Atlanta Braves Holdings, Maintains $69 Price Target", "summary": "", "symbols": ["BATRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887176/rosenblatt-maintains-buy-on-atlanta-braves-holdings-maintains-69-price-target", "tags": ["analyst_other"]}
{"id": 50887289, "time": "2026-02-26 08:59:03", "headline": "Truist Securities Maintains Hold on Global E Online, Lowers Price Target to $42", "summary": "", "symbols": ["GLBE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887289/truist-securities-maintains-hold-on-global-e-online-lowers-price-target-to-42", "tags": ["analyst_other", "price_target_down"]}
{"id": 50887301, "time": "2026-02-26 08:59:26", "headline": "Rosenblatt Maintains Buy on Taboola.com, Raises Price Target to $7", "summary": "", "symbols": ["TBLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887301/rosenblatt-maintains-buy-on-taboola-com-raises-price-target-to-7", "tags": ["analyst_other", "price_target_up"]}
{"id": 50887312, "time": "2026-02-26 08:59:35", "headline": "Iochpe-Maxion Q4 EPS $(0.01) Down From $0.03 YoY, Sales $651.892M Down From $670.548M YoY", "summary": "", "symbols": ["IOCJY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50887312/iochpe-maxion-q4-eps-0-01-down-from-0-03-yoy-sales-651-892m-down-from-670-548m-yoy", "tags": ["earnings"]}
{"id": 50887331, "time": "2026-02-26 09:00:04", "headline": "Eni Q4 Adj. EPS $0.92 Beats $0.78 Estimate, Sales $24.444B Beat $21.420B Estimate", "summary": "", "symbols": ["E"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50887331/eni-q4-adj-eps-0-92-beats-0-78-estimate-sales-24-444b-beat-21-420b-estimate", "tags": ["earnings"]}
{"id": 50887372, "time": "2026-02-26 09:00:10", "headline": "Earnings Summary: Eni Q4", "summary": " ", "symbols": ["E"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50887372/earnings-summary-eni-q4", "tags": ["earnings"]}
{"id": 50887445, "time": "2026-02-26 09:00:30", "headline": "Preview: YPF's Earnings", "summary": " ", "symbols": ["YPF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50887445/preview-ypfs-earnings", "tags": ["earnings"]}
{"id": 50887466, "time": "2026-02-26 09:00:37", "headline": "Looking Into Corning Inc's Recent Short Interest", "summary": " ", "symbols": ["GLW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50887466/looking-into-corning-incs-recent-short-interest", "tags": []}
{"id": 50887469, "time": "2026-02-26 09:00:38", "headline": "Price Over Earnings Overview: Monster Beverage", "summary": " ", "symbols": ["MNST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50887469/price-over-earnings-overview-monster-beverage", "tags": ["earnings"]}
{"id": 50887502, "time": "2026-02-26 09:00:41", "headline": "Hawaiian Electric Indus's Earnings Outlook", "summary": " ", "symbols": ["HE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50887502/hawaiian-electric-induss-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 50887505, "time": "2026-02-26 09:00:42", "headline": "Here's How Much You Would Have Made Owning Ferguson Enterprises Stock In The Last 5 Years", "summary": " ", "symbols": ["FERG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50887505/heres-how-much-you-would-have-made-owning-ferguson-enterprises-stock-in-the-last-5-years", "tags": []}
{"id": 50887508, "time": "2026-02-26 09:00:43", "headline": "Looking Into Abbott Laboratories's Recent Short Interest", "summary": " ", "symbols": ["ABT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50887508/looking-into-abbott-laboratoriess-recent-short-interest", "tags": []}
{"id": 50887511, "time": "2026-02-26 09:00:48", "headline": "How Do Investors Really Feel About Salesforce Inc?", "summary": " ", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50887511/how-do-investors-really-feel-about-salesforce-inc", "tags": []}
{"id": 50887537, "time": "2026-02-26 09:00:53", "headline": "What to Expect from BrightSpring Health's Earnings", "summary": " ", "symbols": ["BTSG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50887537/what-to-expect-from-brightspring-healths-earnings", "tags": ["earnings"]}
{"id": 50887563, "time": "2026-02-26 09:00:59", "headline": "Expert Outlook: Global E Online Through The Eyes Of 4 Analysts", "summary": " ", "symbols": ["GLBE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50887563/expert-outlook-global-e-online-through-the-eyes-of-4-analysts", "tags": ["guidance"]}
{"id": 50887569, "time": "2026-02-26 09:01:02", "headline": "Insights Ahead: Northwest Natural Hldg's Quarterly Earnings", "summary": " ", "symbols": ["NWN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50887569/insights-ahead-northwest-natural-hldgs-quarterly-earnings", "tags": ["earnings"]}
{"id": 50887575, "time": "2026-02-26 09:01:10", "headline": "TransAlta's Earnings: A Preview", "summary": " ", "symbols": ["TAC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50887575/transaltas-earnings-a-preview", "tags": ["earnings"]}
{"id": 50887583, "time": "2026-02-26 09:01:19", "headline": "A Glimpse of Alpha Metallurgical's Earnings Potential", "summary": " ", "symbols": ["AMR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50887583/a-glimpse-of-alpha-metallurgicals-earnings-potential", "tags": ["earnings"]}
{"id": 50887589, "time": "2026-02-26 09:01:28", "headline": "Earnings Outlook For Delek US Hldgs", "summary": " ", "symbols": ["DK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50887589/earnings-outlook-for-delek-us-hldgs", "tags": ["earnings", "guidance"]}
{"id": 50887590, "time": "2026-02-26 09:01:29", "headline": "Rosenblatt Maintains Buy on Xperi, Maintains $10 Price Target", "summary": "", "symbols": ["XPER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887590/rosenblatt-maintains-buy-on-xperi-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 50887593, "time": "2026-02-26 09:01:33", "headline": "Truist Securities Maintains Buy on Lowe's Companies, Lowers Price Target to $293", "summary": "", "symbols": ["LOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887593/truist-securities-maintains-buy-on-lowes-companies-lowers-price-target-to-293", "tags": ["analyst_other", "price_target_down"]}
{"id": 50887600, "time": "2026-02-26 09:01:40", "headline": "Insperity, Workday Announce Availability Of Insperity HRScale Solution", "summary": "", "symbols": ["NSP", "WDAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887600/insperity-workday-announce-availability-of-insperity-hrscale-solution", "tags": []}
{"id": 50887602, "time": "2026-02-26 09:01:41", "headline": "Earnings Outlook For Amneal Pharmaceuticals", "summary": " ", "symbols": ["AMRX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50887602/earnings-outlook-for-amneal-pharmaceuticals", "tags": ["earnings", "guidance"]}
{"id": 50887611, "time": "2026-02-26 09:01:50", "headline": "Preview: Globalstar's Earnings", "summary": " ", "symbols": ["GSAT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50887611/preview-globalstars-earnings", "tags": ["earnings"]}
{"id": 50887613, "time": "2026-02-26 09:01:55", "headline": "Argenx Touts Positive Phase 3 Eye Disease Study Results", "summary": "Argenx reports positive Phase 3 results for Vyvgart in eye disease, beats earnings as sales surge over 70%.", "symbols": ["ARGX"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/markets/earnings/26/02/50887613/argenx-touts-positive-phase-3-eye-disease-study-results", "tags": ["earnings", "fda"]}
{"id": 50887618, "time": "2026-02-26 09:02:00", "headline": "Earnings Preview: Calumet Specialty Prods", "summary": " ", "symbols": ["CLMT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50887618/earnings-preview-calumet-specialty-prods", "tags": ["earnings"]}
{"id": 50887638, "time": "2026-02-26 09:02:13", "headline": "A Look at Frontline's Upcoming Earnings Report", "summary": " ", "symbols": ["FRO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50887638/a-look-at-frontlines-upcoming-earnings-report", "tags": ["earnings"]}
{"id": 50887639, "time": "2026-02-26 09:02:13", "headline": "Subsea 7 Q4 EPS $0.49 Misses $0.59 Estimate, Sales $1.962B Beat $1.951B Estimate", "summary": "", "symbols": ["SUBCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50887639/subsea-7-q4-eps-0-49-misses-0-59-estimate-sales-1-962b-beat-1-951b-estimate", "tags": ["earnings"]}
{"id": 50887650, "time": "2026-02-26 09:02:28", "headline": "These Analysts Slash Their Forecasts On IonQ After Q4 Results", "summary": " ", "symbols": ["IONQ"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50887650/these-analysts-slash-their-forecasts-on-ionq-after-q4-results", "tags": ["earnings"]}
{"id": 50887653, "time": "2026-02-26 09:02:35", "headline": "Femasys' FemBloc Permanent Birth Control System Gets Certification Under Medical Device Single Audit Program", "summary": "", "symbols": ["FEMY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887653/femasys-fembloc-permanent-birth-control-system-gets-certification-under-medical-device-single-audit", "tags": []}
{"id": 50887664, "time": "2026-02-26 09:02:49", "headline": "JAKKS Pacific Signs New Licensing Deal With VIZ Media For Naruto Anime Franchise In U.S., Canada", "summary": "", "symbols": ["JAKK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887664/jakks-pacific-signs-new-licensing-deal-with-viz-media-for-naruto-anime-franchise-in-u-s-canada", "tags": ["contract"]}
{"id": 50887669, "time": "2026-02-26 09:02:59", "headline": "Rosenblatt Maintains Buy on Hut 8, Maintains $65 Price Target", "summary": "", "symbols": ["HUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887669/rosenblatt-maintains-buy-on-hut-8-maintains-65-price-target", "tags": ["analyst_other"]}
{"id": 50887680, "time": "2026-02-26 09:03:10", "headline": "China's Search Giant Baidu Struggles With Weak Ad Spending Despite AI Push", "summary": "Baidu (BIDU) shares fell after reporting Q4 results. Revenue declined 4% YoY but exceeded analysts&#39; estimate.", "symbols": ["BIDU", "IQ"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/markets/earnings/26/02/50887680/chinas-search-giant-baidu-struggles-with-weak-ad-spending-despite-ai-push", "tags": ["earnings"]}
{"id": 50887700, "time": "2026-02-26 09:03:39", "headline": "TIAN RUIXIANG Injects An Additional 15K Bitcoin Tokens Into TIRX, Bringing Total To 30K", "summary": "", "symbols": ["TIRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/26/02/50887700/tian-ruixiang-injects-an-additional-15k-bitcoin-tokens-into-tirx-bringing-total-to-30k", "tags": []}
{"id": 50887716, "time": "2026-02-26 09:03:59", "headline": "Elong Power Commences $7M Offering Of 21.7M Units At $0.3231/Unit", "summary": "", "symbols": ["ELPW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887716/elong-power-commences-7m-offering-of-21-7m-units-at-0-3231unit", "tags": ["offering"]}
{"id": 50887734, "time": "2026-02-26 09:04:23", "headline": "IPG Photonics Bags ~$10M Order From Lockheed Martin For Delivery Of CROSSBOW High-Energy Laser Counter-UAS Defense Systems; Delivery Expected Over Next Several Quarters", "summary": "", "symbols": ["IPGP", "LMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887734/ipg-photonics-bags-10m-order-from-lockheed-martin-for-delivery-of-crossbow-high-energy-laser-counter", "tags": []}
{"id": 50887745, "time": "2026-02-26 09:04:36", "headline": "Rosenblatt Maintains Buy on Miami International Hldgs, Raises Price Target to $59", "summary": "", "symbols": ["MIAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887745/rosenblatt-maintains-buy-on-miami-international-hldgs-raises-price-target-to-59", "tags": ["analyst_other", "price_target_up"]}
{"id": 50887746, "time": "2026-02-26 09:04:36", "headline": "Truist Securities Maintains Buy on NVIDIA, Raises Price Target to $283", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887746/truist-securities-maintains-buy-on-nvidia-raises-price-target-to-283", "tags": ["analyst_other", "price_target_up"]}
{"id": 50887761, "time": "2026-02-26 09:04:56", "headline": "Affirm Collaborates With H&R Block To Roll Out Flexible Payment Options Across Canada", "summary": "", "symbols": ["AFRM", "HRB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887761/affirm-collaborates-with-h-r-block-to-roll-out-flexible-payment-options-across-canada", "tags": []}
{"id": 50887788, "time": "2026-02-26 09:05:20", "headline": "Fate Therapeutics Q4 EPS $(0.27) Misses $(0.26) Estimate, Sales $1.369M Beat $1.186M Estimate", "summary": "", "symbols": ["FATE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50887788/fate-therapeutics-q4-eps-0-27-misses-0-26-estimate-sales-1-369m-beat-1-186m-estimate", "tags": ["earnings"]}
{"id": 50887842, "time": "2026-02-26 09:06:05", "headline": "Rosenblatt Maintains Buy on IonQ, Maintains $100 Price Target", "summary": "", "symbols": ["IONQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887842/rosenblatt-maintains-buy-on-ionq-maintains-100-price-target", "tags": ["analyst_other"]}
{"id": 50887848, "time": "2026-02-26 09:06:07", "headline": "Earnings Summary: Fate Therapeutics Q4", "summary": " ", "symbols": ["FATE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50887848/earnings-summary-fate-therapeutics-q4", "tags": ["earnings"]}
{"id": 50887895, "time": "2026-02-26 09:06:38", "headline": "Truist Securities Maintains Buy on Nerdwallet, Lowers Price Target to $18", "summary": "", "symbols": ["NRDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50887895/truist-securities-maintains-buy-on-nerdwallet-lowers-price-target-to-18", "tags": ["analyst_other", "price_target_down"]}
{"id": 50887929, "time": "2026-02-26 09:07:01", "headline": "Trade Desk Analysts Lower Their Forecasts Following Q4 Results", "summary": " ", "symbols": ["TTD"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50887929/trade-desk-analysts-lower-their-forecasts-following-q4-results", "tags": ["earnings"]}
{"id": 50887940, "time": "2026-02-26 09:07:11", "headline": "Hudson Pacific Properties Q4 Sales $256.027M Beat $191.619M Estimate", "summary": "", "symbols": ["HPP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50887940/hudson-pacific-properties-q4-sales-256-027m-beat-191-619m-estimate", "tags": []}
{"id": 50887981, "time": "2026-02-26 09:07:43", "headline": "Vox Royalty Subsidiary Vox Royalty Australia Completes Acquisition Of Gold And Copper Royalties From Unnamed Subsidiary Of Aurelia Metals Worth AUD 650K", "summary": "", "symbols": ["VOXR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50887981/vox-royalty-subsidiary-vox-royalty-australia-completes-acquisition-of-gold-and-copper-royalties-from", "tags": []}
{"id": 50888004, "time": "2026-02-26 09:08:07", "headline": "BTIG Maintains Buy on Salesforce, Lowers Price Target to $255", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888004/btig-maintains-buy-on-salesforce-lowers-price-target-to-255", "tags": ["analyst_other", "price_target_down"]}
{"id": 50888015, "time": "2026-02-26 09:08:15", "headline": "Truist Securities Maintains Hold on SPX Technologies, Raises Price Target to $244", "summary": "", "symbols": ["SPXC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888015/truist-securities-maintains-hold-on-spx-technologies-raises-price-target-to-244", "tags": ["analyst_other", "price_target_up"]}
{"id": 50888017, "time": "2026-02-26 09:08:19", "headline": "Google Says We're Expanding Beta Access To Text Guidelines For All Advertisers Globally In AI Max", "summary": "", "symbols": ["GOOG", "GOOGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888017/google-says-were-expanding-beta-access-to-text-guidelines-for-all-advertisers-globally-in-ai-max", "tags": []}
{"id": 50888039, "time": "2026-02-26 09:08:41", "headline": "Hudson Pacific Properties Q4 FFO $0.21, Inline", "summary": "", "symbols": ["HPP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50888039/hudson-pacific-properties-q4-ffo-0-21-inline", "tags": []}
{"id": 50888058, "time": "2026-02-26 09:08:50", "headline": "BioCryst Pharma Affirms FY2026 Sales Guidance of $635.000M-$660.000M", "summary": "", "symbols": ["BCRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888058/biocryst-pharma-affirms-fy2026-sales-guidance-of-635-000m-660-000m", "tags": ["guidance"]}
{"id": 50888080, "time": "2026-02-26 09:09:48", "headline": "Hudson Pacific Properties Sees FY2026 FFO $0.96-$1.06 vs $1.00 Est", "summary": "", "symbols": ["HPP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888080/hudson-pacific-properties-sees-fy2026-ffo-0-96-1-06-vs-1-00-est", "tags": []}
{"id": 50888093, "time": "2026-02-26 09:10:08", "headline": "Hudson Pacific Properties: Q4 Earnings Insights", "summary": " ", "symbols": ["HPP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50888093/hudson-pacific-properties-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50888095, "time": "2026-02-26 09:10:13", "headline": "Munchener Q4 EPS $0.86 Up From $0.16 YoY, Sales $17.753B Up From $16.350B YoY", "summary": "", "symbols": ["MURGY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50888095/munchener-q4-eps-0-86-up-from-0-16-yoy-sales-17-753b-up-from-16-350b-yoy", "tags": ["earnings"]}
{"id": 50888096, "time": "2026-02-26 09:10:14", "headline": "Zai Lab: Q4 Earnings Insights", "summary": " ", "symbols": ["ZLAB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50888096/zai-lab-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50888104, "time": "2026-02-26 09:10:24", "headline": "UPDATE: Aurinia Pharmaceuticals Q4 Adj. EPS $0.26 Beats $0.22 Estimate", "summary": "", "symbols": ["AUPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50888104/update-aurinia-pharmaceuticals-q4-adj-eps-0-26-beats-0-22-estimate", "tags": ["earnings"]}
{"id": 50888119, "time": "2026-02-26 09:10:35", "headline": "HC Wainwright & Co. Maintains Buy on Hut 8, Maintains $80 Price Target", "summary": "", "symbols": ["HUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888119/hc-wainwright-co-maintains-buy-on-hut-8-maintains-80-price-target", "tags": ["analyst_other"]}
{"id": 50888132, "time": "2026-02-26 09:10:46", "headline": "Bentley Systems Sees FY2026 Sales $1.685B-$1.715B vs $1.647B Est", "summary": "", "symbols": ["BSY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888132/bentley-systems-sees-fy2026-sales-1-685b-1-715b-vs-1-647b-est", "tags": []}
{"id": 50888151, "time": "2026-02-26 09:11:05", "headline": "'Broadcom Ships New AI Chip to Fujitsu, Plans Wider Rollout' - Bloomberg", "summary": "", "symbols": ["AVGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888151/broadcom-ships-new-ai-chip-to-fujitsu-plans-wider-rollout-bloomberg", "tags": []}
{"id": 50888165, "time": "2026-02-26 09:11:18", "headline": "Truist Securities Maintains Buy on Snowflake, Lowers Price Target to $240", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888165/truist-securities-maintains-buy-on-snowflake-lowers-price-target-to-240", "tags": ["analyst_other", "price_target_down"]}
{"id": 50888177, "time": "2026-02-26 09:11:46", "headline": "These Analysts Cut Their Forecasts On Nutanix After Q2 Results", "summary": " ", "symbols": ["NTNX"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50888177/these-analysts-cut-their-forecasts-on-nutanix-after-q2-results", "tags": ["earnings"]}
{"id": 50888199, "time": "2026-02-26 09:12:17", "headline": "BTIG Maintains Buy on V2X, Raises Price Target to $90", "summary": "", "symbols": ["VVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888199/btig-maintains-buy-on-v2x-raises-price-target-to-90", "tags": ["analyst_other", "price_target_up"]}
{"id": 50888224, "time": "2026-02-26 09:13:01", "headline": "Truist Securities Maintains Buy on Trade Desk, Lowers Price Target to $50", "summary": "", "symbols": ["TTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888224/truist-securities-maintains-buy-on-trade-desk-lowers-price-target-to-50", "tags": ["analyst_other", "price_target_down"]}
{"id": 50888263, "time": "2026-02-26 09:14:08", "headline": "Fate Therapeutics Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["FATE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50888263/fate-therapeutics-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50888265, "time": "2026-02-26 09:14:11", "headline": "BTIG Maintains Buy on Zoom Communications, Lowers Price Target to $100", "summary": "", "symbols": ["ZM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888265/btig-maintains-buy-on-zoom-communications-lowers-price-target-to-100", "tags": ["analyst_other", "price_target_down"]}
{"id": 50888266, "time": "2026-02-26 09:14:14", "headline": "Acushnet Holdings Earnings Report: Q4 Overview", "summary": " ", "symbols": ["GOLF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50888266/acushnet-holdings-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50888318, "time": "2026-02-26 09:15:32", "headline": "$100 Invested In PulteGroup 10 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["PHM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50888318/100-invested-in-pultegroup-10-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 50888326, "time": "2026-02-26 09:15:43", "headline": "BTIG Maintains Buy on BWX Technologies, Raises Price Target to $235", "summary": "", "symbols": ["BWXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888326/btig-maintains-buy-on-bwx-technologies-raises-price-target-to-235", "tags": ["analyst_other", "price_target_up"]}
{"id": 50888337, "time": "2026-02-26 09:15:55", "headline": "Kilroy Realty Appoints Gary Stevenson Board Chair, Effective Immediately, Succeeding Edward F. Brennan", "summary": "", "symbols": ["KRC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888337/kilroy-realty-appoints-gary-stevenson-board-chair-effective-immediately-succeeding-edward-f-brennan", "tags": ["management"]}
{"id": 50888346, "time": "2026-02-26 09:16:01", "headline": "These Analysts Slash Their Forecasts On Snowflake After Q4 Results", "summary": " ", "symbols": ["SNOW"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50888346/these-analysts-slash-their-forecasts-on-snowflake-after-q4-results", "tags": ["earnings"]}
{"id": 50888355, "time": "2026-02-26 09:16:04", "headline": "Stifel Maintains Hold on ACADIA Pharmaceuticals, Lowers Price Target to $24", "summary": "", "symbols": ["ACAD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888355/stifel-maintains-hold-on-acadia-pharmaceuticals-lowers-price-target-to-24", "tags": ["analyst_other", "price_target_down"]}
{"id": 50888377, "time": "2026-02-26 09:16:24", "headline": "JFrog Board Authorizes $300M Share Repurchase Program", "summary": "", "symbols": ["FROG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888377/jfrog-board-authorizes-300m-share-repurchase-program", "tags": ["buyback"]}
{"id": 50888409, "time": "2026-02-26 09:17:19", "headline": "HC Wainwright & Co. Maintains Buy on Arcutis Biotherapeutics, Raises Price Target to $34", "summary": "", "symbols": ["ARQT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888409/hc-wainwright-co-maintains-buy-on-arcutis-biotherapeutics-raises-price-target-to-34", "tags": ["analyst_other", "price_target_up"]}
{"id": 50888424, "time": "2026-02-26 09:17:39", "headline": "Stifel Maintains Buy on Archrock, Raises Price Target to $40", "summary": "", "symbols": ["AROC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888424/stifel-maintains-buy-on-archrock-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 50888462, "time": "2026-02-26 09:18:59", "headline": "Delcath Systems FY2026 Total CHEMOSAT and HEPZATO KIT Revenue expected to be more than $100.000M vs $112.895M Est", "summary": "", "symbols": ["DCTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888462/delcath-systems-fy2026-total-chemosat-and-hepzato-kit-revenue-expected-to-be-more-than-100-000m-vs-1", "tags": ["earnings"]}
{"id": 50888473, "time": "2026-02-26 09:19:19", "headline": "Celsius Stock Surges 10% After Q4 Double Beat", "summary": "Celsius Holdings, Inc. (NASDAQ:CELH) shares are trading higher Thursday after the company reported fourth-quarter financial results.", "symbols": ["CELH"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50888473/celsius-stock-surges-10-after-q4-double-beat", "tags": ["why_moving"]}
{"id": 50888482, "time": "2026-02-26 09:19:40", "headline": "Stifel Reiterates Buy on Celldex Therapeutics, Raises Price Target to $68", "summary": "", "symbols": ["CLDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888482/stifel-reiterates-buy-on-celldex-therapeutics-raises-price-target-to-68", "tags": ["analyst_other", "price_target_up"]}
{"id": 50888504, "time": "2026-02-26 09:20:06", "headline": "'Boeing Lifts Africa's Aircraft Order Outlook on Strong Growth' - Bloomberg", "summary": "", "symbols": ["BA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888504/boeing-lifts-africas-aircraft-order-outlook-on-strong-growth-bloomberg", "tags": ["guidance"]}
{"id": 50888514, "time": "2026-02-26 09:20:18", "headline": "Biofrontera Announces US Patent Trial And Appeal Board Final Written Decision Finding All Challenged Claims Of Sun Pharma's '028 Patent To Be Unpatentable", "summary": "", "symbols": ["BFRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888514/biofrontera-announces-us-patent-trial-and-appeal-board-final-written-decision-finding-all-challenged", "tags": ["fda"]}
{"id": 50888528, "time": "2026-02-26 09:21:47", "headline": "C3.Ai Stock Sinks After Q3 Miss, Fiscal 2026 Forecast Cut Nearly In Half", "summary": "C3.Ai, Inc. (NYSE:AI) shares are trading lower Thursday after the company reported worse-than-expected third-quarter financial results.", "symbols": ["AI"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50888528/c3-ai-stock-sinks-after-q3-miss-fiscal-2026-forecast-cut-nearly-in-half", "tags": ["guidance", "why_moving"]}
{"id": 50888529, "time": "2026-02-26 09:21:47", "headline": "Stifel Maintains Hold on Clear Secure, Raises Price Target to $51", "summary": "", "symbols": ["YOU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888529/stifel-maintains-hold-on-clear-secure-raises-price-target-to-51", "tags": ["analyst_other", "price_target_up"]}
{"id": 50888553, "time": "2026-02-26 09:22:46", "headline": "Compass Point Downgrades Tanger to Neutral, Announces $38 Price Target", "summary": "", "symbols": ["SKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888553/compass-point-downgrades-tanger-to-neutral-announces-38-price-target", "tags": ["analyst_down"]}
{"id": 50888554, "time": "2026-02-26 09:22:46", "headline": "Tevogen Signs Non-Exclusive, Non-Binding LOI To Evaluate Potential Transaction With Sciometrix To Augment Capabilities And Transition Into Revenue\u2011Generating Healthcare Enterprise", "summary": "", "symbols": ["TVGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888554/tevogen-signs-non-exclusive-non-binding-loi-to-evaluate-potential-transaction-with-sciometrix-to-aug", "tags": ["earnings"]}
{"id": 50888575, "time": "2026-02-26 09:23:14", "headline": "JD.com, DHL Ink Memorandum Of Understanding To Support German Brands' Growth In China, Enhance Access In Europe", "summary": "", "symbols": ["JD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888575/jd-com-dhl-ink-memorandum-of-understanding-to-support-german-brands-growth-in-china-enhance-access-i", "tags": []}
{"id": 50888601, "time": "2026-02-26 09:24:36", "headline": "Keybanc Reiterates Overweight on NVIDIA, Maintains $275 Price Target", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888601/keybanc-reiterates-overweight-on-nvidia-maintains-275-price-target", "tags": ["analyst_other"]}
{"id": 50888615, "time": "2026-02-26 09:25:07", "headline": "Stifel Maintains Buy on ExlService Hldgs, Lowers Price Target to $46", "summary": "", "symbols": ["EXLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888615/stifel-maintains-buy-on-exlservice-hldgs-lowers-price-target-to-46", "tags": ["analyst_other", "price_target_down"]}
{"id": 50888639, "time": "2026-02-26 09:26:24", "headline": "Viatris CEO Says Met With FDA In November On Indore Facility Progress, Will Be Ready For Reinspection This Year But Timing Up To FDA; Exec Says About 50% Of $650M Savings Coming From Job Cuts; Assumes Little Less Than 1% Of Indore Recovery Baked Into Top Line Forecast; Indore Would Not Have Material Impact On 2026 Forecast; Has Requalified Other Plants And Found Alternate Sources For Indore Plant", "summary": "", "symbols": ["VTRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888639/viatris-ceo-says-met-with-fda-in-november-on-indore-facility-progress-will-be-ready-for-reinspection", "tags": ["guidance", "fda", "management"]}
{"id": 50888663, "time": "2026-02-26 09:27:23", "headline": "Stifel Reiterates Buy on Hayward Holdings, Raises Price Target to $19.5", "summary": "", "symbols": ["HAYW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888663/stifel-reiterates-buy-on-hayward-holdings-raises-price-target-to-19-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 50888683, "time": "2026-02-26 09:27:47", "headline": "MP Materials Selects 120-Acre Facility In Northlake, Texas, To Develop 10X Rare Earth Magnet Production Campus", "summary": "", "symbols": ["MP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888683/mp-materials-selects-120-acre-facility-in-northlake-texas-to-develop-10x-rare-earth-magnet-productio", "tags": []}
{"id": 50888685, "time": "2026-02-26 09:27:49", "headline": "Keybanc Maintains Underweight on C3.ai, Lowers Price Target to $6", "summary": "", "symbols": ["AI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888685/keybanc-maintains-underweight-on-c3-ai-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 50888686, "time": "2026-02-26 09:27:54", "headline": "'Irenic Makes Unsolicited Bid for Reservoir Media' - Bloomberg News", "summary": "", "symbols": ["RSVR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50888686/irenic-makes-unsolicited-bid-for-reservoir-media-bloomberg-news", "tags": []}
{"id": 50888830, "time": "2026-02-26 09:28:46", "headline": "Irenic Submitted A Bid For Reservoir Media Worth $10-$11 Per Share Or About $1.1B-$1.2B, Including Debt", "summary": "", "symbols": ["RSVR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50888830/irenic-submitted-a-bid-for-reservoir-media-worth-10-11-per-share-or-about-1-1b-1-2b-including-debt", "tags": []}
{"id": 50888853, "time": "2026-02-26 09:29:35", "headline": "Keybanc Maintains Overweight on Applied Industrial Techs, Raises Price Target to $330", "summary": "", "symbols": ["AIT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888853/keybanc-maintains-overweight-on-applied-industrial-techs-raises-price-target-to-330", "tags": ["analyst_other", "price_target_up"]}
{"id": 50888879, "time": "2026-02-26 09:30:01", "headline": "JP Morgan Downgrades ODDITY Tech to Neutral, Lowers Price Target to $16", "summary": "", "symbols": ["ODD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888879/jp-morgan-downgrades-oddity-tech-to-neutral-lowers-price-target-to-16", "tags": ["analyst_down", "price_target_down"]}
{"id": 50888880, "time": "2026-02-26 09:30:02", "headline": "Stifel Maintains Buy on Intapp, Lowers Price Target to $35", "summary": "", "symbols": ["INTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50888880/stifel-maintains-buy-on-intapp-lowers-price-target-to-35", "tags": ["analyst_other", "price_target_down"]}
{"id": 50888901, "time": "2026-02-26 09:30:10", "headline": "Trading Halt: Halt status updated at 9:30:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation", "summary": "", "symbols": ["MYHA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/26/02/50888901/trading-halt-halt-status-updated-at-9-30-00-am-et-quotation-resumption-ipo-security-released-for-quo", "tags": []}
{"id": 50888902, "time": "2026-02-26 09:30:10", "headline": "Trading Halt: Halt status updated at 9:30:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation", "summary": "", "symbols": ["MYHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/26/02/50888902/trading-halt-halt-status-updated-at-9-30-00-am-et-quotation-resumption-ipo-security-released-for-quo", "tags": []}
{"id": 50888903, "time": "2026-02-26 09:30:10", "headline": "Trading Halt: Halt status updated at 9:30:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation", "summary": "", "symbols": ["MYHB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/26/02/50888903/trading-halt-halt-status-updated-at-9-30-00-am-et-quotation-resumption-ipo-security-released-for-quo", "tags": []}
{"id": 50888904, "time": "2026-02-26 09:30:10", "headline": "Trading Halt: Halt status updated at 9:30:01 AM ET: Quotation Resumption: IPO Security - Released for Quotation", "summary": "", "symbols": ["BAIV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/26/02/50888904/trading-halt-halt-status-updated-at-9-30-01-am-et-quotation-resumption-ipo-security-released-for-quo", "tags": []}
{"id": 50888906, "time": "2026-02-26 09:30:11", "headline": "Trading Halt: Halt status updated at 9:30:02 AM ET: Quotation Resumption: IPO Security - Released for Quotation", "summary": "", "symbols": ["MYHE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/26/02/50888906/trading-halt-halt-status-updated-at-9-30-02-am-et-quotation-resumption-ipo-security-released-for-quo", "tags": []}
{"id": 50888908, "time": "2026-02-26 09:30:11", "headline": "Trading Halt: Halt status updated at 9:30:03 AM ET: Quotation Resumption: IPO Security - Released for Quotation", "summary": "", "symbols": ["MYHD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/26/02/50888908/trading-halt-halt-status-updated-at-9-30-03-am-et-quotation-resumption-ipo-security-released-for-quo", "tags": []}
{"id": 50888946, "time": "2026-02-26 09:30:21", "headline": "Here's How Much You Would Have Made Owning Teledyne Technologies Stock In The Last 10 Years", "summary": " ", "symbols": ["TDY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50888946/heres-how-much-you-would-have-made-owning-teledyne-technologies-stock-in-the-last-10-years", "tags": []}
{"id": 50889008, "time": "2026-02-26 09:31:29", "headline": "Keybanc Maintains Overweight on Camping World Holdings, Lowers Price Target to $12", "summary": "", "symbols": ["CWH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889008/keybanc-maintains-overweight-on-camping-world-holdings-lowers-price-target-to-12", "tags": ["analyst_other", "price_target_down"]}
{"id": 50889019, "time": "2026-02-26 09:31:54", "headline": "JP Morgan Downgrades Mosaic to Underweight, Maintains Price Target to $24", "summary": "", "symbols": ["MOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889019/jp-morgan-downgrades-mosaic-to-underweight-maintains-price-target-to-24", "tags": ["analyst_down", "analyst_other"]}
{"id": 50884889, "time": "2026-02-26 08:03:29", "headline": "Eos Energy Enterprises Q4 Adj. EPS $(0.72) Misses $(0.18) Estimate, Sales $57.998M Miss $93.870M Estimate", "summary": "", "symbols": ["EOSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50884889/eos-energy-enterprises-q4-adj-eps-0-72-misses-0-18-estimate-sales-57-998m-miss-93-870m-estimate", "tags": ["earnings"]}
{"id": 50889040, "time": "2026-02-26 09:33:33", "headline": "Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $9", "summary": "", "symbols": ["LFST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889040/keybanc-maintains-overweight-on-lifestance-health-gr-raises-price-target-to-9", "tags": ["analyst_other", "price_target_up"]}
{"id": 50889052, "time": "2026-02-26 09:33:46", "headline": "Barclays Downgrades ODDITY Tech to Underweight, Lowers Price Target to $13", "summary": "", "symbols": ["ODD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889052/barclays-downgrades-oddity-tech-to-underweight-lowers-price-target-to-13", "tags": ["analyst_down", "price_target_down"]}
{"id": 50889068, "time": "2026-02-26 09:34:25", "headline": "Stifel Maintains Buy on Marriott Vacations, Raises Price Target to $85", "summary": "", "symbols": ["VAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889068/stifel-maintains-buy-on-marriott-vacations-raises-price-target-to-85", "tags": ["analyst_other", "price_target_up"]}
{"id": 50889083, "time": "2026-02-26 09:35:00", "headline": "Marco Rubio Says Iran Has Weapons 'Solely Designed To Attack America,' But What Do Prediction Markets Say?", "summary": "US warns of Iran&#39;s weapons, Tehran&#39;s mixed messaging, and the impact on stocks like RTX and Boeing - Predictions: US strike on Iran by Feb 30%.", "symbols": ["BA", "CVX", "LMT", "PLTR", "RTX", "TSX:RE", "XOM"], "source": "benzinga", "author": "Daragh Thomas", "url": "https://www.benzinga.com/markets/prediction-markets/26/02/50889083/marco-rubio-says-iran-has-weapons-solely-designed-to-attack-america-but-what-do-prediction-markets-say", "tags": []}
{"id": 50889084, "time": "2026-02-26 09:35:07", "headline": "Keybanc Maintains Overweight on ODDITY Tech, Lowers Price Target to $30", "summary": "", "symbols": ["ODD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889084/keybanc-maintains-overweight-on-oddity-tech-lowers-price-target-to-30", "tags": ["analyst_other", "price_target_down"]}
{"id": 50889149, "time": "2026-02-26 09:35:23", "headline": "Stifel Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $125", "summary": "", "symbols": ["MIRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889149/stifel-maintains-buy-on-mirum-pharmaceuticals-raises-price-target-to-125", "tags": ["analyst_other", "price_target_up"]}
{"id": 50889221, "time": "2026-02-26 09:36:17", "headline": "Keybanc Maintains Underweight on Zoom Communications, Raises Price Target to $74", "summary": "", "symbols": ["ZM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889221/keybanc-maintains-underweight-on-zoom-communications-raises-price-target-to-74", "tags": ["analyst_other", "price_target_up"]}
{"id": 50889257, "time": "2026-02-26 09:36:58", "headline": "Stifel Maintains Buy on Salesforce, Lowers Price Target to $250", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889257/stifel-maintains-buy-on-salesforce-lowers-price-target-to-250", "tags": ["analyst_other", "price_target_down"]}
{"id": 50889460, "time": "2026-02-26 09:40:14", "headline": "Citizens Maintains Market Outperform on ACADIA Pharmaceuticals, Raises Price Target to $35", "summary": "", "symbols": ["ACAD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889460/citizens-maintains-market-outperform-on-acadia-pharmaceuticals-raises-price-target-to-35", "tags": ["analyst_other", "price_target_up"]}
{"id": 50889554, "time": "2026-02-26 09:41:07", "headline": "Redwire Sees FY2026 Sales $450.000M-$500.000M vs $460.912M Est", "summary": "", "symbols": ["RDW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889554/redwire-sees-fy2026-sales-450-000m-500-000m-vs-460-912m-est", "tags": []}
{"id": 50889587, "time": "2026-02-26 09:41:39", "headline": "Cardano's Hoskinson Says ADA Is 'Still In The Game,' But Is This Rally A Bull Trap?", "summary": "Cardano (CRYPTO: ADA) co-founder Charles Hoskinson defended the project, saying \u201cCardano is still in the game, it\u2019s still fighting\u201d ", "symbols": ["ADAUSD"], "source": "benzinga", "author": "Parshwa Turakhiya", "url": "https://www.benzinga.com/crypto/cryptocurrency/26/02/50889587/cardanos-hoskinson-says-ada-is-still-in-the-game-but-is-this-rally-a-bull-trap", "tags": []}
{"id": 50889614, "time": "2026-02-26 09:42:01", "headline": "Stifel Maintains Buy on Smartstop Self Storage, Lowers Price Target to $38.5", "summary": "", "symbols": ["SMA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889614/stifel-maintains-buy-on-smartstop-self-storage-lowers-price-target-to-38-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 50889653, "time": "2026-02-26 09:42:32", "headline": "Citizens Downgrades C3.ai to Market Perform", "summary": "", "symbols": ["AI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889653/citizens-downgrades-c3-ai-to-market-perform", "tags": ["analyst_down"]}
{"id": 50889687, "time": "2026-02-26 09:43:15", "headline": "Stifel Maintains Buy on Snowflake, Lowers Price Target to $205", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889687/stifel-maintains-buy-on-snowflake-lowers-price-target-to-205", "tags": ["analyst_other", "price_target_down"]}
{"id": 50889737, "time": "2026-02-26 09:44:06", "headline": "Citizens Maintains Market Outperform on Alkami Technology, Lowers Price Target to $28", "summary": "", "symbols": ["ALKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889737/citizens-maintains-market-outperform-on-alkami-technology-lowers-price-target-to-28", "tags": ["analyst_other", "price_target_down"]}
{"id": 50889756, "time": "2026-02-26 09:44:24", "headline": "Citigroup Downgrades Ategrity Specialty to Neutral, Announces $27 Price Target", "summary": "", "symbols": ["ASIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889756/citigroup-downgrades-ategrity-specialty-to-neutral-announces-27-price-target", "tags": ["analyst_down"]}
{"id": 50889773, "time": "2026-02-26 09:44:34", "headline": "Stifel Maintains Hold on Teladoc Health, Lowers Price Target to $6", "summary": "", "symbols": ["TDOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889773/stifel-maintains-hold-on-teladoc-health-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 50889830, "time": "2026-02-26 09:45:28", "headline": "Here's How Much You Would Have Made Owning Waste Connections Stock In The Last 20 Years", "summary": " ", "symbols": ["WCN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50889830/heres-how-much-you-would-have-made-owning-waste-connections-stock-in-the-last-20-years", "tags": []}
{"id": 50889858, "time": "2026-02-26 09:45:48", "headline": "William Blair Initiates Coverage On Builders FirstSource with Outperform Rating", "summary": "", "symbols": ["BLDR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889858/william-blair-initiates-coverage-on-builders-firstsource-with-outperform-rating", "tags": ["analyst_init"]}
{"id": 50889873, "time": "2026-02-26 09:45:57", "headline": "Citizens Maintains Market Outperform on Encore Capital Gr, Raises Price Target to $90", "summary": "", "symbols": ["ECPG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889873/citizens-maintains-market-outperform-on-encore-capital-gr-raises-price-target-to-90", "tags": ["analyst_other", "price_target_up"]}
{"id": 50889971, "time": "2026-02-26 09:47:55", "headline": "Wells Fargo Upgrades Alcon to Overweight, Raises Price Target to $97", "summary": "", "symbols": ["ALC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50889971/wells-fargo-upgrades-alcon-to-overweight-raises-price-target-to-97", "tags": ["analyst_up", "price_target_up"]}
{"id": 50890006, "time": "2026-02-26 09:48:27", "headline": "Citizens Maintains Market Outperform on Ironwood Pharmaceuticals, Raises Price Target to $10", "summary": "", "symbols": ["IRWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890006/citizens-maintains-market-outperform-on-ironwood-pharmaceuticals-raises-price-target-to-10", "tags": ["analyst_other", "price_target_up"]}
{"id": 50890020, "time": "2026-02-26 09:48:37", "headline": "Ericsson Unveils Integrated Sensing And Communication Technology In Plano, Texas", "summary": "", "symbols": ["ERIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890020/ericsson-unveils-integrated-sensing-and-communication-technology-in-plano-texas", "tags": []}
{"id": 50890063, "time": "2026-02-26 09:49:25", "headline": "Wells Fargo Downgrades Merit Medical Systems to Equal-Weight, Lowers Price Target to $78", "summary": "", "symbols": ["MMSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890063/wells-fargo-downgrades-merit-medical-systems-to-equal-weight-lowers-price-target-to-78", "tags": ["analyst_down", "price_target_down"]}
{"id": 50890098, "time": "2026-02-26 09:49:54", "headline": "Citizens Maintains Market Outperform on LeMaitre Vascular, Raises Price Target to $118", "summary": "", "symbols": ["LMAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890098/citizens-maintains-market-outperform-on-lemaitre-vascular-raises-price-target-to-118", "tags": ["analyst_other", "price_target_up"]}
{"id": 50890103, "time": "2026-02-26 09:49:56", "headline": "AtaiBeckley Touts Social Anxiety Breakthrough With Phase 2 Trial Data", "summary": "AtaiBeckley shares move after EMP-01 trial shows 49% patient improvement in social anxiety study with strong safety results.", "symbols": ["ATAI"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/news/health-care/26/02/50890103/ataibeckley-touts-social-anxiety-breakthrough-with-phase-2-trial-data", "tags": ["fda"]}
{"id": 50890162, "time": "2026-02-26 09:50:40", "headline": "Jehoshaphat Research Posts On X \"We are short $GPGI, an industrial conglomerate with easy to borrow stock and $7B of market cap. Below is a summary of some of the key opinions in this idea; for the full short thesis including a downloadable PDF, please see the Jehoshaphat Research website. 1) We believe GPGI is playing a variety of accounting games to inflate the performance of the much larger company it just acquired..\"", "summary": "", "symbols": ["GPGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/short-sellers/26/02/50890162/jehoshaphat-research-posts-on-x-we-are-short-gpgi-an-industrial-conglomerate-with-easy-to-borrow-st", "tags": ["merger"]}
{"id": 50890218, "time": "2026-02-26 09:51:42", "headline": "Citizens Maintains Market Outperform on Mirum Pharmaceuticals, Lowers Price Target to $132", "summary": "", "symbols": ["MIRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890218/citizens-maintains-market-outperform-on-mirum-pharmaceuticals-lowers-price-target-to-132", "tags": ["analyst_other", "price_target_down"]}
{"id": 50890252, "time": "2026-02-26 09:52:16", "headline": "Stifel Maintains Buy on Trade Desk, Lowers Price Target to $48", "summary": "", "symbols": ["TTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890252/stifel-maintains-buy-on-trade-desk-lowers-price-target-to-48", "tags": ["analyst_other", "price_target_down"]}
{"id": 50890274, "time": "2026-02-26 09:52:30", "headline": "Barclays Maintains Overweight on Agilent Technologies, Lowers Price Target to $150", "summary": "", "symbols": ["A"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890274/barclays-maintains-overweight-on-agilent-technologies-lowers-price-target-to-150", "tags": ["analyst_other", "price_target_down"]}
{"id": 50890329, "time": "2026-02-26 09:53:30", "headline": "Barclays Maintains Equal-Weight on Alcon, Raises Price Target to $90", "summary": "", "symbols": ["ALC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890329/barclays-maintains-equal-weight-on-alcon-raises-price-target-to-90", "tags": ["analyst_other", "price_target_up"]}
{"id": 50890360, "time": "2026-02-26 09:53:53", "headline": "Citizens Maintains Market Outperform on Protagonist Therapeutics, Raises Price Target to $112", "summary": "", "symbols": ["PTGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890360/citizens-maintains-market-outperform-on-protagonist-therapeutics-raises-price-target-to-112", "tags": ["analyst_other", "price_target_up"]}
{"id": 50890391, "time": "2026-02-26 09:54:23", "headline": "Stifel Maintains Buy on Veeva Systems, Lowers Price Target to $212", "summary": "", "symbols": ["VEEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890391/stifel-maintains-buy-on-veeva-systems-lowers-price-target-to-212", "tags": ["analyst_other", "price_target_down"]}
{"id": 50890394, "time": "2026-02-26 09:54:28", "headline": "PENN Surges 10% On Q4 Double Beat, Record Interactive Segment Performance", "summary": "PENN Entertainment, Inc. (NASDAQ:PENN) shares are trading higher Thursday after the company reported fourth-quarter financial results.", "symbols": ["PENN"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50890394/penn-surges-10-on-q4-double-beat-record-interactive-segment-performance", "tags": ["why_moving"]}
{"id": 50890499, "time": "2026-02-26 09:55:47", "headline": "Wedbush Initiates Coverage On Eikon Therapeutics with Underperform Rating, Announces Price Target of $7", "summary": "", "symbols": ["EIKN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890499/wedbush-initiates-coverage-on-eikon-therapeutics-with-underperform-rating-announces-price-target-of", "tags": ["analyst_init"]}
{"id": 50890587, "time": "2026-02-26 09:57:42", "headline": "Barclays Maintains Equal-Weight on Align Technology, Raises Price Target to $200", "summary": "", "symbols": ["ALGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890587/barclays-maintains-equal-weight-on-align-technology-raises-price-target-to-200", "tags": ["analyst_other", "price_target_up"]}
{"id": 50890616, "time": "2026-02-26 09:57:55", "headline": "'Pentagon officials sent Anthropic best and final offer for military use of its AI amid dispute, sources say'- CBS News", "summary": "", "symbols": ["AMZN", "GOOG", "GOOGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890616/pentagon-officials-sent-anthropic-best-and-final-offer-for-military-use-of-its-ai-amid-dispute-sourc", "tags": []}
{"id": 50890754, "time": "2026-02-26 09:59:13", "headline": "Wedbush Maintains Outperform on Salesforce, Lowers Price Target to $325", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890754/wedbush-maintains-outperform-on-salesforce-lowers-price-target-to-325", "tags": ["analyst_other", "price_target_down"]}
{"id": 50890771, "time": "2026-02-26 09:59:34", "headline": "Barclays Maintains Equal-Weight on Alkami Technology, Lowers Price Target to $21", "summary": "", "symbols": ["ALKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890771/barclays-maintains-equal-weight-on-alkami-technology-lowers-price-target-to-21", "tags": ["analyst_other", "price_target_down"]}
{"id": 50890831, "time": "2026-02-26 10:00:08", "headline": "Shenandoah Q4 2025 Earnings Call: Complete Transcript", "summary": " ", "symbols": ["SHEN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50890831/shenandoah-q4-2025-earnings-call-complete-transcript", "tags": ["earnings"]}
{"id": 50890835, "time": "2026-02-26 10:00:14", "headline": "Hormel Foods Q1 2026 Earnings Call Transcript", "summary": " ", "symbols": ["HRL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50890835/hormel-foods-q1-2026-earnings-call-transcript", "tags": ["earnings"]}
{"id": 50890839, "time": "2026-02-26 10:00:17", "headline": "Preview: Generate Biomedicines, Inc Set To IPO Tomorrow", "summary": " ", "symbols": ["GENB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/ipos/26/02/50890839/preview-generate-biomedicines-inc-set-to-ipo-tomorrow", "tags": []}
{"id": 50890843, "time": "2026-02-26 10:00:19", "headline": "Transcript: Park Dental Partners Q4 2025 Earnings Conference Call", "summary": " ", "symbols": ["PARK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50890843/transcript-park-dental-partners-q4-2025-earnings-conference-call", "tags": ["earnings"]}
{"id": 50890860, "time": "2026-02-26 10:00:26", "headline": "Peering Into MongoDB Inc's Recent Short Interest", "summary": " ", "symbols": ["MDB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50890860/peering-into-mongodb-incs-recent-short-interest", "tags": []}
{"id": 50890861, "time": "2026-02-26 10:00:27", "headline": "P/E Ratio Insights for AppLovin", "summary": " ", "symbols": ["APP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50890861/pe-ratio-insights-for-applovin", "tags": []}
{"id": 50890864, "time": "2026-02-26 10:00:32", "headline": "Here's How Much $1000 Invested In Hubbell 10 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["HUBB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50890864/heres-how-much-1000-invested-in-hubbell-10-years-ago-would-be-worth-today", "tags": []}
{"id": 50890879, "time": "2026-02-26 10:00:32", "headline": "How Is The Market Feeling About Tenaris SA?", "summary": " ", "symbols": ["TS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50890879/how-is-the-market-feeling-about-tenaris-sa", "tags": []}
{"id": 50890888, "time": "2026-02-26 10:00:38", "headline": "What's Driving the Market Sentiment Around Elbit Systems Ltd?", "summary": " ", "symbols": ["ESLT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50890888/whats-driving-the-market-sentiment-around-elbit-systems-ltd", "tags": []}
{"id": 50890894, "time": "2026-02-26 10:00:51", "headline": "A Preview Of BlackRock TCP Cap's Earnings", "summary": " ", "symbols": ["TCPC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50890894/a-preview-of-blackrock-tcp-caps-earnings", "tags": ["earnings"]}
{"id": 50890897, "time": "2026-02-26 10:00:56", "headline": "Barclays Maintains Overweight on APi Group, Raises Price Target to $52", "summary": "", "symbols": ["APG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890897/barclays-maintains-overweight-on-api-group-raises-price-target-to-52", "tags": ["analyst_other", "price_target_up"]}
{"id": 50890904, "time": "2026-02-26 10:01:01", "headline": "Earnings Preview: Delek Logistics Partners", "summary": " ", "symbols": ["DKL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50890904/earnings-preview-delek-logistics-partners", "tags": ["earnings"]}
{"id": 50890922, "time": "2026-02-26 10:01:13", "headline": "Insights Ahead: Arbor Realty Trust's Quarterly Earnings", "summary": " ", "symbols": ["ABR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50890922/insights-ahead-arbor-realty-trusts-quarterly-earnings", "tags": ["earnings"]}
{"id": 50890934, "time": "2026-02-26 10:01:22", "headline": "Sunstone Hotel Invts's Earnings Outlook", "summary": " ", "symbols": ["SHO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50890934/sunstone-hotel-invtss-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 50890944, "time": "2026-02-26 10:01:30", "headline": "Wedbush Maintains Outperform on C3.ai, Lowers Price Target to $15", "summary": "", "symbols": ["AI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890944/wedbush-maintains-outperform-on-c3-ai-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 50890947, "time": "2026-02-26 10:01:32", "headline": "Insights Ahead: Gogo's Quarterly Earnings", "summary": " ", "symbols": ["GOGO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50890947/insights-ahead-gogos-quarterly-earnings", "tags": ["earnings"]}
{"id": 50890956, "time": "2026-02-26 10:01:40", "headline": "Barclays Maintains Underweight on Atlas Energy Solutions, Raises Price Target to $8", "summary": "", "symbols": ["AESI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50890956/barclays-maintains-underweight-on-atlas-energy-solutions-raises-price-target-to-8", "tags": ["analyst_other", "price_target_up"]}
{"id": 50890963, "time": "2026-02-26 10:01:44", "headline": "A Look Ahead: ANI Pharmaceuticals's Earnings Forecast", "summary": " ", "symbols": ["ANIP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50890963/a-look-ahead-ani-pharmaceuticalss-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 50890968, "time": "2026-02-26 10:01:48", "headline": "This Is What Whales Are Betting On Advanced Micro Devices", "summary": " ", "symbols": ["AMD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/26/02/50890968/this-is-what-whales-are-betting-on-advanced-micro-devices", "tags": []}
{"id": 50890973, "time": "2026-02-26 10:01:54", "headline": "Oracle Unusual Options Activity", "summary": " ", "symbols": ["ORCL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/26/02/50890973/oracle-unusual-options-activity", "tags": []}
{"id": 50890976, "time": "2026-02-26 10:01:59", "headline": "An Overview of Docebo's Earnings", "summary": " ", "symbols": ["DCBO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50890976/an-overview-of-docebos-earnings", "tags": ["earnings"]}
{"id": 50890978, "time": "2026-02-26 10:01:59", "headline": "Decoding Intel's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["INTC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/26/02/50890978/decoding-intels-options-activity-whats-the-big-picture", "tags": []}
{"id": 50890989, "time": "2026-02-26 10:02:10", "headline": "Preview: Global Partners's Earnings", "summary": " ", "symbols": ["GLP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50890989/preview-global-partnerss-earnings", "tags": ["earnings"]}
{"id": 50891004, "time": "2026-02-26 10:02:21", "headline": "A Look Ahead: ALX Oncology Holdings's Earnings Forecast", "summary": " ", "symbols": ["ALXO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50891004/a-look-ahead-alx-oncology-holdingss-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 50891021, "time": "2026-02-26 10:02:33", "headline": "Earnings Preview: Fulgent Genetics", "summary": " ", "symbols": ["FLGT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50891021/earnings-preview-fulgent-genetics", "tags": ["earnings"]}
{"id": 50891029, "time": "2026-02-26 10:02:41", "headline": "Barclays Maintains Equal-Weight on Avis Budget Gr, Lowers Price Target to $95", "summary": "", "symbols": ["CAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891029/barclays-maintains-equal-weight-on-avis-budget-gr-lowers-price-target-to-95", "tags": ["analyst_other", "price_target_down"]}
{"id": 50891031, "time": "2026-02-26 10:02:43", "headline": "A Glimpse of Carter's's Earnings Potential", "summary": " ", "symbols": ["CRI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50891031/a-glimpse-of-carterss-earnings-potential", "tags": ["earnings"]}
{"id": 50891097, "time": "2026-02-26 10:03:35", "headline": "Reported Earlier: 'Shell reviewing some of its Shell Ventures portfolio with option to sell, sources say' - Reuters", "summary": "", "symbols": ["SHEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891097/reported-earlier-shell-reviewing-some-of-its-shell-ventures-portfolio-with-option-to-sell-sources-sa", "tags": []}
{"id": 50891126, "time": "2026-02-26 10:03:59", "headline": "Evercore ISI Group Maintains In-Line on APA, Raises Price Target to $25", "summary": "", "symbols": ["APA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891126/evercore-isi-group-maintains-in-line-on-apa-raises-price-target-to-25", "tags": ["analyst_other", "price_target_up"]}
{"id": 50891151, "time": "2026-02-26 10:04:33", "headline": "Barclays Maintains Equal-Weight on Bank of Montreal, Raises Price Target to C$199", "summary": "", "symbols": ["TSX:BMO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891151/barclays-maintains-equal-weight-on-bank-of-montreal-raises-price-target-to-c-199", "tags": ["analyst_other", "price_target_up"]}
{"id": 50891162, "time": "2026-02-26 10:04:42", "headline": "'Blackstone Private Credit Fund Markets Bond Amid Software Tumult' - Bloomberg", "summary": "", "symbols": ["BX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891162/blackstone-private-credit-fund-markets-bond-amid-software-tumult-bloomberg", "tags": []}
{"id": 50891186, "time": "2026-02-26 10:05:11", "headline": "Evercore ISI Group Maintains Outperform on Chime Financial, Lowers Price Target to $35", "summary": "", "symbols": ["CHYM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891186/evercore-isi-group-maintains-outperform-on-chime-financial-lowers-price-target-to-35", "tags": ["analyst_other", "price_target_down"]}
{"id": 50891201, "time": "2026-02-26 10:05:26", "headline": "Barclays Maintains Underweight on BJ's Restaurants, Raises Price Target to $42", "summary": "", "symbols": ["BJRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891201/barclays-maintains-underweight-on-bjs-restaurants-raises-price-target-to-42", "tags": ["analyst_other", "price_target_up"]}
{"id": 50891260, "time": "2026-02-26 10:06:18", "headline": "Barclays Maintains Overweight on Brown-Forman, Raises Price Target to $33", "summary": "", "symbols": ["BF", "BF/B"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891260/barclays-maintains-overweight-on-brown-forman-raises-price-target-to-33", "tags": ["analyst_other", "price_target_up"]}
{"id": 50891271, "time": "2026-02-26 10:06:23", "headline": "Evercore ISI Group Maintains In-Line on Fidelis Insurance Hldgs, Raises Price Target to $22", "summary": "", "symbols": ["FIHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891271/evercore-isi-group-maintains-in-line-on-fidelis-insurance-hldgs-raises-price-target-to-22", "tags": ["analyst_other", "price_target_up"]}
{"id": 50891320, "time": "2026-02-26 10:07:00", "headline": "'Alphabet and Other Big Tech Could Borrow Hundreds of Billions Each'- The Information", "summary": "", "symbols": ["GOOG", "GOOGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891320/alphabet-and-other-big-tech-could-borrow-hundreds-of-billions-each-the-information", "tags": []}
{"id": 50891338, "time": "2026-02-26 10:07:10", "headline": "Barclays Maintains Overweight on BXP, Lowers Price Target to $66", "summary": "", "symbols": ["BXP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891338/barclays-maintains-overweight-on-bxp-lowers-price-target-to-66", "tags": ["analyst_other", "price_target_down"]}
{"id": 50891357, "time": "2026-02-26 10:07:29", "headline": "Roper Technologies' Aderant Collaborates With First AML To Expand Access To Automated Compliance Technology For Law Firms", "summary": "", "symbols": ["ROP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891357/roper-technologies-aderant-collaborates-with-first-aml-to-expand-access-to-automated-compliance-tech", "tags": []}
{"id": 50890190, "time": "2026-02-26 09:50:54", "headline": "Cass Information Systems Partners With Caspian To Help Importers Manage Tariff Costs", "summary": "Cass and Caspian partner to expand tariff cost management for US importers, improving cash flow, compliance, and insight into true costs.", "symbols": ["CASS"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/markets/equities/26/02/50890190/cass-information-systems-expands-tariff-management-with-ai-partner", "tags": ["contract"]}
{"id": 50891442, "time": "2026-02-26 10:08:33", "headline": "Barclays Maintains Overweight on Cousins Props, Lowers Price Target to $28", "summary": "", "symbols": ["CUZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891442/barclays-maintains-overweight-on-cousins-props-lowers-price-target-to-28", "tags": ["analyst_other", "price_target_down"]}
{"id": 50891472, "time": "2026-02-26 10:09:01", "headline": "Evercore ISI Group Maintains In-Line on GoDaddy, Lowers Price Target to $95", "summary": "", "symbols": ["GDDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891472/evercore-isi-group-maintains-in-line-on-godaddy-lowers-price-target-to-95", "tags": ["analyst_other", "price_target_down"]}
{"id": 50891533, "time": "2026-02-26 10:09:26", "headline": "Avalon GloboCare (ALBT) Stock Surges On AMD AI News", "summary": "Avalon GloboCare shares are soaring Thursday after Benzinga exclusively reported that the company joined AMD&#39;s AI Developer Program.", "symbols": ["ALBT", "AMD"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50891533/avalon-globocare-albt-stock-surges-on-amd-ai-news", "tags": []}
{"id": 50891553, "time": "2026-02-26 10:09:56", "headline": "Barclays Maintains Equal-Weight on Dine Brands Global, Lowers Price Target to $30", "summary": "", "symbols": ["DIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891553/barclays-maintains-equal-weight-on-dine-brands-global-lowers-price-target-to-30", "tags": ["analyst_other", "price_target_down"]}
{"id": 50891563, "time": "2026-02-26 10:10:08", "headline": "Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation", "summary": "", "symbols": ["TRGSU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/26/02/50891563/trading-halt-halt-status-updated-at-10-10-00-am-et-quotation-resumption-ipo-security-released-for-qu", "tags": []}
{"id": 50891565, "time": "2026-02-26 10:10:08", "headline": "'The world's biggest sovereign wealth fund is using Anthropic's Claude AI model to screen investments for ethical issues'- CNBC", "summary": "", "symbols": ["AMZN", "GOOG", "GOOGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891565/the-worlds-biggest-sovereign-wealth-fund-is-using-anthropics-claude-ai-model-to-screen-investments-f", "tags": []}
{"id": 50891655, "time": "2026-02-26 10:11:10", "headline": "Barclays Maintains Overweight on GoDaddy, Lowers Price Target to $118", "summary": "", "symbols": ["GDDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891655/barclays-maintains-overweight-on-godaddy-lowers-price-target-to-118", "tags": ["analyst_other", "price_target_down"]}
{"id": 50891794, "time": "2026-02-26 10:13:08", "headline": "Barclays Maintains Equal-Weight on Keurig Dr Pepper, Raises Price Target to $32", "summary": "", "symbols": ["KDP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891794/barclays-maintains-equal-weight-on-keurig-dr-pepper-raises-price-target-to-32", "tags": ["analyst_other", "price_target_up"]}
{"id": 50891835, "time": "2026-02-26 10:13:53", "headline": "Barclays Maintains Equal-Weight on Kilroy Realty, Lowers Price Target to $31", "summary": "", "symbols": ["KRC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891835/barclays-maintains-equal-weight-on-kilroy-realty-lowers-price-target-to-31", "tags": ["analyst_other", "price_target_down"]}
{"id": 50891844, "time": "2026-02-26 10:13:59", "headline": "Hopscotch Air Engages PTOP Intelligence Labs To Deploy PTOP's Beta Test Of Tier-1 AI Tool Suite", "summary": "", "symbols": ["PTOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891844/hopscotch-air-engages-ptop-intelligence-labs-to-deploy-ptops-beta-test-of-tier-1-ai-tool-suite", "tags": []}
{"id": 50891901, "time": "2026-02-26 10:14:38", "headline": "Wedbush Maintains Outperform on NVIDIA, Raises Price Target to $300", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891901/wedbush-maintains-outperform-on-nvidia-raises-price-target-to-300", "tags": ["analyst_other", "price_target_up"]}
{"id": 50891914, "time": "2026-02-26 10:14:51", "headline": "Barclays Maintains Equal-Weight on National Bank of Canada, Raises Price Target to C$183", "summary": "", "symbols": ["TSX:NA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891914/barclays-maintains-equal-weight-on-national-bank-of-canada-raises-price-target-to-c-183", "tags": ["analyst_other", "price_target_up"]}
{"id": 50891930, "time": "2026-02-26 10:15:00", "headline": "House Democrats Seek Iran War Powers Resolution Vote Next Week", "summary": "", "symbols": ["SPY", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891930/house-democrats-seek-iran-war-powers-resolution-vote-next-week", "tags": []}
{"id": 50891951, "time": "2026-02-26 10:15:11", "headline": "Warren Buffett's Favorite Soda Is Now More 'Expensive' Than Microsoft", "summary": "Coca-Cola&#39;s valuation multiple has surpassed Microsoft&#39;s, as Warren Buffett&#39;s $28B stake trades at a premium to an AI leader.", "symbols": ["AAPL", "BRK", "KO", "MSFT"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/long-ideas/26/02/50891951/warren-buffetts-favorite-soda-is-now-more-expensive-than-microsoft", "tags": []}
{"id": 50891979, "time": "2026-02-26 10:15:34", "headline": "Barclays Maintains Equal-Weight on Nutanix, Lowers Price Target to $47", "summary": "", "symbols": ["NTNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50891979/barclays-maintains-equal-weight-on-nutanix-lowers-price-target-to-47", "tags": ["analyst_other", "price_target_down"]}
{"id": 50891985, "time": "2026-02-26 10:15:39", "headline": "Here's How Much $1000 Invested In Republic Services 20 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["RSG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50891985/heres-how-much-1000-invested-in-republic-services-20-years-ago-would-be-worth-today", "tags": []}
{"id": 50892042, "time": "2026-02-26 10:16:14", "headline": "Barclays Maintains Overweight on Protagonist Therapeutics, Raises Price Target to $113", "summary": "", "symbols": ["PTGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892042/barclays-maintains-overweight-on-protagonist-therapeutics-raises-price-target-to-113", "tags": ["analyst_other", "price_target_up"]}
{"id": 50891996, "time": "2026-02-26 10:15:37", "headline": "Why Is Synopsys Stock Falling Thursday?", "summary": "Synopsys, Inc. (NASDAQ:SNPS) reported Q1 results, cut FY26 EPS guidance and issued lower Q2 sales guidance. Board approved $2B stock buyback.", "symbols": ["SNPS"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/markets/earnings/26/02/50891996/why-is-synopsys-stock-falling-thursday", "tags": ["earnings", "guidance", "why_moving", "buyback"]}
{"id": 50892091, "time": "2026-02-26 10:16:54", "headline": "Barclays Maintains Equal-Weight on Everpure, Raises Price Target to $81", "summary": "", "symbols": ["PSTG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892091/barclays-maintains-equal-weight-on-everpure-raises-price-target-to-81", "tags": ["analyst_other", "price_target_up"]}
{"id": 50892180, "time": "2026-02-26 10:18:05", "headline": "Barclays Maintains Overweight on Salesforce, Lowers Price Target to $252", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892180/barclays-maintains-overweight-on-salesforce-lowers-price-target-to-252", "tags": ["analyst_other", "price_target_down"]}
{"id": 50892220, "time": "2026-02-26 10:18:35", "headline": "Benchmark Maintains Buy on Imax, Raises Price Target to $44", "summary": "", "symbols": ["IMAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892220/benchmark-maintains-buy-on-imax-raises-price-target-to-44", "tags": ["analyst_other", "price_target_up"]}
{"id": 50892239, "time": "2026-02-26 10:18:48", "headline": "Barclays Maintains Overweight on Sensata Technologies, Raises Price Target to $44", "summary": "", "symbols": ["ST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892239/barclays-maintains-overweight-on-sensata-technologies-raises-price-target-to-44", "tags": ["analyst_other", "price_target_up"]}
{"id": 50892292, "time": "2026-02-26 10:19:46", "headline": "Benchmark Maintains Buy on Trip.com Group, Lowers Price Target to $72", "summary": "", "symbols": ["TCOM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892292/benchmark-maintains-buy-on-trip-com-group-lowers-price-target-to-72", "tags": ["analyst_other", "price_target_down"]}
{"id": 50892297, "time": "2026-02-26 10:19:48", "headline": "Barclays Maintains Equal-Weight on SL Green Realty, Lowers Price Target to $43", "summary": "", "symbols": ["SLG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892297/barclays-maintains-equal-weight-on-sl-green-realty-lowers-price-target-to-43", "tags": ["analyst_other", "price_target_down"]}
{"id": 50892425, "time": "2026-02-26 10:21:52", "headline": "Barclays Maintains Equal-Weight on Snowflake, Lowers Price Target to $192", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892425/barclays-maintains-equal-weight-on-snowflake-lowers-price-target-to-192", "tags": ["analyst_other", "price_target_down"]}
{"id": 50892430, "time": "2026-02-26 10:21:56", "headline": "Benchmark Maintains Buy on Sinclair, Raises Price Target to $30", "summary": "", "symbols": ["SBGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892430/benchmark-maintains-buy-on-sinclair-raises-price-target-to-30", "tags": ["analyst_other", "price_target_up"]}
{"id": 50892491, "time": "2026-02-26 10:22:56", "headline": "Barclays Maintains Overweight on Solaris Energy, Raises Price Target to $63", "summary": "", "symbols": ["SEI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892491/barclays-maintains-overweight-on-solaris-energy-raises-price-target-to-63", "tags": ["analyst_other", "price_target_up"]}
{"id": 50892505, "time": "2026-02-26 10:23:09", "headline": "Benchmark Maintains Buy on BJ's Restaurants, Raises Price Target to $48", "summary": "", "symbols": ["BJRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892505/benchmark-maintains-buy-on-bjs-restaurants-raises-price-target-to-48", "tags": ["analyst_other", "price_target_up"]}
{"id": 50892556, "time": "2026-02-26 10:23:58", "headline": "Barclays Maintains Overweight on TJX Companies, Raises Price Target to $183", "summary": "", "symbols": ["TJX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892556/barclays-maintains-overweight-on-tjx-companies-raises-price-target-to-183", "tags": ["analyst_other", "price_target_up"]}
{"id": 50892578, "time": "2026-02-26 10:24:19", "headline": "Evercore ISI Group Maintains In-Line on Ibotta, Lowers Price Target to $29", "summary": "", "symbols": ["IBTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892578/evercore-isi-group-maintains-in-line-on-ibotta-lowers-price-target-to-29", "tags": ["analyst_other", "price_target_down"]}
{"id": 50892580, "time": "2026-02-26 10:24:21", "headline": "'Trump-Xi summit preparations falter as planning gaps unsettle Beijing'- South China Morning Post", "summary": "", "symbols": ["FXI", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892580/trump-xi-summit-preparations-falter-as-planning-gaps-unsettle-beijing-south-china-morning-post", "tags": []}
{"id": 50892590, "time": "2026-02-26 10:24:26", "headline": "Benchmark Maintains Buy on Magnite, Lowers Price Target to $30", "summary": "", "symbols": ["MGNI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892590/benchmark-maintains-buy-on-magnite-lowers-price-target-to-30", "tags": ["analyst_other", "price_target_down"]}
{"id": 50892636, "time": "2026-02-26 10:24:53", "headline": "Barclays Maintains Overweight on Universal Health Services, Raises Price Target to $268", "summary": "", "symbols": ["UHS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892636/barclays-maintains-overweight-on-universal-health-services-raises-price-target-to-268", "tags": ["analyst_other", "price_target_up"]}
{"id": 50892662, "time": "2026-02-26 10:25:06", "headline": "'Trump EPA to shift at least half of waived biofuel obligations to big refiners, sources say' - Reuters Exclusive", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892662/trump-epa-to-shift-at-least-half-of-waived-biofuel-obligations-to-big-refiners-sources-say-reuters-e", "tags": []}
{"id": 50892668, "time": "2026-02-26 10:25:10", "headline": "Evercore ISI Group Maintains In-Line on Lineage, Raises Price Target to $39", "summary": "", "symbols": ["LINE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892668/evercore-isi-group-maintains-in-line-on-lineage-raises-price-target-to-39", "tags": ["analyst_other", "price_target_up"]}
{"id": 50892713, "time": "2026-02-26 10:25:50", "headline": "Barclays Maintains Overweight on UWM Holdings, Lowers Price Target to $6", "summary": "", "symbols": ["UWMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892713/barclays-maintains-overweight-on-uwm-holdings-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 50892766, "time": "2026-02-26 10:27:09", "headline": "Barclays Maintains Underweight on Vornado Realty Trust, Lowers Price Target to $28", "summary": "", "symbols": ["VNO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892766/barclays-maintains-underweight-on-vornado-realty-trust-lowers-price-target-to-28", "tags": ["analyst_other", "price_target_down"]}
{"id": 50892816, "time": "2026-02-26 10:28:12", "headline": "Barclays Maintains Overweight on Xencor, Raises Price Target to $27", "summary": "", "symbols": ["XNCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892816/barclays-maintains-overweight-on-xencor-raises-price-target-to-27", "tags": ["analyst_other", "price_target_up"]}
{"id": 50892855, "time": "2026-02-26 10:28:45", "headline": "RBC Capital Downgrades Clearwater Analytics Hldg to Sector Perform, Lowers Price Target to $24.55", "summary": "", "symbols": ["CWAN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892855/rbc-capital-downgrades-clearwater-analytics-hldg-to-sector-perform-lowers-price-target-to-24-55", "tags": ["analyst_down", "price_target_down"]}
{"id": 50892955, "time": "2026-02-26 10:29:06", "headline": "'CNBC To Unify Digital And Tv News Operations In A Move That Would Result In Layoffs Affecting Nearly A Dozen Employees, Sources Say' - Reuters Exclusive", "summary": "", "symbols": ["VSNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892955/cnbc-to-unify-digital-and-tv-news-operations-in-a-move-that-would-result-in-layoffs-affecting-nearly", "tags": []}
{"id": 50892977, "time": "2026-02-26 10:29:31", "headline": "TJX Delivers Q4 Beat, Analysts Praise 'Notable MarMaxx Strength'", "summary": "Shares of TJX rose after the company&#39;s Q4 print, with sales and earnings topping expectations. Analysts remain bullish, raise price targets.", "symbols": ["TJX"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/26/02/50892977/tjx-delivers-q4-beat-analysts-praise-notable-marmaxx-strength", "tags": ["earnings"]}
{"id": 50892983, "time": "2026-02-26 10:29:39", "headline": "Barclays Maintains Equal-Weight on ZipRecruiter, Lowers Price Target to $3", "summary": "", "symbols": ["ZIP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50892983/barclays-maintains-equal-weight-on-ziprecruiter-lowers-price-target-to-3", "tags": ["analyst_other", "price_target_down"]}
{"id": 50893017, "time": "2026-02-26 10:30:06", "headline": "RBC Capital Maintains Outperform on ACADIA Pharmaceuticals, Lowers Price Target to $30", "summary": "", "symbols": ["ACAD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893017/rbc-capital-maintains-outperform-on-acadia-pharmaceuticals-lowers-price-target-to-30", "tags": ["analyst_other", "price_target_down"]}
{"id": 50893051, "time": "2026-02-26 10:30:26", "headline": "USA Natural Gas Storage -52B Vs -36B Est.", "summary": "", "symbols": ["UNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/26/02/50893051/usa-natural-gas-storage-52b-vs-36b-est", "tags": []}
{"id": 50893058, "time": "2026-02-26 10:30:28", "headline": "Here's How Much $1000 Invested In HCA Healthcare 15 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["HCA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50893058/heres-how-much-1000-invested-in-hca-healthcare-15-years-ago-would-be-worth-today", "tags": []}
{"id": 50893165, "time": "2026-02-26 10:31:44", "headline": "Wells Fargo Maintains Equal-Weight on Urban Outfitters, Lowers Price Target to $75", "summary": "", "symbols": ["URBN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893165/wells-fargo-maintains-equal-weight-on-urban-outfitters-lowers-price-target-to-75", "tags": ["analyst_other", "price_target_down"]}
{"id": 50893242, "time": "2026-02-26 10:32:49", "headline": "U.S. FTC Says Walmart Agrees To $100M Judgment To Settle FTC, States' Charges Over Deceptive Earnings Claims Related To The Company's Spark Driver Delivery Service", "summary": "", "symbols": ["WMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893242/u-s-ftc-says-walmart-agrees-to-100m-judgment-to-settle-ftc-states-charges-over-deceptive-earnings-cl", "tags": ["earnings"]}
{"id": 50893259, "time": "2026-02-26 10:33:02", "headline": "Wells Fargo Maintains Equal-Weight on Viking Holdings, Raises Price Target to $77", "summary": "", "symbols": ["VIK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893259/wells-fargo-maintains-equal-weight-on-viking-holdings-raises-price-target-to-77", "tags": ["analyst_other", "price_target_up"]}
{"id": 50893284, "time": "2026-02-26 10:33:28", "headline": "RBC Capital Maintains Outperform on APi Group, Raises Price Target to $53", "summary": "", "symbols": ["APG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893284/rbc-capital-maintains-outperform-on-api-group-raises-price-target-to-53", "tags": ["analyst_other", "price_target_up"]}
{"id": 50893311, "time": "2026-02-26 10:33:57", "headline": "Wells Fargo Maintains Overweight on Lowe's Companies, Raises Price Target to $290", "summary": "", "symbols": ["LOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893311/wells-fargo-maintains-overweight-on-lowes-companies-raises-price-target-to-290", "tags": ["analyst_other", "price_target_up"]}
{"id": 50893343, "time": "2026-02-26 10:34:34", "headline": "RBC Capital Maintains Outperform on Acadia Healthcare Co, Raises Price Target to $28", "summary": "", "symbols": ["ACHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893343/rbc-capital-maintains-outperform-on-acadia-healthcare-co-raises-price-target-to-28", "tags": ["analyst_other", "price_target_up"]}
{"id": 50893378, "time": "2026-02-26 10:35:04", "headline": "Evercore ISI Group Maintains In-Line on Lowe's Companies, Lowers Price Target to $270", "summary": "", "symbols": ["LOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893378/evercore-isi-group-maintains-in-line-on-lowes-companies-lowers-price-target-to-270", "tags": ["analyst_other", "price_target_down"]}
{"id": 50893391, "time": "2026-02-26 10:35:08", "headline": "Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation", "summary": "", "symbols": ["FVAV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/26/02/50893391/trading-halt-halt-status-updated-at-10-35-00-am-et-quotation-resumption-ipo-security-released-for-qu", "tags": []}
{"id": 50893414, "time": "2026-02-26 10:35:13", "headline": "Wells Fargo Maintains Overweight on MGP Ingredients, Lowers Price Target to $24", "summary": "", "symbols": ["MGPI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893414/wells-fargo-maintains-overweight-on-mgp-ingredients-lowers-price-target-to-24", "tags": ["analyst_other", "price_target_down"]}
{"id": 50893419, "time": "2026-02-26 10:35:14", "headline": "Knightscope Hits $2M In New Sales, Client Renewals", "summary": "", "symbols": ["KSCP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893419/knightscope-hits-2m-in-new-sales-client-renewals", "tags": []}
{"id": 50893441, "time": "2026-02-26 10:35:26", "headline": "RBC Capital Maintains Outperform on Alkermes, Lowers Price Target to $45", "summary": "", "symbols": ["ALKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893441/rbc-capital-maintains-outperform-on-alkermes-lowers-price-target-to-45", "tags": ["analyst_other", "price_target_down"]}
{"id": 50893524, "time": "2026-02-26 10:37:11", "headline": "RBC Capital Maintains Sector Perform on Array Technologies, Lowers Price Target to $9", "summary": "", "symbols": ["ARRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893524/rbc-capital-maintains-sector-perform-on-array-technologies-lowers-price-target-to-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 50893553, "time": "2026-02-26 10:37:47", "headline": "Evercore ISI Group Maintains Outperform on Medline, Raises Price Target to $55", "summary": "", "symbols": ["MDLN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893553/evercore-isi-group-maintains-outperform-on-medline-raises-price-target-to-55", "tags": ["analyst_other", "price_target_up"]}
{"id": 50893602, "time": "2026-02-26 10:39:12", "headline": "Evercore ISI Group Maintains In-Line on Realty Income, Raises Price Target to $65", "summary": "", "symbols": ["O"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893602/evercore-isi-group-maintains-in-line-on-realty-income-raises-price-target-to-65", "tags": ["analyst_other", "price_target_up"]}
{"id": 50893635, "time": "2026-02-26 10:39:41", "headline": "RBC Capital Maintains Sector Perform on Lowe's Companies, Raises Price Target to $264", "summary": "", "symbols": ["LOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893635/rbc-capital-maintains-sector-perform-on-lowes-companies-raises-price-target-to-264", "tags": ["analyst_other", "price_target_up"]}
{"id": 50893652, "time": "2026-02-26 10:40:01", "headline": "'China's Rare Earth Curbs Hit U.S. Aerospace, Chips Hard Despite Trump's Trade Truce; American Firms Face Deepening Yttrium And Scandium Shortages, Threatening Jet Engine Coatings And 5G Chip Production' - SCMP", "summary": "", "symbols": ["FXI", "REMX", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/26/02/50893652/chinas-rare-earth-curbs-hit-u-s-aerospace-chips-hard-despite-trumps-trade-truce-a", "tags": []}
{"id": 50893664, "time": "2026-02-26 10:40:17", "headline": "Perplexity AI Just Turned A $30,000/Year Bloomberg Terminal Into A $200/Month Subscription", "summary": "Perplexity AI&#39;s new &#34;Computer&#34; system is being pitched as a potential alternative to the $30,000-per-year Bloomberg Terminal, raising fresh questions about software pricing power as the IGV ETF slides 24% year to date.", "symbols": ["IGV"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/markets/tech/26/02/50893664/perplexity-ai-computer-bloomberg-terminal-software-disruption", "tags": []}
{"id": 50893685, "time": "2026-02-26 10:40:50", "headline": "RBC Capital Maintains Outperform on Medline, Raises Price Target to $53", "summary": "", "symbols": ["MDLN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893685/rbc-capital-maintains-outperform-on-medline-raises-price-target-to-53", "tags": ["analyst_other", "price_target_up"]}
{"id": 50893700, "time": "2026-02-26 10:41:07", "headline": "Evercore ISI Group Maintains In-Line on Owens-Corning, Raises Price Target to $132", "summary": "", "symbols": ["OC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893700/evercore-isi-group-maintains-in-line-on-owens-corning-raises-price-target-to-132", "tags": ["analyst_other", "price_target_up"]}
{"id": 50893732, "time": "2026-02-26 10:41:41", "headline": "American Airlines Stock Rises On $1 Billion Miami Investment", "summary": "American Airlines shares are trading higher Thursday morning after the company announced a $1 billion investment to expand its facilities at Miami International Airport.", "symbols": ["AAL"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50893732/american-airlines-stock-rises-on-1-billion-miami-investment", "tags": ["why_moving"]}
{"id": 50893759, "time": "2026-02-26 10:42:07", "headline": "Dell Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call", "summary": " ", "symbols": ["DELL"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50893759/dell-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call-2", "tags": ["earnings"]}
{"id": 50893770, "time": "2026-02-26 10:42:17", "headline": "Wells Fargo Maintains Overweight on First Solar, Lowers Price Target to $255", "summary": "", "symbols": ["FSLR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893770/wells-fargo-maintains-overweight-on-first-solar-lowers-price-target-to-255", "tags": ["analyst_other", "price_target_down"]}
{"id": 50893797, "time": "2026-02-26 10:42:46", "headline": "Evercore ISI Group Maintains Outperform on Penumbra, Raises Price Target to $360", "summary": "", "symbols": ["PEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893797/evercore-isi-group-maintains-outperform-on-penumbra-raises-price-target-to-360", "tags": ["analyst_other", "price_target_up"]}
{"id": 50893828, "time": "2026-02-26 10:43:09", "headline": "Wells Fargo Maintains Equal-Weight on Range Resources, Raises Price Target to $46", "summary": "", "symbols": ["RRC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893828/wells-fargo-maintains-equal-weight-on-range-resources-raises-price-target-to-46", "tags": ["analyst_other", "price_target_up"]}
{"id": 50893852, "time": "2026-02-26 10:43:31", "headline": "Opera Announces $300M Buyback Plan", "summary": "", "symbols": ["OPRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893852/opera-announces-300m-buyback-plan", "tags": ["buyback"]}
{"id": 50893866, "time": "2026-02-26 10:43:40", "headline": "Evercore ISI Group Maintains In-Line on Tanger, Raises Price Target to $37", "summary": "", "symbols": ["SKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893866/evercore-isi-group-maintains-in-line-on-tanger-raises-price-target-to-37", "tags": ["analyst_other", "price_target_up"]}
{"id": 50893867, "time": "2026-02-26 10:43:41", "headline": "RBC Capital Maintains Outperform on Mirum Pharmaceuticals, Lowers Price Target to $128", "summary": "", "symbols": ["MIRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893867/rbc-capital-maintains-outperform-on-mirum-pharmaceuticals-lowers-price-target-to-128", "tags": ["analyst_other", "price_target_down"]}
{"id": 50893925, "time": "2026-02-26 10:44:21", "headline": "Reported Earlier: 'Trump's Next Tariff Fight: Keeping The Money; After Trump's Supreme Court Tariff Defeat, Administration Officials Are Devising Legal Strategies That Would Let The President Keep Some \u2014 Or Maybe Even Most \u2014 Of The Revenue, Five People Familiar With The Conversations Told POLITICO'", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/26/02/50893925/reported-earlier-trumps-next-tariff-fight-keeping-the-money-after-trumps-supreme-", "tags": ["earnings", "legal"]}
{"id": 50893953, "time": "2026-02-26 10:44:36", "headline": "Wells Fargo Maintains Outperform on Starwood Property Trust, Lowers Price Target to $21", "summary": "", "symbols": ["STWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50893953/wells-fargo-maintains-outperform-on-starwood-property-trust-lowers-price-target-to-21", "tags": ["analyst_other", "price_target_down"]}
{"id": 50894006, "time": "2026-02-26 10:45:16", "headline": "Evercore ISI Group Maintains Outperform on Snowflake, Lowers Price Target to $225", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894006/evercore-isi-group-maintains-outperform-on-snowflake-lowers-price-target-to-225", "tags": ["analyst_other", "price_target_down"]}
{"id": 50894011, "time": "2026-02-26 10:45:21", "headline": "If You Invested $100 In EQT Stock 5 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["EQT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50894011/if-you-invested-100-in-eqt-stock-5-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 50894030, "time": "2026-02-26 10:45:41", "headline": "RBC Capital Maintains Outperform on NVIDIA, Raises Price Target to $250", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894030/rbc-capital-maintains-outperform-on-nvidia-raises-price-target-to-250", "tags": ["analyst_other", "price_target_up"]}
{"id": 50894004, "time": "2026-02-26 10:45:05", "headline": "Celsius Holdings Q4 2025 Earnings Call Transcript", "summary": "Celsius reported fourth-quarter financial results on Thursday. The transcript from the earnings call has been provided below.", "symbols": ["CELH"], "source": "benzinga", "author": "Alex Perry", "url": "https://www.benzinga.com/markets/earnings/26/02/50894004/celsius-holdings-q4-2025-earnings-transcript", "tags": ["earnings"]}
{"id": 50894042, "time": "2026-02-26 10:45:55", "headline": "Wells Fargo Maintains Equal-Weight on Root, Lowers Price Target to $70", "summary": "", "symbols": ["ROOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894042/wells-fargo-maintains-equal-weight-on-root-lowers-price-target-to-70", "tags": ["analyst_other", "price_target_down"]}
{"id": 50894090, "time": "2026-02-26 10:46:55", "headline": "RBC Capital Maintains Outperform on O-I Glass, Lowers Price Target to $18", "summary": "", "symbols": ["OI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894090/rbc-capital-maintains-outperform-on-o-i-glass-lowers-price-target-to-18", "tags": ["analyst_other", "price_target_down"]}
{"id": 50894114, "time": "2026-02-26 10:47:11", "headline": "Evercore ISI Group Maintains Outperform on Sun Communities, Raises Price Target to $146", "summary": "", "symbols": ["SUI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894114/evercore-isi-group-maintains-outperform-on-sun-communities-raises-price-target-to-146", "tags": ["analyst_other", "price_target_up"]}
{"id": 50894134, "time": "2026-02-26 10:47:32", "headline": "Wells Fargo Maintains Equal-Weight on New Mountain Finance, Lowers Price Target to $8", "summary": "", "symbols": ["NMFC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894134/wells-fargo-maintains-equal-weight-on-new-mountain-finance-lowers-price-target-to-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 50894177, "time": "2026-02-26 10:48:39", "headline": "Wells Fargo Maintains Equal-Weight on Teladoc Health, Lowers Price Target to $6", "summary": "", "symbols": ["TDOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894177/wells-fargo-maintains-equal-weight-on-teladoc-health-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 50894203, "time": "2026-02-26 10:49:02", "headline": "RBC Capital Maintains Sector Perform on Salesforce, Lowers Price Target to $210", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894203/rbc-capital-maintains-sector-perform-on-salesforce-lowers-price-target-to-210", "tags": ["analyst_other", "price_target_down"]}
{"id": 50894206, "time": "2026-02-26 10:49:07", "headline": "Evercore ISI Group Maintains In-Line on Teladoc Health, Lowers Price Target to $5", "summary": "", "symbols": ["TDOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894206/evercore-isi-group-maintains-in-line-on-teladoc-health-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 50894297, "time": "2026-02-26 10:50:39", "headline": "Fed Vice Chair For Supervision Bowman Says Bank Regulators Aiming For New Basel Bank Capital Proposal By End Of March", "summary": "", "symbols": ["KBE", "KRE", "SPY", "XLF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/26/02/50894297/fed-vice-chair-for-supervision-bowman-says-bank-regulators-aiming-for-new-basel-b", "tags": []}
{"id": 50894300, "time": "2026-02-26 10:50:44", "headline": "Opendoor Technologies Stock Is Climbing Thursday: What's Driving The Action?", "summary": "Opendoor Technologies shares are up on Thursday. The company\u00a0last week reported Q4 financial results that exceeded analyst expectations.", "symbols": ["OPEN"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50894300/opendoor-technologies-stock-is-climbing-thursday-whats-driving-the-action", "tags": []}
{"id": 50894356, "time": "2026-02-26 10:51:37", "headline": "Nasdaq Tumbles Over 350 Points; US Initial Jobless Claims Increase", "summary": " ", "symbols": ["AEHL", "ALBT", "ARRY", "CURX", "ELPW", "EOSE"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/markets/market-summary/26/02/50894356/nasdaq-tumbles-over-350-points-us-initial-jobless-claims-increase", "tags": []}
{"id": 50894439, "time": "2026-02-26 10:53:36", "headline": "Hut 8 Posts Q4 Revenue Beat, Analyst Raises Price Target On River Bend Tracking For Early Delivery", "summary": "Hut 8 reports strong Q4 results and plans to reduce bitcoin exposure. Analyst reaffirms Buy rating with $66 price target.", "symbols": ["ABTC", "HUT"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/news/26/02/50894439/hut-8-posts-q4-revenue-beat-analyst-raises-price-target-on-river-bend-tracking-for-early-delivery", "tags": ["price_target_up", "earnings"]}
{"id": 50894460, "time": "2026-02-26 10:53:48", "headline": "RBC Capital Maintains Outperform on Sun Communities, Raises Price Target to $148", "summary": "", "symbols": ["SUI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894460/rbc-capital-maintains-outperform-on-sun-communities-raises-price-target-to-148", "tags": ["analyst_other", "price_target_up"]}
{"id": 50894476, "time": "2026-02-26 10:54:01", "headline": "Watching uniQure; Traders Circulate Unconfirmed Analyst Comments Defending The Company; Says \"We Believe Makary's Comments Do Not Refer To QURE As Their Drug Is Not Delivered In A Ventricle. We Think It's Likely Referring To Another Program\"", "summary": "", "symbols": ["QURE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/26/02/50894476/watching-uniqure-traders-circulate-unconfirmed-analyst-comments-defending-the-company-says-we-bel", "tags": []}
{"id": 50894512, "time": "2026-02-26 10:54:39", "headline": "Wells Fargo Maintains Equal-Weight on RxSight, Lowers Price Target to $11", "summary": "", "symbols": ["RXST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894512/wells-fargo-maintains-equal-weight-on-rxsight-lowers-price-target-to-11", "tags": ["analyst_other", "price_target_down"]}
{"id": 50894563, "time": "2026-02-26 10:55:38", "headline": "RBC Capital Maintains Sector Perform on TaskUs, Lowers Price Target to $13", "summary": "", "symbols": ["TASK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894563/rbc-capital-maintains-sector-perform-on-taskus-lowers-price-target-to-13", "tags": ["analyst_other", "price_target_down"]}
{"id": 50894573, "time": "2026-02-26 10:55:46", "headline": "Dell Earnings Prediction Market Preview: What Will Michael Dell Say?", "summary": "Nvidia (NVDA) beats earnings expectations and guides Q1 revenue above estimate. Dell (DELL) reports record AI server backlog. Traders bet on Dell&#39;s earnings and key words. China and Windows 10 are long shots.", "symbols": ["DELL", "NVDA"], "source": "benzinga", "author": "Daragh Thomas", "url": "https://www.benzinga.com/crypto/cryptocurrency/26/02/50894573/dell-earnings-prediction-market-preview-what-will-michael-dell-say", "tags": ["earnings"]}
{"id": 50894605, "time": "2026-02-26 10:56:44", "headline": "Wells Fargo Maintains Overweight on Alkermes, Raises Price Target to $43", "summary": "", "symbols": ["ALKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894605/wells-fargo-maintains-overweight-on-alkermes-raises-price-target-to-43", "tags": ["analyst_other", "price_target_up"]}
{"id": 50894620, "time": "2026-02-26 10:57:00", "headline": "RBC Capital Maintains Sector Perform on Mosaic, Lowers Price Target to $28", "summary": "", "symbols": ["MOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894620/rbc-capital-maintains-sector-perform-on-mosaic-lowers-price-target-to-28", "tags": ["analyst_other", "price_target_down"]}
{"id": 50894656, "time": "2026-02-26 10:57:45", "headline": "Wells Fargo Maintains Equal-Weight on United Therapeutics, Raises Price Target to $466", "summary": "", "symbols": ["UTHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894656/wells-fargo-maintains-equal-weight-on-united-therapeutics-raises-price-target-to-466", "tags": ["analyst_other", "price_target_up"]}
{"id": 50894698, "time": "2026-02-26 10:58:49", "headline": "Wells Fargo Maintains Overweight on Globus Medical, Raises Price Target to $104", "summary": "", "symbols": ["GMED"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894698/wells-fargo-maintains-overweight-on-globus-medical-raises-price-target-to-104", "tags": ["analyst_other", "price_target_up"]}
{"id": 50894829, "time": "2026-02-26 10:59:40", "headline": "Wells Fargo Maintains Overweight on Agilent Technologies, Lowers Price Target to $165", "summary": "", "symbols": ["A"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894829/wells-fargo-maintains-overweight-on-agilent-technologies-lowers-price-target-to-165", "tags": ["analyst_other", "price_target_down"]}
{"id": 50894842, "time": "2026-02-26 10:59:47", "headline": "Redwire Shares Are Ripping Higher Today: What's Happening?", "summary": "Redwire Corporation (NYSE:RDW) shares were initially trading lower, but have since bounced and are now moving higher Thursday on the heels of the company&#39;s fourth-quarter financial results.", "symbols": ["RDW"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50894842/redwire-shares-are-ripping-higher-today-whats-happening", "tags": []}
{"id": 50894885, "time": "2026-02-26 11:00:18", "headline": "Price Over Earnings Overview: Canadian Imperial Bank", "summary": " ", "symbols": ["CM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50894885/price-over-earnings-overview-canadian-imperial-bank", "tags": ["earnings"]}
{"id": 50894887, "time": "2026-02-26 11:00:20", "headline": "Here's How Much $1000 Invested In iShares Russell 1000 Growth Fund 10 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["IWF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50894887/heres-how-much-1000-invested-in-ishares-russell-1000-growth-fund-10-years-ago-would-be-worth-today", "tags": []}
{"id": 50894935, "time": "2026-02-26 11:00:35", "headline": "Wells Fargo Maintains Overweight on Revolution Medicines, Raises Price Target to $144", "summary": "", "symbols": ["RVMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50894935/wells-fargo-maintains-overweight-on-revolution-medicines-raises-price-target-to-144", "tags": ["analyst_other", "price_target_up"]}
{"id": 50894948, "time": "2026-02-26 11:00:39", "headline": "Is Cheniere Energy Partners LP Gaining or Losing Market Support?", "summary": " ", "symbols": ["CQP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50894948/is-cheniere-energy-partners-lp-gaining-or-losing-market-support", "tags": []}
{"id": 50894978, "time": "2026-02-26 11:00:45", "headline": "Is Coca-Cola Co Gaining or Losing Market Support?", "summary": " ", "symbols": ["KO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50894978/is-coca-cola-co-gaining-or-losing-market-support", "tags": []}
{"id": 50894997, "time": "2026-02-26 11:00:50", "headline": "What's Driving the Market Sentiment Around BeOne Medicines Ltd?", "summary": " ", "symbols": ["ONC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50894997/whats-driving-the-market-sentiment-around-beone-medicines-ltd", "tags": []}
{"id": 50895035, "time": "2026-02-26 11:01:01", "headline": "Looking At Ciena's Recent Unusual Options Activity", "summary": " ", "symbols": ["CIEN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/26/02/50895035/looking-at-cienas-recent-unusual-options-activity", "tags": []}
{"id": 50895054, "time": "2026-02-26 11:01:08", "headline": "Unpacking the Latest Options Trading Trends in Intuitive Surgical", "summary": " ", "symbols": ["ISRG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/26/02/50895054/unpacking-the-latest-options-trading-trends-in-intuitive-surgical", "tags": []}
{"id": 50895064, "time": "2026-02-26 11:01:11", "headline": "Examining the Future: 1stdibs.com's Earnings Outlook", "summary": " ", "symbols": ["DIBS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50895064/examining-the-future-1stdibs-coms-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 50895073, "time": "2026-02-26 11:01:13", "headline": "Looking At Microsoft's Recent Unusual Options Activity", "summary": " ", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/26/02/50895073/looking-at-microsofts-recent-unusual-options-activity", "tags": []}
{"id": 50895097, "time": "2026-02-26 11:01:22", "headline": "Treace Medical Concepts's Earnings: A Preview", "summary": " ", "symbols": ["TMCI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50895097/treace-medical-conceptss-earnings-a-preview", "tags": ["earnings"]}
{"id": 50895134, "time": "2026-02-26 11:01:36", "headline": "Exploring Escalade's Earnings Expectations", "summary": " ", "symbols": ["ESCA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50895134/exploring-escalades-earnings-expectations", "tags": ["earnings"]}
{"id": 50895151, "time": "2026-02-26 11:01:42", "headline": "Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Raises Price Target to $94", "summary": "", "symbols": ["LMAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895151/wells-fargo-maintains-equal-weight-on-lemaitre-vascular-raises-price-target-to-94", "tags": ["analyst_other", "price_target_up"]}
{"id": 50895156, "time": "2026-02-26 11:01:45", "headline": "Earnings Outlook For inTest", "summary": " ", "symbols": ["INTT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50895156/earnings-outlook-for-intest", "tags": ["earnings", "guidance"]}
{"id": 50895178, "time": "2026-02-26 11:01:56", "headline": "What to Expect from LiqTech Intl's Earnings", "summary": " ", "symbols": ["LIQT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50895178/what-to-expect-from-liqtech-intls-earnings", "tags": ["earnings"]}
{"id": 50895259, "time": "2026-02-26 11:02:37", "headline": "Wells Fargo Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $34", "summary": "", "symbols": ["PRCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895259/wells-fargo-maintains-overweight-on-procept-biorobotics-lowers-price-target-to-34", "tags": ["analyst_other", "price_target_down"]}
{"id": 50895343, "time": "2026-02-26 11:03:42", "headline": "Wells Fargo Maintains Underweight on CoStar Group, Lowers Price Target to $40", "summary": "", "symbols": ["CSGP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895343/wells-fargo-maintains-underweight-on-costar-group-lowers-price-target-to-40", "tags": ["analyst_other", "price_target_down"]}
{"id": 50895373, "time": "2026-02-26 11:04:24", "headline": "Wells Fargo Maintains Overweight on Centuri Holdings, Raises Price Target to $34", "summary": "", "symbols": ["CTRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895373/wells-fargo-maintains-overweight-on-centuri-holdings-raises-price-target-to-34", "tags": ["analyst_other", "price_target_up"]}
{"id": 50895375, "time": "2026-02-26 11:04:25", "headline": "Judge Rejects Kenvue Bid To Dismiss Texas Attorney General's Lawsuit Over Marketing Of Tylenol", "summary": "", "symbols": ["JNJ", "KVUE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895375/judge-rejects-kenvue-bid-to-dismiss-texas-attorney-generals-lawsuit-over-marketing-of-tylenol", "tags": ["legal"]}
{"id": 50895393, "time": "2026-02-26 11:04:39", "headline": "Google Rolls Out Gemini Image Model Nano Banana 2", "summary": "", "symbols": ["GOOG", "GOOGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895393/google-rolls-out-gemini-image-model-nano-banana-2", "tags": []}
{"id": 50895424, "time": "2026-02-26 11:05:04", "headline": "Mattel Expands Presence On Creator Platforms With New UNO-Branded Experiences On Roblox, Fortnite", "summary": "", "symbols": ["MAT", "RBLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895424/mattel-expands-presence-on-creator-platforms-with-new-uno-branded-experiences-on-roblox-fortnite", "tags": []}
{"id": 50895462, "time": "2026-02-26 11:05:20", "headline": "Wells Fargo Maintains Equal-Weight on Allison Transmission, Raises Price Target to $127", "summary": "", "symbols": ["ALSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895462/wells-fargo-maintains-equal-weight-on-allison-transmission-raises-price-target-to-127", "tags": ["analyst_other", "price_target_up"]}
{"id": 50895485, "time": "2026-02-26 11:05:48", "headline": "Watching Longeveron; Zacks Small-Cap Research Gives Stock $10.45 Price Valuation", "summary": "", "symbols": ["LGVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895485/watching-longeveron-zacks-small-cap-research-gives-stock-10-45-price-valuation", "tags": []}
{"id": 50895510, "time": "2026-02-26 11:06:09", "headline": "Wells Fargo Maintains Equal-Weight on Primoris Services, Raises Price Target to $168", "summary": "", "symbols": ["PRIM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895510/wells-fargo-maintains-equal-weight-on-primoris-services-raises-price-target-to-168", "tags": ["analyst_other", "price_target_up"]}
{"id": 50895522, "time": "2026-02-26 11:06:17", "headline": "German IG Metall Union Says Reach Settlement With Tesla At Labor Court", "summary": "", "symbols": ["TSLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895522/german-ig-metall-union-says-reach-settlement-with-tesla-at-labor-court", "tags": ["legal"]}
{"id": 50895563, "time": "2026-02-26 11:07:16", "headline": "How To Trade SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, TSLA Using Technical Analysis", "summary": " ", "symbols": [], "source": "benzinga", "author": "RIPS", "url": "https://www.benzinga.com/Opinion/26/02/50895563/how-to-trade-spy-qqq-aapl-msft-nvda-googl-meta-tsla-using-technical-analysis-43", "tags": []}
{"id": 50895567, "time": "2026-02-26 11:07:25", "headline": "Shift4 Payments Sees Q1 Gross Revenue Less Network\tFees $548.000M", "summary": "", "symbols": ["FOUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895567/shift4-payments-sees-q1-gross-revenue-less-network-fees-548-000m", "tags": ["earnings"]}
{"id": 50895569, "time": "2026-02-26 11:07:26", "headline": "Wells Fargo Maintains Equal-Weight on Westlake, Raises Price Target to $100", "summary": "", "symbols": ["WLK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895569/wells-fargo-maintains-equal-weight-on-westlake-raises-price-target-to-100", "tags": ["analyst_other", "price_target_up"]}
{"id": 50895617, "time": "2026-02-26 11:08:15", "headline": "Wells Fargo Maintains Equal-Weight on Sinclair, Raises Price Target to $17", "summary": "", "symbols": ["SBGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895617/wells-fargo-maintains-equal-weight-on-sinclair-raises-price-target-to-17", "tags": ["analyst_other", "price_target_up"]}
{"id": 50895629, "time": "2026-02-26 11:08:31", "headline": "Charles Gasparino Posts On X \"@netflix CEO Ted Sarandos is scheduled to meet with AG @PamBondi, WH chief of staff @SusieWiles and DOJ antitrust officials imminently today as he tries to save his bid to purchase @wbd's studio and streamer from almost certainly being challenged by the Trump Administration on antitrust grounds and its alleged progressive political bias in which it pushes this content with its ever growing market clout. ...\"", "summary": "", "symbols": ["NFLX", "PSKY", "SPY", "WBD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50895629/charles-gasparino-posts-on-x-netflix-ceo-ted-sarandos-is-scheduled-to-meet-with-ag-pambondi-wh-chief", "tags": ["management"]}
{"id": 50895639, "time": "2026-02-26 11:08:44", "headline": "Edgewise Therapeutics Q4 EPS $(0.47) Misses $(0.43) Estimate", "summary": "", "symbols": ["EWTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50895639/edgewise-therapeutics-q4-eps-0-47-misses-0-43-estimate", "tags": ["earnings"]}
{"id": 50895643, "time": "2026-02-26 11:08:46", "headline": "D-Wave Stock Rises Despite Q4 Double Miss: What You Need To Know", "summary": "D-Wave Quantum Inc. (NYSE:QBTS) reported financial results for the fourth quarter before the market open on Thursday. Here&#39;s a look at the key highlights from the quarter.", "symbols": ["QBTS"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50895643/d-wave-stock-rises-despite-q4-double-miss-what-you-need-to-know", "tags": []}
{"id": 50895699, "time": "2026-02-26 11:09:55", "headline": "Wells Fargo Maintains Equal-Weight on Trade Desk, Lowers Price Target to $25", "summary": "", "symbols": ["TTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895699/wells-fargo-maintains-equal-weight-on-trade-desk-lowers-price-target-to-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 50895737, "time": "2026-02-26 11:10:39", "headline": "'Paypal, Stripe Not Currently In Talks' - Semafor Exclusive", "summary": "", "symbols": ["PYPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50895737/paypal-stripe-not-currently-in-talks-semafor-exclusive", "tags": []}
{"id": 50895741, "time": "2026-02-26 11:10:44", "headline": "Wells Fargo Maintains Equal-Weight on Ibotta, Raises Price Target to $34", "summary": "", "symbols": ["IBTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895741/wells-fargo-maintains-equal-weight-on-ibotta-raises-price-target-to-34", "tags": ["analyst_other", "price_target_up"]}
{"id": 50895784, "time": "2026-02-26 11:11:30", "headline": "Wells Fargo Maintains Overweight on Circle Internet Group, Lowers Price Target to $111", "summary": "", "symbols": ["CRCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895784/wells-fargo-maintains-overweight-on-circle-internet-group-lowers-price-target-to-111", "tags": ["analyst_other", "price_target_down"]}
{"id": 50895827, "time": "2026-02-26 11:12:25", "headline": "Intuitive Machines (LUNR) Stock Surges After Sharp Sell-Off: What's Going On?", "summary": "Intuitive Machines Inc (NASDAQ: LUNR) shares are trading higher Thursday, recovering some of the sharp losses seen in the previous session after the company unveiled sizable equity financing.", "symbols": ["LUNR"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50895827/intuitive-machines-lunr-stock-surges-after-sharp-sell-off-whats-going-on", "tags": ["why_moving"]}
{"id": 50895828, "time": "2026-02-26 11:12:29", "headline": "Piper Sandler Maintains Overweight on Nutanix, Lowers Price Target to $63", "summary": "", "symbols": ["NTNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895828/piper-sandler-maintains-overweight-on-nutanix-lowers-price-target-to-63", "tags": ["analyst_other", "price_target_down"]}
{"id": 50895850, "time": "2026-02-26 11:13:08", "headline": "Wells Fargo Maintains Overweight on Snowflake, Lowers Price Target to $210", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895850/wells-fargo-maintains-overweight-on-snowflake-lowers-price-target-to-210", "tags": ["analyst_other", "price_target_down"]}
{"id": 50895899, "time": "2026-02-26 11:14:05", "headline": "Wells Fargo Maintains Equal-Weight on Synopsys, Lowers Price Target to $450", "summary": "", "symbols": ["SNPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895899/wells-fargo-maintains-equal-weight-on-synopsys-lowers-price-target-to-450", "tags": ["analyst_other", "price_target_down"]}
{"id": 50895909, "time": "2026-02-26 11:14:14", "headline": "RBC Capital Maintains Outperform on Trade Desk, Lowers Price Target to $40", "summary": "", "symbols": ["TTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895909/rbc-capital-maintains-outperform-on-trade-desk-lowers-price-target-to-40", "tags": ["analyst_other", "price_target_down"]}
{"id": 50895950, "time": "2026-02-26 11:15:07", "headline": "Wells Fargo Maintains Equal-Weight on Nutanix, Lowers Price Target to $50", "summary": "", "symbols": ["NTNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895950/wells-fargo-maintains-equal-weight-on-nutanix-lowers-price-target-to-50", "tags": ["analyst_other", "price_target_down"]}
{"id": 50895970, "time": "2026-02-26 11:15:18", "headline": "Here's How Much $1000 Invested In Sumitomo Mitsui Finl Gr 10 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["SMFG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50895970/heres-how-much-1000-invested-in-sumitomo-mitsui-finl-gr-10-years-ago-would-be-worth-today", "tags": []}
{"id": 50895986, "time": "2026-02-26 11:15:32", "headline": "Piper Sandler Reiterates Overweight on Lowe's Companies, Raises Price Target to $300", "summary": "", "symbols": ["LOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895986/piper-sandler-reiterates-overweight-on-lowes-companies-raises-price-target-to-300", "tags": ["analyst_other", "price_target_up"]}
{"id": 50896015, "time": "2026-02-26 11:15:57", "headline": "Wells Fargo Maintains Overweight on Everpure, Lowers Price Target to $90", "summary": "", "symbols": ["PSTG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50896015/wells-fargo-maintains-overweight-on-everpure-lowers-price-target-to-90", "tags": ["analyst_other", "price_target_down"]}
{"id": 50896020, "time": "2026-02-26 11:16:01", "headline": "RBC Capital Maintains Outperform on United Therapeutics, Raises Price Target to $643", "summary": "", "symbols": ["UTHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50896020/rbc-capital-maintains-outperform-on-united-therapeutics-raises-price-target-to-643", "tags": ["analyst_other", "price_target_up"]}
{"id": 50896062, "time": "2026-02-26 11:16:58", "headline": "Wells Fargo Maintains Underweight on Clear Secure, Raises Price Target to $33", "summary": "", "symbols": ["YOU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50896062/wells-fargo-maintains-underweight-on-clear-secure-raises-price-target-to-33", "tags": ["analyst_other", "price_target_up"]}
{"id": 50896095, "time": "2026-02-26 11:17:59", "headline": "No, Bitcoin Isn't Artificially Being Kept Below $150,000 By Market Makers", "summary": "Bitwise Invest Chief Investment Officer Jeff Park argues Bitcoin (CRYPTO: BTC) is not being suppressed as claimed by some on social media.", "symbols": ["BTCUSD", "IBIT"], "source": "benzinga", "author": "Parshwa Turakhiya", "url": "https://www.benzinga.com/crypto/cryptocurrency/26/02/50896095/no-bitcoin-isnt-artificially-being-kept-below-150000-by-market-makers", "tags": []}
{"id": 50896100, "time": "2026-02-26 11:18:09", "headline": "Wells Fargo Maintains Equal-Weight on Salesforce, Lowers Price Target to $210", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50896100/wells-fargo-maintains-equal-weight-on-salesforce-lowers-price-target-to-210", "tags": ["analyst_other", "price_target_down"]}
{"id": 50896126, "time": "2026-02-26 11:18:28", "headline": "Piper Sandler Maintains Overweight on Select Water Solutions, Raises Price Target to $16", "summary": "", "symbols": ["WTTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50896126/piper-sandler-maintains-overweight-on-select-water-solutions-raises-price-target-to-16", "tags": ["analyst_other", "price_target_up"]}
{"id": 50896155, "time": "2026-02-26 11:18:51", "headline": "RBC Capital Maintains Outperform on Exchange Income, Raises Price Target to C$133", "summary": "", "symbols": ["TSX:EIF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50896155/rbc-capital-maintains-outperform-on-exchange-income-raises-price-target-to-c-133", "tags": ["analyst_other", "price_target_up"]}
{"id": 50896181, "time": "2026-02-26 11:19:40", "headline": "Wells Fargo Maintains Equal-Weight on Pinnacle West Capital, Raises Price Target to $97", "summary": "", "symbols": ["PNW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50896181/wells-fargo-maintains-equal-weight-on-pinnacle-west-capital-raises-price-target-to-97", "tags": ["analyst_other", "price_target_up"]}
{"id": 50896233, "time": "2026-02-26 11:20:43", "headline": "RBC Capital Maintains Outperform on PMET Resources, Raises Price Target to C$6.7", "summary": "", "symbols": ["TSX:PMET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50896233/rbc-capital-maintains-outperform-on-pmet-resources-raises-price-target-to-c-6-7", "tags": ["analyst_other", "price_target_up"]}
{"id": 50896306, "time": "2026-02-26 11:22:17", "headline": "RBC Capital Maintains Sector Perform on Sienna Senior Living, Raises Price Target to C$25", "summary": "", "symbols": ["TSX:SIA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50896306/rbc-capital-maintains-sector-perform-on-sienna-senior-living-raises-price-target-to-c-25", "tags": ["analyst_other", "price_target_up"]}
{"id": 50896310, "time": "2026-02-26 11:22:23", "headline": "Disc Medicine Q4 EPS $(1.62) Beats $(1.68) Estimate", "summary": "", "symbols": ["IRON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50896310/disc-medicine-q4-eps-1-62-beats-1-68-estimate", "tags": ["earnings"]}
{"id": 50896338, "time": "2026-02-26 11:22:39", "headline": "DA Davidson Maintains Buy on Snowflake, Lowers Price Target to $250", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50896338/da-davidson-maintains-buy-on-snowflake-lowers-price-target-to-250", "tags": ["analyst_other", "price_target_down"]}
{"id": 50896367, "time": "2026-02-26 11:22:50", "headline": "Piper Sandler Maintains Overweight on Skyward Specialty, Lowers Price Target to $55", "summary": "", "symbols": ["SKWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50896367/piper-sandler-maintains-overweight-on-skyward-specialty-lowers-price-target-to-55", "tags": ["analyst_other", "price_target_down"]}
{"id": 50896380, "time": "2026-02-26 11:22:58", "headline": "\"Tennessee AG Joins Multi-State Push To Block \"Culturally Catastrophic\" Netflix-Warner Merger\" - Tampa Free Press", "summary": "", "symbols": ["NFLX", "PSKY", "WBD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50896380/tennessee-ag-joins-multi-state-push-to-block-culturally-catastrophic-netflix-warner-merger-tampa-fre", "tags": ["merger"]}
{"id": 50896501, "time": "2026-02-26 11:25:20", "headline": "RBC Capital Maintains Outperform on Topaz Energy, Raises Price Target to C$34", "summary": "", "symbols": ["TSX:TPZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50896501/rbc-capital-maintains-outperform-on-topaz-energy-raises-price-target-to-c-34", "tags": ["analyst_other", "price_target_up"]}
{"id": 50896750, "time": "2026-02-26 11:29:23", "headline": "'Michael Burry sees Nvidia 'purchase commitment' parallel to Cisco at dot-com bubble top' - CNBC", "summary": "", "symbols": ["CSCO", "NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50896750/michael-burry-sees-nvidia-purchase-commitment-parallel-to-cisco-at-dot-com-bubble-top-cnbc", "tags": []}
{"id": 50896808, "time": "2026-02-26 11:30:20", "headline": "Here's How Much $100 Invested In Axia Energia 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["AXIA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50896808/heres-how-much-100-invested-in-axia-energia-5-years-ago-would-be-worth-today", "tags": []}
{"id": 50896837, "time": "2026-02-26 11:30:59", "headline": "USITC To Investigate Economic Impact Of Revoking PNTR For Products Of China", "summary": "", "symbols": ["FXI", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/26/02/50896837/usitc-to-investigate-economic-impact-of-revoking-pntr-for-products-of-china", "tags": []}
{"id": 50896884, "time": "2026-02-26 11:31:59", "headline": "RBC Capital Maintains Outperform on Topicus, Lowers Price Target to C$150", "summary": "", "symbols": ["TSX:TOI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50896884/rbc-capital-maintains-outperform-on-topicus-lowers-price-target-to-c-150", "tags": ["analyst_other", "price_target_down"]}
{"id": 50896898, "time": "2026-02-26 11:32:08", "headline": "Bitcoin Pauses At $68K Awaiting Next Catalyst", "summary": "Bitcoin (CRYPTO: BTC) is trading near $68,000 after a strong rally earlier this year that was fueled by the launch of spot Bitcoin exchange traded funds and renewed institutional inter", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Hillary Remy", "url": "https://www.benzinga.com/Opinion/26/02/50896898/bitcoin-pauses-at-68k-awaiting-next-catalyst", "tags": []}
{"id": 50896916, "time": "2026-02-26 11:32:21", "headline": "WBD Earnings: Streaming Is Up, TV Is Dying, And A $108 Billion Sale Is Brewing", "summary": "Warner Bros. Discovery reports Q4 results, with a revenue of $9.46B and a loss of 10 cents per share. Streaming subscribers surge to 131.6M.", "symbols": ["NFLX", "PSKY", "WBD"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/markets/earnings/26/02/50896916/wbd-earnings-streaming-is-up-tv-is-dying-and-a-108-billion-sale-is-brewing", "tags": ["earnings"]}
{"id": 50897001, "time": "2026-02-26 11:34:10", "headline": "Boyd Gaming Inks Agreement To Sell Shreveport, Louisiana-Based Sam's Town Hotel & Casino To Bally's; Financial Terms Undisclosed", "summary": "", "symbols": ["BALY", "BYD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50897001/boyd-gaming-inks-agreement-to-sell-shreveport-louisiana-based-sams-town-hotel-casino-to-ballys-finan", "tags": ["contract"]}
{"id": 50897069, "time": "2026-02-26 11:35:26", "headline": "Piper Sandler Maintains Overweight on Slide Insurance Holdings, Raises Price Target to $24", "summary": "", "symbols": ["SLDE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50897069/piper-sandler-maintains-overweight-on-slide-insurance-holdings-raises-price-target-to-24", "tags": ["analyst_other", "price_target_up"]}
{"id": 50897141, "time": "2026-02-26 11:37:47", "headline": "Piper Sandler Maintains Overweight on Kymera Therapeutics, Raises Price Target to $140", "summary": "", "symbols": ["KYMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50897141/piper-sandler-maintains-overweight-on-kymera-therapeutics-raises-price-target-to-140", "tags": ["analyst_other", "price_target_up"]}
{"id": 50897225, "time": "2026-02-26 11:39:21", "headline": "Nutanix (NTNX) Edges Higher After AMD AI Equity Deal", "summary": "Nutanix shares are trading higher Thursday morning following its second-quarter results and AI partnership with Advanced Micro Devices.", "symbols": ["AMD", "NTNX"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50897225/nutanix-ntnx-edges-higher-after-amd-ai-equity-deal", "tags": ["why_moving", "contract"]}
{"id": 50897269, "time": "2026-02-26 11:40:52", "headline": "Piper Sandler Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $28", "summary": "", "symbols": ["PRCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50897269/piper-sandler-maintains-overweight-on-procept-biorobotics-lowers-price-target-to-28", "tags": ["analyst_other", "price_target_down"]}
{"id": 50897349, "time": "2026-02-26 11:42:56", "headline": "ARMOUR Residential REIT Option Alert: Mar 20 $18 Calls Sweep (12) near the Ask: 1923 @ $0.5 vs 1880 OI; Earnings 4/22 After Close [est] Ref=$18.18", "summary": "", "symbols": ["ARR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50897349/armour-residential-reit-option-alert-mar-20-18-calls-sweep-12-near-the-ask-1923-0-5-vs-1880-oi-earni", "tags": ["earnings"]}
{"id": 50897367, "time": "2026-02-26 11:43:29", "headline": "Piper Sandler Maintains Overweight on Revolution Medicines, Raises Price Target to $120", "summary": "", "symbols": ["RVMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50897367/piper-sandler-maintains-overweight-on-revolution-medicines-raises-price-target-to-120", "tags": ["analyst_other", "price_target_up"]}
{"id": 50897420, "time": "2026-02-26 11:45:27", "headline": "If You Invested $1000 In McKesson Stock 5 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["MCK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50897420/if-you-invested-1000-in-mckesson-stock-5-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 50897421, "time": "2026-02-26 11:45:34", "headline": "Piper Sandler Maintains Neutral on RxSight, Lowers Price Target to $10", "summary": "", "symbols": ["RXST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50897421/piper-sandler-maintains-neutral-on-rxsight-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 50897461, "time": "2026-02-26 11:46:32", "headline": "Nvidia Crushes Estimates, But The Real ETF Story Is The 263% Networking Surge", "summary": "Nvidia&#39;s blowout earnings and 263% networking growth reinforce the AI ETF rally, lifting semiconductor, tech, and equal-weight strategies.", "symbols": ["IYW", "NVDA", "NVDD", "NVDU", "QQQ", "QQQE", "SMH", "SOXX"], "source": "benzinga", "author": "Chandrima Sanyal", "url": "https://www.benzinga.com/etfs/sector-etfs/26/02/50897461/nvidia-crushes-estimates-but-the-real-etf-story-is-the-263-networking-surge", "tags": ["earnings"]}
{"id": 50897514, "time": "2026-02-26 11:47:57", "headline": "Piper Sandler Reiterates Overweight on Teladoc Health, Lowers Price Target to $9", "summary": "", "symbols": ["TDOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50897514/piper-sandler-reiterates-overweight-on-teladoc-health-lowers-price-target-to-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 50897573, "time": "2026-02-26 11:48:50", "headline": "Grifols Expects Reaching Free Cash Flow Pre-M&A Pre-Dividends Of \u20ac500M-575M; 2027 Milestones Unchanged; 2026 Adjusted EBITDA Margin Of Over 25%", "summary": "", "symbols": ["GRFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50897573/grifols-expects-reaching-free-cash-flow-pre-m-a-pre-dividends-of-500m-575m-2027-milestones-unchanged", "tags": []}
{"id": 50897609, "time": "2026-02-26 11:49:38", "headline": "EOSE Energy Stock Crashes After Weak Revenue Outlook", "summary": "Eos Energy shares sink after forecasting FY26 revenue of $300\u2013$400 million, significantly below analyst expectations, despite reporting record fourth-quarter revenue.", "symbols": ["EOSE"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50897609/eose-energy-stock-crashes-after-weak-revenue-outlook", "tags": ["earnings", "guidance"]}
{"id": 50897635, "time": "2026-02-26 11:50:14", "headline": "Piper Sandler Maintains Neutral on Intapp, Lowers Price Target to $25", "summary": "", "symbols": ["INTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50897635/piper-sandler-maintains-neutral-on-intapp-lowers-price-target-to-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 50897711, "time": "2026-02-26 11:51:26", "headline": "The White House Portfolio Is Now Worth $9.7 Trillion \u2014 And It's Telling Investors Exactly What To Buy", "summary": "The White House&#39;s $9.7T investment wave is heavily concentrated in AI, chips, and energy\u2014boosting Nvidia, Microsoft, Oracle, and GE Vernova.", "symbols": ["AAPL", "AMZN", "CAT", "CEG", "GEV", "GFS", "META", "MSFT", "MU", "NVDA", "OKLO", "ORCL", "SFTBY", "TSM"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/long-ideas/26/02/50897711/the-white-house-portfolio-is-now-worth-9-7-trillion-and-its-telling-investors-exactly-what-to-buy", "tags": []}
{"id": 50897743, "time": "2026-02-26 11:52:06", "headline": "Can You Really Earn Passive Income With Stablecoins? (Spoiler: It's Not What You Think)", "summary": " ", "symbols": [], "source": "benzinga", "author": "Anndy Lian", "url": "https://www.benzinga.com/Opinion/26/02/50897743/can-you-really-earn-passive-income-with-stablecoins-spoiler-its-not-what-you-think", "tags": []}
{"id": 50897793, "time": "2026-02-26 11:52:55", "headline": "JM Smucker Leans On Coffee Strength To Weather Tariff, Commodity Spike", "summary": "J.M. Smucker reported Q3 fiscal 2026 results, beating analyst expectations with strong sales and adjusted earnings despite cost pressures.", "symbols": ["SJM"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/markets/earnings/26/02/50897793/jm-smucker-leans-on-coffee-strength-to-weather-tariff-commodity-spike", "tags": ["earnings"]}
{"id": 50897897, "time": "2026-02-26 11:55:39", "headline": "Tim Cook Teases Apple Launch On Monday: Here's What To Expect", "summary": "Tim Cook teased a big week ahead, with Apple Inc. expected to kick off three days of product launches Monday, including new MacBooks, iPads and the iPhone 17e, capped by a hands-on event.", "symbols": ["AAPL"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/tech/26/02/50897897/tim-cook-teases-apple-launch-on-monday-heres-what-to-expect", "tags": []}
{"id": 50897988, "time": "2026-02-26 11:58:59", "headline": "Warner Bros. Discovery Q4 2025 Earnings Call Transcript", "summary": "Warner Bros. Discovery reported fourth-quarter financial results on Thursday. The transcript from the earnings call has been provided below.", "symbols": ["WBD"], "source": "benzinga", "author": "Alex Perry", "url": "https://www.benzinga.com/markets/earnings/26/02/50897988/warner-bros-discovery-q4-2025-earnings-call-transcript", "tags": ["earnings"]}
{"id": 50898142, "time": "2026-02-26 12:00:22", "headline": "A Look Into Chevron Inc's Price Over Earnings", "summary": " ", "symbols": ["CVX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50898142/a-look-into-chevron-incs-price-over-earnings", "tags": ["earnings"]}
{"id": 50898144, "time": "2026-02-26 12:00:28", "headline": "What's Driving the Market Sentiment Around KKR & Co Inc?", "summary": " ", "symbols": ["KKR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50898144/whats-driving-the-market-sentiment-around-kkr-co-inc", "tags": []}
{"id": 50898159, "time": "2026-02-26 12:00:33", "headline": "Looking Into Philip Morris International Inc's Recent Short Interest", "summary": " ", "symbols": ["PM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50898159/looking-into-philip-morris-international-incs-recent-short-interest", "tags": []}
{"id": 50898166, "time": "2026-02-26 12:00:39", "headline": "Looking Into Charter Communications Inc's Recent Short Interest", "summary": " ", "symbols": ["CHTR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50898166/looking-into-charter-communications-incs-recent-short-interest", "tags": []}
{"id": 50898250, "time": "2026-02-26 12:02:30", "headline": "CORRECTION: Zai Lab Q4 EPADS $(0.46) Misses $(0.05) Estimate, Sales $127.597M Beat $124.472M Estimate", "summary": "", "symbols": ["ZLAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50898250/correction-zai-lab-q4-epads-0-46-misses-0-05-estimate-sales-127-597m-beat-124-472m-estimate", "tags": []}
{"id": 50898262, "time": "2026-02-26 12:02:42", "headline": "Watching Sigma Lithium; Blue Orca Capital Issues Report On The Co Stating It Is Short", "summary": "", "symbols": ["SGML"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/short-sellers/26/02/50898262/watching-sigma-lithium-blue-orca-capital-issues-report-on-the-co-stating-it-is-short", "tags": []}
{"id": 50898287, "time": "2026-02-26 12:03:12", "headline": "Oppenheimer Maintains Outperform on Array Technologies, Lowers Price Target to $11", "summary": "", "symbols": ["ARRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50898287/oppenheimer-maintains-outperform-on-array-technologies-lowers-price-target-to-11", "tags": ["analyst_other", "price_target_down"]}
{"id": 50898318, "time": "2026-02-26 12:03:52", "headline": "NVIDIA Robotics Posts On X \".@ServeRobotics is redefining last-mile delivery on city sidewalks. By simulating in NVIDIA Isaac Sim and running on NVIDIA Jetson Orin, Serve is deploying one of the largest fleets of physical AI-powered delivery robots, completing 100,000+ autonomous deliveries with a 99.8% completion rate across five major U.S. cities. ...\"", "summary": "", "symbols": ["NVDA", "SERV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50898318/nvidia-robotics-posts-on-x-serverobotics-is-redefining-last-mile-delivery-on-city-sidewalks-by-simul", "tags": []}
{"id": 50898346, "time": "2026-02-26 12:04:35", "headline": "Why Analysts Call Circle 'The Next Tesla'\u2014And Still See It Doubling From $83", "summary": "Circle Internet Group (NYSE:CRCL) received price target cuts to $160 and $130 from two firms that still maintain Buy ratings, as analysts argue the stablecoin issuer\u2019s ", "symbols": ["BTCUSD", "CRCL"], "source": "benzinga", "author": "Parshwa Turakhiya", "url": "https://www.benzinga.com/crypto/cryptocurrency/26/02/50898346/why-analysts-call-circle-the-next-tesla-and-still-see-it-doubling-from-83", "tags": []}
{"id": 50898357, "time": "2026-02-26 12:04:50", "headline": "UPDATE: Acushnet Hldgs Q4 Adj. EPS $(0.30) Misses $(0.29) Estimate. (Adj EPS Excludes Loss On Debt Extinguishment $0.28)", "summary": "", "symbols": ["GOLF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50898357/update-acushnet-hldgs-q4-adj-eps-0-30-misses-0-29-estimate-adj-eps-excludes-loss-on-debt-extinguish", "tags": ["earnings"]}
{"id": 50898372, "time": "2026-02-26 12:04:56", "headline": "Bernstein Maintains Market Perform on Zoom Communications, Lowers Price Target to $88", "summary": "", "symbols": ["ZM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50898372/bernstein-maintains-market-perform-on-zoom-communications-lowers-price-target-to-88", "tags": ["analyst_other", "price_target_down"]}
{"id": 50898407, "time": "2026-02-26 12:05:21", "headline": "AST SpaceMobile Stock Is Rising Thursday: What's Fueling The Move?", "summary": "AST SpaceMobile is trading higher Thursday morning after the satellite-communications company landed a roughly $30 million prime contract earlier this week with the U.S. Space Development Agency.", "symbols": ["ASTS"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50898407/ast-spacemobile-stock-is-rising-thursday-whats-fueling-the-move", "tags": ["contract"]}
{"id": 50898415, "time": "2026-02-26 12:05:31", "headline": "12 Information Technology Stocks Moving In Thursday's Intraday Session", "summary": " ", "symbols": ["ACMR", "AI", "ALOY", "ATOM", "CGTL", "GENVR", "IONQ", "IPWR", "OPRA", "PSTG", "RXT", "YXT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/26/02/50898415/12-information-technology-stocks-moving-in-thursdays-intraday-session", "tags": ["why_moving"]}
{"id": 50898416, "time": "2026-02-26 12:05:31", "headline": "Oppenheimer Maintains Outperform on Flutter Entertainment, Lowers Price Target to $210", "summary": "", "symbols": ["FLUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50898416/oppenheimer-maintains-outperform-on-flutter-entertainment-lowers-price-target-to-210", "tags": ["analyst_other", "price_target_down"]}
{"id": 50898417, "time": "2026-02-26 12:05:33", "headline": "Meta Takes Legal Action Against Scam Advertisers; Issued Cease And Desist Letters To Eight Marketing Consultants Who Advertised The Ability To Evade Our Enforcement Systems; Continue To Invest In New AI Technology That Detects Cloaking; Filed Lawsuits Against Four Scam Advertisers Who Impersonated Well-Known Celebrities And Brands To Deceive And Defraud People; Filed Multiple Lawsuits Against Deceptive Advertisers In Brazil, China And Vietnam", "summary": "", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50898417/meta-takes-legal-action-against-scam-advertisers-issued-cease-and-desist-letters-to-eight-marketing", "tags": []}
{"id": 50898419, "time": "2026-02-26 12:05:36", "headline": "12 Industrials Stocks Moving In Thursday's Intraday Session", "summary": " ", "symbols": ["ARRY", "DXST", "ELPW", "EOSE", "ERII", "FA", "HUHU", "MEG", "MGN", "NCEW", "NCRA", "QH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/26/02/50898419/12-industrials-stocks-moving-in-thursdays-intraday-session", "tags": ["why_moving"]}
{"id": 50898422, "time": "2026-02-26 12:05:41", "headline": "12 Health Care Stocks Moving In Thursday's Intraday Session", "summary": " ", "symbols": ["AIDX", "BFLY", "CELGR", "CURX", "GDRX", "HCTI", "KLTO", "LMAT", "NAUT", "PMVP", "PRCT", "QURE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/26/02/50898422/12-health-care-stocks-moving-in-thursdays-intraday-session", "tags": ["why_moving"]}
{"id": 50898428, "time": "2026-02-26 12:05:46", "headline": "11 Communication Services Stocks Moving In Thursday's Intraday Session", "summary": " ", "symbols": ["AEHL", "CARS", "FTRK", "GTN", "IBTA", "IMAX", "RSVR", "SBGI", "THRY", "VSME", "ZIP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/26/02/50898428/11-communication-services-stocks-moving-in-thursdays-intraday-session", "tags": ["why_moving"]}
{"id": 50882008, "time": "2026-02-26 07:03:35", "headline": "GigaCloud Tech Sees Q1 Sales $330.000M-$355.000M vs $290.117M Est", "summary": "", "symbols": ["GCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50882008/gigacloud-tech-sees-q1-sales-330-000m-355-000m-vs-290-117m-est", "tags": []}
{"id": 50898521, "time": "2026-02-26 12:06:48", "headline": "Bernstein Maintains Market Perform on Snowflake, Lowers Price Target to $195", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50898521/bernstein-maintains-market-perform-on-snowflake-lowers-price-target-to-195", "tags": ["analyst_other", "price_target_down"]}
{"id": 50898531, "time": "2026-02-26 12:06:54", "headline": "Meta Filed A Lawsuit Against Vietnam-Based L\u00fd V\u0103n L\u00e2m; Filed Lawsuits Against Brazil-Based Vitor Louren\u00e7o De Souza And Milena Luciani Sanchez; Filed Lawsuits Against China-based Shenzhen Yunzheng Technology Co.; Filed Lawsuits Against Brazil-Based B&B Suplementos E Cosm\u00e9ticos LTDA", "summary": "", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50898531/meta-filed-a-lawsuit-against-vietnam-based-l-v-n-l-m-filed-lawsuits-against-brazil-based-vitor-loure", "tags": ["legal"]}
{"id": 50898590, "time": "2026-02-26 12:07:47", "headline": "Live On CNBC, Stephanie Link Announces Trimmed Amazon Position", "summary": "", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/26/02/50898590/live-on-cnbc-stephanie-link-announces-trimmed-amazon-position", "tags": []}
{"id": 50898612, "time": "2026-02-26 12:08:04", "headline": "Oppenheimer Reiterates Outperform on NVIDIA, Maintains $265 Price Target", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50898612/oppenheimer-reiterates-outperform-on-nvidia-maintains-265-price-target", "tags": ["analyst_other"]}
{"id": 50898641, "time": "2026-02-26 12:08:50", "headline": "Why Shift4 Payments Stock Just Hit 52-Week Low", "summary": "Shift4 Payments Inc. (FOUR) stock plunged after mixed Q4 results and soft 2026 outlook. Quarterly revenue missed estimates.", "symbols": ["FOUR"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/markets/earnings/26/02/50898641/why-shift4-payments-stock-just-hit-52-week-low", "tags": ["earnings", "guidance"]}
{"id": 50898647, "time": "2026-02-26 12:09:01", "headline": "What's Going On With Shake Shack Stock Today?", "summary": "Shake Shack rose Thursday after an earnings beat and stronger profitability trends offset a slight revenue miss and a mixed near-term sales outlook.", "symbols": ["SHAK"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/markets/equities/26/02/50898647/whats-going-on-with-shake-shack-stock-today-2", "tags": ["earnings", "guidance", "why_moving"]}
{"id": 50898671, "time": "2026-02-26 12:09:30", "headline": "Nvidia Stock Aims For $250 After 'Strongest Quarter Ever' \u2014 Analyst Calls It 'Conservative'", "summary": "Nvidia analysts remain bullish on the company after Q4 earnings and commentary on strong demand going forward. Here are the key highlights.", "symbols": ["NVDA"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/26/02/50898671/nvidia-stock-aims-for-250-after-strongest-quarter-ever-analyst-calls-it-conservative", "tags": ["earnings"]}
{"id": 50898741, "time": "2026-02-26 12:10:48", "headline": "Oppenheimer Maintains Outperform on Nutrien, Raises Price Target to $78", "summary": "", "symbols": ["NTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50898741/oppenheimer-maintains-outperform-on-nutrien-raises-price-target-to-78", "tags": ["analyst_other", "price_target_up"]}
{"id": 50898761, "time": "2026-02-26 12:10:58", "headline": "Alpha Buying: When Insider Conviction Meets High Yield", "summary": " ", "symbols": ["AAT", "EPD", "OXM", "PRU"], "source": "benzinga", "author": "Tim Melvin", "url": "https://www.benzinga.com/opinion/26/02/50898761/alpha-buying-when-insider-conviction-meets-high-yield", "tags": ["insider"]}
{"id": 50898878, "time": "2026-02-26 12:14:08", "headline": "Bernstein Maintains Outperform on NVIDIA, Raises Price Target to $300", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50898878/bernstein-maintains-outperform-on-nvidia-raises-price-target-to-300", "tags": ["analyst_other", "price_target_up"]}
{"id": 50898916, "time": "2026-02-26 12:14:32", "headline": "'Mamdani And Trump Are Set To Meet In Washington; Mayor Zohran Mamdani's Trip To The White House On Thursday Was Unannounced. The Topics He Planned To Discuss With President Trump Were Not Immediately Clear' - NY Times", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/26/02/50898916/mamdani-and-trump-are-set-to-meet-in-washington-mayor-zohran-mamdanis-trip-to-the", "tags": []}
{"id": 50898935, "time": "2026-02-26 12:15:02", "headline": "Oppenheimer Downgrades PROCEPT BioRobotics to Perform", "summary": "", "symbols": ["PRCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50898935/oppenheimer-downgrades-procept-biorobotics-to-perform", "tags": ["analyst_down"]}
{"id": 50898959, "time": "2026-02-26 12:15:29", "headline": "Reported Earlier: Amazon Leo Will Connect Millions Across Rural Africa With Satellite Connectivity; Amazon's Satellite Service Will Work With Vanu To Bring Connectivity To Communities Traditional Infrastructure Can't Reach", "summary": "", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50898959/reported-earlier-amazon-leo-will-connect-millions-across-rural-africa-with-satellite-connectivity-am", "tags": []}
{"id": 50898982, "time": "2026-02-26 12:15:54", "headline": "Bernstein Maintains Outperform on Lowe's Companies, Lowers Price Target to $303", "summary": "", "symbols": ["LOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50898982/bernstein-maintains-outperform-on-lowes-companies-lowers-price-target-to-303", "tags": ["analyst_other", "price_target_down"]}
{"id": 50899026, "time": "2026-02-26 12:17:08", "headline": "Super Micro Computer Debuts AMD EPYC-Powered MicroBlade Platform", "summary": "Super Micro Computer Inc. (SMCI) unveiled what it calls the industry&#39;s first and highest-density blade server platform powered by Advanced Micro Devices Inc.&#39;s (AMD) EPYC 4005 series processors on Wednesday.", "symbols": ["AMD", "AVGO", "NVDA", "SMCI"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50899026/super-micro-computer-debuts-amd-epyc-powered-microblade-platform", "tags": []}
{"id": 50899041, "time": "2026-02-26 12:17:27", "headline": "Bernstein Maintains Underperform on Target, Raises Price Target to $91", "summary": "", "symbols": ["TGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50899041/bernstein-maintains-underperform-on-target-raises-price-target-to-91", "tags": ["analyst_other", "price_target_up"]}
{"id": 50899045, "time": "2026-02-26 12:17:28", "headline": "Oppenheimer Maintains Outperform on Salesforce, Lowers Price Target to $250", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50899045/oppenheimer-maintains-outperform-on-salesforce-lowers-price-target-to-250", "tags": ["analyst_other", "price_target_down"]}
{"id": 50895051, "time": "2026-02-26 11:01:07", "headline": "'Barclays, Atlas Among Firms Exposed to Collapsed UK Lender MFS' - Bloomberg", "summary": "", "symbols": ["BCS", "JEF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50895051/barclays-atlas-among-firms-exposed-to-collapsed-uk-lender-mfs-bloomberg", "tags": []}
{"id": 50899082, "time": "2026-02-26 12:18:07", "headline": "What's Driving Teladoc Health's Rally?", "summary": "Teladoc stock jumps after beating earnings estimates and 2026 guidance below consensus.", "symbols": ["TDOC"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/markets/earnings/26/02/50899082/whats-driving-teladoc-healths-rally", "tags": ["earnings", "guidance"]}
{"id": 50899121, "time": "2026-02-26 12:19:44", "headline": "Oppenheimer Maintains Outperform on Trade Desk, Lowers Price Target to $35", "summary": "", "symbols": ["TTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50899121/oppenheimer-maintains-outperform-on-trade-desk-lowers-price-target-to-35", "tags": ["analyst_other", "price_target_down"]}
{"id": 50899148, "time": "2026-02-26 12:20:21", "headline": "Snowflake Delivers 'Blizzard Of Large Deal Activity,' Q4 Beat: Analysts", "summary": "Shares of Snowflake rose after upbeat Q4 results. Goldman Sachs, Needham, and Rosenblatt maintain Buy ratings with varying PTs.", "symbols": ["SNOW"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/26/02/50899148/snowflake-delivers-blizzard-of-large-deal-activity-q4-beat-analysts", "tags": ["earnings", "contract"]}
{"id": 50899149, "time": "2026-02-26 12:20:21", "headline": "Bernstein Maintains Underperform on Salesforce, Lowers Price Target to $194", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50899149/bernstein-maintains-underperform-on-salesforce-lowers-price-target-to-194", "tags": ["analyst_other", "price_target_down"]}
{"id": 50899193, "time": "2026-02-26 12:21:32", "headline": "Sempra Anticipates An Additional $2.2B Of Cash Generated From The Sempra Infrastructure Partners Transaction Beyond The 2030 Planning Period; Says Texas Rate Base Is Projected To Grow At A 18% CAGR Over The 2026-2030 Plan Period", "summary": "", "symbols": ["SRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50899193/sempra-anticipates-an-additional-2-2b-of-cash-generated-from-the-sempra-infrastructure-partners-tran", "tags": []}
{"id": 50899225, "time": "2026-02-26 12:22:12", "headline": "Oppenheimer Maintains Outperform on United Therapeutics, Raises Price Target to $600", "summary": "", "symbols": ["UTHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50899225/oppenheimer-maintains-outperform-on-united-therapeutics-raises-price-target-to-600", "tags": ["analyst_other", "price_target_up"]}
{"id": 50899251, "time": "2026-02-26 12:22:49", "headline": "Guggenheim Downgrades Arcellx to Neutral, Lowers Price Target to $115", "summary": "", "symbols": ["ACLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50899251/guggenheim-downgrades-arcellx-to-neutral-lowers-price-target-to-115", "tags": ["analyst_down", "price_target_down"]}
{"id": 50899297, "time": "2026-02-26 12:23:23", "headline": "Nasdaq Stress Gauge Just Hit 2022 Levels \u2014 Is A Short-Term Bottom Brewing?", "summary": "Nasdaq put/call ratio jumps to 1.2, highest since 2022. Extreme hedging in QQQ, Nvidia, and Apple signals rising stress and volatility.", "symbols": ["AAPL", "MSFT", "NVDA", "QQQ", "SPY"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/markets/options/26/02/50899297/nasdaq-stress-gauge-just-hit-2022-levels-is-a-short-term-bottom-brewing", "tags": []}
{"id": 50899329, "time": "2026-02-26 12:24:32", "headline": "Live On CNBC, Stephanie Link Announces Bought More Synopsys", "summary": "", "symbols": ["SNPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/26/02/50899329/live-on-cnbc-stephanie-link-announces-bought-more-synopsys", "tags": []}
{"id": 50890840, "time": "2026-02-26 12:25:06", "headline": "Goldman Sachs Stays Bullish On Nvidia Stock, Sees Nearly 30% Upside (UPDATED)", "summary": "Goldman Sachs reiterates its Buy rating on Nvidia (NVDA) after a strong quarter, keeps a $250 price target and sees nearly 30% upside as AI spending accelerates.", "symbols": ["META", "NVDA"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/analyst-stock-ratings/reiteration/26/02/50890840/goldman-sachs-bullish-nvidia-stock-30-percent-upside-after-earnings", "tags": ["analyst_other"]}
{"id": 50899378, "time": "2026-02-26 12:25:33", "headline": "What's Behind Bitcoin's 10 AM Drop? Economist Says Data Tells A Different Story", "summary": "Claims that Bitcoin (CRYPTO: BTC) consistently &#34;dumps&#34; at 10 a.m.", "symbols": ["BTCUSD", "IBIT"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/crypto/cryptocurrency/26/02/50899378/whats-behind-bitcoins-10-am-drop-economist-says-data-tells-a-different-story", "tags": []}
{"id": 50899381, "time": "2026-02-26 12:25:37", "headline": "Itau BBA Downgrades Grupo Cibest to Underperform, Announces $68 Price Target", "summary": "", "symbols": ["CIB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50899381/itau-bba-downgrades-grupo-cibest-to-underperform-announces-68-price-target", "tags": ["analyst_down"]}
{"id": 50899465, "time": "2026-02-26 12:27:03", "headline": "Live On CNBC, Malcolm Ethridge Announces Bought More IBM", "summary": "", "symbols": ["IBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/26/02/50899465/live-on-cnbc-malcolm-ethridge-announces-bought-more-ibm", "tags": []}
{"id": 50899493, "time": "2026-02-26 12:27:20", "headline": "'FDA To Give Staff Bonuses For Speeding Up Drug Reviews; FDA In The Process Of Hiring More Than 1,000 New Scientists To Speed Up Drug Reviews' - Bloomberg News", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/26/02/50899493/fda-to-give-staff-bonuses-for-speeding-up-drug-reviews-fda-in-the-process-of-hiring-more-than-1-0", "tags": ["fda"]}
{"id": 50899498, "time": "2026-02-26 12:27:28", "headline": "Roth Capital Maintains Buy on Pelthos Therapeutics, Lowers Price Target to $55", "summary": "", "symbols": ["PTHS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50899498/roth-capital-maintains-buy-on-pelthos-therapeutics-lowers-price-target-to-55", "tags": ["analyst_other", "price_target_down"]}
{"id": 50899526, "time": "2026-02-26 12:28:00", "headline": "Tight Wallets, Heavy Promotions Pressure Papa John's Results", "summary": "Papa John&#39;s (PZZA) stock fell as company&#39;s quarterly sales missed expectations due to weaker domestic demand and increased promotions.", "symbols": ["PZZA"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/markets/earnings/26/02/50899526/tight-wallets-heavy-promotions-pressure-papa-johns-results", "tags": []}
{"id": 50899527, "time": "2026-02-26 12:28:00", "headline": "What's Going On With Shoals Technologies Shares On Thursday?", "summary": "Shoals Technologies shares fall following an EPS miss and multiple analyst price target reductions despite steady revenue and strong backlog.", "symbols": ["SHLS"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50899527/whats-going-on-with-shoals-technologies-shares-on-thursday", "tags": ["earnings", "why_moving"]}
{"id": 50899538, "time": "2026-02-26 12:28:14", "headline": "Nvidia Slumps Over 4%, Wall Street's Fear Gauge Rallies: What's Moving Markets Thursday?", "summary": "Tech stocks tumbled Thursday as investors sold the news following blockbuster results from Nvidia Corp. (NASDAQ:NVDA), dragging the broader semiconductor space lower despit", "symbols": ["AMD", "AVGO", "BIDU", "BSY", "BTCUSD", "CELH", "CHE", "CNXC", "CRM", "CSCO", "DCI", "DIA", "EVER", "FOUR", "HEI", "IONQ", "IWM", "LNG", "NFLX", "NU", "NVDA", "PENN", "PRMB", "PSKY", "QQQ", "RY", "SNOW", "SNPS", "STRL", "TCOM", "TD", "TTD", "UHS", "VICI", "VOO", "VST", "WBD", "XLE", "XLK", "ZM"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/news/26/02/50899538/stock-market-news-today-nvidia-stock-reaction-to-earnings-vix-spike-sector-movers", "tags": []}
{"id": 50899671, "time": "2026-02-26 12:29:51", "headline": "Roth Capital Maintains Buy on MGP Ingredients, Lowers Price Target to $32", "summary": "", "symbols": ["MGPI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50899671/roth-capital-maintains-buy-on-mgp-ingredients-lowers-price-target-to-32", "tags": ["analyst_other", "price_target_down"]}
{"id": 50899672, "time": "2026-02-26 12:29:53", "headline": "TD Cowen Reiterates Buy on NVIDIA, Maintains $235 Price Target", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50899672/td-cowen-reiterates-buy-on-nvidia-maintains-235-price-target", "tags": ["analyst_other"]}
{"id": 50899703, "time": "2026-02-26 12:30:38", "headline": "SoundHound AI Edges Higher Ahead Of Earnings On Expansion Plans", "summary": "SoundHound AI Inc (NASDAQ: SOUN) shares are edging higher Thursday afternoon as investors look ahead to the voice-AI company&#39;s fourth-quarter results, due after the closing bell.", "symbols": ["SOUN"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50899703/soundhound-ai-edges-higher-ahead-of-earnings-on-expansion-plans", "tags": ["earnings"]}
{"id": 50899741, "time": "2026-02-26 12:31:23", "headline": "TD Cowen Maintains Buy on Snowflake, Lowers Price Target to $255", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50899741/td-cowen-maintains-buy-on-snowflake-lowers-price-target-to-255", "tags": ["analyst_other", "price_target_down"]}
{"id": 50899797, "time": "2026-02-26 12:33:00", "headline": "TD Cowen Upgrades Nasdaq to Buy, Raises Price Target to $106", "summary": "", "symbols": ["NDAQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50899797/td-cowen-upgrades-nasdaq-to-buy-raises-price-target-to-106", "tags": ["analyst_up", "price_target_up"]}
{"id": 50899810, "time": "2026-02-26 12:33:09", "headline": "This 5-Month Oil Trade Has Delivered for 20 Years", "summary": "Make money trading oil seasonally with USO, NEE, OKE. Long calls and bull call spreads are efficient ways to amplify profits from mid-Feb to mid-Jul.Trade USO, NEE, OKE for seasonal oil profits. Use long calls and bull call spreads from mid-Feb to mid-Jul for efficient gains.", "symbols": ["EOG", "NEE", "SU", "USO"], "source": "benzinga", "author": "Tom Gentile", "url": "https://www.benzinga.com/trading-ideas/short-ideas/26/02/50899810/this-5-month-oil-trade-has-delivered-for-20-years", "tags": []}
{"id": 50899843, "time": "2026-02-26 12:33:52", "headline": "Live On CNBC, Malcolm Ethridge Announces Bought More Carlyle Group", "summary": "", "symbols": ["CG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/26/02/50899843/live-on-cnbc-malcolm-ethridge-announces-bought-more-carlyle-group", "tags": []}
{"id": 50899900, "time": "2026-02-26 12:35:17", "headline": "10 Information Technology Stocks With Whale Alerts In Today's Session", "summary": " ", "symbols": ["AMD", "AMKR", "AVGO", "CRCL", "CRWV", "GLW", "INTC", "IREN", "NVDA", "SNDK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/26/02/50899900/10-information-technology-stocks-with-whale-alerts-in-todays-session", "tags": []}
{"id": 50899903, "time": "2026-02-26 12:35:22", "headline": "10 Financials Stocks Whale Activity In Today's Session", "summary": " ", "symbols": ["AFL", "AXP", "BAC", "COIN", "GBDC", "GLXY", "GS", "MTB", "SOFI", "WFC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/26/02/50899903/10-financials-stocks-whale-activity-in-todays-session", "tags": []}
{"id": 50899905, "time": "2026-02-26 12:35:25", "headline": "Roth Capital Maintains Buy on Salesforce, Lowers Price Target to $325", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50899905/roth-capital-maintains-buy-on-salesforce-lowers-price-target-to-325", "tags": ["analyst_other", "price_target_down"]}
{"id": 50899906, "time": "2026-02-26 12:35:27", "headline": "10 Health Care Stocks Whale Activity In Today's Session", "summary": " ", "symbols": ["EW", "HIMS", "LLY", "LQDA", "NTRA", "NVO", "QURE", "THC", "UNH", "UTHR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/26/02/50899906/10-health-care-stocks-whale-activity-in-todays-session", "tags": []}
{"id": 50899912, "time": "2026-02-26 12:35:40", "headline": "TD Cowen Maintains Buy on Acadia Healthcare Co, Raises Price Target to $24", "summary": "", "symbols": ["ACHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50899912/td-cowen-maintains-buy-on-acadia-healthcare-co-raises-price-target-to-24", "tags": ["analyst_other", "price_target_up"]}
{"id": 50899940, "time": "2026-02-26 12:36:16", "headline": "EXCLUSIVE: Energy Transition Infrastructure Has Gaps, Risks And Plenty Of Opportunities, Cresta Partner Says", "summary": "Cresta Fund Management&#39;s partner and head of capital formation discusses the infrastructure market, energy, regulation and more.", "symbols": [], "source": "benzinga", "author": "Caroline Ryan", "url": "https://www.benzinga.com/markets/private-markets/26/02/50899940/exclusive-energy-transition-infrastructure-gaps-risks-opportunities-cresta", "tags": []}
{"id": 50900014, "time": "2026-02-26 12:38:01", "headline": "TD Cowen Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $37", "summary": "", "symbols": ["ACAD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900014/td-cowen-maintains-buy-on-acadia-pharmaceuticals-raises-price-target-to-37", "tags": ["analyst_other", "price_target_up"]}
{"id": 50900026, "time": "2026-02-26 12:38:07", "headline": "Roth Capital Maintains Buy on Barrett Business Services, Lowers Price Target to $42", "summary": "", "symbols": ["BBSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900026/roth-capital-maintains-buy-on-barrett-business-services-lowers-price-target-to-42", "tags": ["analyst_other", "price_target_down"]}
{"id": 50900085, "time": "2026-02-26 12:39:30", "headline": "MARA Holdings Stock Slides Ahead Of Q4 Earnings", "summary": "MARA Holdings Inc (NASDAQ:MARA) shares are under pressure on Thursday.", "symbols": ["BTCUSD", "MARA"], "source": "benzinga", "author": "Evette Mitkov", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50900085/mara-holdings-stock-slides-ahead-of-q4-earnings", "tags": ["earnings"]}
{"id": 50900086, "time": "2026-02-26 12:39:33", "headline": "TD Cowen Maintains Buy on Agilent Technologies, Lowers Price Target to $157", "summary": "", "symbols": ["A"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900086/td-cowen-maintains-buy-on-agilent-technologies-lowers-price-target-to-157", "tags": ["analyst_other", "price_target_down"]}
{"id": 50900091, "time": "2026-02-26 12:39:41", "headline": "Russia's Dmitriev Held Talks With U.S. Officials In Geneva", "summary": "", "symbols": ["SPY", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/26/02/50900091/russias-dmitriev-held-talks-with-u-s-officials-in-geneva", "tags": []}
{"id": 50900133, "time": "2026-02-26 12:40:16", "headline": "Roth Capital Reiterates Buy on Camping World Holdings, Lowers Price Target to $16", "summary": "", "symbols": ["CWH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900133/roth-capital-reiterates-buy-on-camping-world-holdings-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 50900135, "time": "2026-02-26 12:40:19", "headline": "JFrog Stock Pops As Company Bets Big On Itself \u2014 Should You Be Watching FROG?", "summary": "JFrog (NASDAQ: FROG) announces a $300M share repurchase program, reflecting confidence in its strategy and growth potential. Shares jump.", "symbols": ["FROG"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/markets/buybacks/26/02/50900135/jfrog-stock-pops-as-company-bets-big-on-itself-should-you-be-watching-frog", "tags": ["buyback"]}
{"id": 50900159, "time": "2026-02-26 12:40:35", "headline": "IonQ Posts Strong Q4, Guides To 81% Revenue Growth In 2026", "summary": "IonQ posted strong Q4 and positive outlook. Quarterly revenues grew 429% YoY. The company guided to 81% growth for the full year.", "symbols": ["IONQ"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/26/02/50900159/ionq-posts-strong-q4-guides-to-81-revenue-growth-in-2026", "tags": ["earnings", "guidance"]}
{"id": 50900212, "time": "2026-02-26 12:41:22", "headline": "Scotiabank Maintains Sector Perform on Bank of Montreal, Raises Price Target to C$208", "summary": "", "symbols": ["TSX:BMO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900212/scotiabank-maintains-sector-perform-on-bank-of-montreal-raises-price-target-to-c-208", "tags": ["analyst_other", "price_target_up"]}
{"id": 50900237, "time": "2026-02-26 12:41:37", "headline": "TD Cowen Maintains Buy on Arcutis Biotherapeutics, Raises Price Target to $35", "summary": "", "symbols": ["ARQT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900237/td-cowen-maintains-buy-on-arcutis-biotherapeutics-raises-price-target-to-35", "tags": ["analyst_other", "price_target_up"]}
{"id": 50900291, "time": "2026-02-26 12:42:55", "headline": "Roth Capital Maintains Buy on Aspen Aerogels, Lowers Price Target to $3", "summary": "", "symbols": ["ASPN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900291/roth-capital-maintains-buy-on-aspen-aerogels-lowers-price-target-to-3", "tags": ["analyst_other", "price_target_down"]}
{"id": 50900317, "time": "2026-02-26 12:43:46", "headline": "TD Cowen Maintains Buy on Aspen Aerogels, Lowers Price Target to $6", "summary": "", "symbols": ["ASPN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900317/td-cowen-maintains-buy-on-aspen-aerogels-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 50900347, "time": "2026-02-26 12:44:47", "headline": "Scotiabank Maintains Sector Outperform on Cargojet, Raises Price Target to C$118", "summary": "", "symbols": ["TSX:CJT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900347/scotiabank-maintains-sector-outperform-on-cargojet-raises-price-target-to-c-118", "tags": ["analyst_other", "price_target_up"]}
{"id": 50900362, "time": "2026-02-26 12:45:11", "headline": "Roth Capital Reiterates Buy on LeMaitre Vascular, Raises Price Target to $117", "summary": "", "symbols": ["LMAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900362/roth-capital-reiterates-buy-on-lemaitre-vascular-raises-price-target-to-117", "tags": ["analyst_other", "price_target_up"]}
{"id": 50900390, "time": "2026-02-26 12:46:04", "headline": "TD Cowen Maintains Hold on Enovix, Lowers Price Target to $7.5", "summary": "", "symbols": ["ENVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900390/td-cowen-maintains-hold-on-enovix-lowers-price-target-to-7-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 50900435, "time": "2026-02-26 12:47:47", "headline": "Scotiabank Maintains Sector Outperform on Exchange Income, Raises Price Target to C$121", "summary": "", "symbols": ["TSX:EIF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900435/scotiabank-maintains-sector-outperform-on-exchange-income-raises-price-target-to-c-121", "tags": ["analyst_other", "price_target_up"]}
{"id": 50900471, "time": "2026-02-26 12:48:35", "headline": "Live On CNBC, Josh Brown Hosts Segment Titled \"Josh's Best Stock Spotlight: Waste Management\"", "summary": "", "symbols": ["WM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/26/02/50900471/live-on-cnbc-josh-brown-hosts-segment-titled-joshs-best-stock-spotlight-waste-management", "tags": []}
{"id": 50900484, "time": "2026-02-26 12:48:50", "headline": "BMO Capital Maintains Outperform on Salesforce, Lowers Price Target to $225", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900484/bmo-capital-maintains-outperform-on-salesforce-lowers-price-target-to-225", "tags": ["analyst_other", "price_target_down"]}
{"id": 50900493, "time": "2026-02-26 12:48:57", "headline": "Baidu Q4 2025 Earnings Call Transcript", "summary": "Baidu reported fourth-quarter financial results on Thursday. The transcript from the earnings call has been provided below.", "symbols": ["BIDU"], "source": "benzinga", "author": "Alex Perry", "url": "https://www.benzinga.com/markets/earnings/26/02/50900493/baidu-q4-2025-earnings-call-transcript", "tags": ["earnings"]}
{"id": 50900505, "time": "2026-02-26 12:49:22", "headline": "Krispy Kreme Delivers Sweet Beat As Profit Tops Expectations, Shares Jump", "summary": "Krispy Kreme (NASDAQ: DNUT) shares rise after beating profit expectations, reporting $392.4M in sales, and announcing plans for expansion and improved cash generation.", "symbols": ["DNUT"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/markets/equities/26/02/50900505/krispy-kreme-delivers-sweet-beat-as-profit-tops-expectations-shares-jump", "tags": []}
{"id": 50900507, "time": "2026-02-26 12:49:29", "headline": "Scotiabank Maintains Sector Outperform on Ero Copper, Raises Price Target to C$50", "summary": "", "symbols": ["TSX:ERO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900507/scotiabank-maintains-sector-outperform-on-ero-copper-raises-price-target-to-c-50", "tags": ["analyst_other", "price_target_up"]}
{"id": 50900517, "time": "2026-02-26 12:49:40", "headline": "BMO Capital Maintains Outperform on Medline, Raises Price Target to $54", "summary": "", "symbols": ["MDLN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900517/bmo-capital-maintains-outperform-on-medline-raises-price-target-to-54", "tags": ["analyst_other", "price_target_up"]}
{"id": 50900555, "time": "2026-02-26 12:50:12", "headline": "Victory Capital Blasts Janus Henderson For Cold-Shouldering 'Superior' $16 Billion Merger", "summary": "Victory Capital proposes a $57.04 per share deal to acquire Janus Henderson, offering a 37% premium and a lower execution risk.", "symbols": ["JHG", "VCTR"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/m-a/26/02/50900555/victory-capital-blasts-janus-henderson-for-cold-shouldering-superior-16-billion-merger", "tags": ["offering", "merger", "contract"]}
{"id": 50900556, "time": "2026-02-26 12:50:18", "headline": "TD Cowen Maintains Buy on ExlService Hldgs, Lowers Price Target to $45", "summary": "", "symbols": ["EXLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900556/td-cowen-maintains-buy-on-exlservice-hldgs-lowers-price-target-to-45", "tags": ["analyst_other", "price_target_down"]}
{"id": 50900577, "time": "2026-02-26 12:50:43", "headline": "BMO Capital Maintains Market Perform on Pinnacle West Capital, Raises Price Target to $107", "summary": "", "symbols": ["PNW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900577/bmo-capital-maintains-market-perform-on-pinnacle-west-capital-raises-price-target-to-107", "tags": ["analyst_other", "price_target_up"]}
{"id": 50900630, "time": "2026-02-26 12:51:54", "headline": "BMO Capital Maintains Market Perform on CoStar Group, Lowers Price Target to $53", "summary": "", "symbols": ["CSGP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900630/bmo-capital-maintains-market-perform-on-costar-group-lowers-price-target-to-53", "tags": ["analyst_other", "price_target_down"]}
{"id": 50900640, "time": "2026-02-26 12:52:02", "headline": "Scotiabank Maintains Sector Outperform on Loblaw Cos, Raises Price Target to C$70", "summary": "", "symbols": ["TSX:L"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900640/scotiabank-maintains-sector-outperform-on-loblaw-cos-raises-price-target-to-c-70", "tags": ["analyst_other", "price_target_up"]}
{"id": 50900672, "time": "2026-02-26 12:52:58", "headline": "BMO Capital Maintains Outperform on MongoDB, Lowers Price Target to $400", "summary": "", "symbols": ["MDB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900672/bmo-capital-maintains-outperform-on-mongodb-lowers-price-target-to-400", "tags": ["analyst_other", "price_target_down"]}
{"id": 50900710, "time": "2026-02-26 12:54:28", "headline": "BMO Capital Maintains Market Perform on Teladoc Health, Lowers Price Target to $5", "summary": "", "symbols": ["TDOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900710/bmo-capital-maintains-market-perform-on-teladoc-health-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 50900726, "time": "2026-02-26 12:54:49", "headline": "Scotiabank Maintains Sector Outperform on Magnite, Lowers Price Target to $16", "summary": "", "symbols": ["MGNI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900726/scotiabank-maintains-sector-outperform-on-magnite-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 50900755, "time": "2026-02-26 12:55:41", "headline": "BMO Capital Maintains Outperform on Camping World Holdings, Lowers Price Target to $16", "summary": "", "symbols": ["CWH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900755/bmo-capital-maintains-outperform-on-camping-world-holdings-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 50900800, "time": "2026-02-26 12:56:54", "headline": "BMO Capital Maintains Market Perform on Okta, Lowers Price Target to $83", "summary": "", "symbols": ["OKTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900800/bmo-capital-maintains-market-perform-on-okta-lowers-price-target-to-83", "tags": ["analyst_other", "price_target_down"]}
{"id": 50900801, "time": "2026-02-26 12:56:57", "headline": "Scotiabank Maintains Sector Outperform on National Bank of Canada, Raises Price Target to C$202", "summary": "", "symbols": ["TSX:NA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900801/scotiabank-maintains-sector-outperform-on-national-bank-of-canada-raises-price-target-to-c-202", "tags": ["analyst_other", "price_target_up"]}
{"id": 50900862, "time": "2026-02-26 12:58:25", "headline": "BMO Capital Maintains Outperform on Trade Desk, Lowers Price Target to $55", "summary": "", "symbols": ["TTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900862/bmo-capital-maintains-outperform-on-trade-desk-lowers-price-target-to-55", "tags": ["analyst_other", "price_target_down"]}
{"id": 50900945, "time": "2026-02-26 12:59:51", "headline": "Craig-Hallum Downgrades eHealth to Hold, Announces $2 Price Target", "summary": "", "symbols": ["EHTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50900945/craig-hallum-downgrades-ehealth-to-hold-announces-2-price-target", "tags": ["analyst_down"]}
{"id": 50900949, "time": "2026-02-26 12:59:54", "headline": "Eli Lilly's New Oral Weight Loss Drug Outperforms Semaglutide, Eyes Potential US Approval In Q2", "summary": "Eli Lilly shares rise after orforglipron beats Novo&#39;s drug in Phase 3, cutting A1C by 2.2% and boosting weight loss results.", "symbols": ["LLY", "NVO"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/news/health-care/26/02/50900949/eli-lillys-new-oral-weight-loss-drug-outperforms-semaglutide-eyes-potential-us-approval-in-q2", "tags": ["fda"]}
{"id": 50900958, "time": "2026-02-26 13:00:00", "headline": "Takeover Talk Returns To Haunt PayPal", "summary": "PayPal Holdings, Inc. (NASDAQ: PYPL) shares drop amid takeover rumors, but reportedly not in talks with potential buyers.", "symbols": ["HPQ", "PYPL"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50900958/takeover-talk-returns-to-haunt-paypal", "tags": ["merger"]}
{"id": 50900987, "time": "2026-02-26 13:00:20", "headline": "P/E Ratio Insights for Waste Management", "summary": " ", "symbols": ["WM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50900987/pe-ratio-insights-for-waste-management", "tags": []}
{"id": 50900988, "time": "2026-02-26 13:00:22", "headline": "Is the Market Bullish or Bearish on Mizuho Financial Group Inc?", "summary": " ", "symbols": ["MFG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50900988/is-the-market-bullish-or-bearish-on-mizuho-financial-group-inc", "tags": []}
{"id": 50900991, "time": "2026-02-26 13:00:24", "headline": "Forecasting The Future: 4 Analyst Projections For Arcutis Biotherapeutics", "summary": " ", "symbols": ["ARQT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50900991/forecasting-the-future-4-analyst-projections-for-arcutis-biotherapeutics", "tags": []}
{"id": 50900995, "time": "2026-02-26 13:00:26", "headline": "Is Paychex Inc Gaining or Losing Market Support?", "summary": " ", "symbols": ["PAYX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50900995/is-paychex-inc-gaining-or-losing-market-support", "tags": []}
{"id": 50901012, "time": "2026-02-26 13:00:33", "headline": "What Does the Market Think About Willis Towers Watson PLC?", "summary": " ", "symbols": ["WTW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50901012/what-does-the-market-think-about-willis-towers-watson-plc", "tags": []}
{"id": 50901020, "time": "2026-02-26 13:00:35", "headline": "Breaking Down LeMaitre Vascular: 4 Analysts Share Their Views", "summary": " ", "symbols": ["LMAT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50901020/breaking-down-lemaitre-vascular-4-analysts-share-their-views", "tags": []}
{"id": 50901044, "time": "2026-02-26 13:00:44", "headline": "Deep Dive Into Universal Health Services Stock: Analyst Perspectives (5 Ratings)", "summary": " ", "symbols": ["UHS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50901044/deep-dive-into-universal-health-services-stock-analyst-perspectives-5-ratings", "tags": []}
{"id": 50901068, "time": "2026-02-26 13:00:56", "headline": "10 Analysts Have This To Say About Align Technology", "summary": " ", "symbols": ["ALGN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50901068/10-analysts-have-this-to-say-about-align-technology", "tags": []}
{"id": 50901084, "time": "2026-02-26 13:01:03", "headline": "Scotiabank Maintains Sector Outperform on Osisko Metals, Raises Price Target to C$1.5", "summary": "", "symbols": ["TSX:OM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901084/scotiabank-maintains-sector-outperform-on-osisko-metals-raises-price-target-to-c-1-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 50901087, "time": "2026-02-26 13:01:04", "headline": "A Closer Look at GE Vernova's Options Market Dynamics", "summary": " ", "symbols": ["GEV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/26/02/50901087/a-closer-look-at-ge-vernovas-options-market-dynamics", "tags": []}
{"id": 50901090, "time": "2026-02-26 13:01:05", "headline": "5 Analysts Assess C3.ai: What You Need To Know", "summary": " ", "symbols": ["AI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50901090/5-analysts-assess-c3-ai-what-you-need-to-know", "tags": []}
{"id": 50901097, "time": "2026-02-26 13:01:09", "headline": "CNBC Halftime Report Final Trades: Netflix, Zscaler, Joby Aviation, Truist Financial", "summary": "", "symbols": ["JOBY", "NFLX", "TFC", "ZS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/analyst-ratings/26/02/50901097/cnbc-halftime-report-final-trades-netflix-zscaler-joby-aviation-truist-financial", "tags": []}
{"id": 50901107, "time": "2026-02-26 13:01:13", "headline": "13 Analysts Have This To Say About Mirum Pharmaceuticals", "summary": " ", "symbols": ["MIRM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50901107/13-analysts-have-this-to-say-about-mirum-pharmaceuticals", "tags": []}
{"id": 50901108, "time": "2026-02-26 13:01:14", "headline": "Decoding Realty Income's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["O"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/26/02/50901108/decoding-realty-incomes-options-activity-whats-the-big-picture", "tags": []}
{"id": 50901118, "time": "2026-02-26 13:01:23", "headline": "Craig-Hallum Maintains Buy on Enovix, Lowers Price Target to $10", "summary": "", "symbols": ["ENVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901118/craig-hallum-maintains-buy-on-enovix-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 50901167, "time": "2026-02-26 13:02:46", "headline": "ACM Research CEO Defends $4 Billion Vision As Stock Tanks On Soft Margins And Weak 2026 Guide", "summary": "Dr. David Wang says ACM Research (ACMR) is &#34;accelerating investments&#34; in the U.S. even as the stock drops 18%. Get the full breakdown of the company&#39;s 2026 revenue goals and why Wall Street is cooling on the semiconductor player today.", "symbols": ["ACMR"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/markets/earnings/26/02/50901167/acm-research-ceo-defends-4-billion-vision-as-stock-tanks-on-soft-margins-and-weak-2026-guide", "tags": ["earnings", "management"]}
{"id": 50901202, "time": "2026-02-26 13:03:19", "headline": "Morgan Stanley Maintains Overweight on NVIDIA, Raises Price Target to $260", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901202/morgan-stanley-maintains-overweight-on-nvidia-raises-price-target-to-260", "tags": ["analyst_other", "price_target_up"]}
{"id": 50901254, "time": "2026-02-26 13:04:26", "headline": "Morgan Stanley Maintains Equal-Weight on Trade Desk, Lowers Price Target to $30", "summary": "", "symbols": ["TTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901254/morgan-stanley-maintains-equal-weight-on-trade-desk-lowers-price-target-to-30", "tags": ["analyst_other", "price_target_down"]}
{"id": 50901263, "time": "2026-02-26 13:04:33", "headline": "Scotiabank Maintains Sector Outperform on Snowflake, Lowers Price Target to $205", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901263/scotiabank-maintains-sector-outperform-on-snowflake-lowers-price-target-to-205", "tags": ["analyst_other", "price_target_down"]}
{"id": 50901333, "time": "2026-02-26 13:05:41", "headline": "Morgan Stanley Maintains Overweight on Snowflake, Lowers Price Target to $245", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901333/morgan-stanley-maintains-overweight-on-snowflake-lowers-price-target-to-245", "tags": ["analyst_other", "price_target_down"]}
{"id": 50901398, "time": "2026-02-26 13:07:02", "headline": "Scotiabank Maintains Sector Perform on Trade Desk, Lowers Price Target to $32", "summary": "", "symbols": ["TTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901398/scotiabank-maintains-sector-perform-on-trade-desk-lowers-price-target-to-32", "tags": ["analyst_other", "price_target_down"]}
{"id": 50901401, "time": "2026-02-26 13:07:04", "headline": "Mizuho Maintains Outperform on Salesforce, Lowers Price Target to $265", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901401/mizuho-maintains-outperform-on-salesforce-lowers-price-target-to-265", "tags": ["analyst_other", "price_target_down"]}
{"id": 50901430, "time": "2026-02-26 13:07:25", "headline": "Apple Says iPhone And iPad Approved To Handle Classified NATO Information; iPhone And iPad Running iOS 26 And iPadOS 26 Are Certified For Classified Information Use In All NATO Nations", "summary": "", "symbols": ["AAPL", "SPY", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/26/02/50901430/apple-says-iphone-and-ipad-approved-to-handle-classified-nato-information-iphone-", "tags": []}
{"id": 50901481, "time": "2026-02-26 13:08:41", "headline": "UBS Maintains Buy on Acadia Healthcare Co, Raises Price Target to $27", "summary": "", "symbols": ["ACHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901481/ubs-maintains-buy-on-acadia-healthcare-co-raises-price-target-to-27", "tags": ["analyst_other", "price_target_up"]}
{"id": 50901500, "time": "2026-02-26 13:09:07", "headline": "Google Introduces New AI-Powered Features In Google Translate; AI-Powered Updates In Google Translate Available In U.S. And India On Translate App, Coming Soon To Web", "summary": "", "symbols": ["GOOG", "GOOGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901500/google-introduces-new-ai-powered-features-in-google-translate-ai-powered-updates-in-google-translate", "tags": []}
{"id": 50901530, "time": "2026-02-26 13:09:56", "headline": "UBS Maintains Buy on APi Group, Raises Price Target to $54", "summary": "", "symbols": ["APG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901530/ubs-maintains-buy-on-api-group-raises-price-target-to-54", "tags": ["analyst_other", "price_target_up"]}
{"id": 50901575, "time": "2026-02-26 13:11:18", "headline": "TD Cowen Maintains Hold on Lowe's Companies, Lowers Price Target to $280", "summary": "", "symbols": ["LOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901575/td-cowen-maintains-hold-on-lowes-companies-lowers-price-target-to-280", "tags": ["analyst_other", "price_target_down"]}
{"id": 50901605, "time": "2026-02-26 13:12:09", "headline": "What's Going On With Brand Engagement Network Stock Thursday?", "summary": "BNAI shares dipped Thursday following a massive rally. Explore what to expect from the March 30 earnings report.", "symbols": ["BNAI"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50901605/whats-going-on-with-brand-engagement-network-stock-thursday", "tags": ["earnings", "why_moving"]}
{"id": 50901637, "time": "2026-02-26 13:12:53", "headline": "TD Cowen Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $117", "summary": "", "symbols": ["MIRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901637/td-cowen-maintains-buy-on-mirum-pharmaceuticals-raises-price-target-to-117", "tags": ["analyst_other", "price_target_up"]}
{"id": 50901647, "time": "2026-02-26 13:13:00", "headline": "EBay Stock Is Trending Today: What's Going On?", "summary": "EBay Inc (NASDAQ:EBAY) shares are trading higher on Thursday even as the company announced it will cut about 800 jobs, roughly 6% of its full\u2011time workforce, as part of an effort to realign staffing with its strategic priorities. Here&#39;s what you may want to know.", "symbols": ["EBAY"], "source": "benzinga", "author": "Evette Mitkov", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50901647/ebay-stock-is-trending-today-whats-going-on", "tags": ["why_moving"]}
{"id": 50901649, "time": "2026-02-26 13:13:02", "headline": "International Bancshares Q4 EPS $1.72 Beats $1.63 Estimate", "summary": "", "symbols": ["IBOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50901649/international-bancshares-q4-eps-1-72-beats-1-63-estimate", "tags": ["earnings"]}
{"id": 50901726, "time": "2026-02-26 13:14:46", "headline": "Sable Offshore Shares Resume Trade", "summary": "", "symbols": ["SOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/26/02/50901726/sable-offshore-shares-resume-trade", "tags": []}
{"id": 50901743, "time": "2026-02-26 13:15:05", "headline": "TD Cowen Maintains Buy on Outfront Media, Raises Price Target to $32", "summary": "", "symbols": ["OUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901743/td-cowen-maintains-buy-on-outfront-media-raises-price-target-to-32", "tags": ["analyst_other", "price_target_up"]}
{"id": 50901749, "time": "2026-02-26 13:15:08", "headline": "Hormel Mixed Q1: Retail Weakness Weigh On Strong Foodservice, International Sales", "summary": "Hormel Foods stock falls after reporting Q1 FY26 adjusted EPS beat, but sales missed estimates. Retail weakness offsets strong international and foodservice performance.", "symbols": ["HRL"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/markets/earnings/26/02/50901749/hormel-mixed-q1-retail-weakness-weigh-on-strong-foodservice-international-sales", "tags": ["earnings"]}
{"id": 50901782, "time": "2026-02-26 13:15:31", "headline": "What's Going On With Celsius Stock Today?", "summary": "Celsius jumped early Thursday after a Q4 earnings-and-revenue beat, upbeat market-share commentary and a bullish Goldman Sachs reiteration outweighed margin and distribution-transition costs.", "symbols": ["CELH"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/markets/earnings/26/02/50901782/whats-going-on-with-celsius-stock-today", "tags": ["earnings", "why_moving"]}
{"id": 50901819, "time": "2026-02-26 13:17:11", "headline": "TD Cowen Maintains Hold on Paramount Skydance, Lowers Price Target to $13", "summary": "", "symbols": ["PSKY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901819/td-cowen-maintains-hold-on-paramount-skydance-lowers-price-target-to-13", "tags": ["analyst_other", "price_target_down"]}
{"id": 50901864, "time": "2026-02-26 13:18:30", "headline": "What's Going On With Carvana Stock Thursday?", "summary": "Carvana shares are up on Thursday as investors continue to digest the company&#39;s recent earnings report.", "symbols": ["CVNA"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50901864/whats-going-on-with-carvana-stock-thursday-2", "tags": ["earnings", "why_moving"]}
{"id": 50901868, "time": "2026-02-26 13:18:36", "headline": "TD Cowen Maintains Hold on Pinnacle West Capital, Raises Price Target to $100", "summary": "", "symbols": ["PNW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901868/td-cowen-maintains-hold-on-pinnacle-west-capital-raises-price-target-to-100", "tags": ["analyst_other", "price_target_up"]}
{"id": 50901911, "time": "2026-02-26 13:19:42", "headline": "UBS Maintains Neutral on Bank of Montreal, Raises Price Target to C$214", "summary": "", "symbols": ["TSX:BMO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901911/ubs-maintains-neutral-on-bank-of-montreal-raises-price-target-to-c-214", "tags": ["analyst_other", "price_target_up"]}
{"id": 50901893, "time": "2026-02-26 13:19:04", "headline": "Watching Sable Offshore; Shares Spike Lower, Company Currently Awaits The U.S. Department of Transportation's Pipeline and Hazardous Materials Safety Administration Grant Of A Special Permit To Restart Two Segments Of The Santa Ynez pipeline System", "summary": "", "symbols": ["SOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901893/watching-sable-offshore-shares-spike-lower-company-currently-awaits-the-u-s-department-of-transporta", "tags": []}
{"id": 50901943, "time": "2026-02-26 13:20:12", "headline": "TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $34", "summary": "", "symbols": ["PRCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901943/td-cowen-maintains-buy-on-procept-biorobotics-lowers-price-target-to-34", "tags": ["analyst_other", "price_target_down"]}
{"id": 50901968, "time": "2026-02-26 13:21:24", "headline": "'Pentagon's First Kamikaze Drone Unit Ready for Any Iran Strikes' - Bloomberg", "summary": "", "symbols": ["SPY", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901968/pentagons-first-kamikaze-drone-unit-ready-for-any-iran-strikes-bloomberg", "tags": []}
{"id": 50901970, "time": "2026-02-26 13:21:26", "headline": "TD Cowen Maintains Buy on Protagonist Therapeutics, Raises Price Target to $100", "summary": "", "symbols": ["PTGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50901970/td-cowen-maintains-buy-on-protagonist-therapeutics-raises-price-target-to-100", "tags": ["analyst_other", "price_target_up"]}
{"id": 50902008, "time": "2026-02-26 13:22:18", "headline": "UBS Maintains Neutral on Chime Financial, Raises Price Target to $27", "summary": "", "symbols": ["CHYM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50902008/ubs-maintains-neutral-on-chime-financial-raises-price-target-to-27", "tags": ["analyst_other", "price_target_up"]}
{"id": 50902015, "time": "2026-02-26 13:22:24", "headline": "California Gov. Gavin Newsom Pressed On Families Fleeing Over 'Highest Cost Of Living' As He Defends State As 'Fourth-Largest Economy In The World'", "summary": " ", "symbols": [], "source": "benzinga", "author": "Casey B. Renner", "url": "https://www.benzinga.com/personal-finance/management/26/02/50902015/california-gov-gavin-newsom-pressed-on-families-fleeing-over-highest-cost-of-living-as-he-defends-state-as-fourth-largest-economy-in-the-world", "tags": []}
{"id": 50902023, "time": "2026-02-26 13:22:34", "headline": "Sable Offshore Shares Halted On Circuit Breaker To The Upside, Stock Now Down -12.71%", "summary": "", "symbols": ["SOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/26/02/50902023/sable-offshore-shares-halted-on-circuit-breaker-to-the-upside-stock-now-down-12-71", "tags": ["halt"]}
{"id": 50902024, "time": "2026-02-26 13:22:39", "headline": "Velo3D Shares Are Up Thursday \u2014 What's Going On?", "summary": "Velo3D Inc. (VELO) shares were up on Thursday, continuing a rally rooted in defense sector momentum.", "symbols": ["VELO"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50902024/velo3d-shares-are-up-thursday-whats-going-on", "tags": ["why_moving"]}
{"id": 50902068, "time": "2026-02-26 13:23:15", "headline": "Antelope Enterprise Shares Halted On Circuit Breaker To The Upside, Stock Now Up 218.57%", "summary": "", "symbols": ["AEHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/26/02/50902068/antelope-enterprise-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-218-57", "tags": ["halt"]}
{"id": 50902092, "time": "2026-02-26 13:23:43", "headline": "TD Cowen Maintains Hold on RenaissanceRe Holdings, Raises Price Target to $290", "summary": "", "symbols": ["RNR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50902092/td-cowen-maintains-hold-on-renaissancere-holdings-raises-price-target-to-290", "tags": ["analyst_other", "price_target_up"]}
{"id": 50902102, "time": "2026-02-26 13:23:50", "headline": "UBS Maintains Buy on LifeStance Health Gr, Raises Price Target to $12", "summary": "", "symbols": ["LFST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50902102/ubs-maintains-buy-on-lifestance-health-gr-raises-price-target-to-12", "tags": ["analyst_other", "price_target_up"]}
{"id": 50902179, "time": "2026-02-26 13:26:28", "headline": "TD Cowen Maintains Buy on Salesforce, Lowers Price Target to $250", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50902179/td-cowen-maintains-buy-on-salesforce-lowers-price-target-to-250", "tags": ["analyst_other", "price_target_down"]}
{"id": 50902129, "time": "2026-02-26 13:24:28", "headline": "Chewy Taps Amazon Veteran Chris Deppe As CFO", "summary": "Chewy (NYSE:CHWY) shares rise despite a sector downturn following the appointment of former Amazon exec Chris Deppe as CFO.", "symbols": ["AMZN", "CHWY", "GM", "NKE", "SBUX"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50902129/chewy-taps-amazon-veteran-chris-deppe-as-cfo", "tags": ["management"]}
{"id": 50902190, "time": "2026-02-26 13:26:44", "headline": "J M Smucker, Krispy Kreme, Shake Shack, Accenture And Other Big Stocks Moving Higher On Thursday", "summary": " ", "symbols": ["ACN", "BFLY", "CHYM", "DNUT", "EFXT", "FTDR", "GCT", "IBTA", "IONQ", "LMAT", "PRMB", "RXT", "SHAK", "SJM", "VAC", "WRBY"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50902190/j-m-smucker-krispy-kreme-shake-shack-accenture-and-other-big-stocks-moving-higher-on-thursday", "tags": ["why_moving"]}
{"id": 50902197, "time": "2026-02-26 13:26:58", "headline": "Why Retail Traders Are Ditching Crypto For Equities In 2026", "summary": "Bitcoin (CRYPTO: BTC) and the broader $2.3 trillion digital asset market are bleeding retail capital as traders aggressively pivot into equities, driven by plunging cr", "symbols": ["BTCUSD", "SPY"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/crypto/cryptocurrency/26/02/50902197/why-retail-traders-are-ditching-crypto-for-equities-in-2026", "tags": []}
{"id": 50902286, "time": "2026-02-26 13:28:22", "headline": "Tesla Sales In Freefall\u2014Here's What Prediction Markets Say About The Company's Robotaxi Lifeline", "summary": " ", "symbols": ["BYDDY", "GOOGL", "TSLA"], "source": "benzinga", "author": "Daragh Thomas", "url": "https://www.benzinga.com/m-a/26/02/50902286/tesla-sales-in-freefall-heres-what-prediction-markets-say-about-the-companys-robotaxi-lifeline", "tags": []}
{"id": 50902297, "time": "2026-02-26 13:28:34", "headline": "Sable Offshore Shares Resume Trading", "summary": "", "symbols": ["SOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/26/02/50902297/sable-offshore-shares-resume-trading", "tags": []}
{"id": 50902320, "time": "2026-02-26 13:28:51", "headline": "Lanvin Shares Recover Nicely From Initial Sell-Off After Caruso Sale", "summary": " ", "symbols": ["LANV", "LVMHF", "LVMUY", "PPRUF", "PPRUY"], "source": "benzinga", "author": "Bamboo Works", "url": "https://www.benzinga.com/Opinion/26/02/50902320/lanvin-shares-recover-nicely-from-initial-sell-off-after-caruso-sale", "tags": []}
{"id": 50902523, "time": "2026-02-26 13:32:14", "headline": "UBS Maintains Buy on Medline, Raises Price Target to $57", "summary": "", "symbols": ["MDLN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50902523/ubs-maintains-buy-on-medline-raises-price-target-to-57", "tags": ["analyst_other", "price_target_up"]}
{"id": 50902555, "time": "2026-02-26 13:32:45", "headline": "TD Cowen Maintains Buy on Soleno Therapeutics, Lowers Price Target to $85", "summary": "", "symbols": ["SLNO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50902555/td-cowen-maintains-buy-on-soleno-therapeutics-lowers-price-target-to-85", "tags": ["analyst_other", "price_target_down"]}
{"id": 50902591, "time": "2026-02-26 13:34:05", "headline": "TD Cowen Maintains Hold on Teladoc Health, Lowers Price Target to $6", "summary": "", "symbols": ["TDOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50902591/td-cowen-maintains-hold-on-teladoc-health-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 50902618, "time": "2026-02-26 13:34:30", "headline": "Crude Oil Gains Over 1%; Hormel Foods Posts Upbeat Earnings", "summary": " ", "symbols": ["ALBT", "ARRY", "BFLY", "ELPW", "EOSE", "HRL", "IBTA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/markets/market-summary/26/02/50902618/crude-oil-gains-over-1-hormel-foods-posts-upbeat-earnings", "tags": ["earnings"]}
{"id": 50902677, "time": "2026-02-26 13:35:37", "headline": "UBS Maintains Buy on Nutanix, Raises Price Target to $60", "summary": "", "symbols": ["NTNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50902677/ubs-maintains-buy-on-nutanix-raises-price-target-to-60", "tags": ["analyst_other", "price_target_up"]}
{"id": 50902699, "time": "2026-02-26 13:35:58", "headline": "Antelope Enterprise Shares Resume Trading", "summary": "", "symbols": ["AEHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50902699/antelope-enterprise-shares-resume-trading", "tags": []}
{"id": 50902700, "time": "2026-02-26 13:35:58", "headline": "TD Cowen Maintains Buy on Trip.com Group, Lowers Price Target to $68", "summary": "", "symbols": ["TCOM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50902700/td-cowen-maintains-buy-on-trip-com-group-lowers-price-target-to-68", "tags": ["analyst_other", "price_target_down"]}
{"id": 50902751, "time": "2026-02-26 13:37:29", "headline": "This US Bancorp Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday", "summary": " ", "symbols": ["ALC", "CEVA", "JOBY", "MRK", "NDAQ", "PFE", "USB"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/upgrades/26/02/50902751/this-us-bancorp-analyst-turns-bullish-here-are-top-4-upgrades-for-thursday", "tags": ["analyst_up"]}
{"id": 50902752, "time": "2026-02-26 13:37:29", "headline": "This US Bancorp Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday", "summary": " ", "symbols": ["ALC", "CEVA", "JOBY", "MRK", "NDAQ", "PFE", "USB"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/upgrades/26/02/50902752/this-us-bancorp-analyst-turns-bullish-here-are-top-4-upgrades-for-thursday", "tags": ["analyst_up"]}
{"id": 50902779, "time": "2026-02-26 13:38:11", "headline": "TD Cowen Maintains Buy on United Therapeutics, Raises Price Target to $575", "summary": "", "symbols": ["UTHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50902779/td-cowen-maintains-buy-on-united-therapeutics-raises-price-target-to-575", "tags": ["analyst_other", "price_target_up"]}
{"id": 50902928, "time": "2026-02-26 13:40:49", "headline": "EXCLUSIVE: Pokemon YouTuber Leonhart Opening Every Pack Ever Made To Celebrate 30th Anniversary \u2013 'I Have To Go Massive'", "summary": "Pokemon celebrates its 30th anniversary on Friday, Feb. 27. Popular YouTuber shares with Benzinga how he&#39;s celebrating and how the brand stays so popular.", "symbols": ["NTDOY"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/news/gaming/26/02/50902928/exclusive-pokemon-youtuber-leonhart-opening-every-pack-ever-made-to-celebrate-30th-anniversary-i-have-to-go-massive", "tags": []}
{"id": 50902938, "time": "2026-02-26 13:40:53", "headline": "Why This Analyst Expects Lowe's To Outperform The Industry", "summary": "Lowe&#39;s posts better-than-expected earnings. 2026 guidance falls short of expectations. Analyst raised price target.", "symbols": ["HD", "LOW"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/26/02/50902938/why-this-analyst-expects-lowes-to-outperform-the-industry", "tags": ["earnings", "guidance"]}
{"id": 50902979, "time": "2026-02-26 13:41:08", "headline": "BTIG Maintains Buy on Kymera Therapeutics, Lowers Price Target to $134", "summary": "", "symbols": ["KYMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50902979/btig-maintains-buy-on-kymera-therapeutics-lowers-price-target-to-134", "tags": ["analyst_other", "price_target_down"]}
{"id": 50903022, "time": "2026-02-26 13:41:40", "headline": "Hecla Mining Option Alert: Jun 18 $26 Calls Sweep (4) near the Ask: 1000 @ $3.8 vs 1490 OI; Ref=$24.105", "summary": "", "symbols": ["HL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903022/hecla-mining-option-alert-jun-18-26-calls-sweep-4-near-the-ask-1000-3-8-vs-1490-oi-ref-24-105", "tags": []}
{"id": 50903085, "time": "2026-02-26 13:43:12", "headline": "BTIG Maintains Buy on Enovis, Raises Price Target to $43", "summary": "", "symbols": ["ENOV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903085/btig-maintains-buy-on-enovis-raises-price-target-to-43", "tags": ["analyst_other", "price_target_up"]}
{"id": 50903105, "time": "2026-02-26 13:43:54", "headline": "These Analysts Slash Their Forecasts On Teladoc Health After Q4 Results", "summary": " ", "symbols": ["TDOC"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50903105/these-analysts-slash-their-forecasts-on-teladoc-health-after-q4-results", "tags": ["earnings"]}
{"id": 50903126, "time": "2026-02-26 13:44:24", "headline": "UBS Maintains Buy on Owens-Corning, Raises Price Target to $172", "summary": "", "symbols": ["OC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903126/ubs-maintains-buy-on-owens-corning-raises-price-target-to-172", "tags": ["analyst_other", "price_target_up"]}
{"id": 50903147, "time": "2026-02-26 13:45:07", "headline": "IonQ Crushes Q4 Estimates\u2014 Rigetti, Quantum Computing On Deck", "summary": "Quantum stocks are moving after IonQ crushed Q4 estimates. Rigetti and Quantum Computing report next week.", "symbols": ["IONQ", "QBTS", "QUBT", "RGTI"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/markets/earnings/26/02/50903147/ionq-crushes-q4-estimates-rigetti-quantum-computing-on-deck", "tags": []}
{"id": 50903156, "time": "2026-02-26 13:45:28", "headline": "HC Wainwright & Co. Maintains Buy on United Therapeutics, Raises Price Target to $600", "summary": "", "symbols": ["UTHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903156/hc-wainwright-co-maintains-buy-on-united-therapeutics-raises-price-target-to-600", "tags": ["analyst_other", "price_target_up"]}
{"id": 50903172, "time": "2026-02-26 13:45:46", "headline": "Why Is CRISPR Therapeutics Stock Surging Thursday?", "summary": "CRSP shares jump on earnings report, strong pipeline for gene therapy. Revenue grows with increased patient treatment and analyst confidence.", "symbols": ["ARWR", "CRSP", "LLY", "REGN"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50903172/why-is-crispr-therapeutics-stock-surging-thursday", "tags": ["earnings", "why_moving"]}
{"id": 50903197, "time": "2026-02-26 13:46:25", "headline": "VivaVision Eyes Hong Kong Listing Before Cash Coffers Dry Up", "summary": " ", "symbols": ["ABT", "AMGN"], "source": "benzinga", "author": "Bamboo Works", "url": "https://www.benzinga.com/Opinion/26/02/50903197/vivavision-eyes-hong-kong-listing-before-cash-coffers-dry-up", "tags": []}
{"id": 50903249, "time": "2026-02-26 13:48:40", "headline": "HC Wainwright & Co. Maintains Buy on NovoCure, Raises Price Target to $49", "summary": "", "symbols": ["NVCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903249/hc-wainwright-co-maintains-buy-on-novocure-raises-price-target-to-49", "tags": ["analyst_other", "price_target_up"]}
{"id": 50903265, "time": "2026-02-26 13:49:05", "headline": "Medline Analysts Boost Their Forecasts Following Q4 Results", "summary": " ", "symbols": ["MDLN"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50903265/medline-analysts-boost-their-forecasts-following-q4-results", "tags": ["earnings"]}
{"id": 50903306, "time": "2026-02-26 13:50:16", "headline": "UBS Maintains Sell on Everpure, Raises Price Target to $63", "summary": "", "symbols": ["PSTG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903306/ubs-maintains-sell-on-everpure-raises-price-target-to-63", "tags": ["analyst_other", "price_target_up"]}
{"id": 50903323, "time": "2026-02-26 13:50:32", "headline": "Eaton Raises Quarterly Dividend From $1.04 to $1.10/Share", "summary": "", "symbols": ["ETN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903323/eaton-raises-quarterly-dividend-from-1-04-to-1-10share", "tags": ["dividend"]}
{"id": 50903351, "time": "2026-02-26 13:51:19", "headline": "Antelope Enterprise (AEHL) Shares Soar On Bitcoin 'Genius Plan'", "summary": "Antelope Enterprise Holdings Ltd (NASDAQ:AEHL) shares are trading sharply higher Thursday after the company outlined a new structured Bitcoin ", "symbols": ["AEHL", "BTCUSD"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50903351/antelope-enterprise-aehl-shares-soar-on-bitcoin-genius-plan", "tags": []}
{"id": 50903381, "time": "2026-02-26 13:51:54", "headline": "BTIG Maintains Buy on Delcath Systems, Lowers Price Target to $19", "summary": "", "symbols": ["DCTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903381/btig-maintains-buy-on-delcath-systems-lowers-price-target-to-19", "tags": ["analyst_other", "price_target_down"]}
{"id": 50903436, "time": "2026-02-26 13:53:22", "headline": "UBS Maintains Neutral on RxSight, Raises Price Target to $9", "summary": "", "symbols": ["RXST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903436/ubs-maintains-neutral-on-rxsight-raises-price-target-to-9", "tags": ["analyst_other", "price_target_up"]}
{"id": 50903466, "time": "2026-02-26 13:54:07", "headline": "BTIG Maintains Buy on International Seaways, Raises Price Target to $80", "summary": "", "symbols": ["INSW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903466/btig-maintains-buy-on-international-seaways-raises-price-target-to-80", "tags": ["analyst_other", "price_target_up"]}
{"id": 50903486, "time": "2026-02-26 13:54:27", "headline": "These Analysts Increase Their Forecasts On United Therapeutics After Upbeat Q4 Earnings", "summary": " ", "symbols": ["UTHR"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50903486/these-analysts-increase-their-forecasts-on-united-therapeutics-after-upbeat-q4-earnings", "tags": ["earnings"]}
{"id": 50903518, "time": "2026-02-26 13:55:17", "headline": "UBS Maintains Neutral on StandardAero, Raises Price Target to $35", "summary": "", "symbols": ["SARO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903518/ubs-maintains-neutral-on-standardaero-raises-price-target-to-35", "tags": ["analyst_other", "price_target_up"]}
{"id": 50903600, "time": "2026-02-26 13:57:20", "headline": "UBS Maintains Buy on TKO Group Holdings, Raises Price Target to $238", "summary": "", "symbols": ["TKO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903600/ubs-maintains-buy-on-tko-group-holdings-raises-price-target-to-238", "tags": ["analyst_other", "price_target_up"]}
{"id": 50903616, "time": "2026-02-26 13:57:40", "headline": "Salesforce: Agentforce To Drive Positive Estimate Revisions, Says Bullish Analyst", "summary": "Agentforce shows strong growth in Q4 and its ARR reaches $800 million.", "symbols": ["CRM"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/26/02/50903616/salesforce-agentforce-to-drive-positive-estimate-revisions-says-bullish-analyst", "tags": []}
{"id": 50903631, "time": "2026-02-26 13:58:08", "headline": "15th Five-Year Plan: Inside China's push To Become A Financial Powerhouse", "summary": " ", "symbols": [], "source": "benzinga", "author": "Bamboo Works", "url": "https://www.benzinga.com/Opinion/26/02/50903631/15th-five-year-plan-inside-chinas-push-to-become-a-financial-powerhouse", "tags": []}
{"id": 50903634, "time": "2026-02-26 13:58:14", "headline": "Salesforce Stock Climbs Thursday: What's Going On?", "summary": "Salesforce Inc (NYSE:CRM) shares are climbing on Thursday after the company delivered a stronger\u2011than\u2011expected fourth quarter.", "symbols": ["CRM"], "source": "benzinga", "author": "Evette Mitkov", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50903634/salesforce-stock-climbs-thursday-whats-going-on", "tags": ["why_moving"]}
{"id": 50903649, "time": "2026-02-26 13:58:36", "headline": "Pete Hegseth To Visit General Dynamics, L3 Harris On Friday", "summary": "", "symbols": ["GD", "LHX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903649/pete-hegseth-to-visit-general-dynamics-l3-harris-on-friday", "tags": []}
{"id": 50903701, "time": "2026-02-26 13:59:18", "headline": "UBS Maintains Neutral on Tronox Holdings, Raises Price Target to $7.5", "summary": "", "symbols": ["TROX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903701/ubs-maintains-neutral-on-tronox-holdings-raises-price-target-to-7-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 50903749, "time": "2026-02-26 13:59:32", "headline": "Needham Maintains Buy on Payoneer Global, Lowers Price Target to $8", "summary": "", "symbols": ["PAYO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903749/needham-maintains-buy-on-payoneer-global-lowers-price-target-to-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 50903780, "time": "2026-02-26 14:00:09", "headline": "Trump\u2013Backed American Bitcoin Celebrates 'Amazing Story' After Q4 Earnings", "summary": "American Bitcoin (NASDAQ:ABTC) reported strong Q4 and full-year 2025 results, highlighting rapid operational expansion and aggressive accumulation of Bitcoin", "symbols": ["ABTC", "BTCUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/crypto/cryptocurrency/26/02/50903780/trump-backed-american-bitcoin-celebrates-amazing-story-after-q4-earnings", "tags": ["earnings"]}
{"id": 50903784, "time": "2026-02-26 14:00:13", "headline": "'US, Iran to Hold Talks at Technical Level Next Week, Oman Says' - Bloomberg", "summary": "", "symbols": ["SPY", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903784/us-iran-to-hold-talks-at-technical-level-next-week-oman-says-bloomberg", "tags": []}
{"id": 50903800, "time": "2026-02-26 14:00:24", "headline": "How Is The Market Feeling About Toyota Motor Corp?", "summary": " ", "symbols": ["TM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50903800/how-is-the-market-feeling-about-toyota-motor-corp", "tags": []}
{"id": 50903805, "time": "2026-02-26 14:00:25", "headline": "P/E Ratio Insights for NextEra Energy", "summary": " ", "symbols": ["NEE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50903805/pe-ratio-insights-for-nextera-energy", "tags": []}
{"id": 50903811, "time": "2026-02-26 14:00:30", "headline": "Is the Market Bullish or Bearish on Telefonica Brasil SA?", "summary": " ", "symbols": ["VIV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50903811/is-the-market-bullish-or-bearish-on-telefonica-brasil-sa", "tags": []}
{"id": 50903815, "time": "2026-02-26 14:00:34", "headline": "Breaking Down Range Resources: 9 Analysts Share Their Views", "summary": " ", "symbols": ["RRC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50903815/breaking-down-range-resources-9-analysts-share-their-views", "tags": []}
{"id": 50903819, "time": "2026-02-26 14:00:36", "headline": "What Does the Market Think About Republic Services Inc?", "summary": " ", "symbols": ["RSG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50903819/what-does-the-market-think-about-republic-services-inc", "tags": []}
{"id": 50903830, "time": "2026-02-26 14:00:44", "headline": "Forecasting The Future: 13 Analyst Projections For Nasdaq", "summary": " ", "symbols": ["NDAQ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50903830/forecasting-the-future-13-analyst-projections-for-nasdaq", "tags": []}
{"id": 50903845, "time": "2026-02-26 14:00:56", "headline": "UBS Maintains Buy on Agilent Technologies, Lowers Price Target to $165", "summary": "", "symbols": ["A"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903845/ubs-maintains-buy-on-agilent-technologies-lowers-price-target-to-165", "tags": ["analyst_other", "price_target_down"]}
{"id": 50903849, "time": "2026-02-26 14:00:59", "headline": "Where Alkami Technology Stands With Analysts", "summary": " ", "symbols": ["ALKT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50903849/where-alkami-technology-stands-with-analysts", "tags": []}
{"id": 50903850, "time": "2026-02-26 14:01:02", "headline": "Coinbase Global Unusual Options Activity For February 26", "summary": " ", "symbols": ["COIN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/26/02/50903850/coinbase-global-unusual-options-activity-for-february-26", "tags": []}
{"id": 50903854, "time": "2026-02-26 14:01:11", "headline": "A Glimpse Into The Expert Outlook On Realty Income Through 7 Analysts", "summary": " ", "symbols": ["O"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50903854/a-glimpse-into-the-expert-outlook-on-realty-income-through-7-analysts", "tags": ["guidance"]}
{"id": 50903862, "time": "2026-02-26 14:01:20", "headline": "CSX Raises Quarterly Dividend From $0.13 To $0.14/Share", "summary": "", "symbols": ["CSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903862/csx-raises-quarterly-dividend-from-0-13-to-0-14share", "tags": ["dividend"]}
{"id": 50903864, "time": "2026-02-26 14:01:20", "headline": "4 Analysts Have This To Say About Alkermes", "summary": " ", "symbols": ["ALKS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50903864/4-analysts-have-this-to-say-about-alkermes", "tags": []}
{"id": 50903871, "time": "2026-02-26 14:01:27", "headline": "Demystifying Teladoc Health: Insights From 8 Analyst Reviews", "summary": " ", "symbols": ["TDOC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50903871/demystifying-teladoc-health-insights-from-8-analyst-reviews", "tags": []}
{"id": 50903872, "time": "2026-02-26 14:01:28", "headline": "Needham Maintains Buy on Collegium Pharmaceutical, Lowers Price Target to $54", "summary": "", "symbols": ["COLL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903872/needham-maintains-buy-on-collegium-pharmaceutical-lowers-price-target-to-54", "tags": ["analyst_other", "price_target_down"]}
{"id": 50903969, "time": "2026-02-26 14:03:20", "headline": "Needham Maintains Buy on D-Wave Quantum, Lowers Price Target to $40", "summary": "", "symbols": ["QBTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903969/needham-maintains-buy-on-d-wave-quantum-lowers-price-target-to-40", "tags": ["analyst_other", "price_target_down"]}
{"id": 50903983, "time": "2026-02-26 14:03:26", "headline": "Beast Industries CEO: BitMine Is 'Leader In Ethereum Staking Market'", "summary": "Beast Industries CEO Jeff Housenbold on Thursdaycalled BitMine (NYSE:BMNR) \u201ca leader in the Ethereum ", "symbols": ["BMNR", "ETHUSD"], "source": "benzinga", "author": "Parshwa Turakhiya", "url": "https://www.benzinga.com/crypto/cryptocurrency/26/02/50903983/beast-industries-ceo-bitmine-is-leader-in-ethereum-staking-market", "tags": ["management"]}
{"id": 50903984, "time": "2026-02-26 14:03:29", "headline": "New Era Energy & Digital Strikes Letter Of Intent To Acquire ~54 Acres Of Land Adjacent To Its Texas Data Centers Campus; Terms Undisclosed", "summary": "", "symbols": ["NUAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50903984/new-era-energy-digital-strikes-letter-of-intent-to-acquire-54-acres-of-land-adjacent-to-its-texas-da", "tags": ["merger"]}
{"id": 50904063, "time": "2026-02-26 14:04:33", "headline": "Zoom Boasts Strong Q4, Scores Big 'Displacement Wins': Analyst", "summary": "Zoom (ZM) reported strong Q4 and FY results with revenue growth and enterprise wins. Analyst maintains Buy rating and $115 PT.", "symbols": ["ZM"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/26/02/50904063/zoom-communications-displacement-wins-says-bullish-analyst", "tags": ["analyst_other", "earnings"]}
{"id": 50904081, "time": "2026-02-26 14:04:49", "headline": "Belfry Announces Partnership With WTW Subsidiary Willis On Providing Insurance Portal Access", "summary": "", "symbols": ["WTW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50904081/belfry-announces-partnership-with-wtw-subsidiary-willis-on-providing-insurance-portal-access", "tags": ["contract"]}
{"id": 50904130, "time": "2026-02-26 14:06:02", "headline": "Needham Maintains Buy on NCR Voyix, Lowers Price Target to $12", "summary": "", "symbols": ["VYX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50904130/needham-maintains-buy-on-ncr-voyix-lowers-price-target-to-12", "tags": ["analyst_other", "price_target_down"]}
{"id": 50904149, "time": "2026-02-26 14:06:18", "headline": "UBS Maintains Neutral on C3.ai, Lowers Price Target to $9", "summary": "", "symbols": ["AI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50904149/ubs-maintains-neutral-on-c3-ai-lowers-price-target-to-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 50904201, "time": "2026-02-26 14:08:01", "headline": "UBS Maintains Neutral on Brown-Forman, Lowers Price Target to $30", "summary": "", "symbols": ["BF", "BF/B"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50904201/ubs-maintains-neutral-on-brown-forman-lowers-price-target-to-30", "tags": ["analyst_other", "price_target_down"]}
{"id": 50904247, "time": "2026-02-26 14:09:55", "headline": "UBS Maintains Neutral on Dine Brands Global, Lowers Price Target to $33", "summary": "", "symbols": ["DIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50904247/ubs-maintains-neutral-on-dine-brands-global-lowers-price-target-to-33", "tags": ["analyst_other", "price_target_down"]}
{"id": 50904328, "time": "2026-02-26 14:12:41", "headline": "UBS Maintains Buy on Evolent Health, Lowers Price Target to $5", "summary": "", "symbols": ["EVH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50904328/ubs-maintains-buy-on-evolent-health-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 50904546, "time": "2026-02-26 14:19:37", "headline": "COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb", "summary": "Novavax shares jump 21% after posting a surprise profit and 67% revenue growth, while outlining lower 2026 revenue guidance.", "symbols": ["NVAX"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/markets/earnings/26/02/50904546/covid-19-vaccine-maker-novavax-swings-to-profit-as-sales-climb", "tags": ["earnings", "guidance"]}
{"id": 50904621, "time": "2026-02-26 14:21:05", "headline": "UBS Maintains Buy on Lowe's Companies, Lowers Price Target to $315", "summary": "", "symbols": ["LOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50904621/ubs-maintains-buy-on-lowes-companies-lowers-price-target-to-315", "tags": ["analyst_other", "price_target_down"]}
{"id": 50904633, "time": "2026-02-26 14:21:23", "headline": "Stock Of The Day: False Breakout In Nvidia?", "summary": "Nvidia (NVDA) shares may have staged a false breakout. These tend to be bearish dynamics that are followed by moves lower.", "symbols": ["NVDA"], "source": "benzinga", "author": "Mark Putrino", "url": "https://www.benzinga.com/trading-ideas/technicals/26/02/50904633/stock-of-the-day-false-breakout-in-nvidia", "tags": []}
{"id": 50904656, "time": "2026-02-26 14:21:58", "headline": "UBS Maintains Neutral on Boston Beer Co, Lowers Price Target to $230", "summary": "", "symbols": ["SAM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50904656/ubs-maintains-neutral-on-boston-beer-co-lowers-price-target-to-230", "tags": ["analyst_other", "price_target_down"]}
{"id": 50904711, "time": "2026-02-26 14:23:10", "headline": "UBS Maintains Buy on Snowflake, Lowers Price Target to $235", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50904711/ubs-maintains-buy-on-snowflake-lowers-price-target-to-235", "tags": ["analyst_other", "price_target_down"]}
{"id": 50904783, "time": "2026-02-26 14:24:42", "headline": "UBS Maintains Buy on Trade Desk, Lowers Price Target to $44", "summary": "", "symbols": ["TTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50904783/ubs-maintains-buy-on-trade-desk-lowers-price-target-to-44", "tags": ["analyst_other", "price_target_down"]}
{"id": 50904817, "time": "2026-02-26 14:25:43", "headline": "UBS Maintains Neutral on ZipRecruiter, Lowers Price Target to $2.5", "summary": "", "symbols": ["ZIP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50904817/ubs-maintains-neutral-on-ziprecruiter-lowers-price-target-to-2-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 50904840, "time": "2026-02-26 14:26:23", "headline": "Bristol Myers Says New Breast Cancer Drug Shows Survival Benefit In Pretreated Patients", "summary": "Bristol Myers reports that Phase 3 breast cancer trial meets key goals, showing improved survival over chemotherapy options.", "symbols": ["BMY"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/markets/large-cap/26/02/50904840/bristol-myers-says-new-breast-cancer-drug-shows-survival-benefit-in-pretreated-patients", "tags": ["fda"]}
{"id": 50904841, "time": "2026-02-26 14:26:30", "headline": "Bitcoin Wobbles At $67,000, Ethereum, XRP, Dogecoin Drop 2%", "summary": "Bitcoin slipped back below $68,000 on Thursday, reversing its recent two-day uptrend as capital rotated out of altcoins and meme coins in a broader risk-off move.", "symbols": ["BTCUSD", "DOGEUSD", "ETHUSD", "SHIBUSD", "SOLUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/crypto/cryptocurrency/26/02/50904841/bitcoin-wobbles-at-67000-ethereum-xrp-dogecoin-drop-2", "tags": []}
{"id": 50904870, "time": "2026-02-26 14:27:15", "headline": "Ripple Announces $550M Deployed To XRPL\u2014Here's What Changes In 2026", "summary": "Ripple (CRYPTO: XRP) has deployed over $550 million to XRP Ledger ecosystem since 2017 as it shifts to distributed funding with new FinTech Builder Program and regiona", "symbols": ["XRPUSD"], "source": "benzinga", "author": "Parshwa Turakhiya", "url": "https://www.benzinga.com/crypto/cryptocurrency/26/02/50904870/ripple-announces-550m-deployed-to-xrpl-heres-what-changes-in-2026", "tags": []}
{"id": 50904873, "time": "2026-02-26 14:27:21", "headline": "What's Driving The Weakness In Broadcom Stock Thursday?", "summary": "Broadcom Inc (NASDAQ:AVGO) shares are dropping on Thursday as a sector\u2011wide sell\u2011off triggered by Nvidia Corp&#39;s (NASDAQ:NVDA) post\u2011earnings decline weighs on chip stocks.", "symbols": ["AMD", "AVGO", "NVDA", "TSM"], "source": "benzinga", "author": "Evette Mitkov", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50904873/whats-driving-the-weakness-in-broadcom-stock-thursday", "tags": ["earnings"]}
{"id": 50904913, "time": "2026-02-26 14:28:15", "headline": "Boston Scientific Halts Use Of Select Stent Delivery Devices After Patient Deaths", "summary": "Boston Scientific removes certain AXIOS stents after deployment issues linked to 167 injuries and three deaths, FDA says.", "symbols": ["BSX"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/news/fda/26/02/50904913/boston-scientific-halts-use-of-select-stent-delivery-devices-after-patient-deaths", "tags": ["fda"]}
{"id": 50904996, "time": "2026-02-26 14:29:47", "headline": "Watching Shares Of Inspire Medical, Nyxoah; KeyBanc Note Indicates CMS Appears Ready to Add INSP V Specific C-Codes in April 2026 IOCE Update For Inspire, Nyxoah", "summary": "", "symbols": ["INSP", "NYXH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50904996/watching-shares-of-inspire-medical-nyxoah-keybanc-note-indicates-cms-appears-ready-to-add-insp-v-spe", "tags": []}
{"id": 50905007, "time": "2026-02-26 14:29:57", "headline": "Leerink Partners Maintains Market Perform on Acadia Healthcare Co, Raises Price Target to $22", "summary": "", "symbols": ["ACHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905007/leerink-partners-maintains-market-perform-on-acadia-healthcare-co-raises-price-target-to-22", "tags": ["analyst_other", "price_target_up"]}
{"id": 50905025, "time": "2026-02-26 14:30:13", "headline": "Something Unseen Since The Russian Invasion Of Ukraine Is Happening On Wall Street", "summary": "Energy stocks are outperforming technology by the widest margin since 2022 \u2014 but this time there&#39;s no war or oil shock. Here&#39;s how AI and the rise of &#34;HALO&#34; stocks are reshaping market leadership in 2026.", "symbols": ["IGV", "OIH", "RSP", "SPY", "XLE", "XLK"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/etfs/broad-u-s-equity-etfs/26/02/50905025/ai-driven-sector-rotation-wall-street-why-energy-outperforms-tech-2026-goldman-halo-trade", "tags": []}
{"id": 50905154, "time": "2026-02-26 14:33:35", "headline": "Leerink Partners Maintains Outperform on AdaptHealth, Lowers Price Target to $12", "summary": "", "symbols": ["AHCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905154/leerink-partners-maintains-outperform-on-adapthealth-lowers-price-target-to-12", "tags": ["analyst_other", "price_target_down"]}
{"id": 50905209, "time": "2026-02-26 14:34:35", "headline": "Howard Marks: AI Is Multi-Trillion Dollar 'Labor Replacement,' But Prediction Markets Disagree", "summary": "AI has moved from helping to replacing workers, leading to a potential multi-trillion dollar market. Recent examples show AI&#39;s increasing autonomy, but prediction markets suggest a 10% unemployment rate and industry downturn are unlikely.", "symbols": ["AMZN", "CRM", "CRWD", "DDOG", "GOOGL", "MSFT", "NVDA"], "source": "benzinga", "author": "Daragh Thomas", "url": "https://www.benzinga.com/markets/prediction-markets/26/02/50905209/howard-marks-ai-is-multi-trillion-dollar-labor-replacement-but-prediction-markets-disagree", "tags": []}
{"id": 50905227, "time": "2026-02-26 14:35:02", "headline": "Inspire Medical Systems Trading Halted", "summary": "", "symbols": ["INSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905227/inspire-medical-systems-trading-halted", "tags": ["halt"]}
{"id": 50905280, "time": "2026-02-26 14:37:12", "headline": "Leerink Partners Maintains Outperform on Cytokinetics, Raises Price Target to $84", "summary": "", "symbols": ["CYTK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905280/leerink-partners-maintains-outperform-on-cytokinetics-raises-price-target-to-84", "tags": ["analyst_other", "price_target_up"]}
{"id": 50905281, "time": "2026-02-26 14:37:42", "headline": "Johnson & Johnson's Preliminary Data From Phase 1b Trial Of Pasritamig In Combination With Docetaxel In Participants With Metastatic Castration-Resistant Prostate Cancer Shows Consistent Safety Profile, Clinically Meaningful Efficacy", "summary": "", "symbols": ["JNJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905281/johnson-johnsons-preliminary-data-from-phase-1b-trial-of-pasritamig-in-combination-with-docetaxel-in", "tags": ["fda"]}
{"id": 50905357, "time": "2026-02-26 14:39:16", "headline": "Leerink Partners Maintains Outperform on Mirum Pharmaceuticals, Lowers Price Target to $118", "summary": "", "symbols": ["MIRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905357/leerink-partners-maintains-outperform-on-mirum-pharmaceuticals-lowers-price-target-to-118", "tags": ["analyst_other", "price_target_down"]}
{"id": 50905407, "time": "2026-02-26 14:41:34", "headline": "Leerink Partners Maintains Outperform on PROCEPT BioRobotics, Lowers Price Target to $30", "summary": "", "symbols": ["PRCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905407/leerink-partners-maintains-outperform-on-procept-biorobotics-lowers-price-target-to-30", "tags": ["analyst_other", "price_target_down"]}
{"id": 50905438, "time": "2026-02-26 14:42:31", "headline": "DOE Quantum Research Centers Reach Milestone Toward Scalable Quantum Computers", "summary": "", "symbols": ["RGTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905438/doe-quantum-research-centers-reach-milestone-toward-scalable-quantum-computers", "tags": []}
{"id": 50905402, "time": "2026-02-26 14:41:11", "headline": "What's Next Probabilities \u2013 Nvidia and Salesforce Earnings Fail To Uncoil Market", "summary": "\n\n\n\nUnresolved Coiled Spring\n\n\n", "symbols": ["AAPL", "AMZN", "BTCUSD", "GOOG", "META", "MSFT", "NVDA", "QQQ", "SPY", "TSLA"], "source": "benzinga", "author": "The Arora Report", "url": "https://www.benzinga.com/Opinion/26/02/50905402/what-is-next-probabilities-nvidia-salesforce-earnings-fail-to-uncoil-market", "tags": ["earnings"]}
{"id": 50905535, "time": "2026-02-26 14:45:44", "headline": "Leerink Partners Maintains Market Perform on Teladoc Health, Lowers Price Target to $5.5", "summary": "", "symbols": ["TDOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905535/leerink-partners-maintains-market-perform-on-teladoc-health-lowers-price-target-to-5-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 50905549, "time": "2026-02-26 14:45:56", "headline": "Inspire Medical Systems Trading Resumed", "summary": "", "symbols": ["INSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905549/inspire-medical-systems-trading-resumed", "tags": []}
{"id": 50905682, "time": "2026-02-26 14:51:00", "headline": "DraftKings Secures License From Arkansas Racing Commission To Launch Online Sportsbook In The State", "summary": "", "symbols": ["DKNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905682/draftkings-secures-license-from-arkansas-racing-commission-to-launch-online-sportsbook-in-the-state", "tags": []}
{"id": 50905704, "time": "2026-02-26 14:51:26", "headline": "Canaccord Genuity Maintains Hold on C3.ai, Lowers Price Target to $7", "summary": "", "symbols": ["AI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905704/canaccord-genuity-maintains-hold-on-c3-ai-lowers-price-target-to-7", "tags": ["analyst_other", "price_target_down"]}
{"id": 50905744, "time": "2026-02-26 14:52:50", "headline": "Canaccord Genuity Maintains Buy on BioMarin Pharmaceutical, Raises Price Target to $104", "summary": "", "symbols": ["BMRN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905744/canaccord-genuity-maintains-buy-on-biomarin-pharmaceutical-raises-price-target-to-104", "tags": ["analyst_other", "price_target_up"]}
{"id": 50905777, "time": "2026-02-26 14:53:33", "headline": "Caterpillar Shares Rise 3% After Key Trading Signal", "summary": "A key trading signal flashed for Caterpillar shares at a price of $729.81, after which CAT rose 3% to an intraday high.", "symbols": ["CAT"], "source": "benzinga", "author": "TradePulse", "url": "https://www.benzinga.com/Opinion/26/02/50905777/caterpillar-shares-rise-3-percent-after-key-trading-signal", "tags": []}
{"id": 50905820, "time": "2026-02-26 14:55:05", "headline": "IonQ Earnings Recast Quantum As A Semiconductor ETF Story", "summary": "IonQ&#39;s earnings and semiconductor roadmap shift focus from quantum ETFs to chip funds as potential beneficiaries.", "symbols": ["ARKK", "IONQ", "SMH", "SOXX"], "source": "benzinga", "author": "Chandrima Sanyal", "url": "https://www.benzinga.com/etfs/sector-etfs/26/02/50905820/ionq-earnings-recast-quantum-as-a-semiconductor-etf-story", "tags": ["earnings"]}
{"id": 50905847, "time": "2026-02-26 14:55:58", "headline": "Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $15", "summary": "", "symbols": ["ENVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905847/canaccord-genuity-maintains-buy-on-enovix-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 50905870, "time": "2026-02-26 14:56:36", "headline": "Fed's Goolsbee Says Rates Can Come Down, But Don't Want To Front Load Before Inflation Eases; We Can Overheat The Economy; I Want Us To Be Careful; I Am One Of The More Optimistic Folks On The Fed About Rate Cuts This Year; Economy Has Been Solid; Job Market Stable", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905870/feds-goolsbee-says-rates-can-come-down-but-dont-want-to-front-load-before-inflation-eases-we-can-ove", "tags": []}
{"id": 50905891, "time": "2026-02-26 14:57:05", "headline": "Canaccord Genuity Maintains Buy on CS Disco, Lowers Price Target to $6", "summary": "", "symbols": ["LAW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905891/canaccord-genuity-maintains-buy-on-cs-disco-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 50905914, "time": "2026-02-26 14:58:00", "headline": "Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $10", "summary": "", "symbols": ["LFST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905914/canaccord-genuity-maintains-buy-on-lifestance-health-gr-raises-price-target-to-10", "tags": ["analyst_other", "price_target_up"]}
{"id": 50905944, "time": "2026-02-26 14:59:05", "headline": "Canaccord Genuity Maintains Buy on Snowflake, Lowers Price Target to $240", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50905944/canaccord-genuity-maintains-buy-on-snowflake-lowers-price-target-to-240", "tags": ["analyst_other", "price_target_down"]}
{"id": 50906050, "time": "2026-02-26 15:00:18", "headline": "How Do Investors Really Feel About Sanofi SA?", "summary": " ", "symbols": ["SNY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50906050/how-do-investors-really-feel-about-sanofi-sa", "tags": []}
{"id": 50906052, "time": "2026-02-26 15:00:20", "headline": "Deep Dive Into Collegium Pharmaceutical Stock: Analyst Perspectives (5 Ratings)", "summary": " ", "symbols": ["COLL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50906052/deep-dive-into-collegium-pharmaceutical-stock-analyst-perspectives-5-ratings", "tags": []}
{"id": 50906053, "time": "2026-02-26 15:00:25", "headline": "Canaccord Genuity Maintains Buy on Teladoc Health, Lowers Price Target to $10", "summary": "", "symbols": ["TDOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906053/canaccord-genuity-maintains-buy-on-teladoc-health-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 50906054, "time": "2026-02-26 15:00:25", "headline": "A Look Into Halliburton Inc's Price Over Earnings", "summary": " ", "symbols": ["HAL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50906054/a-look-into-halliburton-incs-price-over-earnings", "tags": ["earnings"]}
{"id": 50906055, "time": "2026-02-26 15:00:28", "headline": "Is the Market Bullish or Bearish on Lowe's Companies Inc?", "summary": " ", "symbols": ["LOW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50906055/is-the-market-bullish-or-bearish-on-lowes-companies-inc", "tags": []}
{"id": 50906065, "time": "2026-02-26 15:00:32", "headline": "Here's How Much You Would Have Made Owning AutoZone Stock In The Last 20 Years", "summary": " ", "symbols": ["AZO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50906065/heres-how-much-you-would-have-made-owning-autozone-stock-in-the-last-20-years", "tags": []}
{"id": 50906071, "time": "2026-02-26 15:00:33", "headline": "Peering Into Mettler-Toledo International Inc's Recent Short Interest", "summary": " ", "symbols": ["MTD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/26/02/50906071/peering-into-mettler-toledo-international-incs-recent-short-interest", "tags": []}
{"id": 50906072, "time": "2026-02-26 15:00:33", "headline": "Intapp Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)", "summary": " ", "symbols": ["INTA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50906072/intapp-stock-a-deep-dive-into-analyst-perspectives-9-ratings", "tags": []}
{"id": 50906073, "time": "2026-02-26 15:00:34", "headline": "Check Out What Whales Are Doing With SNPS", "summary": " ", "symbols": ["SNPS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/26/02/50906073/check-out-what-whales-are-doing-with-snps", "tags": []}
{"id": 50906082, "time": "2026-02-26 15:00:45", "headline": "Market Whales and Their Recent Bets on RCL Options", "summary": " ", "symbols": ["RCL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/26/02/50906082/market-whales-and-their-recent-bets-on-rcl-options", "tags": []}
{"id": 50906083, "time": "2026-02-26 15:00:48", "headline": "Mosaic Stock: A Deep Dive Into Analyst Perspectives (10 Ratings)", "summary": " ", "symbols": ["MOS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50906083/mosaic-stock-a-deep-dive-into-analyst-perspectives-10-ratings", "tags": []}
{"id": 50906093, "time": "2026-02-26 15:00:57", "headline": "Assessing ExlService Hldgs: Insights From 4 Financial Analysts", "summary": " ", "symbols": ["EXLS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50906093/assessing-exlservice-hldgs-insights-from-4-financial-analysts", "tags": []}
{"id": 50906111, "time": "2026-02-26 15:01:06", "headline": "6 Analysts Assess LifeStance Health Gr: What You Need To Know", "summary": " ", "symbols": ["LFST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50906111/6-analysts-assess-lifestance-health-gr-what-you-need-to-know", "tags": []}
{"id": 50906122, "time": "2026-02-26 15:01:12", "headline": "Rocket Lab Pauses Ahead Of Q4 Earnings: What Investors Need To Know", "summary": "Rocket Lab shares are trading marginally higher Thursday as investors await its fourth-quarter earnings report, due after the bell.", "symbols": ["RKLB"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50906122/rocket-lab-pauses-ahead-of-q4-earnings-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50906126, "time": "2026-02-26 15:01:16", "headline": "Analyst Expectations For Kymera Therapeutics's Future", "summary": " ", "symbols": ["KYMR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50906126/analyst-expectations-for-kymera-therapeuticss-future", "tags": []}
{"id": 50906130, "time": "2026-02-26 15:01:19", "headline": "Canaccord Genuity Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $90", "summary": "", "symbols": ["ESTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906130/canaccord-genuity-maintains-buy-on-establishment-labs-hldgs-raises-price-target-to-90", "tags": ["analyst_other", "price_target_up"]}
{"id": 50906191, "time": "2026-02-26 15:02:19", "headline": "Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $20", "summary": "", "symbols": ["OFIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906191/canaccord-genuity-maintains-buy-on-orthofix-medical-lowers-price-target-to-20", "tags": ["analyst_other", "price_target_down"]}
{"id": 50906238, "time": "2026-02-26 15:03:19", "headline": "Cycurion Adjourns Shareholder Meeting Until Thursday, March 19 To Allow Additional Voting Time On Private Share Placement", "summary": "", "symbols": ["CYCU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906238/cycurion-adjourns-shareholder-meeting-until-thursday-march-19-to-allow-additional-voting-time-on-pri", "tags": []}
{"id": 50906355, "time": "2026-02-26 15:05:30", "headline": "Citigroup Maintains Buy on NVIDIA, Raises Price Target to $300", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906355/citigroup-maintains-buy-on-nvidia-raises-price-target-to-300", "tags": ["analyst_other", "price_target_up"]}
{"id": 50906443, "time": "2026-02-26 15:08:11", "headline": "Elevance Health Reiterates 2026 EPS Of At Least $22.30, Adjusted EPS Of At least $25.50", "summary": "", "symbols": ["ELV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906443/elevance-health-reiterates-2026-eps-of-at-least-22-30-adjusted-eps-of-at-least-25-50", "tags": ["analyst_other", "earnings"]}
{"id": 50906472, "time": "2026-02-26 15:09:06", "headline": "Citigroup Maintains Neutral on Shoals Technologies Group, Lowers Price Target to $8.5", "summary": "", "symbols": ["SHLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906472/citigroup-maintains-neutral-on-shoals-technologies-group-lowers-price-target-to-8-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 50906567, "time": "2026-02-26 15:11:35", "headline": "Citigroup Maintains Buy on Veeco Instruments, Raises Price Target to $40", "summary": "", "symbols": ["VECO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906567/citigroup-maintains-buy-on-veeco-instruments-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 50906657, "time": "2026-02-26 15:13:06", "headline": "Citigroup Maintains Buy on Medline, Raises Price Target to $60", "summary": "", "symbols": ["MDLN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906657/citigroup-maintains-buy-on-medline-raises-price-target-to-60", "tags": ["analyst_other", "price_target_up"]}
{"id": 50906696, "time": "2026-02-26 15:13:50", "headline": "Senate Democrats Target Private Equity's Housing Playbook With Bill To End Key Tax Breaks", "summary": "Senate Democrats introduced a legislative measure that would end major federal tax deductions for private equity and Wall Street landlords.", "symbols": [], "source": "benzinga", "author": "Caroline Ryan", "url": "https://www.benzinga.com/markets/private-markets/26/02/50906696/senate-democrats-private-equity-housing-tax-breaks", "tags": []}
{"id": 50906714, "time": "2026-02-26 15:14:17", "headline": "Citigroup Maintains Buy on TechnipFMC, Raises Price Target to $76", "summary": "", "symbols": ["FTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906714/citigroup-maintains-buy-on-technipfmc-raises-price-target-to-76", "tags": ["analyst_other", "price_target_up"]}
{"id": 50906740, "time": "2026-02-26 15:15:21", "headline": "Here's How Much You Would Have Made Owning Insmed Stock In The Last 10 Years", "summary": " ", "symbols": ["INSM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50906740/heres-how-much-you-would-have-made-owning-insmed-stock-in-the-last-10-years", "tags": []}
{"id": 50906755, "time": "2026-02-26 15:16:03", "headline": "Citigroup Maintains Buy on Wayfair, Lowers Price Target to $110", "summary": "", "symbols": ["W"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906755/citigroup-maintains-buy-on-wayfair-lowers-price-target-to-110", "tags": ["analyst_other", "price_target_down"]}
{"id": 50906790, "time": "2026-02-26 15:17:16", "headline": "Citigroup Maintains Neutral on Trex Co, Raises Price Target to $46", "summary": "", "symbols": ["TREX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906790/citigroup-maintains-neutral-on-trex-co-raises-price-target-to-46", "tags": ["analyst_other", "price_target_up"]}
{"id": 50906840, "time": "2026-02-26 15:18:32", "headline": "Citigroup Maintains Buy on Ethos Technologies, Raises Price Target to $16", "summary": "", "symbols": ["LIFE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906840/citigroup-maintains-buy-on-ethos-technologies-raises-price-target-to-16", "tags": ["analyst_other", "price_target_up"]}
{"id": 50906863, "time": "2026-02-26 15:19:34", "headline": "Citigroup Maintains Buy on Select Water Solutions, Raises Price Target to $16.5", "summary": "", "symbols": ["WTTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906863/citigroup-maintains-buy-on-select-water-solutions-raises-price-target-to-16-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 50906897, "time": "2026-02-26 15:20:27", "headline": "Citigroup Maintains Buy on APi Group, Raises Price Target to $52", "summary": "", "symbols": ["APG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906897/citigroup-maintains-buy-on-api-group-raises-price-target-to-52", "tags": ["analyst_other", "price_target_up"]}
{"id": 50906920, "time": "2026-02-26 15:21:17", "headline": "Citigroup Maintains Neutral on Toll Brothers, Raises Price Target to $162", "summary": "", "symbols": ["TOL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906920/citigroup-maintains-neutral-on-toll-brothers-raises-price-target-to-162", "tags": ["analyst_other", "price_target_up"]}
{"id": 50906946, "time": "2026-02-26 15:22:24", "headline": "Citigroup Maintains Neutral on Flywire, Lowers Price Target to $13", "summary": "", "symbols": ["FLYW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906946/citigroup-maintains-neutral-on-flywire-lowers-price-target-to-13", "tags": ["analyst_other", "price_target_down"]}
{"id": 50906976, "time": "2026-02-26 15:23:25", "headline": "Citigroup Maintains Buy on Evolent Health, Lowers Price Target to $4", "summary": "", "symbols": ["EVH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50906976/citigroup-maintains-buy-on-evolent-health-lowers-price-target-to-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 50907023, "time": "2026-02-26 15:24:54", "headline": "Citigroup Maintains Buy on GoDaddy, Lowers Price Target to $110", "summary": "", "symbols": ["GDDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50907023/citigroup-maintains-buy-on-godaddy-lowers-price-target-to-110", "tags": ["analyst_other", "price_target_down"]}
{"id": 50907056, "time": "2026-02-26 15:25:41", "headline": "Citigroup Maintains Neutral on BJ's Restaurants, Raises Price Target to $49", "summary": "", "symbols": ["BJRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50907056/citigroup-maintains-neutral-on-bjs-restaurants-raises-price-target-to-49", "tags": ["analyst_other", "price_target_up"]}
{"id": 50907113, "time": "2026-02-26 15:26:39", "headline": "Citigroup Maintains Neutral on Bloomin Brands, Raises Price Target to $7", "summary": "", "symbols": ["BLMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50907113/citigroup-maintains-neutral-on-bloomin-brands-raises-price-target-to-7", "tags": ["analyst_other", "price_target_up"]}
{"id": 50907143, "time": "2026-02-26 15:27:23", "headline": "Citigroup Maintains Buy on Westlake, Raises Price Target to $124", "summary": "", "symbols": ["WLK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50907143/citigroup-maintains-buy-on-westlake-raises-price-target-to-124", "tags": ["analyst_other", "price_target_up"]}
{"id": 50907195, "time": "2026-02-26 15:28:52", "headline": "Citigroup Maintains Neutral on Pinnacle West Capital, Raises Price Target to $109", "summary": "", "symbols": ["PNW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50907195/citigroup-maintains-neutral-on-pinnacle-west-capital-raises-price-target-to-109", "tags": ["analyst_other", "price_target_up"]}
{"id": 50907268, "time": "2026-02-26 15:30:21", "headline": "If You Invested $100 In Canadian Imperial Bank Stock 5 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["CM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50907268/if-you-invested-100-in-canadian-imperial-bank-stock-5-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 50907313, "time": "2026-02-26 15:31:08", "headline": "Citigroup Maintains Neutral on Workday, Lowers Price Target to $148", "summary": "", "symbols": ["WDAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50907313/citigroup-maintains-neutral-on-workday-lowers-price-target-to-148", "tags": ["analyst_other", "price_target_down"]}
{"id": 50907357, "time": "2026-02-26 15:31:52", "headline": "Healthcare Triangle Commences ~$3.959M Offering Of 681,553 Common Shares At $5.81/Share", "summary": "", "symbols": ["HCTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50907357/healthcare-triangle-commences-3-959m-offering-of-681-553-common-shares-at-5-81share", "tags": ["offering"]}
{"id": 50907381, "time": "2026-02-26 15:32:32", "headline": "Citigroup Maintains Buy on CCC Intelligent Solutions, Lowers Price Target to $10", "summary": "", "symbols": ["CCC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50907381/citigroup-maintains-buy-on-ccc-intelligent-solutions-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 50907548, "time": "2026-02-26 15:38:20", "headline": "DA Davidson Maintains Buy on Douglas Dynamics, Raises Price Target to $55", "summary": "", "symbols": ["PLOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50907548/da-davidson-maintains-buy-on-douglas-dynamics-raises-price-target-to-55", "tags": ["analyst_other", "price_target_up"]}
{"id": 50907588, "time": "2026-02-26 15:39:06", "headline": "'Bitcoin Senator' Slams SBF's Trump Support: 'We Do Not Need\u2014Nor Want\u2014Your Support'", "summary": "Senator Cynthia Lummis (R-Wyo.) torched imprisoned FTX founder Sam Bankman-Fried Thursday morning after he endorsed the CLARITY Act from behind bars, calling it \u201ca huge milestone for crypto\u201d and \u201ca huge achievement\u201d for President Donald Trump.", "symbols": ["BTCUSD", "COIN"], "source": "benzinga", "author": "Daragh Thomas", "url": "https://www.benzinga.com/markets/prediction-markets/26/02/50907588/bitcoin-senator-slams-sbfs-trump-support-we-do-not-need-nor-want-your-support", "tags": []}
{"id": 50907589, "time": "2026-02-26 15:39:11", "headline": "'Cigna, Extending Reach Into Prescription Drugs, Acquires Major Pharmacy Used By Hospitals, CarepathRx' - STAT News", "summary": "", "symbols": ["CI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50907589/cigna-extending-reach-into-prescription-drugs-acquires-major-pharmacy-used-by-hospitals-carepathrx-s", "tags": ["merger"]}
{"id": 50907690, "time": "2026-02-26 15:42:05", "headline": "Caesars Entertainment Shares Halted On Circuit Breaker To The Upside, Stock Now Up 15.98%", "summary": "", "symbols": ["CZR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/26/02/50907690/caesars-entertainment-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-15-98", "tags": ["halt"]}
{"id": 50907731, "time": "2026-02-26 15:43:11", "headline": "DA Davidson Maintains Neutral on Everus Construction Group, Raises Price Target to $130", "summary": "", "symbols": ["ECG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50907731/da-davidson-maintains-neutral-on-everus-construction-group-raises-price-target-to-130", "tags": ["analyst_other", "price_target_up"]}
{"id": 50907744, "time": "2026-02-26 15:43:20", "headline": "Healthcare Triangle Shares Resume Trade Following Circuit Breaker Halt", "summary": "", "symbols": ["HCTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/26/02/50907744/healthcare-triangle-shares-resume-trade-following-circuit-breaker-halt", "tags": ["halt"]}
{"id": 50907786, "time": "2026-02-26 15:44:12", "headline": "Caesars Entertainment Shares Resume Trade", "summary": "", "symbols": ["CZR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/26/02/50907786/caesars-entertainment-shares-resume-trade", "tags": []}
{"id": 50907828, "time": "2026-02-26 15:45:15", "headline": "Mexican President Sheinbaum Says Coca-Cola CEO Informed Her Of $6B Investment In Mexico", "summary": "", "symbols": ["EWW", "KO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50907828/mexican-president-sheinbaum-says-coca-cola-ceo-informed-her-of-6b-investment-in-mexico", "tags": ["management"]}
{"id": 50907829, "time": "2026-02-26 15:45:18", "headline": "If You Invested $1000 In Exxon Mobil Stock 5 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["XOM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50907829/if-you-invested-1000-in-exxon-mobil-stock-5-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 50907864, "time": "2026-02-26 15:46:14", "headline": "DA Davidson Maintains Underperform on C3.ai, Lowers Price Target to $7", "summary": "", "symbols": ["AI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50907864/da-davidson-maintains-underperform-on-c3-ai-lowers-price-target-to-7", "tags": ["analyst_other", "price_target_down"]}
{"id": 50907899, "time": "2026-02-26 15:47:45", "headline": "DA Davidson Maintains Buy on Clear Secure, Raises Price Target to $54", "summary": "", "symbols": ["YOU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50907899/da-davidson-maintains-buy-on-clear-secure-raises-price-target-to-54", "tags": ["analyst_other", "price_target_up"]}
{"id": 50907673, "time": "2026-02-26 15:41:27", "headline": "'Las Vegas Casino Group Caesars Weighs Takeover Interest; Caesars Is Exploring A Sale After Receiving Takeover Interest From Several Potential Bidders Including Fertitta Entertainment' - Financial Times", "summary": "", "symbols": ["CZR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50907673/las-vegas-casino-group-caesars-weighs-takeover-interest-caesars-is-exploring-a-sale-after-receiving", "tags": ["merger"]}
{"id": 50907997, "time": "2026-02-26 15:50:23", "headline": "DA Davidson Maintains Buy on Zeta Global Holdings, Raises Price Target to $30", "summary": "", "symbols": ["ZETA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50907997/da-davidson-maintains-buy-on-zeta-global-holdings-raises-price-target-to-30", "tags": ["analyst_other", "price_target_up"]}
{"id": 50908119, "time": "2026-02-26 15:52:45", "headline": "Live On Fox Business, NVIDIA CEO Jensen Huang Says NVIDIA Is Micron's Largest Customer", "summary": "", "symbols": ["MU", "NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908119/live-on-fox-business-nvidia-ceo-jensen-huang-says-nvidia-is-microns-largest-customer", "tags": ["management"]}
{"id": 50908288, "time": "2026-02-26 15:57:16", "headline": "'Redfin Will Display Compass's Exclusive Home Listings' - WSJ Exclusive", "summary": "", "symbols": ["COMP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908288/redfin-will-display-compasss-exclusive-home-listings-wsj-exclusive", "tags": []}
{"id": 50908523, "time": "2026-02-26 16:00:21", "headline": "7 Analysts Assess Kilroy Realty: What You Need To Know", "summary": " ", "symbols": ["KRC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50908523/7-analysts-assess-kilroy-realty-what-you-need-to-know", "tags": []}
{"id": 50908526, "time": "2026-02-26 16:00:23", "headline": "P/E Ratio Insights for Palo Alto Networks", "summary": " ", "symbols": ["PANW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50908526/pe-ratio-insights-for-palo-alto-networks", "tags": []}
{"id": 50908533, "time": "2026-02-26 16:00:29", "headline": "If You Invested $100 In Trane Technologies Stock 10 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["TT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50908533/if-you-invested-100-in-trane-technologies-stock-10-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 50908536, "time": "2026-02-26 16:00:34", "headline": "Forecasting The Future: 5 Analyst Projections For Cousins Props", "summary": " ", "symbols": ["CUZ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50908536/forecasting-the-future-5-analyst-projections-for-cousins-props", "tags": []}
{"id": 50908540, "time": "2026-02-26 16:00:42", "headline": "Intuit Q2 Adj. EPS $4.15 Beats $3.66 Estimate, Sales $4.651B Beat $4.532B Estimate", "summary": "", "symbols": ["INTU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908540/intuit-q2-adj-eps-4-15-beats-3-66-estimate-sales-4-651b-beat-4-532b-estimate", "tags": ["earnings"]}
{"id": 50908541, "time": "2026-02-26 16:00:44", "headline": "The Analyst Verdict: Agilent Technologies In The Eyes Of 9 Experts", "summary": " ", "symbols": ["A"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50908541/the-analyst-verdict-agilent-technologies-in-the-eyes-of-9-experts", "tags": []}
{"id": 50908555, "time": "2026-02-26 16:00:54", "headline": "MDxHealth Q4 EPS $(0.17) Misses $(0.13) Estimate, Sales $29.545M Miss $30.530M Estimate", "summary": "", "symbols": ["MDXH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908555/mdxhealth-q4-eps-0-17-misses-0-13-estimate-sales-29-545m-miss-30-530m-estimate", "tags": ["earnings"]}
{"id": 50908558, "time": "2026-02-26 16:00:55", "headline": "A Glimpse Into The Expert Outlook On Protagonist Therapeutics Through 8 Analysts", "summary": " ", "symbols": ["PTGX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50908558/a-glimpse-into-the-expert-outlook-on-protagonist-therapeutics-through-8-analysts", "tags": ["guidance"]}
{"id": 50908578, "time": "2026-02-26 16:01:04", "headline": "What 5 Analyst Ratings Have To Say About RxSight", "summary": " ", "symbols": ["RXST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50908578/what-5-analyst-ratings-have-to-say-about-rxsight", "tags": []}
{"id": 50908619, "time": "2026-02-26 16:01:12", "headline": "What 7 Analyst Ratings Have To Say About Lineage", "summary": " ", "symbols": ["LINE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50908619/what-7-analyst-ratings-have-to-say-about-lineage", "tags": []}
{"id": 50908631, "time": "2026-02-26 16:01:21", "headline": "Intuit Affirms FY2026 Adj EPS Guidance of $22.98-$23.18 vs $23.20 Est; Affirms FY2026 Sales Guidance of $20.997B-$21.186B vs $21.216B Est", "summary": "", "symbols": ["INTU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908631/intuit-affirms-fy2026-adj-eps-guidance-of-22-98-23-18-vs-23-20-est-affirms-fy2026-sales-guidance-of", "tags": ["earnings", "guidance"]}
{"id": 50908636, "time": "2026-02-26 16:01:24", "headline": "Data I/O Q4 EPS $(0.27) Misses $(0.11) Estimate, Sales $3.983M Miss $5.409M Estimate", "summary": "", "symbols": ["DAIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908636/data-io-q4-eps-0-27-misses-0-11-estimate-sales-3-983m-miss-5-409m-estimate", "tags": ["earnings"]}
{"id": 50908637, "time": "2026-02-26 16:01:24", "headline": "MDxHealth Affirms FY2026 Sales Guidance of $137.000M-$140.000M", "summary": "", "symbols": ["MDXH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908637/mdxhealth-affirms-fy2026-sales-guidance-of-137-000m-140-000m", "tags": ["guidance"]}
{"id": 50908640, "time": "2026-02-26 16:01:27", "headline": "Expensify Q4 Adj. EPS $(0.02) Misses $0.04 Estimate, Sales $35.198M Miss $35.495M Estimate", "summary": "", "symbols": ["EXFY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908640/expensify-q4-adj-eps-0-02-misses-0-04-estimate-sales-35-198m-miss-35-495m-estimate", "tags": ["earnings"]}
{"id": 50908654, "time": "2026-02-26 16:01:37", "headline": "Autodesk Q4 Adj. EPS $2.85 Beats $2.64 Estimate, Sales $1.957B Beat $1.912B Estimate", "summary": "", "symbols": ["ADSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908654/autodesk-q4-adj-eps-2-85-beats-2-64-estimate-sales-1-957b-beat-1-912b-estimate", "tags": ["earnings"]}
{"id": 50908662, "time": "2026-02-26 16:01:41", "headline": "Intuit Affirms FY2026 GAAP EPS Guidance of $15.49-$15.69 vs $15.83 Est", "summary": "", "symbols": ["INTU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908662/intuit-affirms-fy2026-gaap-eps-guidance-of-15-49-15-69-vs-15-83-est", "tags": ["earnings", "guidance"]}
{"id": 50908694, "time": "2026-02-26 16:02:09", "headline": "Data I/O Earnings Report: Q4 Overview", "summary": " ", "symbols": ["DAIO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50908694/data-io-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50908704, "time": "2026-02-26 16:02:14", "headline": "Expensify Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["EXFY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50908704/expensify-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50908709, "time": "2026-02-26 16:02:15", "headline": "Expensify Sees FY26 Free Cash Flow $6M-$9M", "summary": "", "symbols": ["EXFY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908709/expensify-sees-fy26-free-cash-flow-6m-9m", "tags": []}
{"id": 50908715, "time": "2026-02-26 16:02:20", "headline": "MidCap Financial Q3 EPS $0.39 Beats $0.37 Estimate, Sales $78.356M Miss $80.590M Estimate", "summary": "", "symbols": ["MFIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908715/midcap-financial-q3-eps-0-39-beats-0-37-estimate-sales-78-356m-miss-80-590m-estimate", "tags": ["earnings"]}
{"id": 50908717, "time": "2026-02-26 16:02:22", "headline": "Alignment Healthcare Q4 EPS $(0.05) Beats $(0.15) Estimate, Sales $1.013B Beat $1.003B Estimate", "summary": "", "symbols": ["ALHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908717/alignment-healthcare-q4-eps-0-05-beats-0-15-estimate-sales-1-013b-beat-1-003b-estimate", "tags": ["earnings"]}
{"id": 50908719, "time": "2026-02-26 16:02:23", "headline": "Dentsply Sirona Q4 Adj. EPS $0.27 Misses $0.28 Estimate, Sales $961.000M Beat $927.081M Estimate", "summary": "", "symbols": ["XRAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908719/dentsply-sirona-q4-adj-eps-0-27-misses-0-28-estimate-sales-961-000m-beat-927-081m-estimate", "tags": ["earnings"]}
{"id": 50908737, "time": "2026-02-26 16:02:46", "headline": "SBA Comms Q4 EPS $3.47 Misses $3.89 Estimate, Sales $719.583M Miss $726.146M Estimate", "summary": "", "symbols": ["SBAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908737/sba-comms-q4-eps-3-47-misses-3-89-estimate-sales-719-583m-miss-726-146m-estimate", "tags": ["earnings"]}
{"id": 50908741, "time": "2026-02-26 16:02:51", "headline": "Dentsply Sirona Sees FY2026 Adj EPS $1.40-$1.50 vs $1.50 Est; Sees Sales $3.500B-$3.600B vs $3.675B Est", "summary": "", "symbols": ["XRAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908741/dentsply-sirona-sees-fy2026-adj-eps-1-40-1-50-vs-1-50-est-sees-sales-3-500b-3-600b-vs-3-675b-est", "tags": ["earnings"]}
{"id": 50908756, "time": "2026-02-26 16:03:00", "headline": "OneSpan Q4 Adj. EPS $0.36 Beats $0.29 Estimate, Sales $62.915M Beat $59.779M Estimate", "summary": "", "symbols": ["OSPN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908756/onespan-q4-adj-eps-0-36-beats-0-29-estimate-sales-62-915m-beat-59-779m-estimate", "tags": ["earnings"]}
{"id": 50908780, "time": "2026-02-26 16:03:16", "headline": "Alignment Healthcare Sees Q1 Sales $1.205B-$1.225B vs $1.230B Est", "summary": "", "symbols": ["ALHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908780/alignment-healthcare-sees-q1-sales-1-205b-1-225b-vs-1-230b-est", "tags": []}
{"id": 50908801, "time": "2026-02-26 16:03:27", "headline": "NetApp Q3 Adj. EPS $2.12 Beats $2.06 Estimate, Sales $1.713B Beat $1.695B Estimate", "summary": "", "symbols": ["NTAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908801/netapp-q3-adj-eps-2-12-beats-2-06-estimate-sales-1-713b-beat-1-695b-estimate", "tags": ["earnings"]}
{"id": 50908803, "time": "2026-02-26 16:03:28", "headline": "Alignment Healthcare Sees FY2026 Sales $5.135B-$5.190B vs $5.240B Est", "summary": "", "symbols": ["ALHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908803/alignment-healthcare-sees-fy2026-sales-5-135b-5-190b-vs-5-240b-est", "tags": []}
{"id": 50908809, "time": "2026-02-26 16:03:31", "headline": "Autodesk Sees Q1 Adj EPS $2.82-$2.86 vs $2.59 Est; Sees Sales $1.885B-$1.900B vs $1.838B Est", "summary": "", "symbols": ["ADSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908809/autodesk-sees-q1-adj-eps-2-82-2-86-vs-2-59-est-sees-sales-1-885b-1-900b-vs-1-838b-est", "tags": ["earnings"]}
{"id": 50908815, "time": "2026-02-26 16:03:33", "headline": "Definium Therapeutics Q4 EPS $(0.50) Misses $(0.46) Estimate.", "summary": "", "symbols": ["DFTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908815/definium-therapeutics-q4-eps-0-50-misses-0-46-estimate", "tags": ["earnings"]}
{"id": 50908823, "time": "2026-02-26 16:03:36", "headline": "Rocket Pharmaceuticals Q4 EPS $(0.38) Beats $(0.44) Estimate", "summary": "", "symbols": ["RCKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908823/rocket-pharmaceuticals-q4-eps-0-38-beats-0-44-estimate", "tags": ["earnings"]}
{"id": 50908830, "time": "2026-02-26 16:03:39", "headline": "OneSpan Sees FY2026 Sales $244.000M-$249.000M vs $244.748M Est", "summary": "", "symbols": ["OSPN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908830/onespan-sees-fy2026-sales-244-000m-249-000m-vs-244-748m-est", "tags": []}
{"id": 50908837, "time": "2026-02-26 16:03:43", "headline": "Figure Technology Q4 EPS $0.06 Misses $0.08 Estimate, Sales $159.913M Beat $151.379M Estimate", "summary": "", "symbols": ["FIGR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908837/figure-technology-q4-eps-0-06-misses-0-08-estimate-sales-159-913m-beat-151-379m-estimate", "tags": ["earnings"]}
{"id": 50908838, "time": "2026-02-26 16:03:43", "headline": "Biodesix Q4 EPS $(0.49) Beats $(0.85) Estimate, Sales $28.755M Beat $25.728M Estimate", "summary": "", "symbols": ["BDSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908838/biodesix-q4-eps-0-49-beats-0-85-estimate-sales-28-755m-beat-25-728m-estimate", "tags": ["earnings"]}
{"id": 50908845, "time": "2026-02-26 16:03:45", "headline": "Clipper Realty Q4 FFO $0.04 Misses $0.11 Estimate, Sales $37.070M Miss $38.100M Estimate", "summary": "", "symbols": ["CLPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908845/clipper-realty-q4-ffo-0-04-misses-0-11-estimate-sales-37-070m-miss-38-100m-estimate", "tags": []}
{"id": 50908848, "time": "2026-02-26 16:03:47", "headline": "Rate Volatility Is Here To Stay \u2014 Invesco Bets On It With 4 New Fixed Income ETFs", "summary": "Invesco launches four bond ETFs, including duration-rotation and hybrid strategies, as investors hunt for income amid rate volatility.", "symbols": ["FLXI", "HBRD", "IMTG", "IVZ", "TROT"], "source": "benzinga", "author": "Chandrima Sanyal", "url": "https://www.benzinga.com/etfs/new-etfs/26/02/50908848/invesco-new-fixed-income-etfs-rate-volatility", "tags": []}
{"id": 50908854, "time": "2026-02-26 16:03:53", "headline": "SBA Communications Sees FY2026 Sales $2.815B-$2.860B vs $2.860B Est", "summary": "", "symbols": ["SBAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908854/sba-communications-sees-fy2026-sales-2-815b-2-860b-vs-2-860b-est", "tags": []}
{"id": 50908859, "time": "2026-02-26 16:03:58", "headline": "Autodesk Sees Q1 GAAP EPS $1.68-$1.83 vs $1.54 Est", "summary": "", "symbols": ["ADSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908859/autodesk-sees-q1-gaap-eps-1-68-1-83-vs-1-54-est", "tags": ["earnings"]}
{"id": 50908876, "time": "2026-02-26 16:04:08", "headline": "Vtex Q4 EPS $0.05 Beats $0.04 Estimate, Sales $67.954M Miss $67.972M Estimate", "summary": "", "symbols": ["VTEX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908876/vtex-q4-eps-0-05-beats-0-04-estimate-sales-67-954m-miss-67-972m-estimate", "tags": ["earnings"]}
{"id": 50908881, "time": "2026-02-26 16:04:11", "headline": "'Meta's Internal Chip Design Efforts Hit Roadblocks' - The Information", "summary": "", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908881/metas-internal-chip-design-efforts-hit-roadblocks-the-information", "tags": []}
{"id": 50908888, "time": "2026-02-26 16:04:14", "headline": "Sunrun Q4 EPS $0.76 Beats $(0.08) Estimate, Sales $1.159B Beat $614.408M Estimate", "summary": "", "symbols": ["RUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908888/sunrun-q4-eps-0-76-beats-0-08-estimate-sales-1-159b-beat-614-408m-estimate", "tags": ["earnings"]}
{"id": 50908889, "time": "2026-02-26 16:04:14", "headline": "Sunrun Earnings Review: Q4 Summary", "summary": " ", "symbols": ["RUN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50908889/sunrun-earnings-review-q4-summary", "tags": ["earnings"]}
{"id": 50908896, "time": "2026-02-26 16:04:19", "headline": "Vtex Earnings Report: Q4 Overview", "summary": " ", "symbols": ["VTEX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50908896/vtex-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50908898, "time": "2026-02-26 16:04:20", "headline": "Biodesix Sees FY2026 Sales $106.000M-$112.000M vs $105.624M Est", "summary": "", "symbols": ["BDSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908898/biodesix-sees-fy2026-sales-106-000m-112-000m-vs-105-624m-est", "tags": []}
{"id": 50908905, "time": "2026-02-26 16:04:24", "headline": "Insights into Clipper Realty Q4 Earnings", "summary": " ", "symbols": ["CLPR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50908905/insights-into-clipper-realty-q4-earnings", "tags": ["earnings"]}
{"id": 50908911, "time": "2026-02-26 16:04:26", "headline": "NetApp Raises FY2026 GAAP EPS Guidance from $5.82-$6.12 to $6.07-$6.17 vs $6.16 Est", "summary": "", "symbols": ["NTAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908911/netapp-raises-fy2026-gaap-eps-guidance-from-5-82-6-12-to-6-07-6-17-vs-6-16-est", "tags": ["earnings", "guidance"]}
{"id": 50908914, "time": "2026-02-26 16:04:27", "headline": "Alpha Teknova Q4 EPS $(0.09), Inline, Sales $9.984M Beat $9.716M Estimate", "summary": "", "symbols": ["TKNO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908914/alpha-teknova-q4-eps-0-09-inline-sales-9-984m-beat-9-716m-estimate", "tags": ["earnings"]}
{"id": 50908920, "time": "2026-02-26 16:04:29", "headline": "Biodesix Earnings Report: Q4 Overview", "summary": " ", "symbols": ["BDSX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50908920/biodesix-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50908928, "time": "2026-02-26 16:04:34", "headline": "NetApp Q3 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["NTAP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50908928/netapp-q3-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50908937, "time": "2026-02-26 16:04:38", "headline": "OneSpan Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["OSPN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50908937/onespan-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50908939, "time": "2026-02-26 16:04:39", "headline": "Autodesk Sees FY2027 Adj EPS $12.29-$12.56 vs $11.62 Est; Sees Sales $8.100B-$8.170B vs $7.965B Est", "summary": "", "symbols": ["ADSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908939/autodesk-sees-fy2027-adj-eps-12-29-12-56-vs-11-62-est-sees-sales-8-100b-8-170b-vs-7-965b-est", "tags": ["earnings"]}
{"id": 50908945, "time": "2026-02-26 16:04:42", "headline": "NetApp Narrows FY2026 Adj EPS Guidance from $7.75-$8.05 to $7.92-$8.02 vs $7.90 Est; Raises FY2026 Sales Guidance from $6.625B-$6.875B to $6.772B-$6.922B vs $6.758B Est", "summary": "", "symbols": ["NTAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908945/netapp-narrows-fy2026-adj-eps-guidance-from-7-75-8-05-to-7-92-8-02-vs-7-90-est-raises-fy2026-sales-g", "tags": ["earnings", "guidance"]}
{"id": 50908947, "time": "2026-02-26 16:04:43", "headline": "SBA Communications Earnings Review: Q4 Summary", "summary": " ", "symbols": ["SBAC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50908947/sba-communications-earnings-review-q4-summary", "tags": ["earnings"]}
{"id": 50908957, "time": "2026-02-26 16:04:48", "headline": "Earnings Summary: Dentsply Sirona Q4", "summary": " ", "symbols": ["XRAY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50908957/earnings-summary-dentsply-sirona-q4", "tags": ["earnings"]}
{"id": 50908969, "time": "2026-02-26 16:04:53", "headline": "Earnings Summary: MidCap Financial Q3", "summary": " ", "symbols": ["MFIC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50908969/earnings-summary-midcap-financial-q3", "tags": ["earnings"]}
{"id": 50908974, "time": "2026-02-26 16:04:57", "headline": "Progyny Q4 Adj. EPS $0.48 Beats $0.14 Estimate, Sales $318.403M Beat $307.454M Estimate", "summary": "", "symbols": ["PGNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908974/progyny-q4-adj-eps-0-48-beats-0-14-estimate-sales-318-403m-beat-307-454m-estimate", "tags": ["earnings"]}
{"id": 50908986, "time": "2026-02-26 16:05:01", "headline": "Pacira BioSciences Q4 Adj. EPS $0.57 Misses $0.90 Estimate, Sales $196.873M Miss $200.424M Estimate.", "summary": "", "symbols": ["PCRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50908986/pacira-biosciences-q4-adj-eps-0-57-misses-0-90-estimate-sales-196-873m-miss-200-424m-estimate", "tags": ["earnings"]}
{"id": 50908995, "time": "2026-02-26 16:05:04", "headline": "Autodesk Sees FY2027 GAAP EPS $7.76-$8.39 vs $7.43 Est", "summary": "", "symbols": ["ADSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50908995/autodesk-sees-fy2027-gaap-eps-7-76-8-39-vs-7-43-est", "tags": ["earnings"]}
{"id": 50909102, "time": "2026-02-26 16:05:18", "headline": "NetApp Sees Q4 Adj EPS $2.21-$2.31 vs $2.23 Est; Sees Sales $1.795B-$1.945B vs $1.795B Est", "summary": "", "symbols": ["NTAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909102/netapp-sees-q4-adj-eps-2-21-2-31-vs-2-23-est-sees-sales-1-795b-1-945b-vs-1-795b-est", "tags": ["earnings"]}
{"id": 50909107, "time": "2026-02-26 16:05:20", "headline": "Alpha Teknova Sees FY2026 Sales $42.000M-$44.000M vs $44.111M Est", "summary": "", "symbols": ["TKNO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909107/alpha-teknova-sees-fy2026-sales-42-000m-44-000m-vs-44-111m-est", "tags": []}
{"id": 50909150, "time": "2026-02-26 16:05:27", "headline": "NetApp Sees Q4 GAAP EPS $1.76-$1.86 vs $1.78 Est", "summary": "", "symbols": ["NTAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909150/netapp-sees-q4-gaap-eps-1-76-1-86-vs-1-78-est", "tags": ["earnings"]}
{"id": 50909160, "time": "2026-02-26 16:05:30", "headline": "Duolingo Announces $400M Buyback Plan", "summary": "", "symbols": ["DUOL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909160/duolingo-announces-400m-buyback-plan", "tags": ["buyback"]}
{"id": 50909178, "time": "2026-02-26 16:05:40", "headline": "Zscaler Q2 Adj. EPS $1.01 Beats $0.90 Estimate, Sales $815.751M Beat $798.816M Estimate", "summary": "", "symbols": ["ZS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909178/zscaler-q2-adj-eps-1-01-beats-0-90-estimate-sales-815-751m-beat-798-816m-estimate", "tags": ["earnings"]}
{"id": 50909189, "time": "2026-02-26 16:05:45", "headline": "12 Information Technology Stocks Moving In Thursday's After-Market Session", "summary": " ", "symbols": ["ADSK", "AIXI", "AUID", "CISO", "DAIO", "EXFY", "GCTS", "HKD", "IMTE", "INTZ", "LASR", "NTAP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/26/02/50909189/12-information-technology-stocks-moving-in-thursdays-after-market-session", "tags": ["why_moving"]}
{"id": 50909203, "time": "2026-02-26 16:05:50", "headline": "12 Industrials Stocks Moving In Thursday's After-Market Session", "summary": " ", "symbols": ["AREB", "ELPW", "FOFO", "GFAI", "MGN", "PXS", "QH", "RUN", "RYDE", "SKK", "SVRN", "VHUB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/26/02/50909203/12-industrials-stocks-moving-in-thursdays-after-market-session", "tags": ["why_moving"]}
{"id": 50909211, "time": "2026-02-26 16:05:56", "headline": "12 Health Care Stocks Moving In Thursday's After-Market Session", "summary": " ", "symbols": ["BIAF", "BLRX", "CUE", "CURX", "CYPH", "KAPA", "NGNE", "PGNY", "PMCB", "VSEE", "VVOS", "XRAY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/26/02/50909211/12-health-care-stocks-moving-in-thursdays-after-market-session", "tags": ["why_moving"]}
{"id": 50909221, "time": "2026-02-26 16:06:00", "headline": "Curaleaf Holdings Q4 Adj. EPS $(0.05) Beats $(0.07) Estimate, Sales $333.068M Beat $329.129M Estimate", "summary": "", "symbols": ["CURLF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909221/curaleaf-holdings-q4-adj-eps-0-05-beats-0-07-estimate-sales-333-068m-beat-329-129m-estimate", "tags": ["earnings"]}
{"id": 50909223, "time": "2026-02-26 16:06:01", "headline": "12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session", "summary": " ", "symbols": ["AIIO", "BTBD", "DUOL", "HCHL", "JDZG", "QVCD", "REAL", "SMJF", "TOUR", "VIOT", "XWEL", "YMAT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/26/02/50909223/12-consumer-discretionary-stocks-moving-in-thursdays-after-market-session", "tags": ["why_moving"]}
{"id": 50909224, "time": "2026-02-26 16:06:00", "headline": "Personalis Q4 EPS $(0.26) Beats $(0.29) Estimate, Sales $17.345M Miss $17.383M Estimate", "summary": "", "symbols": ["PSNL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909224/personalis-q4-eps-0-26-beats-0-29-estimate-sales-17-345m-miss-17-383m-estimate", "tags": ["earnings"]}
{"id": 50909238, "time": "2026-02-26 16:06:05", "headline": "Dell Technologies Q4 Adj. EPS $3.89 Beats $3.53 Estimate, Sales $33.379B Beat $31.727B Estimate", "summary": "", "symbols": ["DELL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909238/dell-technologies-q4-adj-eps-3-89-beats-3-53-estimate-sales-33-379b-beat-31-727b-estimate", "tags": ["earnings"]}
{"id": 50909241, "time": "2026-02-26 16:06:05", "headline": "Puma Biotechnology Q4 Adj. EPS $0.30 Beats $0.23 Estimate, Sales $75.500M Beat $68.600M Estimate", "summary": "", "symbols": ["PBYI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909241/puma-biotechnology-q4-adj-eps-0-30-beats-0-23-estimate-sales-75-500m-beat-68-600m-estimate", "tags": ["earnings"]}
{"id": 50909253, "time": "2026-02-26 16:06:09", "headline": "Puma Biotechnology Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["PBYI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909253/puma-biotechnology-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50909269, "time": "2026-02-26 16:06:14", "headline": "Earnings Breakdown: Dell Technologies Q4", "summary": " ", "symbols": ["DELL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909269/earnings-breakdown-dell-technologies-q4", "tags": ["earnings"]}
{"id": 50909271, "time": "2026-02-26 16:06:14", "headline": "AvePoint Q4 EPS $0.07 Beats $0.06 Estimate, Sales $114.687M Beat $110.950M Estimate", "summary": "", "symbols": ["AVPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909271/avepoint-q4-eps-0-07-beats-0-06-estimate-sales-114-687m-beat-110-950m-estimate", "tags": ["earnings"]}
{"id": 50909282, "time": "2026-02-26 16:06:19", "headline": "Earnings Breakdown: Personalis Q4", "summary": " ", "symbols": ["PSNL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909282/earnings-breakdown-personalis-q4", "tags": ["earnings"]}
{"id": 50909288, "time": "2026-02-26 16:06:21", "headline": "Definitive Healthcare Q4 Adj. EPS $0.06, Inline, Sales $61.534M Beat $59.569M Estimate", "summary": "", "symbols": ["DH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909288/definitive-healthcare-q4-adj-eps-0-06-inline-sales-61-534m-beat-59-569m-estimate", "tags": ["earnings"]}
{"id": 50909292, "time": "2026-02-26 16:06:23", "headline": "Aurinia Pharmaceuticals (AUPH) Stock Drops After Strong Quarter, Softer Forward Revenue Targets", "summary": "Aurinia Pharmaceuticals shares are trading lower Thursday afternoon after the lupus-focused drugmaker posts a blowout fourth quarter and raises expectations for continued growth in 2026.", "symbols": ["AUPH"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50909292/aurinia-pharmaceuticals-auph-stock-drops-after-strong-quarter-softer-forward-revenue-targets", "tags": ["earnings", "why_moving"]}
{"id": 50909293, "time": "2026-02-26 16:06:23", "headline": "Castle Biosciences Q4 Adj. EPS $(0.08) Beats $(0.29) Estimate, Sales $87.010M Beat $79.048M Estimate", "summary": "", "symbols": ["CSTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909293/castle-biosciences-q4-adj-eps-0-08-beats-0-29-estimate-sales-87-010m-beat-79-048m-estimate", "tags": ["earnings"]}
{"id": 50909294, "time": "2026-02-26 16:06:24", "headline": "Curaleaf Holdings Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["CURLF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909294/curaleaf-holdings-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50909297, "time": "2026-02-26 16:06:25", "headline": "Strategic Education Q4 Adj. EPS $1.75 Beats $1.41 Estimate, Sales $323.210M Beat $322.233M Estimate", "summary": "", "symbols": ["STRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909297/strategic-education-q4-adj-eps-1-75-beats-1-41-estimate-sales-323-210m-beat-322-233m-estimate", "tags": ["earnings"]}
{"id": 50909303, "time": "2026-02-26 16:06:29", "headline": "Pacira BioSciences Q4 Earnings Assessment", "summary": " ", "symbols": ["PCRX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909303/pacira-biosciences-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50909307, "time": "2026-02-26 16:06:31", "headline": "Puma Biotechnology Sees FY2026 Sales $214.000-$221.000M vs $220.000M Est", "summary": "", "symbols": ["PBYI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909307/puma-biotechnology-sees-fy2026-sales-214-000-221-000m-vs-220-000m-est", "tags": []}
{"id": 50909312, "time": "2026-02-26 16:06:34", "headline": "Alpha Teknova: Q4 Earnings Insights", "summary": " ", "symbols": ["TKNO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909312/alpha-teknova-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50909341, "time": "2026-02-26 16:06:46", "headline": "Castle Biosciences Sees FY2026 Sales $340.000M-$350.000M vs $333.778M Est", "summary": "", "symbols": ["CSTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909341/castle-biosciences-sees-fy2026-sales-340-000m-350-000m-vs-333-778m-est", "tags": []}
{"id": 50909344, "time": "2026-02-26 16:06:47", "headline": "Personalis Sees FY2026 Sales $78.000M-$80.000M vs $81.594M Est", "summary": "", "symbols": ["PSNL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909344/personalis-sees-fy2026-sales-78-000m-80-000m-vs-81-594m-est", "tags": []}
{"id": 50909349, "time": "2026-02-26 16:06:49", "headline": "Puma Biotechnology Sees Q1 Sales $38.000M-$42.000M vs $49.000M Est", "summary": "", "symbols": ["PBYI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909349/puma-biotechnology-sees-q1-sales-38-000m-42-000m-vs-49-000m-est", "tags": []}
{"id": 50909370, "time": "2026-02-26 16:06:59", "headline": "Zscaler Raises FY2026 Adj EPS Guidance from $3.78-$3.82 to $3.99-$4.02 vs $3.81 Est; Lowers FY2026 Sales Guidance from $3.698B-$3.718B to $3.309B-$3.322B vs $3.296B Est", "summary": "", "symbols": ["ZS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909370/zscaler-raises-fy2026-adj-eps-guidance-from-3-78-3-82-to-3-99-4-02-vs-3-81-est-lowers-fy2026-sales-g", "tags": ["earnings", "guidance"]}
{"id": 50909383, "time": "2026-02-26 16:07:02", "headline": "Definitive Healthcare Sees Q1 Adj EPS $0.03 vs $0.06 Est; Sees Sales $54.000M-$56.000M vs $57.228M Est", "summary": "", "symbols": ["DH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909383/definitive-healthcare-sees-q1-adj-eps-0-03-vs-0-06-est-sees-sales-54-000m-56-000m-vs-57-228m-est", "tags": ["earnings"]}
{"id": 50909423, "time": "2026-02-26 16:07:22", "headline": "Fidus Investment Q4 Adj. EPS $0.52 Beats $0.49 Estimate, Sales $42.153M Beat $39.375M Estimate", "summary": "", "symbols": ["FDUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909423/fidus-investment-q4-adj-eps-0-52-beats-0-49-estimate-sales-42-153m-beat-39-375m-estimate", "tags": ["earnings"]}
{"id": 50909431, "time": "2026-02-26 16:07:27", "headline": "Definitive Healthcare Sees FY2026 Adj EPS $0.14-$0.17 vs $0.26 Est; Sees Sales $220.000M-$226.000M vs $234.138M Est", "summary": "", "symbols": ["DH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909431/definitive-healthcare-sees-fy2026-adj-eps-0-14-0-17-vs-0-26-est-sees-sales-220-000m-226-000m-vs-234", "tags": ["earnings"]}
{"id": 50909440, "time": "2026-02-26 16:07:29", "headline": "Zscaler Sees Q3 Adj EPS $1.00-$1.01 vs $0.95 Est; Sees Sales $834.000M-$836.000M vs $831.884M Est", "summary": "", "symbols": ["ZS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909440/zscaler-sees-q3-adj-eps-1-00-1-01-vs-0-95-est-sees-sales-834-000m-836-000m-vs-831-884m-est", "tags": ["earnings"]}
{"id": 50909455, "time": "2026-02-26 16:07:35", "headline": "Flutter Entertainment Q4 Adj. EPS $1.74 Misses $1.99 Estimate, Sales $4.737B Miss $4.973B Estimate", "summary": "", "symbols": ["FLUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909455/flutter-entertainment-q4-adj-eps-1-74-misses-1-99-estimate-sales-4-737b-miss-4-973b-estimate", "tags": ["earnings"]}
{"id": 50909462, "time": "2026-02-26 16:07:40", "headline": "Dell Technologies Sees Q1 Adj EPS $2.90 vs $2.37 Est; Sees Sales $34.700B-$35.700B vs $29.128B Est", "summary": "", "symbols": ["DELL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909462/dell-technologies-sees-q1-adj-eps-2-90-vs-2-37-est-sees-sales-34-700b-35-700b-vs-29-128b-est", "tags": ["earnings"]}
{"id": 50909468, "time": "2026-02-26 16:07:41", "headline": "Amphastar Pharma Q4 Adj. EPS $0.73 Misses $0.92 Estimate, Sales $183.105M Miss $190.480M Estimate", "summary": "", "symbols": ["AMPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909468/amphastar-pharma-q4-adj-eps-0-73-misses-0-92-estimate-sales-183-105m-miss-190-480m-estimate", "tags": ["earnings"]}
{"id": 50909469, "time": "2026-02-26 16:07:42", "headline": "Pacira BioSciences Sees FY2026 Sales $745.000M-$770.000M vs $790.214M Est.", "summary": "", "symbols": ["PCRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909469/pacira-biosciences-sees-fy2026-sales-745-000m-770-000m-vs-790-214m-est", "tags": []}
{"id": 50909477, "time": "2026-02-26 16:07:44", "headline": "Duolingo Sees Q1 Sales $288.500M vs $290.516M Est", "summary": "", "symbols": ["DUOL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909477/duolingo-sees-q1-sales-288-500m-vs-290-516m-est", "tags": []}
{"id": 50909486, "time": "2026-02-26 16:07:49", "headline": "Dell Technologies Sees Q1 GAAP EPS $2.55 vs $1.96 Est", "summary": "", "symbols": ["DELL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909486/dell-technologies-sees-q1-gaap-eps-2-55-vs-1-96-est", "tags": ["earnings"]}
{"id": 50909489, "time": "2026-02-26 16:07:51", "headline": "TTEC Holdings Q4 Adj. EPS $0.47 Beats $0.36 Estimate, Sales $570.000M Beat $514.519M Estimate", "summary": "", "symbols": ["TTEC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909489/ttec-holdings-q4-adj-eps-0-47-beats-0-36-estimate-sales-570-000m-beat-514-519m-estimate", "tags": ["earnings"]}
{"id": 50909496, "time": "2026-02-26 16:07:55", "headline": "Duolingo Sees FY2026 Sales $1.197B-$1.221B vs $1.264B Est", "summary": "", "symbols": ["DUOL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909496/duolingo-sees-fy2026-sales-1-197b-1-221b-vs-1-264b-est", "tags": []}
{"id": 50909510, "time": "2026-02-26 16:08:03", "headline": "Arlo Technologies Q4 Adj. EPS $0.22 Beats $0.16 Estimate, Sales $141.297M Beat $135.574M Estimate", "summary": "", "symbols": ["ARLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909510/arlo-technologies-q4-adj-eps-0-22-beats-0-16-estimate-sales-141-297m-beat-135-574m-estimate", "tags": ["earnings"]}
{"id": 50909513, "time": "2026-02-26 16:08:03", "headline": "Dell Technologies Sees FY2027 Adj EPS $12.90 vs $11.59 Est; Sees Sales $138.000B-$142.000B vs $125.539B Est", "summary": "", "symbols": ["DELL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909513/dell-technologies-sees-fy2027-adj-eps-12-90-vs-11-59-est-sees-sales-138-000b-142-000b-vs-125-539b-es", "tags": ["earnings"]}
{"id": 50909526, "time": "2026-02-26 16:08:11", "headline": "Earnings Summary: TTEC Holdings Q4", "summary": " ", "symbols": ["TTEC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909526/earnings-summary-ttec-holdings-q4", "tags": ["earnings"]}
{"id": 50909527, "time": "2026-02-26 16:08:12", "headline": "Elastic Q3 Adj. EPS $0.73 Beats $0.65 Estimate, Sales $449.881M Beat $438.481M Estimate", "summary": "", "symbols": ["ESTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909527/elastic-q3-adj-eps-0-73-beats-0-65-estimate-sales-449-881m-beat-438-481m-estimate", "tags": ["earnings"]}
{"id": 50909533, "time": "2026-02-26 16:08:15", "headline": "Earnings Summary: Amphastar Pharma Q4", "summary": " ", "symbols": ["AMPH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909533/earnings-summary-amphastar-pharma-q4", "tags": ["earnings"]}
{"id": 50909534, "time": "2026-02-26 16:08:16", "headline": "Starz Entertainment Q4 EPS $(1.24) Misses $(0.94) Estimate, Sales $322.800M Miss $327.350M Estimate", "summary": "", "symbols": ["STRZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909534/starz-entertainment-q4-eps-1-24-misses-0-94-estimate-sales-322-800m-miss-327-350m-estimate", "tags": ["earnings"]}
{"id": 50909537, "time": "2026-02-26 16:08:17", "headline": "Dell Technologies Sees FY2027 GAAP EPS $11.52 vs $9.61 Est", "summary": "", "symbols": ["DELL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909537/dell-technologies-sees-fy2027-gaap-eps-11-52-vs-9-61-est", "tags": ["earnings"]}
{"id": 50909549, "time": "2026-02-26 16:08:20", "headline": "Earnings Breakdown: Fidus Investment Q4", "summary": " ", "symbols": ["FDUS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909549/earnings-breakdown-fidus-investment-q4", "tags": ["earnings"]}
{"id": 50909557, "time": "2026-02-26 16:08:24", "headline": "Strategic Education: Q4 Earnings Insights", "summary": " ", "symbols": ["STRA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909557/strategic-education-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50909564, "time": "2026-02-26 16:08:29", "headline": "Castle Biosciences Q4 Earnings Assessment", "summary": " ", "symbols": ["CSTL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909564/castle-biosciences-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50909574, "time": "2026-02-26 16:08:33", "headline": "Diamondrock Hospitality Q4 FFO $0.27 Beats $0.23 Estimate, Sales $274.534M Beat $273.818M Estimate", "summary": "", "symbols": ["DRH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909574/diamondrock-hospitality-q4-ffo-0-27-beats-0-23-estimate-sales-274-534m-beat-273-818m-estimate", "tags": []}
{"id": 50909575, "time": "2026-02-26 16:08:34", "headline": "Definitive Healthcare Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["DH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909575/definitive-healthcare-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50909585, "time": "2026-02-26 16:08:38", "headline": "Flutter Entertainment FY2026  Revenue expected to be more than $18.400B vs $19.344B Est", "summary": "", "symbols": ["FLUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909585/flutter-entertainment-fy2026-revenue-expected-to-be-more-than-18-400b-vs-19-344b-est", "tags": ["earnings"]}
{"id": 50909586, "time": "2026-02-26 16:08:38", "headline": "Earnings Summary: AvePoint Q4", "summary": " ", "symbols": ["AVPT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909586/earnings-summary-avepoint-q4", "tags": ["earnings"]}
{"id": 50909587, "time": "2026-02-26 16:08:39", "headline": "Innodata Q4 EPS $0.25 Beats $0.21 Estimate, Sales $72.376M Beat $69.466M Estimate", "summary": "", "symbols": ["INOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909587/innodata-q4-eps-0-25-beats-0-21-estimate-sales-72-376m-beat-69-466m-estimate", "tags": ["earnings"]}
{"id": 50909593, "time": "2026-02-26 16:08:43", "headline": "Insights into Zscaler Q2 Earnings", "summary": " ", "symbols": ["ZS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909593/insights-into-zscaler-q2-earnings", "tags": ["earnings"]}
{"id": 50909615, "time": "2026-02-26 16:08:51", "headline": "Elastic Sees Q4 Adj EPS $0.55-$0.57 vs $0.56 Est; Sees Sales $445.000M-$447.000M vs $442.471M Est", "summary": "", "symbols": ["ESTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909615/elastic-sees-q4-adj-eps-0-55-0-57-vs-0-56-est-sees-sales-445-000m-447-000m-vs-442-471m-est", "tags": ["earnings"]}
{"id": 50909625, "time": "2026-02-26 16:08:55", "headline": "Arlo Technologies Sees Q1 GAAP EPS $0.01-$0.07 vs $0.06 Est; Sees Sales $135.000M-$145.000M", "summary": "", "symbols": ["ARLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909625/arlo-technologies-sees-q1-gaap-eps-0-01-0-07-vs-0-06-est-sees-sales-135-000m-145-000m", "tags": ["earnings"]}
{"id": 50909637, "time": "2026-02-26 16:09:01", "headline": "TTEC Holdings Sees FY2026 Adj EPS $1.06-$1.32 vs $1.33 Est; Sees Sales $2.005B-$2.055B vs $2.081B Est", "summary": "", "symbols": ["TTEC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909637/ttec-holdings-sees-fy2026-adj-eps-1-06-1-32-vs-1-33-est-sees-sales-2-005b-2-055b-vs-2-081b-est", "tags": ["earnings"]}
{"id": 50909665, "time": "2026-02-26 16:09:18", "headline": "Rocket Companies Q4 Adj. EPS $0.11 Beats $0.09 Estimate, Sales $2.440B Beat $2.255B Estimate", "summary": "", "symbols": ["RKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909665/rocket-companies-q4-adj-eps-0-11-beats-0-09-estimate-sales-2-440b-beat-2-255b-estimate", "tags": ["earnings"]}
{"id": 50909672, "time": "2026-02-26 16:09:21", "headline": "Elastic Raises FY2026 Adj EPS Guidance from $2.40-$2.46 to $2.50-$2.54 vs $2.45 Est; Raises FY2026 Sales Guidance from $1.715B-$1.721B to $1.734B-$1.736B vs $1.720B Est", "summary": "", "symbols": ["ESTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909672/elastic-raises-fy2026-adj-eps-guidance-from-2-40-2-46-to-2-50-2-54-vs-2-45-est-raises-fy2026-sales-g", "tags": ["earnings", "guidance"]}
{"id": 50909673, "time": "2026-02-26 16:09:21", "headline": "Syndax Pharmaceuticals Q4 EPS $(0.78) Misses $(0.58) Estimate, Sales $68.728M Beat $63.968M Estimate.", "summary": "", "symbols": ["SNDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909673/syndax-pharmaceuticals-q4-eps-0-78-misses-0-58-estimate-sales-68-728m-beat-63-968m-estimate", "tags": ["earnings"]}
{"id": 50909680, "time": "2026-02-26 16:09:24", "headline": "Nerdy Q4 EPS $(0.08) Misses $(0.05) Estimate, Sales $49.111M Beat $45.950M Estimate", "summary": "", "symbols": ["NRDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909680/nerdy-q4-eps-0-08-misses-0-05-estimate-sales-49-111m-beat-45-950m-estimate", "tags": ["earnings"]}
{"id": 50909682, "time": "2026-02-26 16:09:24", "headline": "Arlo Technologies Sees Q1 Adj EPS $0.17-$0.23 vs $0.17 Est; Sees Sales $135.000M-$145.000M vs $132.149M Est", "summary": "", "symbols": ["ARLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909682/arlo-technologies-sees-q1-adj-eps-0-17-0-23-vs-0-17-est-sees-sales-135-000m-145-000m-vs-132-149m-est", "tags": ["earnings"]}
{"id": 50909692, "time": "2026-02-26 16:09:30", "headline": "Nerdy Sees Q1 Sales $46.000M-$48.000M vs $47.400M Est", "summary": "", "symbols": ["NRDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909692/nerdy-sees-q1-sales-46-000m-48-000m-vs-47-400m-est", "tags": []}
{"id": 50909699, "time": "2026-02-26 16:09:34", "headline": "Applied Optoelectronics Q4 Adj. EPS $(0.01) Beats $(0.11) Estimate, Sales $134.274M Beat $134.120M Estimate", "summary": "", "symbols": ["AAOI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909699/applied-optoelectronics-q4-adj-eps-0-01-beats-0-11-estimate-sales-134-274m-beat-134-120m-estimate", "tags": ["earnings"]}
{"id": 50909705, "time": "2026-02-26 16:09:39", "headline": "Rocket Companies Sees Q1 Sales $2.600B-$2.800B vs $2.374B Est", "summary": "", "symbols": ["RKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909705/rocket-companies-sees-q1-sales-2-600b-2-800b-vs-2-374b-est", "tags": []}
{"id": 50909709, "time": "2026-02-26 16:09:40", "headline": "nLight Q4 Adj. EPS $0.14 Beats $0.11 Estimate, Sales $81.185M Beat $76.713M Estimate", "summary": "", "symbols": ["LASR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909709/nlight-q4-adj-eps-0-14-beats-0-11-estimate-sales-81-185m-beat-76-713m-estimate", "tags": ["earnings"]}
{"id": 50909711, "time": "2026-02-26 16:09:40", "headline": "Diamondrock Hospitality Sees FY2026 FFO $1.09-$1.16", "summary": "", "symbols": ["DRH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909711/diamondrock-hospitality-sees-fy2026-ffo-1-09-1-16", "tags": []}
{"id": 50909712, "time": "2026-02-26 16:09:41", "headline": "Nerdy Sees FY2026 Sales $180.000M-$190.000M vs $186.000M Est", "summary": "", "symbols": ["NRDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909712/nerdy-sees-fy2026-sales-180-000m-190-000m-vs-186-000m-est", "tags": []}
{"id": 50909720, "time": "2026-02-26 16:09:48", "headline": "Evertec Q4 Adj. EPS $0.93 Beats $0.89 Estimate, Sales $241.124M Beat $236.818M Estimate", "summary": "", "symbols": ["EVTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909720/evertec-q4-adj-eps-0-93-beats-0-89-estimate-sales-241-124m-beat-236-818m-estimate", "tags": ["earnings"]}
{"id": 50909727, "time": "2026-02-26 16:09:53", "headline": "FIGS Q4 EPS $0.10 Beats $0.02 Estimate, Sales $201.896M Beat $165.324M Estimate", "summary": "", "symbols": ["FIGS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909727/figs-q4-eps-0-10-beats-0-02-estimate-sales-201-896m-beat-165-324m-estimate", "tags": ["earnings"]}
{"id": 50909735, "time": "2026-02-26 16:09:58", "headline": "Duolingo Q4 Sales $282.868M Beat $275.925M Estimate", "summary": "", "symbols": ["DUOL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909735/duolingo-q4-sales-282-868m-beat-275-925m-estimate", "tags": []}
{"id": 50909751, "time": "2026-02-26 16:10:04", "headline": "Intuit Sees Q3 GAAP EPS $10.56-$10.62 vs $11.27 Est", "summary": "", "symbols": ["INTU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909751/intuit-sees-q3-gaap-eps-10-56-10-62-vs-11-27-est", "tags": ["earnings"]}
{"id": 50909760, "time": "2026-02-26 16:10:09", "headline": "Cytek Biosciences Q4 EPS $(0.34) Misses $(0.02) Estimate, Sales $62.141M Beat $57.187M Estimate", "summary": "", "symbols": ["CTKB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909760/cytek-biosciences-q4-eps-0-34-misses-0-02-estimate-sales-62-141m-beat-57-187m-estimate", "tags": ["earnings"]}
{"id": 50909763, "time": "2026-02-26 16:10:10", "headline": "Earnings Breakdown: Cytek Biosciences Q4", "summary": " ", "symbols": ["CTKB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909763/earnings-breakdown-cytek-biosciences-q4", "tags": ["earnings"]}
{"id": 50909776, "time": "2026-02-26 16:10:15", "headline": "Insights into FIGS Q4 Earnings", "summary": " ", "symbols": ["FIGS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909776/insights-into-figs-q4-earnings", "tags": ["earnings"]}
{"id": 50909787, "time": "2026-02-26 16:10:20", "headline": "Earnings Breakdown: Applied Optoelectronics Q4", "summary": " ", "symbols": ["AAOI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909787/earnings-breakdown-applied-optoelectronics-q4", "tags": ["earnings"]}
{"id": 50909794, "time": "2026-02-26 16:10:24", "headline": "Applied Optoelectronics Q1  expected to be more than $(0.09) vs $(0.05) Est; Sees Q1 Sales $150.000M-$165.000M vs $145.283M Est", "summary": "", "symbols": ["AAOI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909794/applied-optoelectronics-q1-expected-to-be-more-than-0-09-vs-0-05-est-sees-q1-sales-150-000m-165-000m", "tags": []}
{"id": 50909800, "time": "2026-02-26 16:10:25", "headline": "Nerdy Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["NRDY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909800/nerdy-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50909802, "time": "2026-02-26 16:10:25", "headline": "MP Materials Q4 Adj. EPS $0.09 Beats $0.00 Estimate, Sales $52.685M Miss $67.382M Estimate", "summary": "", "symbols": ["MP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909802/mp-materials-q4-adj-eps-0-09-beats-0-00-estimate-sales-52-685m-miss-67-382m-estimate", "tags": ["earnings"]}
{"id": 50909812, "time": "2026-02-26 16:10:30", "headline": "Insights into Syndax Pharmaceuticals Q4 Earnings", "summary": " ", "symbols": ["SNDX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909812/insights-into-syndax-pharmaceuticals-q4-earnings", "tags": ["earnings"]}
{"id": 50909820, "time": "2026-02-26 16:10:33", "headline": "nLight Sees Q1 Sales $70.000M-$76.000M vs $67.427M Est", "summary": "", "symbols": ["LASR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909820/nlight-sees-q1-sales-70-000m-76-000m-vs-67-427m-est", "tags": []}
{"id": 50909823, "time": "2026-02-26 16:10:35", "headline": "Rocket Companies Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["RKT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909823/rocket-companies-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50909832, "time": "2026-02-26 16:10:38", "headline": "Evertec Sees FY2026 Adj EPS $3.84-$3.96 vs $3.75 Est; Sees Sales $1.024B-$1.036B vs $975.941M Est", "summary": "", "symbols": ["EVTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909832/evertec-sees-fy2026-adj-eps-3-84-3-96-vs-3-75-est-sees-sales-1-024b-1-036b-vs-975-941m-est", "tags": ["earnings"]}
{"id": 50909833, "time": "2026-02-26 16:10:39", "headline": "Cytek Biosciences Sees FY2026 Sales $205.000M-$212.000M vs $207.058M Est", "summary": "", "symbols": ["CTKB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909833/cytek-biosciences-sees-fy2026-sales-205-000m-212-000m-vs-207-058m-est", "tags": []}
{"id": 50909836, "time": "2026-02-26 16:10:40", "headline": "Innodata Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["INOD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909836/innodata-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50909839, "time": "2026-02-26 16:10:40", "headline": "FIGS Sees FY26 Net Revenue Growth Up 10%-12% YoY", "summary": "", "symbols": ["FIGS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909839/figs-sees-fy26-net-revenue-growth-up-10-12-yoy", "tags": ["earnings"]}
{"id": 50909842, "time": "2026-02-26 16:10:41", "headline": "The Baldwin Insurance Q4 Adj. EPS $0.31 Beats $0.29 Estimate, Sales $347.279M Miss $351.988M Estimate", "summary": "", "symbols": ["BWIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909842/the-baldwin-insurance-q4-adj-eps-0-31-beats-0-29-estimate-sales-347-279m-miss-351-988m-estimate", "tags": ["earnings"]}
{"id": 50909852, "time": "2026-02-26 16:10:45", "headline": "Earnings Breakdown: Diamondrock Hospitality Q4", "summary": " ", "symbols": ["DRH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909852/earnings-breakdown-diamondrock-hospitality-q4", "tags": ["earnings"]}
{"id": 50909861, "time": "2026-02-26 16:10:50", "headline": "Elastic Q3 Earnings Assessment", "summary": " ", "symbols": ["ESTC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50909861/elastic-q3-earnings-assessment", "tags": ["earnings"]}
{"id": 50909866, "time": "2026-02-26 16:10:53", "headline": "Fox Factory Hldg Q4 Adj. EPS $0.20 Beats $0.15 Estimate, Sales $361.072M Beat $353.877M Estimate", "summary": "", "symbols": ["FOXF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909866/fox-factory-hldg-q4-adj-eps-0-20-beats-0-15-estimate-sales-361-072m-beat-353-877m-estimate", "tags": ["earnings"]}
{"id": 50909870, "time": "2026-02-26 16:10:54", "headline": "Monster Beverage Q4 Adj. EPS $0.51 Beats $0.48 Estimate, Sales $2.131B Beat $2.040B Estimate", "summary": "", "symbols": ["MNST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909870/monster-beverage-q4-adj-eps-0-51-beats-0-48-estimate-sales-2-131b-beat-2-040b-estimate", "tags": ["earnings"]}
{"id": 50909880, "time": "2026-02-26 16:10:59", "headline": "Emergent BioSolutions Q4 Adj. EPS $(0.43) Misses $0.11 Estimate, Sales $148.700M Miss $217.500M Estimate", "summary": "", "symbols": ["EBS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909880/emergent-biosolutions-q4-adj-eps-0-43-misses-0-11-estimate-sales-148-700m-miss-217-500m-estimate", "tags": ["earnings"]}
{"id": 50909886, "time": "2026-02-26 16:11:01", "headline": "Natera Q4 Sales $665.500M Beat $592.417M Estimate", "summary": "", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909886/natera-q4-sales-665-500m-beat-592-417m-estimate", "tags": []}
{"id": 50909909, "time": "2026-02-26 16:11:15", "headline": "Block Inc Expects To Reduce Workforce By More Than 40%", "summary": "", "symbols": ["XYZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909909/block-inc-expects-to-reduce-workforce-by-more-than-40", "tags": []}
{"id": 50909958, "time": "2026-02-26 16:11:34", "headline": "OneStream Q4 Adj. EPS $0.12 Beats $0.05 Estimate, Sales $163.732M Beat $157.282M Estimate", "summary": "", "symbols": ["OS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909958/onestream-q4-adj-eps-0-12-beats-0-05-estimate-sales-163-732m-beat-157-282m-estimate", "tags": ["earnings"]}
{"id": 50909960, "time": "2026-02-26 16:11:35", "headline": "Intuit Sees Q3 Adj EPS $12.45-$12.51 vs $12.96 Est; Sees Sales $8.529B vs $8.522B Est", "summary": "", "symbols": ["INTU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50909960/intuit-sees-q3-adj-eps-12-45-12-51-vs-12-96-est-sees-sales-8-529b-vs-8-522b-est", "tags": ["earnings"]}
{"id": 50909977, "time": "2026-02-26 16:11:42", "headline": "Rocket Lab USA Q4 EPS $(0.09) Beats $(0.10) Estimate, Sales $179.652M Beat $178.471M Estimate", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909977/rocket-lab-usa-q4-eps-0-09-beats-0-10-estimate-sales-179-652m-beat-178-471m-estimate", "tags": ["earnings"]}
{"id": 50909992, "time": "2026-02-26 16:11:47", "headline": "Willdan Group Q4 Adj. EPS $1.57 Beats $0.92 Estimate, Sales $89.507M Miss $89.533M Estimate", "summary": "", "symbols": ["WLDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50909992/willdan-group-q4-adj-eps-1-57-beats-0-92-estimate-sales-89-507m-miss-89-533m-estimate", "tags": ["earnings"]}
{"id": 50910000, "time": "2026-02-26 16:11:50", "headline": "National Health Investors Q4 FFO $1.22, Inline, Sales $105.823M Beat $94.123M Estimate", "summary": "", "symbols": ["NHI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910000/national-health-investors-q4-ffo-1-22-inline-sales-105-823m-beat-94-123m-estimate", "tags": []}
{"id": 50910009, "time": "2026-02-26 16:11:56", "headline": "OrthoPediatrics Q4 Adj. EPS $(0.26) Beats $(0.34) Estimate, Sales $61.605M Beat $59.949M Estimate", "summary": "", "symbols": ["KIDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910009/orthopediatrics-q4-adj-eps-0-26-beats-0-34-estimate-sales-61-605m-beat-59-949m-estimate", "tags": ["earnings"]}
{"id": 50910026, "time": "2026-02-26 16:12:02", "headline": "Baldwin Group Board Authorized $250M Stock Buyback", "summary": "", "symbols": ["BWIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910026/baldwin-group-board-authorized-250m-stock-buyback", "tags": ["buyback"]}
{"id": 50910046, "time": "2026-02-26 16:12:10", "headline": "The Apple Catalyst Investors Could Be Missing And Why It Might Mean More iPhones Sold", "summary": "A potential launch of something from Apple could be a catalyst investors are missing and it&#39;s not new phones.", "symbols": ["AAPL", "AMZN", "GOOGL", "MA", "V", "WMT"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/markets/asia/26/02/50910046/the-apple-catalyst-investors-could-be-missing-and-why-it-might-mean-more-iphones-sold", "tags": []}
{"id": 50910050, "time": "2026-02-26 16:12:12", "headline": "Earnings Breakdown: National Health Investors Q4", "summary": " ", "symbols": ["NHI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910050/earnings-breakdown-national-health-investors-q4", "tags": ["earnings"]}
{"id": 50910060, "time": "2026-02-26 16:12:16", "headline": "Fox Factory Holding Sees Q1 Sales $343.000M-$369.000M vs $356.864M Est", "summary": "", "symbols": ["FOXF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910060/fox-factory-holding-sees-q1-sales-343-000m-369-000m-vs-356-864m-est", "tags": []}
{"id": 50910061, "time": "2026-02-26 16:12:17", "headline": "Rocket Lab Q4 Earnings Assessment", "summary": " ", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910061/rocket-lab-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50910063, "time": "2026-02-26 16:12:17", "headline": "Emergent BioSolutions Sees FY2026 Sales $720.000M-$760.000M vs $1.155B Est", "summary": "", "symbols": ["EBS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910063/emergent-biosolutions-sees-fy2026-sales-720-000m-760-000m-vs-1-155b-est", "tags": []}
{"id": 50910066, "time": "2026-02-26 16:12:18", "headline": "Rocket Lab Sees Q1 Sales $185.000M-$200.000M vs $184.981M Est", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910066/rocket-lab-sees-q1-sales-185-000m-200-000m-vs-184-981m-est", "tags": []}
{"id": 50910071, "time": "2026-02-26 16:12:21", "headline": "Willdan Group Sees FY2026 Adj EPS $4.50-$4.70 vs $4.33 Est; Sees Sales $390.000M-$405.000M vs $391.267M Est", "summary": "", "symbols": ["WLDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910071/willdan-group-sees-fy2026-adj-eps-4-50-4-70-vs-4-33-est-sees-sales-390-000m-405-000m-vs-391-267m-est", "tags": ["earnings"]}
{"id": 50910072, "time": "2026-02-26 16:12:22", "headline": "OneStream Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["OS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910072/onestream-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50910076, "time": "2026-02-26 16:12:23", "headline": "National Health Investors Sees FY2026 FFO $4.94-$4.99 vs $5.12 Est", "summary": "", "symbols": ["NHI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910076/national-health-investors-sees-fy2026-ffo-4-94-4-99-vs-5-12-est", "tags": []}
{"id": 50910080, "time": "2026-02-26 16:12:26", "headline": "Earnings Summary: Emergent BioSolutions Q4", "summary": " ", "symbols": ["EBS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910080/earnings-summary-emergent-biosolutions-q4", "tags": ["earnings"]}
{"id": 50910083, "time": "2026-02-26 16:12:27", "headline": "Fox Factory Holding Sees FY2026 Sales $1.328B-$1.416B vs $1.512B Est", "summary": "", "symbols": ["FOXF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910083/fox-factory-holding-sees-fy2026-sales-1-328b-1-416b-vs-1-512b-est", "tags": []}
{"id": 50910089, "time": "2026-02-26 16:12:31", "headline": "Fox Factory Holding Earnings Report: Q4 Overview", "summary": " ", "symbols": ["FOXF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910089/fox-factory-holding-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50910096, "time": "2026-02-26 16:12:37", "headline": "Monster Beverage Earnings Review: Q4 Summary", "summary": " ", "symbols": ["MNST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910096/monster-beverage-earnings-review-q4-summary", "tags": ["earnings"]}
{"id": 50910097, "time": "2026-02-26 16:12:37", "headline": "OrthoPediatrics Sees FY2026 Sales $262.000M-$266.000M vs $263.431M Est", "summary": "", "symbols": ["KIDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910097/orthopediatrics-sees-fy2026-sales-262-000m-266-000m-vs-263-431m-est", "tags": []}
{"id": 50910106, "time": "2026-02-26 16:12:42", "headline": "Earnings Summary: Baldwin Insurance Q4", "summary": " ", "symbols": ["BWIN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910106/earnings-summary-baldwin-insurance-q4", "tags": ["earnings"]}
{"id": 50910115, "time": "2026-02-26 16:12:49", "headline": "nLight Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["LASR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910115/nlight-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50910118, "time": "2026-02-26 16:12:49", "headline": "Ambarella Q4 Adj. EPS $0.13 Beats $0.10 Estimate, Sales $100.867M Beat $100.183M Estimate", "summary": "", "symbols": ["AMBA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910118/ambarella-q4-adj-eps-0-13-beats-0-10-estimate-sales-100-867m-beat-100-183m-estimate", "tags": ["earnings"]}
{"id": 50910141, "time": "2026-02-26 16:13:05", "headline": "Aeva Technologies Q4 Adj. EPS $(0.40) Beats $(0.44) Estimate, Sales $5.621M Beat $4.323M Estimate", "summary": "", "symbols": ["AEVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910141/aeva-technologies-q4-adj-eps-0-40-beats-0-44-estimate-sales-5-621m-beat-4-323m-estimate", "tags": ["earnings"]}
{"id": 50910152, "time": "2026-02-26 16:13:12", "headline": "Curaleaf Holdings Q4 Adj. EPS $(0.05) Beats $(0.09) Estimate, Sales $333.068M Beat $329.142M Estimate", "summary": "", "symbols": ["TSX:CURA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910152/curaleaf-holdings-q4-adj-eps-0-05-beats-0-09-estimate-sales-333-068m-beat-329-142m-estimate", "tags": ["earnings"]}
{"id": 50910164, "time": "2026-02-26 16:13:16", "headline": "Ambarella Sees Q1 Sales $97.000M-$103.000M vs $97.088M Est", "summary": "", "symbols": ["AMBA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910164/ambarella-sees-q1-sales-97-000m-103-000m-vs-97-088m-est", "tags": []}
{"id": 50910177, "time": "2026-02-26 16:13:21", "headline": "Seer Q4 EPS $(0.29) Beats $(0.32) Estimate, Sales $4.201M Miss $4.600M Estimate", "summary": "", "symbols": ["SEER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910177/seer-q4-eps-0-29-beats-0-32-estimate-sales-4-201m-miss-4-600m-estimate", "tags": ["earnings"]}
{"id": 50910207, "time": "2026-02-26 16:13:32", "headline": "PubMatic Q4 Adj. EPS $0.29 Beats $(0.01) Estimate, Sales $80.046M Beat $75.294M Estimate", "summary": "", "symbols": ["PUBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910207/pubmatic-q4-adj-eps-0-29-beats-0-01-estimate-sales-80-046m-beat-75-294m-estimate", "tags": ["earnings"]}
{"id": 50910213, "time": "2026-02-26 16:13:34", "headline": "Natera Sees FY2026 Sales $2.620B-$2.700B vs $2.605B Est", "summary": "", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910213/natera-sees-fy2026-sales-2-620b-2-700b-vs-2-605b-est", "tags": []}
{"id": 50910238, "time": "2026-02-26 16:13:46", "headline": "BioLife Solns Q4 Adj. EPS $0.04 Beats $(0.02) Estimate, Sales $24.764M Beat $24.082M Estimate.", "summary": "", "symbols": ["BLFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910238/biolife-solns-q4-adj-eps-0-04-beats-0-02-estimate-sales-24-764m-beat-24-082m-estimate", "tags": ["earnings"]}
{"id": 50910244, "time": "2026-02-26 16:13:47", "headline": "Relay Therapeutics Q4 EPS $(0.32) Beats $(0.39) Estimate, Sales $7.000M Beat $4.966M Estimate", "summary": "", "symbols": ["RLAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910244/relay-therapeutics-q4-eps-0-32-beats-0-39-estimate-sales-7-000m-beat-4-966m-estimate", "tags": ["earnings"]}
{"id": 50910245, "time": "2026-02-26 16:13:47", "headline": "Seer Sees FY2026 Sales $16.000M-$18.000M vs $22.100M Est", "summary": "", "symbols": ["SEER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910245/seer-sees-fy2026-sales-16-000m-18-000m-vs-22-100m-est", "tags": []}
{"id": 50910258, "time": "2026-02-26 16:13:55", "headline": "Solventum Q4 Adj. EPS $1.57 Beats $1.50 Estimate, Sales $1.998B Beat $1.962B Estimate", "summary": "", "symbols": ["SOLV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910258/solventum-q4-adj-eps-1-57-beats-1-50-estimate-sales-1-998b-beat-1-962b-estimate", "tags": ["earnings"]}
{"id": 50910262, "time": "2026-02-26 16:13:59", "headline": "OPKO Health Q4 EPS $(0.04) Beats $(0.07) Estimate, Sales $148.500M Beat $139.757M Estimate", "summary": "", "symbols": ["OPK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910262/opko-health-q4-eps-0-04-beats-0-07-estimate-sales-148-500m-beat-139-757m-estimate", "tags": ["earnings"]}
{"id": 50910276, "time": "2026-02-26 16:14:06", "headline": "PubMatic Sees Q1 Sales $58.000M-$60.000M vs $57.610M Est", "summary": "", "symbols": ["PUBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910276/pubmatic-sees-q1-sales-58-000m-60-000m-vs-57-610m-est", "tags": []}
{"id": 50910283, "time": "2026-02-26 16:14:12", "headline": "Assured Guaranty Q4 Adj. EPS $2.32 Beats $1.68 Estimate, Sales $277.000M Beat $191.500M Estimate", "summary": "", "symbols": ["AGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910283/assured-guaranty-q4-adj-eps-2-32-beats-1-68-estimate-sales-277-000m-beat-191-500m-estimate", "tags": ["earnings"]}
{"id": 50910284, "time": "2026-02-26 16:14:14", "headline": "Progyny Sees FY2026 Adj EPS $1.83-$1.95 vs $1.55 Est; Sees Sales $1.355B-$1.405B vs $1.392B Est", "summary": "", "symbols": ["PGNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910284/progyny-sees-fy2026-adj-eps-1-83-1-95-vs-1-55-est-sees-sales-1-355b-1-405b-vs-1-392b-est", "tags": ["earnings"]}
{"id": 50910291, "time": "2026-02-26 16:14:17", "headline": "Oportun Financial Q4 Adj. EPS $0.27 Beats $0.24 Estimate, Sales $247.700M Beat $243.133M Estimate", "summary": "", "symbols": ["OPRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910291/oportun-financial-q4-adj-eps-0-27-beats-0-24-estimate-sales-247-700m-beat-243-133m-estimate", "tags": ["earnings"]}
{"id": 50910310, "time": "2026-02-26 16:14:25", "headline": "Sprout Social Q4 Adj. EPS $0.20 Beats $0.16 Estimate, Sales $120.887M Beat $118.767M Estimate", "summary": "", "symbols": ["SPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910310/sprout-social-q4-adj-eps-0-20-beats-0-16-estimate-sales-120-887m-beat-118-767m-estimate", "tags": ["earnings"]}
{"id": 50910315, "time": "2026-02-26 16:14:27", "headline": "Progyny Sees Q1 Adj EPS $0.42-$0.45 vs $0.39 Est; Sees Sales $319.000M-$332.000M vs $344.896M Est", "summary": "", "symbols": ["PGNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910315/progyny-sees-q1-adj-eps-0-42-0-45-vs-0-39-est-sees-sales-319-000m-332-000m-vs-344-896m-est", "tags": ["earnings"]}
{"id": 50910318, "time": "2026-02-26 16:14:29", "headline": "Solventum Sees FY2026 Adj EPS $6.40-$6.60 vs $6.34 Est", "summary": "", "symbols": ["SOLV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910318/solventum-sees-fy2026-adj-eps-6-40-6-60-vs-6-34-est", "tags": ["earnings"]}
{"id": 50910379, "time": "2026-02-26 16:14:54", "headline": "BioLife Solutions Sees FY2026 Sales $112.500M-$115.000M vs $111.058M Est.", "summary": "", "symbols": ["BLFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910379/biolife-solutions-sees-fy2026-sales-112-500m-115-000m-vs-111-058m-est", "tags": []}
{"id": 50910382, "time": "2026-02-26 16:14:58", "headline": "Sprout Social Sees Q1 Adj EPS $0.15-$0.16 vs $0.20 Est; Sees Sales $119.900M-$120.700M vs $121.498M Est", "summary": "", "symbols": ["SPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910382/sprout-social-sees-q1-adj-eps-0-15-0-16-vs-0-20-est-sees-sales-119-900m-120-700m-vs-121-498m-est", "tags": ["earnings"]}
{"id": 50910385, "time": "2026-02-26 16:14:58", "headline": "Rocket Lab USA And BlackSky Technology Sign Multi-Launch Deal To Deploy Black Sky's AI-Enabled Gen-3 Earth Observation Constellation", "summary": "", "symbols": ["BKSY", "RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910385/rocket-lab-usa-and-blacksky-technology-sign-multi-launch-deal-to-deploy-black-skys-ai-enabled-gen-3", "tags": ["contract"]}
{"id": 50910439, "time": "2026-02-26 16:15:09", "headline": "Block Q4 Adj. EPS $0.65, Inline, Sales $6.252B Miss $6.275B Estimate", "summary": "", "symbols": ["XYZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910439/block-q4-adj-eps-0-65-inline-sales-6-252b-miss-6-275b-estimate", "tags": ["earnings"]}
{"id": 50910464, "time": "2026-02-26 16:15:18", "headline": "Oportun Financial Sees Q1 Sales $225.000M-$230.000M vs $241.843M Est", "summary": "", "symbols": ["OPRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910464/oportun-financial-sees-q1-sales-225-000m-230-000m-vs-241-843m-est", "tags": []}
{"id": 50910468, "time": "2026-02-26 16:15:19", "headline": "SoundHound AI Q4 Adj. EPS $(0.02), Inline, Sales $55.059M Beat $53.991M Estimate", "summary": "", "symbols": ["SOUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910468/soundhound-ai-q4-adj-eps-0-02-inline-sales-55-059m-beat-53-991m-estimate", "tags": ["earnings"]}
{"id": 50910473, "time": "2026-02-26 16:15:22", "headline": "Here's How Much You Would Have Made Owning Fastenal Stock In The Last 10 Years", "summary": " ", "symbols": ["FAST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50910473/heres-how-much-you-would-have-made-owning-fastenal-stock-in-the-last-10-years", "tags": []}
{"id": 50910487, "time": "2026-02-26 16:15:23", "headline": "Sprout Social Sees FY2026 Adj EPS $0.88-$0.97 vs $0.90 Est; Sees Sales $490.200M-$495.200M vs $506.572M Est", "summary": "", "symbols": ["SPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910487/sprout-social-sees-fy2026-adj-eps-0-88-0-97-vs-0-90-est-sees-sales-490-200m-495-200m-vs-506-572m-est", "tags": ["earnings"]}
{"id": 50910493, "time": "2026-02-26 16:15:25", "headline": "OPKO Health Sees Q1 Sales $125.000M-$140.000M vs $135.640M Est", "summary": "", "symbols": ["OPK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910493/opko-health-sees-q1-sales-125-000m-140-000m-vs-135-640m-est", "tags": []}
{"id": 50910499, "time": "2026-02-26 16:15:28", "headline": "Oportun Financial Sees FY2026 Adj EPS $1.50-$1.65 vs $1.47 Est; Sees Sales $935.000M-$955.000M vs $990.274M Est", "summary": "", "symbols": ["OPRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910499/oportun-financial-sees-fy2026-adj-eps-1-50-1-65-vs-1-47-est-sees-sales-935-000m-955-000m-vs-990-274m", "tags": ["earnings"]}
{"id": 50910528, "time": "2026-02-26 16:15:50", "headline": "SoundHound AI Sees FY2026 Sales $225.000M-$260.000M vs $230.165M Est", "summary": "", "symbols": ["SOUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910528/soundhound-ai-sees-fy2026-sales-225-000m-260-000m-vs-230-165m-est", "tags": []}
{"id": 50910538, "time": "2026-02-26 16:15:54", "headline": "Caris Life Sciences Q4 EPS $0.28 Beats $(0.03) Estimate, Sales $292.886M Beat $208.626M Estimate", "summary": "", "symbols": ["CAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910538/caris-life-sciences-q4-eps-0-28-beats-0-03-estimate-sales-292-886m-beat-208-626m-estimate", "tags": ["earnings"]}
{"id": 50910555, "time": "2026-02-26 16:16:00", "headline": "Neurogene Announces FDA Breakthrough Therapy Designation For NGN-401 Gene Therapy For Rett Syndrome", "summary": "", "symbols": ["NGNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910555/neurogene-announces-fda-breakthrough-therapy-designation-for-ngn-401-gene-therapy-for-rett-syndrome", "tags": ["fda"]}
{"id": 50910558, "time": "2026-02-26 16:16:01", "headline": "OPKO Health Sees FY2026 Sales $530.000M-$560.000M vs $580.971M Est", "summary": "", "symbols": ["OPK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910558/opko-health-sees-fy2026-sales-530-000m-560-000m-vs-580-971m-est", "tags": []}
{"id": 50910589, "time": "2026-02-26 16:16:13", "headline": "Caris Life Sciences Sees FY2026 Sales $1.000B-$1.020B vs $1.198B Est", "summary": "", "symbols": ["CAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910589/caris-life-sciences-sees-fy2026-sales-1-000b-1-020b-vs-1-198b-est", "tags": []}
{"id": 50910592, "time": "2026-02-26 16:16:15", "headline": "American Healthcares Q4 FFO $0.46, Inline, Sales $604.080M Miss $608.125M Estimate", "summary": "", "symbols": ["AHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910592/american-healthcares-q4-ffo-0-46-inline-sales-604-080m-miss-608-125m-estimate", "tags": []}
{"id": 50910669, "time": "2026-02-26 16:16:49", "headline": "MasTec Q4 Adj. EPS $2.07 Beats $1.95 Estimate, Sales $3.940B Beat $3.713B Estimate", "summary": "", "symbols": ["MTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910669/mastec-q4-adj-eps-2-07-beats-1-95-estimate-sales-3-940b-beat-3-713b-estimate", "tags": ["earnings"]}
{"id": 50910707, "time": "2026-02-26 16:17:08", "headline": "Brink's Q4 Adj. EPS $2.54 Beats $2.47 Estimate, Sales $1.379B Beat $1.354B Estimate", "summary": "", "symbols": ["BCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910707/brinks-q4-adj-eps-2-54-beats-2-47-estimate-sales-1-379b-beat-1-354b-estimate", "tags": ["earnings"]}
{"id": 50910716, "time": "2026-02-26 16:17:12", "headline": "ICF International Q4 Adj. EPS $1.47 Misses $1.49 Estimate, Sales $443.673M Beat $440.942M Estimate", "summary": "", "symbols": ["ICFI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910716/icf-international-q4-adj-eps-1-47-misses-1-49-estimate-sales-443-673m-beat-440-942m-estimate", "tags": ["earnings"]}
{"id": 50910721, "time": "2026-02-26 16:17:13", "headline": "NCR Atleos Q4 Adj. EPS $1.49 Beats $1.36 Estimate, Sales $1.152B Beat $1.147B Estimate", "summary": "", "symbols": ["NATL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910721/ncr-atleos-q4-adj-eps-1-49-beats-1-36-estimate-sales-1-152b-beat-1-147b-estimate", "tags": ["earnings"]}
{"id": 50910724, "time": "2026-02-26 16:17:15", "headline": "Arcosa Q4 Adj. EPS $1.15 Beats $0.92 Estimate, Sales $716.700M Miss $718.440M Estimate", "summary": "", "symbols": ["ACA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910724/arcosa-q4-adj-eps-1-15-beats-0-92-estimate-sales-716-700m-miss-718-440m-estimate", "tags": ["earnings"]}
{"id": 50910751, "time": "2026-02-26 16:17:30", "headline": "American Healthcare REIT Sees FY2026 NFFO $1.99-$2.05 vs $1.98 Est", "summary": "", "symbols": ["AHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910751/american-healthcare-reit-sees-fy2026-nffo-1-99-2-05-vs-1-98-est", "tags": []}
{"id": 50910757, "time": "2026-02-26 16:17:33", "headline": "Xponential Fitness Q4 Adj. EPS $(0.91) Misses $(0.02) Estimate, Sales $82.964M Beat $73.443M Estimate", "summary": "", "symbols": ["XPOF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910757/xponential-fitness-q4-adj-eps-0-91-misses-0-02-estimate-sales-82-964m-beat-73-443m-estimate", "tags": ["earnings"]}
{"id": 50910787, "time": "2026-02-26 16:17:47", "headline": "Airgain Q4 Adj. EPS $0.03 Beats $(0.02) Estimate, Sales $12.125M Miss $12.700M Estimate", "summary": "", "symbols": ["AIRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910787/airgain-q4-adj-eps-0-03-beats-0-02-estimate-sales-12-125m-miss-12-700m-estimate", "tags": ["earnings"]}
{"id": 50910801, "time": "2026-02-26 16:17:53", "headline": "Main Street Capital Q4 Adj. EPS $1.11 Beats $0.98 Estimate, Sales $145.541M Beat $140.545M Estimate", "summary": "", "symbols": ["MAIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910801/main-street-capital-q4-adj-eps-1-11-beats-0-98-estimate-sales-145-541m-beat-140-545m-estimate", "tags": ["earnings"]}
{"id": 50910847, "time": "2026-02-26 16:18:08", "headline": "PACS Group Q4 EPS $0.49 Beats $0.47 Estimate, Sales $1.360B Miss $1.383B Estimate", "summary": "", "symbols": ["PACS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910847/pacs-group-q4-eps-0-49-beats-0-47-estimate-sales-1-360b-miss-1-383b-estimate", "tags": ["earnings"]}
{"id": 50910848, "time": "2026-02-26 16:18:09", "headline": "Arcosa Sees FY2026 Sales $2.950B-$3.100B vs $3.039B Est", "summary": "", "symbols": ["ACA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910848/arcosa-sees-fy2026-sales-2-950b-3-100b-vs-3-039b-est", "tags": []}
{"id": 50910857, "time": "2026-02-26 16:18:13", "headline": "Earnings Breakdown: Airgain Q4", "summary": " ", "symbols": ["AIRG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910857/earnings-breakdown-airgain-q4", "tags": ["earnings"]}
{"id": 50910858, "time": "2026-02-26 16:18:13", "headline": "Xponential Fitness Sees FY2026 Sales $260.000M-$270.000M vs $302.716M Est", "summary": "", "symbols": ["XPOF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910858/xponential-fitness-sees-fy2026-sales-260-000m-270-000m-vs-302-716m-est", "tags": []}
{"id": 50910867, "time": "2026-02-26 16:18:18", "headline": "Xponential Fitness: Q4 Earnings Insights", "summary": " ", "symbols": ["XPOF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910867/xponential-fitness-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50910873, "time": "2026-02-26 16:18:22", "headline": "Brink's Sees Q1 Sales $1.335B-$1.395B vs $1.331B Est", "summary": "", "symbols": ["BCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910873/brinks-sees-q1-sales-1-335b-1-395b-vs-1-331b-est", "tags": []}
{"id": 50910875, "time": "2026-02-26 16:18:22", "headline": "Arcosa Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["ACA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910875/arcosa-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50910882, "time": "2026-02-26 16:18:27", "headline": "NCR Atleos Q4 Earnings Assessment", "summary": " ", "symbols": ["NATL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910882/ncr-atleos-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50910889, "time": "2026-02-26 16:18:31", "headline": "ICF International Earnings Review: Q4 Summary", "summary": " ", "symbols": ["ICFI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910889/icf-international-earnings-review-q4-summary", "tags": ["earnings"]}
{"id": 50910893, "time": "2026-02-26 16:18:36", "headline": "Brink's Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["BCO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910893/brinks-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50910894, "time": "2026-02-26 16:18:36", "headline": "PACS Group Sees FY2026 Sales $5.650B-$5.750B vs $5.724B Est", "summary": "", "symbols": ["PACS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910894/pacs-group-sees-fy2026-sales-5-650b-5-750b-vs-5-724b-est", "tags": []}
{"id": 50910903, "time": "2026-02-26 16:18:40", "headline": "MasTec Sees FY2026 Adj EPS $8.40 vs $8.17 Est; FY2026 Revenue expected to be more than $17.000B vs $15.501B Est", "summary": "", "symbols": ["MTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910903/mastec-sees-fy2026-adj-eps-8-40-vs-8-17-est-fy2026-revenue-expected-to-be-more-than-17-000b-vs-15-50", "tags": ["earnings"]}
{"id": 50910904, "time": "2026-02-26 16:18:41", "headline": "Airgain Sees Q1 GAAP EPS $(0.17) vs $(0.17) Est", "summary": "", "symbols": ["AIRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910904/airgain-sees-q1-gaap-eps-0-17-vs-0-17-est", "tags": ["earnings"]}
{"id": 50910905, "time": "2026-02-26 16:18:41", "headline": "American Healthcare REIT Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["AHR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910905/american-healthcare-reit-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50910914, "time": "2026-02-26 16:18:46", "headline": "SoundHound AI: Q4 Earnings Insights", "summary": " ", "symbols": ["SOUN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910914/soundhound-ai-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50910925, "time": "2026-02-26 16:18:51", "headline": "Sprout Social Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["SPT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910925/sprout-social-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50910932, "time": "2026-02-26 16:18:54", "headline": "Airgain Sees Q1 Adj EPS $(0.07) vs $(0.04) Est; Sees Sales $10.500M-$12.500M vs $12.533M Est", "summary": "", "symbols": ["AIRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910932/airgain-sees-q1-adj-eps-0-07-vs-0-04-est-sees-sales-10-500m-12-500m-vs-12-533m-est", "tags": ["earnings"]}
{"id": 50910938, "time": "2026-02-26 16:18:56", "headline": "Warner Bros. Discovery's Board Determines Paramount Skydance's Revised Proposal Constitutes Company Superior Proposal", "summary": "", "symbols": ["NFLX", "PSKY", "WBD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910938/warner-bros-discoverys-board-determines-paramount-skydances-revised-proposal-constitutes-company-sup", "tags": []}
{"id": 50910939, "time": "2026-02-26 16:18:56", "headline": "Oportun Financial: Q4 Earnings Insights", "summary": " ", "symbols": ["OPRT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910939/oportun-financial-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50910940, "time": "2026-02-26 16:18:56", "headline": "Grindr Announces Additional $400M Share Buyback, Extended Through March 2029", "summary": "", "symbols": ["GRND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50910940/grindr-announces-additional-400m-share-buyback-extended-through-march-2029", "tags": ["buyback"]}
{"id": 50910952, "time": "2026-02-26 16:19:01", "headline": "Assured Guaranty Q4 Earnings Assessment", "summary": " ", "symbols": ["AGO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910952/assured-guaranty-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50910966, "time": "2026-02-26 16:19:06", "headline": "Earnings Breakdown: OPKO Health Q4", "summary": " ", "symbols": ["OPK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910966/earnings-breakdown-opko-health-q4", "tags": ["earnings"]}
{"id": 50910970, "time": "2026-02-26 16:19:08", "headline": "Coupang Q4 Adj. EPS $(0.01) Misses $0.03 Estimate, Sales $8.835B Miss $9.048B Estimate.", "summary": "", "symbols": ["CPNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910970/coupang-q4-adj-eps-0-01-misses-0-03-estimate-sales-8-835b-miss-9-048b-estimate", "tags": ["earnings"]}
{"id": 50910977, "time": "2026-02-26 16:19:10", "headline": "Globant Q4 Adj. EPS $1.54, Inline, Sales $612.469M Beat $605.463M Estimate", "summary": "", "symbols": ["GLOB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910977/globant-q4-adj-eps-1-54-inline-sales-612-469m-beat-605-463m-estimate", "tags": ["earnings"]}
{"id": 50910978, "time": "2026-02-26 16:19:11", "headline": "Solventum Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["SOLV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910978/solventum-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50910986, "time": "2026-02-26 16:19:15", "headline": "Relay Therapeutics Q4 Earnings Assessment", "summary": " ", "symbols": ["RLAY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910986/relay-therapeutics-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50910990, "time": "2026-02-26 16:19:18", "headline": "Alta Equipment Group Q4 Adj. EPS $(0.27) Beats $(0.29) Estimate, Sales $509.100M Beat $489.561M Estimate", "summary": "", "symbols": ["ALTG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50910990/alta-equipment-group-q4-adj-eps-0-27-beats-0-29-estimate-sales-509-100m-beat-489-561m-estimate", "tags": ["earnings"]}
{"id": 50910995, "time": "2026-02-26 16:19:21", "headline": "BioLife Solutions Earnings Report: Q4 Overview", "summary": " ", "symbols": ["BLFS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50910995/biolife-solutions-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50911004, "time": "2026-02-26 16:19:26", "headline": "PubMatic: Q4 Earnings Insights", "summary": " ", "symbols": ["PUBM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911004/pubmatic-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50911009, "time": "2026-02-26 16:19:29", "headline": "FTAI Infrastructure Q4 EPS $(1.08) Misses $(0.43) Estimate, Sales $143.517M Miss $169.067M Estimate", "summary": "", "symbols": ["FIP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911009/ftai-infrastructure-q4-eps-1-08-misses-0-43-estimate-sales-143-517m-miss-169-067m-estimate", "tags": ["earnings"]}
{"id": 50911012, "time": "2026-02-26 16:19:30", "headline": "Compass Q4 EPS $(0.07) Misses $(0.06) Estimate, Sales $1.700B Beat $1.687B Estimate", "summary": "", "symbols": ["COMP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911012/compass-q4-eps-0-07-misses-0-06-estimate-sales-1-700b-beat-1-687b-estimate", "tags": ["earnings"]}
{"id": 50911014, "time": "2026-02-26 16:19:30", "headline": "Seer Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["SEER"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911014/seer-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50911021, "time": "2026-02-26 16:19:33", "headline": "MasTec Sees FY2026 GAAP EPS $6.62 vs $6.74 Est", "summary": "", "symbols": ["MTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50911021/mastec-sees-fy2026-gaap-eps-6-62-vs-6-74-est", "tags": ["earnings"]}
{"id": 50911047, "time": "2026-02-26 16:19:50", "headline": "Retail Investors Buy The Dip In Nvidia As Small-Investor Activity Hits 14-Year High", "summary": "Record retail buying signals confidence in Nvidia despite early volatility, as mom-and-pop investors post biggest net buying since 2012 and analysts remain bullish.", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Senior Editor", "url": "https://www.benzinga.com/markets/tech/26/02/50911047/retail-investors-buy-the-dip-in-nvidia-as-small-investor-activity-hits-14-year-high", "tags": []}
{"id": 50911067, "time": "2026-02-26 16:20:03", "headline": "National CineMedia Q4 Adj. EPS $0.31 Beats $0.25 Estimate, Sales $93.200M Beat $90.910M Estimate", "summary": "", "symbols": ["NCMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911067/national-cinemedia-q4-adj-eps-0-31-beats-0-25-estimate-sales-93-200m-beat-90-910m-estimate", "tags": ["earnings"]}
{"id": 50911089, "time": "2026-02-26 16:20:12", "headline": "Compass Sees Q1 Sales $2.550B-$2.750B vs $1.942B Est", "summary": "", "symbols": ["COMP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50911089/compass-sees-q1-sales-2-550b-2-750b-vs-1-942b-est", "tags": []}
{"id": 50911108, "time": "2026-02-26 16:20:20", "headline": "National CineMedia Earnings Report: Q4 Overview", "summary": " ", "symbols": ["NCMI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911108/national-cinemedia-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50911119, "time": "2026-02-26 16:20:25", "headline": "Earnings Summary: FTAI Infrastructure Q4", "summary": " ", "symbols": ["FIP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911119/earnings-summary-ftai-infrastructure-q4", "tags": ["earnings"]}
{"id": 50911132, "time": "2026-02-26 16:20:30", "headline": "Globant Earnings Report: Q4 Overview", "summary": " ", "symbols": ["GLOB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911132/globant-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50911139, "time": "2026-02-26 16:20:35", "headline": "Alta Equipment Group Earnings Review: Q4 Summary", "summary": " ", "symbols": ["ALTG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911139/alta-equipment-group-earnings-review-q4-summary", "tags": ["earnings"]}
{"id": 50911148, "time": "2026-02-26 16:20:40", "headline": "Coupang Earnings Review: Q4 Summary", "summary": " ", "symbols": ["CPNG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911148/coupang-earnings-review-q4-summary", "tags": ["earnings"]}
{"id": 50911151, "time": "2026-02-26 16:20:42", "headline": "Alta Equipment Sees FY26 Adj. EBITDA Of $172.5M-$187.5M", "summary": "", "symbols": ["ALTG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50911151/alta-equipment-sees-fy26-adj-ebitda-of-172-5m-187-5m", "tags": []}
{"id": 50911160, "time": "2026-02-26 16:20:45", "headline": "Earnings Summary: PACS Group Q4", "summary": " ", "symbols": ["PACS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911160/earnings-summary-pacs-group-q4", "tags": ["earnings"]}
{"id": 50911169, "time": "2026-02-26 16:20:50", "headline": "Main Street Capital Earnings Report: Q4 Overview", "summary": " ", "symbols": ["MAIN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911169/main-street-capital-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50911208, "time": "2026-02-26 16:21:08", "headline": "MasTec Sees Q1 Adj EPS $1.00 vs $0.90 Est; Sees Sales $3.475B vs $3.231B Est", "summary": "", "symbols": ["MTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50911208/mastec-sees-q1-adj-eps-1-00-vs-0-90-est-sees-sales-3-475b-vs-3-231b-est", "tags": ["earnings"]}
{"id": 50911217, "time": "2026-02-26 16:21:13", "headline": "Globant Sees FY2026 Adj EPS $6.10-$6.50 vs $6.29 Est; Sees Sales $2.460B-$2.510B vs $2.489B Est", "summary": "", "symbols": ["GLOB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50911217/globant-sees-fy2026-adj-eps-6-10-6-50-vs-6-29-est-sees-sales-2-460b-2-510b-vs-2-489b-est", "tags": ["earnings"]}
{"id": 50911223, "time": "2026-02-26 16:21:16", "headline": "Crinetics Pharmaceuticals Q4 EPS $(1.29) Beats $(1.36) Estimate, Sales $6.161M Beat $4.605M Estimate.", "summary": "", "symbols": ["CRNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911223/crinetics-pharmaceuticals-q4-eps-1-29-beats-1-36-estimate-sales-6-161m-beat-4-605m-estimate", "tags": ["earnings"]}
{"id": 50911232, "time": "2026-02-26 16:21:19", "headline": "PAR Technology Q4 Adj. EPS $0.06 Beats $0.04 Estimate, Sales $120.101M Beat $116.683M Estimate", "summary": "", "symbols": ["PAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911232/par-technology-q4-adj-eps-0-06-beats-0-04-estimate-sales-120-101m-beat-116-683m-estimate", "tags": ["earnings"]}
{"id": 50911248, "time": "2026-02-26 16:21:26", "headline": "Globant Sees Q1 Adj EPS $1.44-$1.54 vs $1.49 Est; Sees Sales $598.000M-$604.000M vs $599.874M Est", "summary": "", "symbols": ["GLOB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50911248/globant-sees-q1-adj-eps-1-44-1-54-vs-1-49-est-sees-sales-598-000m-604-000m-vs-599-874m-est", "tags": ["earnings"]}
{"id": 50911254, "time": "2026-02-26 16:21:29", "headline": "MasTec Sees Q1 GAAP EPS $0.57 vs $0.41 Est", "summary": "", "symbols": ["MTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50911254/mastec-sees-q1-gaap-eps-0-57-vs-0-41-est", "tags": ["earnings"]}
{"id": 50911272, "time": "2026-02-26 16:21:37", "headline": "Compass Diversified Hldgs Q4 Adj. EPS $0.86 Beats $0.13 Estimate, Sales $468.557M Miss $472.840M Estimate", "summary": "", "symbols": ["CODI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911272/compass-diversified-hldgs-q4-adj-eps-0-86-beats-0-13-estimate-sales-468-557m-miss-472-840m-estimate", "tags": ["earnings"]}
{"id": 50911317, "time": "2026-02-26 16:22:03", "headline": "Clover Health Investments Q4 EPS $(0.10), Inline, Sales $487.707M Beat $467.056M Estimate", "summary": "", "symbols": ["CLOV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911317/clover-health-investments-q4-eps-0-10-inline-sales-487-707m-beat-467-056m-estimate", "tags": ["earnings"]}
{"id": 50911330, "time": "2026-02-26 16:22:09", "headline": "Aeva Selected By Unnamed Top Five Global Passenger OEM For Vehicle Development Program", "summary": "", "symbols": ["AEVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50911330/aeva-selected-by-unnamed-top-five-global-passenger-oem-for-vehicle-development-program", "tags": []}
{"id": 50911331, "time": "2026-02-26 16:22:10", "headline": "Clover Health Investments Earnings Report: Q4 Overview", "summary": " ", "symbols": ["CLOV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911331/clover-health-investments-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50911336, "time": "2026-02-26 16:22:15", "headline": "Compass Diversified Hldgs Earnings Report: Q4 Overview", "summary": " ", "symbols": ["CODI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911336/compass-diversified-hldgs-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50911344, "time": "2026-02-26 16:22:20", "headline": "Crinetics Pharmaceuticals Earnings Report: Q4 Overview", "summary": " ", "symbols": ["CRNX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911344/crinetics-pharmaceuticals-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50911361, "time": "2026-02-26 16:22:30", "headline": "SITE Centers Q4 FFO $0.05 Misses $0.10 Estimate, Sales $17.506M Miss $22.387M Estimate", "summary": "", "symbols": ["SITC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911361/site-centers-q4-ffo-0-05-misses-0-10-estimate-sales-17-506m-miss-22-387m-estimate", "tags": []}
{"id": 50911409, "time": "2026-02-26 16:22:50", "headline": "CubeSmart Q4 FFO $0.64 Misses $0.65 Estimate, Sales $234.703M Miss $277.811M Estimate", "summary": "", "symbols": ["CUBE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911409/cubesmart-q4-ffo-0-64-misses-0-65-estimate-sales-234-703m-miss-277-811m-estimate", "tags": []}
{"id": 50911449, "time": "2026-02-26 16:23:10", "headline": "Clover Health Sees FY2026 Sales $2.810B-$2.920B vs $2.740B Est", "summary": "", "symbols": ["CLOV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50911449/clover-health-sees-fy2026-sales-2-810b-2-920b-vs-2-740b-est", "tags": []}
{"id": 50911498, "time": "2026-02-26 16:23:30", "headline": "Aeva Technologies Sees FY2026 Sales $30.000M-$36.000M vs $28.341M Est", "summary": "", "symbols": ["AEVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50911498/aeva-technologies-sees-fy2026-sales-30-000m-36-000m-vs-28-341m-est", "tags": []}
{"id": 50911508, "time": "2026-02-26 16:23:35", "headline": "CubeSmart Sees FY2026 FFO $2.52-$2.60 vs $2.60 Est", "summary": "", "symbols": ["CUBE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50911508/cubesmart-sees-fy2026-ffo-2-52-2-60-vs-2-60-est", "tags": []}
{"id": 50911545, "time": "2026-02-26 16:24:04", "headline": "CubeSmart Sees Q1 FFO $0.61-$0.63 vs $0.64 Est", "summary": "", "symbols": ["CUBE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50911545/cubesmart-sees-q1-ffo-0-61-0-63-vs-0-64-est", "tags": []}
{"id": 50911546, "time": "2026-02-26 16:24:04", "headline": "Coterra Energy Q4 Adj. EPS $0.39 Misses $0.48 Estimate, Sales $1.959B Beat $1.875B Estimate", "summary": "", "symbols": ["CTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911546/coterra-energy-q4-adj-eps-0-39-misses-0-48-estimate-sales-1-959b-beat-1-875b-estimate", "tags": ["earnings"]}
{"id": 50911554, "time": "2026-02-26 16:24:11", "headline": "Coterra Energy Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["CTRA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911554/coterra-energy-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50911563, "time": "2026-02-26 16:24:16", "headline": "CubeSmart Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["CUBE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911563/cubesmart-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50911576, "time": "2026-02-26 16:24:21", "headline": "SITE Centers Earnings Report: Q4 Overview", "summary": " ", "symbols": ["SITC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911576/site-centers-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50911601, "time": "2026-02-26 16:24:34", "headline": "Plug Power Strikes $132.5M Deal With Stream Data Centers Under Its $275M Initiative In Liquidity Enhancement", "summary": "", "symbols": ["APO", "PLUG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50911601/plug-power-strikes-132-5m-deal-with-stream-data-centers-under-its-275m-initiative-in-liquidity-enhan", "tags": ["contract"]}
{"id": 50911636, "time": "2026-02-26 16:24:54", "headline": "Jamieson Wellness Q4 Adj. EPS $0.90 Misses $0.91 Estimate, Sales $277.659M Beat $274.978M Estimate", "summary": "", "symbols": ["TSX:JWEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911636/jamieson-wellness-q4-adj-eps-0-90-misses-0-91-estimate-sales-277-659m-beat-274-978m-estimate", "tags": ["earnings"]}
{"id": 50911659, "time": "2026-02-26 16:25:04", "headline": "UBS Upgrades Palantir Technologies to Buy, Maintains Price Target to $180", "summary": "", "symbols": ["PLTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50911659/ubs-upgrades-palantir-technologies-to-buy-maintains-price-target-to-180", "tags": ["analyst_up", "analyst_other"]}
{"id": 50911675, "time": "2026-02-26 16:25:16", "headline": "Smart Sand Q4 EPS $0.03 Down From $0.09 YoY, Sales $86.045M Down From $91.363M YoY", "summary": "", "symbols": ["SND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911675/smart-sand-q4-eps-0-03-down-from-0-09-yoy-sales-86-045m-down-from-91-363m-yoy", "tags": ["earnings"]}
{"id": 50911680, "time": "2026-02-26 16:25:20", "headline": "Organogenesis Hldgs Q4 Adj. EPS $0.40 Beats $0.21 Estimate, Sales $225.607M Beat $172.700M Estimate.", "summary": "", "symbols": ["ORGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911680/organogenesis-hldgs-q4-adj-eps-0-40-beats-0-21-estimate-sales-225-607m-beat-172-700m-estimate", "tags": ["earnings"]}
{"id": 50911744, "time": "2026-02-26 16:26:08", "headline": "Organogenesis Holdings Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["ORGO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911744/organogenesis-holdings-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50911754, "time": "2026-02-26 16:26:14", "headline": "PRA Group Q4 EPS $1.46 Beats $0.26 Estimate, Sales $333.390M Beat $288.862M Estimate", "summary": "", "symbols": ["PRAA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911754/pra-group-q4-eps-1-46-beats-0-26-estimate-sales-333-390m-beat-288-862m-estimate", "tags": ["earnings"]}
{"id": 50911763, "time": "2026-02-26 16:26:18", "headline": "DoubleVerify Hldgs Q4 Adj. EPS $0.31 Beats $0.16 Estimate, Sales $205.588M Miss $208.761M Estimate", "summary": "", "symbols": ["DV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911763/doubleverify-hldgs-q4-adj-eps-0-31-beats-0-16-estimate-sales-205-588m-miss-208-761m-estimate", "tags": ["earnings"]}
{"id": 50911785, "time": "2026-02-26 16:26:34", "headline": "Organogenesis Holdings Sees FY2026 Sales $350.000M-$420.000M vs $543.400M Est.", "summary": "", "symbols": ["ORGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50911785/organogenesis-holdings-sees-fy2026-sales-350-000m-420-000m-vs-543-400m-est", "tags": []}
{"id": 50911820, "time": "2026-02-26 16:26:56", "headline": "Janux Therapeutics Q4 EPS $(0.51) Beats $(0.64) Estimate", "summary": "", "symbols": ["JANX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911820/janux-therapeutics-q4-eps-0-51-beats-0-64-estimate", "tags": ["earnings"]}
{"id": 50911868, "time": "2026-02-26 16:27:24", "headline": "Dell Stock Surges On Q4 Earnings Beat: What To Know", "summary": "Here&#39;s a look inside the Q4 earnings report from Dell Technologies.", "symbols": ["DELL"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/markets/earnings/26/02/50911868/dell-stock-surges-on-q4-earnings-beat-what-to-know", "tags": ["earnings"]}
{"id": 50911886, "time": "2026-02-26 16:27:31", "headline": "Sweetgreen Q4 EPS $(0.42) Misses $(0.22) Estimate, Sales $155.194M Miss $158.863M Estimate", "summary": "", "symbols": ["SG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911886/sweetgreen-q4-eps-0-42-misses-0-22-estimate-sales-155-194m-miss-158-863m-estimate", "tags": ["earnings"]}
{"id": 50911919, "time": "2026-02-26 16:27:53", "headline": "NuScale Power Q4 EPS $(0.08) Beats $(0.13) Estimate, Sales $1.808M", "summary": "", "symbols": ["SMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50911919/nuscale-power-q4-eps-0-08-beats-0-13-estimate-sales-1-808m", "tags": ["earnings"]}
{"id": 50911934, "time": "2026-02-26 16:28:01", "headline": "DoubleVerify Holdings Sees FY2026 Sales $810.000M-$826.000M vs $829.777M Est", "summary": "", "symbols": ["DV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50911934/doubleverify-holdings-sees-fy2026-sales-810-000m-826-000m-vs-829-777m-est", "tags": []}
{"id": 50911948, "time": "2026-02-26 16:28:09", "headline": "Sweetgreen Earnings Report: Q4 Overview", "summary": " ", "symbols": ["SG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911948/sweetgreen-earnings-report-q4-overview", "tags": ["earnings"]}
{"id": 50911960, "time": "2026-02-26 16:28:14", "headline": "NuScale Power Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["SMR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911960/nuscale-power-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50911962, "time": "2026-02-26 16:28:15", "headline": "DoubleVerify Holdings Sees Q1 Sales $177.000M-$183.000M vs $180.242M Est", "summary": "", "symbols": ["DV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50911962/doubleverify-holdings-sees-q1-sales-177-000m-183-000m-vs-180-242m-est", "tags": []}
{"id": 50911968, "time": "2026-02-26 16:28:19", "headline": "PRA Group: Q4 Earnings Insights", "summary": " ", "symbols": ["PRAA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50911968/pra-group-q4-earnings-insights", "tags": ["earnings"]}
{"id": 50912025, "time": "2026-02-26 16:29:05", "headline": "Figure Technology Announces $200M Buyback Plan", "summary": "", "symbols": ["FIGR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912025/figure-technology-announces-200m-buyback-plan", "tags": ["buyback"]}
{"id": 50912057, "time": "2026-02-26 16:29:21", "headline": "Emergent BioSolutions Announces $50M Share Buyback", "summary": "", "symbols": ["EBS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912057/emergent-biosolutions-announces-50m-share-buyback", "tags": ["buyback"]}
{"id": 50912217, "time": "2026-02-26 16:29:55", "headline": "Nexa Res Q4 Adj. EPS $0.60 Beats $0.46 Estimate, Sales $903.000M Beat $786.941M Estimate", "summary": "", "symbols": ["NEXA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50912217/nexa-res-q4-adj-eps-0-60-beats-0-46-estimate-sales-903-000m-beat-786-941m-estimate", "tags": ["earnings"]}
{"id": 50912227, "time": "2026-02-26 16:30:00", "headline": "Figure Technology Collaborates With Agora Data To Launch Auto Finance Assets On Figure Connect Marketplace, Democratized Prime", "summary": "", "symbols": ["FIGR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912227/figure-technology-collaborates-with-agora-data-to-launch-auto-finance-assets-on-figure-connect-marke", "tags": []}
{"id": 50912234, "time": "2026-02-26 16:30:03", "headline": "Emergent BioSolutions Announces ~$140M In Contract Awards With The Government Of Canada", "summary": "", "symbols": ["EBS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912234/emergent-biosolutions-announces-140m-in-contract-awards-with-the-government-of-canada", "tags": ["contract"]}
{"id": 50912265, "time": "2026-02-26 16:30:09", "headline": "Nexa Res Q4 Earnings Assessment", "summary": " ", "symbols": ["NEXA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50912265/nexa-res-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50912311, "time": "2026-02-26 16:30:29", "headline": "Here's How Much You Would Have Made Owning Hilton Worldwide Holdings Stock In The Last 10 Years", "summary": " ", "symbols": ["HLT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50912311/heres-how-much-you-would-have-made-owning-hilton-worldwide-holdings-stock-in-the-last-10-years", "tags": []}
{"id": 50912358, "time": "2026-02-26 16:30:55", "headline": "Asure Software Q4 EPS $0.03 Up From $(0.12) YoY, Sales $39.311M Beat $38.757M Estimate.", "summary": "", "symbols": ["ASUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50912358/asure-software-q4-eps-0-03-up-from-0-12-yoy-sales-39-311m-beat-38-757m-estimate", "tags": ["earnings"]}
{"id": 50912391, "time": "2026-02-26 16:31:13", "headline": "Radnet Subsidiary DeepHealth Achieves CE Marking For European Commercialization", "summary": "", "symbols": ["RDNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912391/radnet-subsidiary-deephealth-achieves-ce-marking-for-european-commercialization", "tags": []}
{"id": 50912397, "time": "2026-02-26 16:31:15", "headline": "GRINDR Announced Cooperation Agreement With Largest Stockholder Zage, Including 18-Month Standstill Restrictions,", "summary": "", "symbols": ["GRND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912397/grindr-announced-cooperation-agreement-with-largest-stockholder-zage-including-18-month-standstill-r", "tags": ["contract"]}
{"id": 50912459, "time": "2026-02-26 16:31:48", "headline": "Rocket Companies, Compass Ink Three-Year Collaboration To Expand Home Listing Inventory On Redfin", "summary": "", "symbols": ["COMP", "RKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912459/rocket-companies-compass-ink-three-year-collaboration-to-expand-home-listing-inventory-on-redfin", "tags": []}
{"id": 50912476, "time": "2026-02-26 16:31:54", "headline": "Concentra Group Holdings Q4 Adj. EPS $0.28 Beats $0.23 Estimate, Sales $539.080M Beat $532.057M Estimate", "summary": "", "symbols": ["CON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50912476/concentra-group-holdings-q4-adj-eps-0-28-beats-0-23-estimate-sales-539-080m-beat-532-057m-estimate", "tags": ["earnings"]}
{"id": 50912502, "time": "2026-02-26 16:32:06", "headline": "CoreWeave Q4 Adj. EPS $(0.56) Misses $(0.50) Estimate, Sales $1.572B Beat $1.548B Estimate", "summary": "", "symbols": ["CRWV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50912502/coreweave-q4-adj-eps-0-56-misses-0-50-estimate-sales-1-572b-beat-1-548b-estimate", "tags": ["earnings"]}
{"id": 50912515, "time": "2026-02-26 16:32:12", "headline": "Concentra Group Holdings Q4 Earnings Report: What Investors Need to Know", "summary": " ", "symbols": ["CON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50912515/concentra-group-holdings-q4-earnings-report-what-investors-need-to-know", "tags": ["earnings"]}
{"id": 50912550, "time": "2026-02-26 16:32:29", "headline": "Epsilon Energy Announces $15M Buyback Plan", "summary": "", "symbols": ["EPSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912550/epsilon-energy-announces-15m-buyback-plan", "tags": ["buyback"]}
{"id": 50912551, "time": "2026-02-26 16:32:30", "headline": "Concentra Group Holdings Sees FY2026 Sales $2.250B-$2.350B vs $2.318B Est", "summary": "", "symbols": ["CON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912551/concentra-group-holdings-sees-fy2026-sales-2-250b-2-350b-vs-2-318b-est", "tags": []}
{"id": 50912558, "time": "2026-02-26 16:32:38", "headline": "Intelligent Protection Management Extends Current Phoenix Colocation License Agreement With Unnamed Data Center Provider Through August 2032", "summary": "", "symbols": ["IPM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912558/intelligent-protection-management-extends-current-phoenix-colocation-license-agreement-with-unnamed", "tags": ["contract"]}
{"id": 50912589, "time": "2026-02-26 16:32:56", "headline": "Rocket Lab Beats Q4 Earnings, Issues Strong Guidance, Targets Late 2026 For First Neutron Launch", "summary": "Rocket Lab Corp (NASDAQ:RKLB) reports financial results for the fourth quarter after the market close on Thursday.", "symbols": ["RKLB"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/markets/earnings/26/02/50912589/rocket-lab-beats-q4-earnings-issues-strong-guidance-targets-late-2026-for-first-neutron-launch", "tags": ["earnings", "guidance"]}
{"id": 50912599, "time": "2026-02-26 16:33:03", "headline": "Asure Software Sees Q1 Sales $41.000M-$43.000M vs $41.739M Est.", "summary": "", "symbols": ["ASUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912599/asure-software-sees-q1-sales-41-000m-43-000m-vs-41-739m-est", "tags": []}
{"id": 50912606, "time": "2026-02-26 16:33:08", "headline": "Ginkgo Bioworks Holdings Q4 EPS $(1.41) Misses $(1.36) Estimate, Sales $33.318M Miss $37.617M Estimate", "summary": "", "symbols": ["DNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50912606/ginkgo-bioworks-holdings-q4-eps-1-41-misses-1-36-estimate-sales-33-318m-miss-37-617m-estimate", "tags": ["earnings"]}
{"id": 50912612, "time": "2026-02-26 16:33:12", "headline": "RLJ Lodging Q4 EPS $(0.04) Beats $(0.06) Estimate, Sales $328.593M Beat $319.604M Estimate", "summary": "", "symbols": ["RLJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50912612/rlj-lodging-q4-eps-0-04-beats-0-06-estimate-sales-328-593m-beat-319-604m-estimate", "tags": ["earnings"]}
{"id": 50912627, "time": "2026-02-26 16:33:17", "headline": "Asure Software Sees FY2026 Sales $159.000M-$162.000M vs $159.589M Est.", "summary": "", "symbols": ["ASUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912627/asure-software-sees-fy2026-sales-159-000m-162-000m-vs-159-589m-est", "tags": []}
{"id": 50912644, "time": "2026-02-26 16:33:26", "headline": "Hingham Institution for Savings Responds To Recent Report Made By Wolfpack Research; Says Report Contains Material Factual Inaccuracies, Errors Of Interpretation, And Unsupported Conclusions", "summary": "", "symbols": ["HIFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912644/hingham-institution-for-savings-responds-to-recent-report-made-by-wolfpack-research-says-report-cont", "tags": []}
{"id": 50912659, "time": "2026-02-26 16:33:34", "headline": "JP Morgan Maintains Overweight on NVIDIA, Raises Price Target to $265", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912659/jp-morgan-maintains-overweight-on-nvidia-raises-price-target-to-265", "tags": ["analyst_other", "price_target_up"]}
{"id": 50912663, "time": "2026-02-26 16:33:38", "headline": "Cable One Q4 EPS $(1.35) Misses $6.54 Estimate, Sales $363.739M Miss $368.379M Estimate", "summary": "", "symbols": ["CABO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50912663/cable-one-q4-eps-1-35-misses-6-54-estimate-sales-363-739m-miss-368-379m-estimate", "tags": ["earnings"]}
{"id": 50912666, "time": "2026-02-26 16:33:40", "headline": "Unity Bancorp Increases Quarterly Dividend From $0.15 To $0.17/Share", "summary": "", "symbols": ["UNTY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912666/unity-bancorp-increases-quarterly-dividend-from-0-15-to-0-17share", "tags": ["dividend"]}
{"id": 50912682, "time": "2026-02-26 16:33:47", "headline": "RLJ Lodging Sees FY2026 FFO $1.21-$1.41 vs $1.39 Est", "summary": "", "symbols": ["RLJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912682/rlj-lodging-sees-fy2026-ffo-1-21-1-41-vs-1-39-est", "tags": []}
{"id": 50912705, "time": "2026-02-26 16:33:57", "headline": "Intchains Gr Q4 Adj. EPS $(0.15) Misses $(0.01) Estimate, Sales $5.167M Miss $6.101M Estimate", "summary": "", "symbols": ["ICG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50912705/intchains-gr-q4-adj-eps-0-15-misses-0-01-estimate-sales-5-167m-miss-6-101m-estimate", "tags": ["earnings"]}
{"id": 50912731, "time": "2026-02-26 16:34:09", "headline": "Earnings Summary: Cable One Q4", "summary": " ", "symbols": ["CABO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50912731/earnings-summary-cable-one-q4", "tags": ["earnings"]}
{"id": 50912734, "time": "2026-02-26 16:34:14", "headline": "RLJ Lodging Q4 Earnings Assessment", "summary": " ", "symbols": ["RLJ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50912734/rlj-lodging-q4-earnings-assessment", "tags": ["earnings"]}
{"id": 50912751, "time": "2026-02-26 16:34:22", "headline": "RealReal Q4 Adj. EPS $0.06 Beats $0.04 Estimate, Sales $194.051M Beat $190.700M Estimate.", "summary": "", "symbols": ["REAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50912751/realreal-q4-adj-eps-0-06-beats-0-04-estimate-sales-194-051m-beat-190-700m-estimate", "tags": ["earnings"]}
{"id": 50912784, "time": "2026-02-26 16:34:42", "headline": "Marathon Digital Holdings Q4 EPS $(4.52) Misses $(0.30) Estimate, Sales $202.300M Miss $257.458M Estimate", "summary": "", "symbols": ["MARA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50912784/marathon-digital-holdings-q4-eps-4-52-misses-0-30-estimate-sales-202-300m-miss-257-458m-estimate", "tags": ["earnings"]}
{"id": 50912785, "time": "2026-02-26 16:34:42", "headline": "Allison Transmission Holdings Raises Quarterly Dividend From $0.27 To $0.29/Share", "summary": "", "symbols": ["ALSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912785/allison-transmission-holdings-raises-quarterly-dividend-from-0-27-to-0-29share", "tags": ["dividend"]}
{"id": 50912811, "time": "2026-02-26 16:34:59", "headline": "Xenon Pharmaceuticals Q4 EPS $(1.31) Misses $(1.19) Estimate", "summary": "", "symbols": ["XENE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50912811/xenon-pharmaceuticals-q4-eps-1-31-misses-1-19-estimate", "tags": ["earnings"]}
{"id": 50912846, "time": "2026-02-26 16:35:18", "headline": "Kratos Defense & Security Announces Proposed Share Offering Up To $2.5B", "summary": "", "symbols": ["KTOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912846/kratos-defense-security-announces-proposed-share-offering-up-to-2-5b", "tags": ["offering"]}
{"id": 50912876, "time": "2026-02-26 16:35:38", "headline": "Natera Q4 EPS $0.36 Beats $(0.49) Estimate, Sales $665.500M Beat $592.417M Estimate", "summary": "", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50912876/natera-q4-eps-0-36-beats-0-49-estimate-sales-665-500m-beat-592-417m-estimate", "tags": ["earnings"]}
{"id": 50912878, "time": "2026-02-26 16:35:40", "headline": "JP Morgan Maintains Neutral on IonQ, Lowers Price Target to $42", "summary": "", "symbols": ["IONQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912878/jp-morgan-maintains-neutral-on-ionq-lowers-price-target-to-42", "tags": ["analyst_other", "price_target_down"]}
{"id": 50912879, "time": "2026-02-26 16:35:40", "headline": "MARA Q4 2025 Mined 2,011 BTC And Purchased 1,670 BTC", "summary": "", "symbols": ["MARA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/26/02/50912879/mara-q4-2025-mined-2-011-btc-and-purchased-1-670-btc", "tags": []}
{"id": 50912913, "time": "2026-02-26 16:35:53", "headline": "RealReal Sees Q1 Sales $185.000M-$189.000M vs $182.003M Est.", "summary": "", "symbols": ["REAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912913/realreal-sees-q1-sales-185-000m-189-000m-vs-182-003m-est", "tags": []}
{"id": 50912934, "time": "2026-02-26 16:36:08", "headline": "RealReal Sees FY2026 Sales $765.000M-$780.000M vs $764.519M Est.", "summary": "", "symbols": ["REAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912934/realreal-sees-fy2026-sales-765-000m-780-000m-vs-764-519m-est", "tags": []}
{"id": 50912935, "time": "2026-02-26 16:36:09", "headline": "Earnings Summary: Natera Q4", "summary": " ", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50912935/earnings-summary-natera-q4", "tags": ["earnings"]}
{"id": 50912943, "time": "2026-02-26 16:36:15", "headline": "Insights into MARA Holdings Q4 Earnings", "summary": " ", "symbols": ["MARA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50912943/insights-into-mara-holdings-q4-earnings", "tags": ["earnings"]}
{"id": 50912951, "time": "2026-02-26 16:36:20", "headline": "Earnings Breakdown: RealReal Q4", "summary": " ", "symbols": ["REAL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50912951/earnings-breakdown-realreal-q4", "tags": ["earnings"]}
{"id": 50912965, "time": "2026-02-26 16:36:30", "headline": "Federal Realty Highlights $400M Mixed Residential-Over-Retail Development Project", "summary": "", "symbols": ["FRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50912965/federal-realty-highlights-400m-mixed-residential-over-retail-development-project", "tags": []}
{"id": 50912997, "time": "2026-02-26 16:36:52", "headline": "D-MARKET Electronic Q4 EPS $(0.24) Down From $(0.06) YoY, Sales $661.614M Up From $524.777M YoY", "summary": "", "symbols": ["HEPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50912997/d-market-electronic-q4-eps-0-24-down-from-0-06-yoy-sales-661-614m-up-from-524-777m-yoy", "tags": ["earnings"]}
{"id": 50913033, "time": "2026-02-26 16:37:06", "headline": "Google Gemini Image Upgrade Pressures Adobe, Figma Shares Thursday", "summary": "Shares of Adobe and Figma trade lower Thursday afternoon as investors react to Google&#39;s unveiling of Nano Banana 2, a new image model inside the Gemini app.", "symbols": ["ADBE", "FIG", "GOOG", "GOOGL"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50913033/google-gemini-image-upgrade-pressures-adobe-figma-shares-thursday", "tags": ["analyst_up"]}
{"id": 50913129, "time": "2026-02-26 16:38:17", "headline": "JP Morgan Maintains Overweight on Salesforce, Lowers Price Target to $320", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50913129/jp-morgan-maintains-overweight-on-salesforce-lowers-price-target-to-320", "tags": ["analyst_other", "price_target_down"]}
{"id": 50913144, "time": "2026-02-26 16:38:30", "headline": "Diamond Hill Investment Q4 EPS $3.41 Up From $2.73 YoY, Sales $36.553M Down From $39.121M YoY", "summary": "", "symbols": ["DHIL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50913144/diamond-hill-investment-q4-eps-3-41-up-from-2-73-yoy-sales-36-553m-down-from-39-121m-yoy", "tags": ["earnings"]}
{"id": 50913173, "time": "2026-02-26 16:38:51", "headline": "Betterware de Mexico SAPI Q4 Adj. EPS US$0.37 Misses US$0.55 Estimate, Sales US$208.974M Miss US$210.900M Estimate.", "summary": "", "symbols": ["BWMX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50913173/betterware-de-mexico-sapi-q4-adj-eps-us-0-37-misses-us-0-55-estimate-sales-us-208-974m-miss-us-210-", "tags": ["earnings"]}
{"id": 50913177, "time": "2026-02-26 16:38:56", "headline": "Rocket Lab Acquires Optical Support To Support National Security And Commercial Satellites Production; Terms Not Disclosed", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50913177/rocket-lab-acquires-optical-support-to-support-national-security-and-commercial-satellites-productio", "tags": ["merger"]}
{"id": 50913216, "time": "2026-02-26 16:39:20", "headline": "Galectin Therapeutics To Host Virtual KOL Event On March 10, Focusing On Unmet Need And Current Treatment Landscape For MASH Cirrhosis And Portal Hypertension", "summary": "", "symbols": ["GALT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50913216/galectin-therapeutics-to-host-virtual-kol-event-on-march-10-focusing-on-unmet-need-and-current-treat", "tags": []}
{"id": 50913222, "time": "2026-02-26 16:39:24", "headline": "Block Plans To Replace Nearly Half Its Workforce with AI \u2014 Stock Rallies", "summary": "Here&#39;s a look at the details from Block&#39;s Q4 earnings report.", "symbols": ["XYZ"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/markets/earnings/26/02/50913222/block-plans-to-replace-nearly-half-its-workforce-with-ai-stock-rallies", "tags": ["earnings"]}
{"id": 50913300, "time": "2026-02-26 16:40:08", "headline": "Betterware de Mexico SAPI Q4 Earnings Summary & Key Takeaways", "summary": " ", "symbols": ["BWMX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/26/02/50913300/betterware-de-mexico-sapi-q4-earnings-summary-key-takeaways", "tags": ["earnings"]}
{"id": 50913359, "time": "2026-02-26 16:41:03", "headline": "JP Morgan Maintains Overweight on Snowflake, Lowers Price Target to $245", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50913359/jp-morgan-maintains-overweight-on-snowflake-lowers-price-target-to-245", "tags": ["analyst_other", "price_target_down"]}
{"id": 50913376, "time": "2026-02-26 16:41:15", "headline": "ICF International Sees FY2026 GAAP EPS $5.95-$6.25 vs $5.90 Est", "summary": "", "symbols": ["ICFI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50913376/icf-international-sees-fy2026-gaap-eps-5-95-6-25-vs-5-90-est", "tags": ["earnings"]}
{"id": 50913396, "time": "2026-02-26 16:41:24", "headline": "ICF International Sees FY2026 Adj EPS $6.95-$7.25 vs $7.10 Est; Sees Sales $1.890B-$1.960B vs $1.917B Est", "summary": "", "symbols": ["ICFI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50913396/icf-international-sees-fy2026-adj-eps-6-95-7-25-vs-7-10-est-sees-sales-1-890b-1-960b-vs-1-917b-est", "tags": ["earnings"]}
{"id": 50913416, "time": "2026-02-26 16:41:37", "headline": "Betterware de Mexico SAPI Sees FY2026 Sales US$808.465M-US$841.240M.", "summary": "", "symbols": ["BWMX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50913416/betterware-de-mexico-sapi-sees-fy2026-sales-us-808-465m-us-841-240m", "tags": []}
{"id": 50913441, "time": "2026-02-26 16:41:56", "headline": "Rocket Lab Acquires New Zealand-Based Precision Components; Terms Not Disclosed", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50913441/rocket-lab-acquires-new-zealand-based-precision-components-terms-not-disclosed", "tags": ["merger"]}
{"id": 50913482, "time": "2026-02-26 16:42:43", "headline": "Brink's To Acquire NCR Atleos In Cash And Stock Transaction Valued At ~$6.6B", "summary": "", "symbols": ["BCO", "NATL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50913482/brinks-to-acquire-ncr-atleos-in-cash-and-stock-transaction-valued-at-6-6b", "tags": ["merger"]}
{"id": 50913508, "time": "2026-02-26 16:43:02", "headline": "CoreWeave Stock Slides On Mixed Q4 Earnings Despite Signaling 'Hypergrowth' Ahead", "summary": "CoreWeave reported financial results for the fourth quarter after the bell on Thursday. Here&#39;s a look at the key details from the print.", "symbols": ["CRWV"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/markets/earnings/26/02/50913508/coreweave-stock-slides-on-mixed-q4-earnings-despite-signaling-hypergrowth-ahead", "tags": ["earnings"]}
{"id": 50913556, "time": "2026-02-26 16:43:45", "headline": "Rexford Industrial Realty Names John Nahas As COO Effective April 1, 2026", "summary": "", "symbols": ["REXR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50913556/rexford-industrial-realty-names-john-nahas-as-coo-effective-april-1-2026", "tags": []}
{"id": 50913610, "time": "2026-02-26 16:44:26", "headline": "Rocket Lab Announces Advanced Silicon Solar Arrays To Power Space-Based Data Centers", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50913610/rocket-lab-announces-advanced-silicon-solar-arrays-to-power-space-based-data-centers", "tags": []}
{"id": 50913637, "time": "2026-02-26 16:44:55", "headline": "JP Morgan Maintains Overweight on AutoZone, Raises Price Target to $4300", "summary": "", "symbols": ["AZO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50913637/jp-morgan-maintains-overweight-on-autozone-raises-price-target-to-4300", "tags": ["analyst_other", "price_target_up"]}
{"id": 50913686, "time": "2026-02-26 16:45:19", "headline": "BGM Group Receives Nasdaq Noncompliance Notice, Gets 60 Days To Regain Compliance", "summary": "", "symbols": ["BGM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50913686/bgm-group-receives-nasdaq-noncompliance-notice-gets-60-days-to-regain-compliance", "tags": []}
{"id": 50913706, "time": "2026-02-26 16:45:28", "headline": "Here's How Much $100 Invested In Cigna Group 15 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["CI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50913706/heres-how-much-100-invested-in-cigna-group-15-years-ago-would-be-worth-today", "tags": []}
{"id": 50913709, "time": "2026-02-26 16:45:30", "headline": "AXIS Capital Holdings Announces $300M Share Buyback Program", "summary": "", "symbols": ["AXS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50913709/axis-capital-holdings-announces-300m-share-buyback-program", "tags": ["buyback"]}
{"id": 50913751, "time": "2026-02-26 16:45:45", "headline": "Molina Healthcare Reaffirms 2026 Adj. EPS Guidance At Least $5.00", "summary": "", "symbols": ["MOH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50913751/molina-healthcare-reaffirms-2026-adj-eps-guidance-at-least-5-00", "tags": ["earnings", "guidance"]}
{"id": 50913811, "time": "2026-02-26 16:46:32", "headline": "Talen Energy Q4 Adj. EPS $3.86 Beats $3.23 Estimate, Sales $749.000M Beat $653.134M Estimate", "summary": "", "symbols": ["TLN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50913811/talen-energy-q4-adj-eps-3-86-beats-3-23-estimate-sales-749-000m-beat-653-134m-estimate", "tags": ["earnings"]}
{"id": 50913817, "time": "2026-02-26 16:46:35", "headline": "MARA Holdings Collaborates With Starwood Capital Group Over Converting Select MARA Sites Into Digital Infrastructure", "summary": "", "symbols": ["MARA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50913817/mara-holdings-collaborates-with-starwood-capital-group-over-converting-select-mara-sites-into-digita", "tags": []}
{"id": 50913842, "time": "2026-02-26 16:46:47", "headline": "Diversified Energy Executes Purchase And Sale Agreement For Acquisition Of Natural Gas Properties And Related Facilities In East Texas From Sheridan Production For $245M In Cash", "summary": "", "symbols": ["DEC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/26/02/50913842/diversified-energy-executes-purchase-and-sale-agreement-for-acquisition-of-natural-gas-properties-an", "tags": ["contract"]}
{"id": 50913872, "time": "2026-02-26 16:47:15", "headline": "Ginkgo Bioworks To Spin Off Biosecurity Business To Investor Consortium In Exchange For A Minority Equity Position In The Business Alongside The Investors", "summary": "", "symbols": ["DNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50913872/ginkgo-bioworks-to-spin-off-biosecurity-business-to-investor-consortium-in-exchange-for-a-minority-e", "tags": []}
{"id": 50913925, "time": "2026-02-26 16:47:52", "headline": "JP Morgan Maintains Neutral on BJ's Wholesale Club Hldgs, Raises Price Target to $94", "summary": "", "symbols": ["BJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50913925/jp-morgan-maintains-neutral-on-bjs-wholesale-club-hldgs-raises-price-target-to-94", "tags": ["analyst_other", "price_target_up"]}
{"id": 50913947, "time": "2026-02-26 16:48:10", "headline": "Lamar Advertising Company Announces Extension Of $250M Share Buyback Program Through September 2027", "summary": "", "symbols": ["LAMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50913947/lamar-advertising-company-announces-extension-of-250m-share-buyback-program-through-september-2027", "tags": ["buyback"]}
{"id": 50913991, "time": "2026-02-26 16:48:56", "headline": "TeraWulf Q4 EPS $(0.29) Misses $(0.13) Estimate, Sales $35.836M Miss $45.782M Estimate", "summary": "", "symbols": ["WULF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50913991/terawulf-q4-eps-0-29-misses-0-13-estimate-sales-35-836m-miss-45-782m-estimate", "tags": ["earnings"]}
{"id": 50913992, "time": "2026-02-26 16:48:56", "headline": "Lamar Advertising Raises Quarterly Dividend From $1.55 To $1.60/Share", "summary": "", "symbols": ["LAMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50913992/lamar-advertising-raises-quarterly-dividend-from-1-55-to-1-60share", "tags": ["dividend"]}
{"id": 50914036, "time": "2026-02-26 16:49:30", "headline": "JP Morgan Maintains Neutral on Target, Raises Price Target to $115", "summary": "", "symbols": ["TGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914036/jp-morgan-maintains-neutral-on-target-raises-price-target-to-115", "tags": ["analyst_other", "price_target_up"]}
{"id": 50914057, "time": "2026-02-26 16:49:53", "headline": "United Rentals Announces Strategic Partnership With Procore Technologies On Telematics Integration", "summary": "", "symbols": ["PCOR", "URI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914057/united-rentals-announces-strategic-partnership-with-procore-technologies-on-telematics-integration", "tags": ["contract"]}
{"id": 50914062, "time": "2026-02-26 16:49:55", "headline": "Revelation Biosciences Q4 EPS $(1.65) Misses $(0.96) Estimate", "summary": "", "symbols": ["REVB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50914062/revelation-biosciences-q4-eps-1-65-misses-0-96-estimate", "tags": ["earnings"]}
{"id": 50914081, "time": "2026-02-26 16:50:06", "headline": "MBIA Q4 Adj. EPS $(0.24) Misses $(0.12) Estimate, Sales $28.000M Beat $6.000M Estimate", "summary": "", "symbols": ["MBI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50914081/mbia-q4-adj-eps-0-24-misses-0-12-estimate-sales-28-000m-beat-6-000m-estimate", "tags": ["earnings"]}
{"id": 50914134, "time": "2026-02-26 16:51:03", "headline": "ICF International Sees Q1 GAAP EPS $1.20 vs $1.35 Est", "summary": "", "symbols": ["ICFI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914134/icf-international-sees-q1-gaap-eps-1-20-vs-1-35-est", "tags": ["earnings"]}
{"id": 50914137, "time": "2026-02-26 16:51:05", "headline": "JP Morgan Maintains Overweight on Array Technologies, Lowers Price Target to $11", "summary": "", "symbols": ["ARRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914137/jp-morgan-maintains-overweight-on-array-technologies-lowers-price-target-to-11", "tags": ["analyst_other", "price_target_down"]}
{"id": 50914156, "time": "2026-02-26 16:51:15", "headline": "ICF International Sees Q1 Adj EPS $1.55 vs $1.70 Est; Sees Sales $450.000M vs $467.385M Est", "summary": "", "symbols": ["ICFI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914156/icf-international-sees-q1-adj-eps-1-55-vs-1-70-est-sees-sales-450-000m-vs-467-385m-est", "tags": ["earnings"]}
{"id": 50914157, "time": "2026-02-26 16:51:16", "headline": "MP Materials Stock Slips On Mixed Q4 Results", "summary": "MP Materials Corp (NYSE:MP) reports fourth-quarter financial results Thursday after the close. Here are the key highlights from the quarter.", "symbols": ["MP"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/markets/earnings/26/02/50914157/mp-materials-stock-slips-on-mixed-q4-results", "tags": ["earnings"]}
{"id": 50914166, "time": "2026-02-26 16:51:22", "headline": "AAR Signs New Agreement With Otto Instrument Services To Expand OEM Business Aviation Distribution", "summary": "", "symbols": ["AIR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914166/aar-signs-new-agreement-with-otto-instrument-services-to-expand-oem-business-aviation-distribution", "tags": ["contract"]}
{"id": 50914224, "time": "2026-02-26 16:52:04", "headline": "Barings Corporate Investors Reports Q4 Preliminary Net Investment Income Of $0.29/Share", "summary": "", "symbols": ["MCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914224/barings-corporate-investors-reports-q4-preliminary-net-investment-income-of-0-29share", "tags": []}
{"id": 50914288, "time": "2026-02-26 16:53:11", "headline": "MSC Income Fund Announced Supplemental Dividend Of $0.01/Share", "summary": "", "symbols": ["MAIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914288/msc-income-fund-announced-supplemental-dividend-of-0-01share", "tags": ["dividend"]}
{"id": 50914304, "time": "2026-02-26 16:53:21", "headline": "Barings Participation Investors Reports Q4 Preliminary Net Investment Income Of $0.27/Share", "summary": "", "symbols": ["MPV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914304/barings-participation-investors-reports-q4-preliminary-net-investment-income-of-0-27share", "tags": []}
{"id": 50914361, "time": "2026-02-26 16:54:16", "headline": "Tectonic Therapeutic Q4 EPS $(1.03) Beats $(1.10) Estimate", "summary": "", "symbols": ["TECX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50914361/tectonic-therapeutic-q4-eps-1-03-beats-1-10-estimate", "tags": ["earnings"]}
{"id": 50914395, "time": "2026-02-26 16:54:44", "headline": "SoundHound AI Stock Flat After Q4 Earnings: Details", "summary": "Here&#39;s a detailed look inside the Q4 earnings report from SoundHound AI.", "symbols": ["SOUN"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/markets/earnings/26/02/50914395/soundhound-ai-stock-flat-after-q4-earnings-details", "tags": ["earnings"]}
{"id": 50914418, "time": "2026-02-26 16:55:03", "headline": "JP Morgan Maintains Underweight on C3.ai, Lowers Price Target to $7", "summary": "", "symbols": ["AI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914418/jp-morgan-maintains-underweight-on-c3-ai-lowers-price-target-to-7", "tags": ["analyst_other", "price_target_down"]}
{"id": 50914471, "time": "2026-02-26 16:56:01", "headline": "Red River Bancshares Raises Quarterly Dividend From $0.15 To $0.25/Share", "summary": "", "symbols": ["RRBI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914471/red-river-bancshares-raises-quarterly-dividend-from-0-15-to-0-25share", "tags": ["dividend"]}
{"id": 50914488, "time": "2026-02-26 16:56:10", "headline": "Caterpillar Subsidiary Progress Rail And Wabtec Reach Settlement; Details Not Disclosed", "summary": "", "symbols": ["WAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914488/caterpillar-subsidiary-progress-rail-and-wabtec-reach-settlement-details-not-disclosed", "tags": ["legal"]}
{"id": 50914491, "time": "2026-02-26 16:56:12", "headline": "SoundHound AI Beats Q4 Estimates, Guides Up To $260M In 2026 Revenue", "summary": "For the fourth quarter, SoundHound reported revenue of $55.1 million, up 59% year-over-year and ahead of consensus expectations of roughly $54 million.", "symbols": ["SOUN"], "source": "benzinga", "author": "Stjepan Kalinic", "url": "https://www.benzinga.com/markets/earnings/26/02/50914491/soundhound-ai-beats-q4-estimates-guides-up-to-260m-in-2026-revenue", "tags": ["earnings"]}
{"id": 50914528, "time": "2026-02-26 16:56:39", "headline": "Capital City Bank Group Increases Its Quarterly Cash Dividend From $0.26 To $0.27", "summary": "", "symbols": ["CCBG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914528/capital-city-bank-group-increases-its-quarterly-cash-dividend-from-0-26-to-0-27", "tags": ["dividend"]}
{"id": 50914630, "time": "2026-02-26 16:58:03", "headline": "Leidos Small Cruise Missile Designated As The AGM-190A By U.S. Air Force", "summary": "", "symbols": ["LDOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914630/leidos-small-cruise-missile-designated-as-the-agm-190a-by-u-s-air-force", "tags": []}
{"id": 50914683, "time": "2026-02-26 16:59:10", "headline": "Accelerant Holdings Expects Q4 Revenue To Be $248M, Up 30% YoY; Sees FY25 Revenue to be $913M, Up 51% YoY", "summary": "", "symbols": ["ARX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914683/accelerant-holdings-expects-q4-revenue-to-be-248m-up-30-yoy-sees-fy25-revenue-to-be-913m-up-51-yoy", "tags": ["earnings"]}
{"id": 50914691, "time": "2026-02-26 16:59:21", "headline": "Duos Technologies Group Reveals Proposed Public Offering of Common Stock; No Size Disclosed", "summary": "", "symbols": ["DUOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914691/duos-technologies-group-reveals-proposed-public-offering-of-common-stock-no-size-disclosed", "tags": ["offering"]}
{"id": 50914716, "time": "2026-02-26 16:59:37", "headline": "RB Global Announces Ritchie Bros Auctioneers Generated Over $265M In Gross Sales During Global Auction Premier In Orlando, Florida", "summary": "", "symbols": ["RBA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914716/rb-global-announces-ritchie-bros-auctioneers-generated-over-265m-in-gross-sales-during-global-auctio", "tags": []}
{"id": 50914862, "time": "2026-02-26 17:00:21", "headline": "If You Invested $100 In D.R. Horton Stock 5 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["DHI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50914862/if-you-invested-100-in-d-r-horton-stock-5-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 50914879, "time": "2026-02-26 17:00:28", "headline": "Analyst Expectations For Shoals Technologies Group's Future", "summary": " ", "symbols": ["SHLS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50914879/analyst-expectations-for-shoals-technologies-groups-future", "tags": []}
{"id": 50914895, "time": "2026-02-26 17:00:42", "headline": "Where Viking Holdings Stands With Analysts", "summary": " ", "symbols": ["VIK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50914895/where-viking-holdings-stands-with-analysts", "tags": []}
{"id": 50914897, "time": "2026-02-26 17:00:43", "headline": "P/E Ratio Insights for Airbnb", "summary": " ", "symbols": ["ABNB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50914897/pe-ratio-insights-for-airbnb", "tags": []}
{"id": 50914909, "time": "2026-02-26 17:00:53", "headline": "Where Fidelis Insurance Hldgs Stands With Analysts", "summary": " ", "symbols": ["FIHL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50914909/where-fidelis-insurance-hldgs-stands-with-analysts", "tags": []}
{"id": 50914953, "time": "2026-02-26 17:01:15", "headline": "5 Analysts Assess Skyward Specialty: What You Need To Know", "summary": " ", "symbols": ["SKWD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50914953/5-analysts-assess-skyward-specialty-what-you-need-to-know", "tags": []}
{"id": 50914966, "time": "2026-02-26 17:01:22", "headline": "NovoCure Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)", "summary": " ", "symbols": ["NVCR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50914966/novocure-stock-a-deep-dive-into-analyst-perspectives-4-ratings", "tags": []}
{"id": 50914984, "time": "2026-02-26 17:01:31", "headline": "Acadia Healthcare Co Stock: A Deep Dive Into Analyst Perspectives (17 Ratings)", "summary": " ", "symbols": ["ACHC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/26/02/50914984/acadia-healthcare-co-stock-a-deep-dive-into-analyst-perspectives-17-ratings", "tags": []}
{"id": 50915074, "time": "2026-02-26 17:02:37", "headline": "RedBird Capital Portfolio Company Bishop Street Underwriters Announces $125M Investment From White Mountains Insurance", "summary": "", "symbols": ["WTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50915074/redbird-capital-portfolio-company-bishop-street-underwriters-announces-125m-investment-from-white-mo", "tags": []}
{"id": 50915084, "time": "2026-02-26 17:02:43", "headline": "Macquarie Initiates Coverage On Dynatrace with Neutral Rating, Announces Price Target of $36", "summary": "", "symbols": ["DT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50915084/macquarie-initiates-coverage-on-dynatrace-with-neutral-rating-announces-price-target-of-36", "tags": ["analyst_init"]}
{"id": 50915117, "time": "2026-02-26 17:03:09", "headline": "NewMarket Raises Quarterly Dividend From $2.75 To $3/Share", "summary": "", "symbols": ["NEU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50915117/newmarket-raises-quarterly-dividend-from-2-75-to-3share", "tags": ["dividend"]}
{"id": 50915118, "time": "2026-02-26 17:03:09", "headline": "Suncor Energy Renews NCIB To Repurchase Up To 118.7M Shares Through March 2027", "summary": "", "symbols": ["SU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50915118/suncor-energy-renews-ncib-to-repurchase-up-to-118-7m-shares-through-march-2027", "tags": ["buyback"]}
{"id": 50914965, "time": "2026-02-26 17:01:22", "headline": "X3 Holdings Announce 1-For-30 Reverse Stock Split, Effective March 5, 2026", "summary": "", "symbols": ["XTKG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50914965/x3-holdings-announce-1-for-30-reverse-stock-split-effective-march-5-2026", "tags": []}
{"id": 50915225, "time": "2026-02-26 17:04:17", "headline": "Nelnet Q4 Adj. EPS $1.56 Misses $1.63 Estimate, Sales $391.995M Beat $382.280M Estimate", "summary": "", "symbols": ["NNI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50915225/nelnet-q4-adj-eps-1-56-misses-1-63-estimate-sales-391-995m-beat-382-280m-estimate", "tags": ["earnings"]}
{"id": 50915236, "time": "2026-02-26 17:04:32", "headline": "Obsidian Energy Receives Approval From Toronto Stock Exchange For Normal Course Issuer Bid To Purchase Up To 6.45M Shares", "summary": "", "symbols": ["OBE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50915236/obsidian-energy-receives-approval-from-toronto-stock-exchange-for-normal-course-issuer-bid-to-purcha", "tags": []}
{"id": 50915318, "time": "2026-02-26 17:06:19", "headline": "Pembina Pipeline Q4 EPS $0.56 Beats $0.50 Estimate, Sales $1.372B Beat $1.120B Estimate", "summary": "", "symbols": ["PBA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50915318/pembina-pipeline-q4-eps-0-56-beats-0-50-estimate-sales-1-372b-beat-1-120b-estimate", "tags": ["earnings"]}
{"id": 50915323, "time": "2026-02-26 17:06:27", "headline": "Denali Therapeutics Q4 EPS $(0.73) Beats $(0.76) Estimate", "summary": "", "symbols": ["DNLI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50915323/denali-therapeutics-q4-eps-0-73-beats-0-76-estimate", "tags": ["earnings"]}
{"id": 50915340, "time": "2026-02-26 17:06:49", "headline": "Macquarie Maintains Neutral on Snowflake, Lowers Price Target to $177", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50915340/macquarie-maintains-neutral-on-snowflake-lowers-price-target-to-177", "tags": ["analyst_other", "price_target_down"]}
{"id": 50915354, "time": "2026-02-26 17:07:01", "headline": "Black Diamond Gr Q4 EPS $0.11 Misses $0.16 Estimate, Sales $144.000M Beat $114.373M Estimate", "summary": "", "symbols": ["TSX:BDI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50915354/black-diamond-gr-q4-eps-0-11-misses-0-16-estimate-sales-144-000m-beat-114-373m-estimate", "tags": ["earnings"]}
{"id": 50915382, "time": "2026-02-26 17:07:40", "headline": "MARA Holdings Stock Surges On Data Center Development Deal With Starwood", "summary": "MARA Holdings Inc (NASDAQ:MARA) shares are rising in extended trading on Thursday after the company reported fourth-quarter results and announced an agreement to convert fa", "symbols": ["BTCUSD", "MARA"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50915382/mara-holdings-stock-surges-on-data-center-development-deal-with-starwood", "tags": ["contract"]}
{"id": 50915413, "time": "2026-02-26 17:08:28", "headline": "Macquarie Maintains Outperform on Imax, Raises Price Target to $45", "summary": "", "symbols": ["IMAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50915413/macquarie-maintains-outperform-on-imax-raises-price-target-to-45", "tags": ["analyst_other", "price_target_up"]}
{"id": 50915439, "time": "2026-02-26 17:09:23", "headline": "Pembina Pipeline Q4 EPS $0.78 Beats $0.70 Estimate, Sales $1.913B Miss $2.241B Estimate", "summary": "", "symbols": ["TSX:PPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50915439/pembina-pipeline-q4-eps-0-78-beats-0-70-estimate-sales-1-913b-miss-2-241b-estimate", "tags": ["earnings"]}
{"id": 50915441, "time": "2026-02-26 17:09:30", "headline": "Gold Is Sending A Message We Haven't Heard Since 2008", "summary": "Gold has outperformed the S&amp;P 500 for 7 consecutive months, signaling a potential market downturn. This happened before in early 2008, when gold noticed the impending financial crisis before others did. The current outperformance raises concerns about the state of the software sector, which has been seen as insulated but may now be showing signs of fragility.", "symbols": ["GLD", "IGV", "VNQ"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/markets/commodities/26/02/50915441/gold-is-sending-a-message-we-havent-heard-since-2008", "tags": []}
{"id": 50915459, "time": "2026-02-26 17:09:53", "headline": "Macquarie Maintains Neutral on AMC Entertainment Hldgs, Lowers Price Target to $1.5", "summary": "", "symbols": ["AMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50915459/macquarie-maintains-neutral-on-amc-entertainment-hldgs-lowers-price-target-to-1-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 50915496, "time": "2026-02-26 17:12:04", "headline": "Macquarie Maintains Neutral on Salesforce, Lowers Price Target to $200", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50915496/macquarie-maintains-neutral-on-salesforce-lowers-price-target-to-200", "tags": ["analyst_other", "price_target_down"]}
{"id": 50915509, "time": "2026-02-26 17:12:17", "headline": "Ready Capital Q4 Adj. EPS $0.09 Beats $(0.14) Estimate, Sales $13.122M Miss $30.689M Estimate", "summary": "", "symbols": ["RC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50915509/ready-capital-q4-adj-eps-0-09-beats-0-14-estimate-sales-13-122m-miss-30-689m-estimate", "tags": ["earnings"]}
{"id": 50915547, "time": "2026-02-26 17:13:36", "headline": "IonQ's Romania Breakthrough Validates Quantum Trade Days After QTUM Crosses $3.5 Billion", "summary": "QTUM topped $3.5B before IonQ&#39;s Romania launch, underscoring rising conviction in quantum security.", "symbols": ["IONQ", "QTUM"], "source": "benzinga", "author": "Chandrima Sanyal", "url": "https://www.benzinga.com/etfs/specialty-etfs/26/02/50915547/ionqs-romania-breakthrough-validates-quantum-trade-days-after-qtum-crosses-3-5-billion", "tags": []}
{"id": 50915564, "time": "2026-02-26 17:14:33", "headline": "Barrington Research Maintains Outperform on Barrett Business Services, Lowers Price Target to $41", "summary": "", "symbols": ["BBSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50915564/barrington-research-maintains-outperform-on-barrett-business-services-lowers-price-target-to-41", "tags": ["analyst_other", "price_target_down"]}
{"id": 50915579, "time": "2026-02-26 17:14:50", "headline": "PureCycle Technologies Q4 EPS $(0.14) Beats $(0.26) Estimate, Sales $2.695M Miss $7.503M Estimate", "summary": "", "symbols": ["PCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50915579/purecycle-technologies-q4-eps-0-14-beats-0-26-estimate-sales-2-695m-miss-7-503m-estimate", "tags": ["earnings"]}
{"id": 50915601, "time": "2026-02-26 17:15:32", "headline": "If You Invested $1000 In Westinghouse Air Brake Stock 20 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["WAB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50915601/if-you-invested-1000-in-westinghouse-air-brake-stock-20-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 50915611, "time": "2026-02-26 17:15:45", "headline": "Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $105", "summary": "", "symbols": ["LMAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50915611/barrington-research-maintains-outperform-on-lemaitre-vascular-raises-price-target-to-105", "tags": ["analyst_other", "price_target_up"]}
{"id": 50915633, "time": "2026-02-26 17:16:25", "headline": "Structure Therapeutics Q4 Adj. EPS $(0.36) Beats $(0.40) Estimate.", "summary": "", "symbols": ["GPCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50915633/structure-therapeutics-q4-adj-eps-0-36-beats-0-40-estimate", "tags": ["earnings"]}
{"id": 50915665, "time": "2026-02-26 17:17:56", "headline": "DA Davidson Maintains Buy on Trade Desk, Lowers Price Target to $32", "summary": "", "symbols": ["TTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50915665/da-davidson-maintains-buy-on-trade-desk-lowers-price-target-to-32", "tags": ["analyst_other", "price_target_down"]}
{"id": 50915847, "time": "2026-02-26 17:27:46", "headline": "Chartwell Retirement Q4 FFO $0.26 Up From $0.21 YoY, Sales $292.258M Up From $218.445M YoY", "summary": "", "symbols": ["TSX:CSH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50915847/chartwell-retirement-q4-ffo-0-26-up-from-0-21-yoy-sales-292-258m-up-from-218-445m-yoy", "tags": []}
{"id": 50915860, "time": "2026-02-26 17:28:29", "headline": "DoubleVerify  Authorizes $300M For Share Repurchases As Of February 26, 2026", "summary": "", "symbols": ["DV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50915860/doubleverify-authorizes-300m-for-share-repurchases-as-of-february-26-2026", "tags": []}
{"id": 50915930, "time": "2026-02-26 17:29:55", "headline": "Tutor Perini Q4 Adj. EPS $1.07 Beats $0.58 Estimate, Sales $1.507B Beat $1.358B Estimate.", "summary": "", "symbols": ["TPC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50915930/tutor-perini-q4-adj-eps-1-07-beats-0-58-estimate-sales-1-507b-beat-1-358b-estimate", "tags": ["earnings"]}
{"id": 50916002, "time": "2026-02-26 17:30:35", "headline": "$100 Invested In Dover 10 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["DOV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50916002/100-invested-in-dover-10-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 50916003, "time": "2026-02-26 17:30:41", "headline": "Intuit Stock Slides On Q2 Earnings: What You Need To Know", "summary": "Intuit Inc (NASDAQ:INTU) reports financial results for the second quarter of fiscal 2026 after the market close on Thursday.", "symbols": ["INTU"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/markets/earnings/26/02/50916003/intuit-stock-slides-on-q2-earnings-what-you-need-to-know", "tags": ["earnings"]}
{"id": 50916022, "time": "2026-02-26 17:31:00", "headline": "Energy Fuels Q4 EPS $(0.09), Inline, Sales $27.102M Beat $21.833M Estimate", "summary": "", "symbols": ["UUUU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50916022/energy-fuels-q4-eps-0-09-inline-sales-27-102m-beat-21-833m-estimate", "tags": ["earnings"]}
{"id": 50916023, "time": "2026-02-26 17:31:01", "headline": "AvePoint Sees Q1 Sales $115.000M-$117.000M vs $111.401M Est", "summary": "", "symbols": ["AVPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916023/avepoint-sees-q1-sales-115-000m-117-000m-vs-111-401m-est", "tags": []}
{"id": 50916036, "time": "2026-02-26 17:31:10", "headline": "CORRECTION: Tutor Perini Q4 Adj. EPS $1.07 Beats $0.92 Estimate, Sales $1.507B Beat $1.324B Estimate.", "summary": "", "symbols": ["TPC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50916036/correction-tutor-perini-q4-adj-eps-1-07-beats-0-92-estimate-sales-1-507b-beat-1-324b-estimate", "tags": ["earnings"]}
{"id": 50916042, "time": "2026-02-26 17:31:11", "headline": "AvePoint Sees FY2026 Sales $509.400M-$517.400M vs $489.120M Est", "summary": "", "symbols": ["AVPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916042/avepoint-sees-fy2026-sales-509-400m-517-400m-vs-489-120m-est", "tags": []}
{"id": 50916080, "time": "2026-02-26 17:32:17", "headline": "'U.S. Defense Dept Offered To Anthropic To \"Put It In Writing\" That Internal Policies Restrict How The Military Can Use Autonomous Weapons '- CBS News", "summary": "", "symbols": ["AMZN", "GOOG", "GOOGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916080/u-s-defense-dept-offered-to-anthropic-to-put-it-in-writing-that-internal-policies-restrict-how-the-m", "tags": []}
{"id": 50916092, "time": "2026-02-26 17:32:33", "headline": "Braemar Hotels & Resorts Q4 FFO $(0.02), Inline, Sales $165.562M Beat $159.250M Estimate", "summary": "", "symbols": ["BHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50916092/braemar-hotels-resorts-q4-ffo-0-02-inline-sales-165-562m-beat-159-250m-estimate", "tags": []}
{"id": 50916110, "time": "2026-02-26 17:33:40", "headline": "Caesars Entertainment Shares Surge 19% On Reported Takeover Interest From Billionaire Tilman Fertitta", "summary": "Caesars Entertainment is considering takeover offers, including one from Fertitta Entertainment, as it reports record digital profits.", "symbols": ["CZR"], "source": "benzinga", "author": "Benzinga Senior Editor", "url": "https://www.benzinga.com/markets/equities/26/02/50916110/caesars-entertainment-shares-surge-19-on-reported-takeover-interest-from-billionaire-tilman-fertitta", "tags": ["merger"]}
{"id": 50916128, "time": "2026-02-26 17:35:24", "headline": "'Anthropic rejects Pentagon's \"final offer\" in AI safeguards fight'- Axios", "summary": "", "symbols": ["AMZN", "GOOG", "GOOGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916128/anthropic-rejects-pentagons-final-offer-in-ai-safeguards-fight-axios", "tags": []}
{"id": 50916142, "time": "2026-02-26 17:35:38", "headline": "NuScale Stock Slips After Q4 Earnings Despite Narrowing Losses", "summary": "Here&#39;s a look inside the Q4 earnings report from NuScale Power.", "symbols": ["SMR"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/markets/earnings/26/02/50916142/nuscale-stock-slips-after-q4-earnings-despite-narrowing-losses", "tags": ["earnings"]}
{"id": 50916160, "time": "2026-02-26 17:36:57", "headline": "Lipocine Files For Common Stock Offering Of Up To $50M", "summary": "", "symbols": ["LPCN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916160/lipocine-files-for-common-stock-offering-of-up-to-50m", "tags": ["offering"]}
{"id": 50916184, "time": "2026-02-26 17:40:03", "headline": "Rhythm Pharmaceuticals Files For Mixed Shelf; Size Not Disclosed", "summary": "", "symbols": ["RYTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916184/rhythm-pharmaceuticals-files-for-mixed-shelf-size-not-disclosed", "tags": []}
{"id": 50916224, "time": "2026-02-26 17:45:30", "headline": "$100 Invested In LPL Finl Hldgs 15 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["LPLA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50916224/100-invested-in-lpl-finl-hldgs-15-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 50916233, "time": "2026-02-26 17:45:53", "headline": "Anthropic's CEO Dario Amodei Issues Statement On The Discussions With The Department Of War", "summary": "", "symbols": ["AMZN", "GOOG", "GOOGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916233/anthropics-ceo-dario-amodei-issues-statement-on-the-discussions-with-the-department-of-war", "tags": ["management"]}
{"id": 50916246, "time": "2026-02-26 17:46:51", "headline": "Flutter Entertainment Stock Hits 52-Week Lows On Q4 Results: Here's What Company Said About Prediction Markets", "summary": "Flutter shares are falling after Q4 results. The company shares an update on its prediction market and the overall sector.", "symbols": ["DKNG", "FLUT"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/markets/earnings/26/02/50916246/flutter-entertainment-stock-hits-52-week-lows-on-q4-results-heres-what-company-said-about-prediction-markets", "tags": ["earnings"]}
{"id": 50916276, "time": "2026-02-26 17:48:13", "headline": "Grupo Aval Acciones Q4 EPS $0.07 Misses $0.10 Estimate, Sales $545.798M Miss $1.090B Estimate", "summary": "", "symbols": ["AVAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50916276/grupo-aval-acciones-q4-eps-0-07-misses-0-10-estimate-sales-545-798m-miss-1-090b-estimate", "tags": ["earnings"]}
{"id": 50916287, "time": "2026-02-26 17:48:58", "headline": "Netflix Declines To Raise Offer For Warner Bros. Discovery;  Says Deal Is No Longer Financially Attractive, So We Are Declining To Match Paramount Skydance Bid; Co, To Invest $20B In Films And Series This Year; Says Consistent With Our Capital Allocation Policy, We'll Also Resume Our Share Repurchase Program", "summary": "", "symbols": ["NFLX", "PSKY", "WBD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916287/netflix-declines-to-raise-offer-for-warner-bros-discovery-says-deal-is-no-longer-financially-attract", "tags": ["contract", "buyback"]}
{"id": 50916305, "time": "2026-02-26 17:49:52", "headline": "Vera Therapeutics Q4 EPS $(1.39) Misses $(1.31) Estimate", "summary": "", "symbols": ["VERA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50916305/vera-therapeutics-q4-eps-1-39-misses-1-31-estimate", "tags": ["earnings"]}
{"id": 50916318, "time": "2026-02-26 17:51:05", "headline": "TeraWulf Stock Slumps After Q4 Earnings: Here's Why", "summary": "Here&#39;s a detailed look inside the Q4 earnings report from TeraWulf.", "symbols": ["WULF"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/markets/earnings/26/02/50916318/terawulf-stock-slumps-after-q4-earnings-heres-why", "tags": ["earnings"]}
{"id": 50916329, "time": "2026-02-26 17:51:32", "headline": "Pason Sys Q4 EPS $0.10 Misses $0.15 Estimate, Sales $108.712M Beat $98.800M Estimate", "summary": "", "symbols": ["TSX:PSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50916329/pason-sys-q4-eps-0-10-misses-0-15-estimate-sales-108-712m-beat-98-800m-estimate", "tags": ["earnings"]}
{"id": 50916339, "time": "2026-02-26 17:52:16", "headline": "Janus Henderson Group Confirms Receipt of Unsolicited, Non-Binding Proposal; Says No Shareholder Action Required at the Time", "summary": "", "symbols": ["JHG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916339/janus-henderson-group-confirms-receipt-of-unsolicited-non-binding-proposal-says-no-shareholder-actio", "tags": []}
{"id": 50916361, "time": "2026-02-26 17:55:24", "headline": "National CineMedia Sees Q1 Sales $32.500M-$36.500M vs $40.225M Est", "summary": "", "symbols": ["NCMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916361/national-cinemedia-sees-q1-sales-32-500m-36-500m-vs-40-225m-est", "tags": []}
{"id": 50916362, "time": "2026-02-26 17:55:26", "headline": "Rocket Shares Blast Off After Q4 Earnings: Here's Why", "summary": "Here&#39;s a look at the details from Rocket&#39;s Q4 earnings report.", "symbols": ["RKT"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/markets/earnings/26/02/50916362/rocket-shares-blast-off-after-q4-earnings-heres-why", "tags": ["earnings"]}
{"id": 50916416, "time": "2026-02-26 17:57:38", "headline": "Rhythm Pharmaceuticals Says In Addition, Offering Of Up To 2.4M Shares Of Common Stock By Selling Stockholders", "summary": "", "symbols": ["RYTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916416/rhythm-pharmaceuticals-says-in-addition-offering-of-up-to-2-4m-shares-of-common-stock-by-selling-sto", "tags": ["offering"]}
{"id": 50916426, "time": "2026-02-26 17:58:49", "headline": "Tutor Perini Sees FY2026 Adj EPS $4.90-$5.30 vs $3.35 Est", "summary": "", "symbols": ["TPC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916426/tutor-perini-sees-fy2026-adj-eps-4-90-5-30-vs-3-35-est", "tags": ["earnings"]}
{"id": 50916559, "time": "2026-02-26 18:00:52", "headline": "Here's How Much $1000 Invested In Entergy 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["ETR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50916559/heres-how-much-1000-invested-in-entergy-5-years-ago-would-be-worth-today", "tags": []}
{"id": 50916570, "time": "2026-02-26 18:01:25", "headline": "Innodata FY2026  Revenue expected to be more than $339.745M vs $313.261M Est", "summary": "", "symbols": ["INOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916570/innodata-fy2026-revenue-expected-to-be-more-than-339-745m-vs-313-261m-est", "tags": ["earnings"]}
{"id": 50916593, "time": "2026-02-26 18:03:48", "headline": "CORRECTION: Sunrun Q4 EPS $0.38 Beats $(0.08) Estimate, Sales $1.159B Beat $614.408M Estimate", "summary": "", "symbols": ["RUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50916593/correction-sunrun-q4-eps-0-38-beats-0-08-estimate-sales-1-159b-beat-614-408m-estimate", "tags": ["earnings"]}
{"id": 50916603, "time": "2026-02-26 18:04:07", "headline": "Xeris Biopharma's Subsidiaries, Xeris Pharmaceuticals And Strongbridge Dublin Limited, File Recorlev Patent Infringement Lawsuit; Filed Patent Infringement Lawsuit Related To Recorlev Against Torrent Pharmaceuticals & Somerset Therapeutics", "summary": "", "symbols": ["XERS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916603/xeris-biopharmas-subsidiaries-xeris-pharmaceuticals-and-strongbridge-dublin-limited-file-recorlev-pa", "tags": ["legal"]}
{"id": 50916604, "time": "2026-02-26 18:04:12", "headline": "Kratos Defense Stock Falls After Hours: Here's Why", "summary": "Kratos Defense &amp; Security Solutions Inc (NASDAQ:KTOS) shares are trading lower in after-hours Thursday after the company announced a proposed offering.", "symbols": ["KTOS"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/markets/earnings/26/02/50916604/kratos-defense-stock-falls-after-hours-heres-why", "tags": ["why_moving", "offering"]}
{"id": 50916625, "time": "2026-02-26 18:05:21", "headline": "Sui Group Holdings Q4 EPS $(5.52) , Sales $2.400M Beat $1.581M Estimate", "summary": "", "symbols": ["SUIG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50916625/sui-group-holdings-q4-eps-5-52-sales-2-400m-beat-1-581m-estimate", "tags": ["earnings"]}
{"id": 50916638, "time": "2026-02-26 18:06:36", "headline": "Caris Life Sciences Announces Interim Readout of Achieve 1 Study; Results Demonstrate The Superiority Of Whole Genome Sequencing Compared To Methylation-Based Approaches", "summary": "", "symbols": ["CAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/26/02/50916638/caris-life-sciences-announces-interim-readout-of-achieve-1-study-results-demonstrate-the-superior", "tags": []}
{"id": 50916656, "time": "2026-02-26 18:07:58", "headline": "Aura Minerals Signs DNIT Road Relocation Agreement, Increases Borborema Gold Reserves 82% To 1.5M Ounces", "summary": "", "symbols": ["AUGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916656/aura-minerals-signs-dnit-road-relocation-agreement-increases-borborema-gold-reserves-82-to-1-5m-ounc", "tags": ["contract"]}
{"id": 50916680, "time": "2026-02-26 18:08:43", "headline": "UPDATE: Strategic Education Q4 Adj. EPS $1.74 Beats $1.41 Estimate, Sales $323.210M Beat $322.233M Estimate", "summary": "", "symbols": ["STRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50916680/update-strategic-education-q4-adj-eps-1-74-beats-1-41-estimate-sales-323-210m-beat-322-233m-estimat", "tags": ["earnings"]}
{"id": 50916689, "time": "2026-02-26 18:08:53", "headline": "CoreWeave Sees Q1 Sales $1.900B-$2.000B vs $2.291B Est", "summary": "", "symbols": ["CRWV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916689/coreweave-sees-q1-sales-1-900b-2-000b-vs-2-291b-est", "tags": []}
{"id": 50916698, "time": "2026-02-26 18:09:04", "headline": "CoreWeave Sees FY2026 Sales $12.000B-$13.000B vs $12.087B Est", "summary": "", "symbols": ["CRWV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916698/coreweave-sees-fy2026-sales-12-000b-13-000b-vs-12-087b-est", "tags": []}
{"id": 50916709, "time": "2026-02-26 18:09:39", "headline": "UPDATE: Puma Biotechnology Q4 Adj. EPS $0.29 Beats $0.23 Estimate, Sales $75.500M Beat $68.600M Estimate", "summary": "", "symbols": ["PBYI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50916709/update-puma-biotechnology-q4-adj-eps-0-29-beats-0-23-estimate-sales-75-500m-beat-68-600m-estimate", "tags": ["earnings"]}
{"id": 50916750, "time": "2026-02-26 18:14:04", "headline": "Bain Capital Specialty Q4 EPS $0.46 Misses $0.48 Estimate, Sales $68.200M Miss $68.484M Estimate", "summary": "", "symbols": ["BCSF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50916750/bain-capital-specialty-q4-eps-0-46-misses-0-48-estimate-sales-68-200m-miss-68-484m-estimate", "tags": ["earnings"]}
{"id": 50916770, "time": "2026-02-26 18:15:21", "headline": "Here's How Much $100 Invested In Raymond James Finl 10 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["RJF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50916770/heres-how-much-100-invested-in-raymond-james-finl-10-years-ago-would-be-worth-today", "tags": []}
{"id": 50916774, "time": "2026-02-26 18:15:29", "headline": "Anteris Technologies Glb Q4 EPS $(0.75) Misses $(0.58) Estimate, Sales $310.000K Beat $200.000K Estimate", "summary": "", "symbols": ["AVR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50916774/anteris-technologies-glb-q4-eps-0-75-misses-0-58-estimate-sales-310-000k-beat-200-000k-estimate", "tags": ["earnings"]}
{"id": 50916790, "time": "2026-02-26 18:16:36", "headline": "UPDATE: National CineMedia Q4 Adj. EPS $0.28 Beats $0.25 Estimate, Sales $93.200M Beat $90.910M Estimate", "summary": "", "symbols": ["NCMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50916790/update-national-cinemedia-q4-adj-eps-0-28-beats-0-25-estimate-sales-93-200m-beat-90-910m-estimate", "tags": ["earnings"]}
{"id": 50916792, "time": "2026-02-26 18:16:42", "headline": "National Healthcare Q4 Adj. EPS $1.83 Up From $1.66 YoY, Sales $386.513M Up From $369.350M YoY", "summary": "", "symbols": ["NHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50916792/national-healthcare-q4-adj-eps-1-83-up-from-1-66-yoy-sales-386-513m-up-from-369-350m-yoy", "tags": ["earnings"]}
{"id": 50916812, "time": "2026-02-26 18:17:28", "headline": "CORRECTION: Airgain Q4 Adj. EPS $(0.03) Misses $(0.02) Estimate, Sales $12.125M Miss $12.700M Estimate", "summary": "", "symbols": ["AIRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50916812/correction-airgain-q4-adj-eps-0-03-misses-0-02-estimate-sales-12-125m-miss-12-700m-estimate", "tags": ["earnings"]}
{"id": 50916828, "time": "2026-02-26 18:18:57", "headline": "'Google Strikes Multibillion-Dollar AI Chip Deal With Meta, Sharpening Nvidia Rivalry'- The Information", "summary": "", "symbols": ["GOOG", "GOOGL", "META"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50916828/google-strikes-multibillion-dollar-ai-chip-deal-with-meta-sharpening-nvidia-rivalry-the-information", "tags": ["contract"]}
{"id": 50916885, "time": "2026-02-26 18:24:40", "headline": "Netflix Will Not Raise Offer for Warner Bros: Stock Climbs", "summary": "Netflix stock climbs in Thursday extended trading after the company declines to raise its offer to acquire Warner Bros. Discovery.", "symbols": ["NFLX", "PSKY", "WBD"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/trading-ideas/movers/26/02/50916885/netflix-will-not-raise-offer-for-warner-bros-stock-climbs", "tags": ["merger"]}
{"id": 50916924, "time": "2026-02-26 18:28:54", "headline": "CORRECTION: NuScale Power Q4 EPS $(0.80) Misses $(0.13) Estimate, Sales $1.808M Miss $8.569M Estimate", "summary": "", "symbols": ["SMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50916924/correction-nuscale-power-q4-eps-0-80-misses-0-13-estimate-sales-1-808m-miss-8-569m-estimate", "tags": ["earnings"]}
{"id": 50916999, "time": "2026-02-26 18:30:17", "headline": "If You Invested $100 In Expand Energy Stock 10 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["EXE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50916999/if-you-invested-100-in-expand-energy-stock-10-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 50917014, "time": "2026-02-26 18:31:38", "headline": "UPDATE: International Bancshares Q4 EPS $1.71 Beats $1.63 Estimate", "summary": "", "symbols": ["IBOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50917014/update-international-bancshares-q4-eps-1-71-beats-1-63-estimate", "tags": ["earnings"]}
{"id": 50917088, "time": "2026-02-26 18:45:17", "headline": "Here's How Much You Would Have Made Owning Barrick Mining Stock In The Last 10 Years", "summary": " ", "symbols": ["B"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/26/02/50917088/heres-how-much-you-would-have-made-owning-barrick-mining-stock-in-the-last-10-years", "tags": []}
{"id": 50917144, "time": "2026-02-26 18:58:35", "headline": "UPDATE: Puma Biotechnology Sees FY2026 Sales $214.000M-$221.000M vs $220.000M Est", "summary": "", "symbols": ["PBYI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/26/02/50917144/update-puma-biotechnology-sees-fy2026-sales-214-000m-221-000m-vs-220-000m-est", "tags": []}
{"id": 50917314, "time": "2026-02-26 19:02:41", "headline": "Tesla Seeing Strong Demand For Cheaper Cybertruck, But Musk's 10-Day Deadline Remains In Place", "summary": "Tesla is seeing new demand for the Cybertruck thanks to a less expensive model. The demand might disappear as the company is standing behind a short deadline.", "symbols": ["TSLA"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/markets/large-cap/26/02/50917314/tesla-seeing-strong-demand-for-cheaper-cybertruck-but-musks-10-day-deadline-remains-in-place", "tags": []}
{"id": 50917380, "time": "2026-02-26 19:18:19", "headline": "BYD Takes On Tesla In Chinese Market With Daily Financing As Low As $4.20, A Price Elon Musk Would Love", "summary": "BYD surpasses Tesla as top EV seller in 2025, launches new deals in China to combat sales decline. Tesla fights back with low interest rates.", "symbols": ["BYDDF", "BYDDY", "TSLA"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/markets/asia/26/02/50917380/byd-takes-on-tesla-in-chinese-market-with-daily-financing-as-low-as-4-20-a-price-elon-musk-would-love", "tags": []}
{"id": 50917626, "time": "2026-02-26 19:50:05", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["XRPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/26/02/50917626/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 50917627, "time": "2026-02-26 19:50:05", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["SOLT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/26/02/50917627/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 50917628, "time": "2026-02-26 19:50:05", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["SFHG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/26/02/50917628/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 50917629, "time": "2026-02-26 19:50:05", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["VCIG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/26/02/50917629/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 50917630, "time": "2026-02-26 19:50:05", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["IXHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/26/02/50917630/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 50917799, "time": "2026-02-26 20:03:14", "headline": "Source Energy Services Q4 EPS $0.16 Misses $0.32 Estimate, Sales $164.533M Beat $161.700M Estimate", "summary": "", "symbols": ["TSX:SHLE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/26/02/50917799/source-energy-services-q4-eps-0-16-misses-0-32-estimate-sales-164-533m-beat-161-700m-estimate", "tags": ["earnings"]}
{"id": 50917902, "time": "2026-02-26 20:25:47", "headline": "Netflix, Block, CoreWeave, Rocket Lab And Dell: Why These 5 Stocks Are On Investors' Radars Today", "summary": "NFLX, XYZ, CRWV, RKLB, DELL were among the stocks seen trending among investors on Thursday, Feb.26, 2026.", "symbols": ["CRWV", "DELL", "NFLX", "RKLB", "XYZ"], "source": "benzinga", "author": "Shivdeep Dhaliwal", "url": "https://www.benzinga.com/markets/equities/26/02/50917902/netflix-block-coreweave-rocket-lab-and-dell-why-these-5-stocks-are-on-investors-radars-today", "tags": []}
{"id": 50918129, "time": "2026-02-26 20:59:55", "headline": "Cathie Wood Seeing AI Gold In Amazon And Baidu? Ark Invest Is Betting On These Stocks Today", "summary": "ARK Invest&#39;s Cathie Wood bought $12M in Baidu and $800K in Amazon on Thursday, Feb. 26, 2026.", "symbols": ["AMZN", "ARKK", "ARKQ", "ARKW", "BIDU", "CRM"], "source": "benzinga", "author": "Shivdeep Dhaliwal", "url": "https://www.benzinga.com/etfs/broad-u-s-equity-etfs/26/02/50918129/cathie-wood-seeing-ai-gold-in-amazon-and-baidu-ark-invest-is-betting-on-these-stocks-today", "tags": []}
{"id": 50918288, "time": "2026-02-26 21:11:39", "headline": "Bitcoin, Ethereum, XRP, Dogecoin Retreat As Nvidia Drags Down Tech Stocks: Analyst Highlights Historical 'Sweet Spot' Where BTC Bottomed", "summary": "Leading cryptocurrencies cooled down on Thursday amid uncertainty over potential market bottoms.", "symbols": ["BTC", "BTCUSD", "COIN", "DOGEUSD", "ETHUSD", "MSTR", "NVDA", "SOLUSD", "XRPUSD", "XYZ"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/crypto/cryptocurrency/26/02/50918288/bitcoin-ethereum-xrp-dogecoin-retreat-as-nvidia-drags-down-tech-stocks-analyst-highlights-historical-sweet-spot-where-btc-bottomed", "tags": []}
{"id": 50918289, "time": "2026-02-26 21:11:53", "headline": "Google Scores Major Win As Meta Reportedly Agrees To Multi-Year AI Chip Rental Deal, Challenging Nvidia's Dominance", "summary": "Meta Platforms has reportedly signed a multi-billion-dollar deal to lease AI chips from Google, expanding beyond Nvidia and Advanced Micro Devices as it accelerates spending on AI infrastructure and data centers.", "symbols": ["AMD", "GLW", "GOOG", "GOOGL", "META"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/markets/tech/26/02/50918289/google-scores-major-win-as-meta-reportedly-agrees-to-multi-year-ai-chip-rental-deal-challenging-nvidias-dominance", "tags": ["contract"]}
{"id": 50918450, "time": "2026-02-26 21:31:19", "headline": "JD Vance Announces Halt To Minnesota Medicaid Reimbursements Amid Misuse Allegations, Tim Walz Shoots Back: 'Nothing To Do With Fraud'", "summary": "Trump admin halts Medicaid funding to MN, citing fraud risks. VP Vance &amp; CMS head Oz urge state to tighten oversight. No harm expected for residents.", "symbols": [], "source": "benzinga", "author": "Shomik Sen Bhattacharjee", "url": "https://www.benzinga.com/news/politics/26/02/50918450/jd-vance-announces-halt-to-minnesota-medicaid-reimbursements-amid-misuse-allegations-tim-walz-shoots-back-nothing-to-do-with-fraud", "tags": []}
{"id": 50918574, "time": "2026-02-26 22:01:47", "headline": "MrBeast Wires $5 Million To Contestant That Won 'Beast Games' Season 2, Victorious Air Force Pilot Says He's Taking His 'Fair Share'", "summary": "U.S. Air Force pilot Tyler Lucas won $5 million on Season 2 of Beast Games, prompting MrBeast to confirm the payout as the Amazon Prime Video series moves forward despite an ongoing lawsuit and amid weakness in Amazon&#39;s stock.", "symbols": ["AMZN", "CRWD"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/markets/tech/26/02/50918574/mrbeast-wires-5-million-to-contestant-that-won-beast-games-season-2-victorious-air-force-pilot-says-hes-taking-his-fair-share", "tags": ["legal"]}
{"id": 50918597, "time": "2026-02-26 22:20:51", "headline": "Elizabeth Warren Says Trump's Banking Regulator Looking Into His Family's Crypto Bank Application: 'The Public Deserves Transparency'", "summary": "Sen.\u00a0Elizabeth Warren pressed for details on Thursday, February 26, on the Trump family&#39;s application to establish a stablecoin bank linked to their World Liberty Financial platform.", "symbols": [], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/crypto/cryptocurrency/26/02/50918597/elizabeth-warren-says-trumps-banking-regulator-looking-into-his-familys-crypto-bank-application-the-public-deserves-transparency", "tags": []}
{"id": 50918710, "time": "2026-02-26 23:04:52", "headline": "Elon Musk Predicts Tesla Moon Factories Within 20 Years, Tells Investors To 'Hold On' To TSLA: 'Gonna Be Worth A Lot'", "summary": "Tesla CEO Elon Musk predicts major growth for the automaker in the future, including lunar factories in 20 years.", "symbols": ["TSLA"], "source": "benzinga", "author": "Badar Shaikh", "url": "https://www.benzinga.com/markets/tech/26/02/50918710/elon-musk-predicts-tesla-moon-factories-within-20-years-tells-investors-to-hold-on-to-tsla-gonna-be-worth-a-lot", "tags": ["management"]}
{"id": 50918735, "time": "2026-02-26 23:24:21", "headline": "Dario Amodei Is A 'Liar' With God Complex Says Trump Official As Anthropic Refuses To Comply With Pentagon's Request For Unrestricted AI", "summary": "On Thursday, Anthropic CEO Dario Amodei said that the AI startup &#34;cannot in good conscience accede&#34; to new Defense Department contract language that would permit ", "symbols": ["ETHUSD", "GOOG", "GOOGL"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/markets/tech/26/02/50918735/dario-amodei-is-a-liar-with-god-complex-says-trump-official-as-anthropic-refuses-to-comply-with-pentagons-request-for-unrestricted-ai", "tags": ["contract", "management"]}
{"id": 50918807, "time": "2026-02-26 23:34:29", "headline": "Pakistan Strikes Afghan Capital After 'Unprovoked' Attacks, Taliban Claims Retaliation Amid Reports Of Heavy Casualties", "summary": "Pakistan airstrikes Afghanistan&#39;s Kabul and border areas, claiming self-defense against Taliban attacks. Dueling claims of casualties and captured posts.", "symbols": [], "source": "benzinga", "author": "Shomik Sen Bhattacharjee", "url": "https://www.benzinga.com/news/politics/26/02/50918807/pakistan-strikes-afghan-capital-after-unprovoked-attacks-taliban-claims-retaliation-amid-reports-of-heavy-casualties", "tags": []}
{"id": 50916067, "time": "2026-02-26 17:31:45", "headline": "Waymo And Udacity Co-founder Says \"China And US Should Be Very Close Friends\"", "summary": "Waymo And Udacity Co-founder&#39;s view of the global tech landscape, particularly between the U.S. and China, is notably collaborative rather than combative.", "symbols": [], "source": "benzinga", "author": "Anna Tutova", "url": "https://www.benzinga.com/Opinion/26/02/50916067/waymo-udacity-co-founder-says-china-us-should-be-very-close-friends", "tags": []}
